CCL episode 20260929_CCL_MIDDAY
Public episode JSON embedded as readable text for automated access.
{
"schema_version": "tryding-agent-episode.v1",
"episode_id": "20260929_CCL_MIDDAY",
"episode_url": "https://trydingday.com/data/agents/v1/episodes/20260929_CCL_MIDDAY.html",
"public_page_url": "https://trydingday.com/coverage/ccl/2026-09-29/midday/",
"published_at": "2026-09-29T18:28:36.745578Z",
"updated_at": "2026-10-20T22:24:59.041871Z",
"lifecycle": {
"tracking_status": "closed",
"active_for_tracking": false,
"stage": "closed"
},
"instrument": {
"type": "equity",
"symbol": "CCL",
"exchange": "NYSE",
"name": "Carnival Corporation Ltd."
},
"technical_reference": {
"status": "ok",
"reference_price": 24.79,
"model_downside_reference": 23.41,
"model_upside_scenario_1": 26.16,
"model_upside_scenario_2": 27.55,
"atr_14": 0.92,
"method": "reference_price_plus_minus_atr14"
},
"public_content": {
"date": "September 29, 2026",
"generated_at": "2026-09-29T18:28:36.745578Z",
"original_published_at": null,
"session_tag": "midday",
"label": "Market coverage",
"try_label": "Try of the Day",
"public_status": "Try of the Day",
"why_today": "Both companies have earnings catalysts. CCL's event move held near its high and its 20-session return was 11.23 percentage points ahead of its sector proxy. KMX's active model estimates are more favorable: estimated positive-return probabilities for sessions 3, 8, and 15 are 54.7%, 56.7%, and 52.8%, versus CCL's 47.0%, 46.9%, and 50.2%. The modeled adverse-MAE medians are also less negative for KMX at each horizon. Those comparisons use eight cases; MAE describes the worst interim adverse move from the entry reference, not the final return. A separate audit-only H15 historical-dispersion output favors KMX as well, but it is contextual and not a selection score. CCL remains the current choice because its supplied event-session tape and sector-relative record are stronger. Confidence is reduced, and follow-through remains the key test.",
"entry_reasoning": "Panel thesis: The reported earnings beat and slightly raised full-year adjusted EPS outlook give CCL's event-session move a company-specific basis. The current 15-session thesis is that the repricing persists if CCL retains its event-driven relative strength. KMX's more favorable model comparison is a meaningful countercase, but its supplied event-session tape weakened. Invalidation boundary: A regular-session close at or below the sealed prior regular close of $22.14, together with relative weakness against SPY and XLY, would falsify the event-repricing thesis.",
"reference_price": 24.79,
"scanner": {
"price": 24.79,
"reference": 24.79,
"score": 6,
"score_version": "v0_legacy_reconstructed",
"change": 11.95,
"volume": 40246633,
"average_volume": 19653290,
"volume_ratio": 2.05,
"rsi": 67.02,
"ema_trend": "22.72 > 23.14 > 24.44",
"position_52w": 72.74,
"atr_14": 0.92,
"vwap": 24.72,
"vwap_state": "above",
"vwap_distance_pct": 0.28,
"vwap_reading": {
"price": 24.72,
"state": "above",
"distance_pct": 0.28
},
"range_position": 0.666,
"gap_pct": 0.0,
"relative_strength": {
"excess_pct": 12.13,
"index": "SPY",
"index_chg_pct": -0.18,
"status": "idiosyncratic"
},
"volume_percentile": {
"median_vol": 18553900,
"percentile": 98.4,
"status": "exceptional",
"today_vol": 40246633
},
"extension": {
"atr": 0.92,
"dist_atr": 1.79,
"ema_ref": 23.14,
"status": "healthy"
},
"atr_move_signal": {
"atr_pct": 3.71,
"status": "strong",
"z": 3.22
},
"sector_breadth": {
"chg_pct": -0.09,
"etf": "XLY",
"status": "neutral"
},
"sentiment": null,
"sentiment_score": null,
"earnings_warning": {
"days_away": 0,
"earnings_date": "2026-09-29",
"has_earnings_soon": true,
"status": "earnings_day"
},
"options_snapshot": null,
"extended_hours": {
"ext_pct": null,
"market_state": "REGULAR",
"phase": "regular",
"post_market_pct": null,
"pre_market_pct": null,
"status": "none"
},
"coiled_spring": {
"component_count": 0,
"components": {},
"count": 0,
"detector_version": "coiled-compression-ohlc.v1",
"reason": "coiled_ohlc_detector_runs_on_research_and_known_ticker_rails",
"schema_version": "coiled-features.v2",
"status": "not_evaluated"
},
"short_pct_float": 3.79,
"days_to_cover": 2.51,
"catalyst": "These S&P500 stocks are gapping in today's session",
"sector": "Consumer Cyclical",
"exchange": "NYSE",
"sec_signal": "NO_RECENT_FORM4_SIGNAL"
},
"levels": {
"reference": 24.79,
"downside": 23.41,
"upside_1": 26.16,
"upside_2": 27.55
},
"review": {
"score": 6,
"status": "Try Of The Day",
"summary": "Both companies have earnings catalysts. CCL's event move held near its high and its 20-session return was 11.23 percentage points ahead of its sector proxy. KMX's active model estimates are more favorable: estimated positive-return probabilities for sessions 3, 8, and 15 are 54.7%, 56.7%, and 52.8%, versus CCL's 47.0%, 46.9%, and 50.2%. The modeled adverse-MAE medians are also less negative for KMX at each horizon. Those comparisons use eight cases; MAE describes the worst interim adverse move from the entry reference, not the final return. A separate audit-only H15 historical-dispersion output favors KMX as well, but it is contextual and not a selection score. CCL remains the provisional choice because its supplied event-session tape and sector-relative record are stronger. Confidence is reduced, and follow-through remains the key test.",
"views": [
{
"name": "Elena Vartanyan",
"role": "independent statistical auditor",
"icon": "🎯",
"view": "Start with the whole session. The dated snapshot has the S&P 500 and Russell 2000 under pressure, while the Nasdaq 100 is nearly steady. The separate breadth proxy also leaned weak, within its own coverage.",
"reasoning": "MAE is the deepest interim adverse move from the entry reference, not the ending return. The separate audit-only P10-to-P90 figures describe a wide historical range from only eight cases; they should increase caution, not be read as a forecast."
},
{
"name": "Kenji Osei",
"role": "AI Systems & Market Data Integrity Analyst",
"icon": "🧠",
"view": "Timestamp matters: that benchmark snapshot is about 25 minutes before our cut, beyond its six-minute refresh threshold. The 10-year yield level is 5.272%; the reported change is +3.20 basis points. A basis point is one hundredth of a percentage point, so the change is about 0.032 percentage points.",
"reasoning": "And CCL's 20-session asset return was +4.48% against -6.75% for its sector proxy. That relative record is observed evidence in its favor. It does not cancel the KMX model countercase."
},
{
"name": "Nate Brooks",
"role": "market structure and timing analyst",
"icon": "📈",
"view": "And the breadth record is an intraday proxy; end-of-day breadth was unavailable. It tells us participation looked weak in that defined sample, not that every stock faced the same pressure.",
"reasoning": "Observed tape still separates them. KMX's provider trajectory faded from about +5.72% to +3.24%, with price below VWAP and a downward intraday reading. CCL's N0 capture was +11.95%, and its last supplied provider observation remained near that move."
},
{
"name": "Marcus Feld",
"role": "information, fundamentals and catalyst analyst",
"icon": "🦊",
"view": "The news cut adds energy and geopolitical uncertainty, plus the IEA's grid-delay reporting. That's a tougher backdrop for risk-taking, but it doesn't explain any one company's move.",
"reasoning": "There is another distinction: the audit-only H15 historical-dispersion output favors KMX too. Its median is +4.18%, with P10 -5.31% and P90 +16.31%; CCL's is -1.26%, with P10 -19.62% and P90 +7.16%. That's a relevant countercase, but it is a separate contextual output, not a selection score."
},
{
"name": "Priya Nandakumar",
"role": "institutional risk and execution manager",
"icon": "🛡️",
"view": "NTWK's results and guidance are concrete, but the tape is thin. The dossier puts price 3.06 ATR above its EMA reference. ATR is the stock's typical daily range; a gap of more than three of those ranges raises the chance that a reversal will be sharp.",
"reasoning": "I still dissent on the strength of the 15-session claim. KMX's model case is better across the supplied horizons, and CCL's fuel and updated balance-sheet picture remain unresolved. Keep CCL conditional and let the next regular-session observation test the tape."
}
],
"conviction": {
"status_phrase": "recorded",
"basis": "CCL retains the stronger observed event tape and sector-relative record. The omitted KMX comparison is now weighed explicitly and materially reduces confidence. The small eight-case samples and CCL's dated, context-only SEC features limit the model evidence.",
"risk": "",
"resolution_pct": 58.0,
"counter_case_pct": 30.0,
"unresolved_pct": 12.0
},
"context_roundtable": {
"mode": "coffee",
"status": "complete",
"consulted_voice_ids": [
"nate",
"kenji",
"elena",
"marcus",
"priya"
],
"summary": "The day’s market snapshot leaned weak, with broad participation also soft in its covered intraday basket. Other signals diverged: August labor-market measures changed little, mortgage scoring access broadened, and electricity investment and grid constraints remained a structural theme. Oil and policy headlines add uncertainty, but the shared context does not quantify any company’s demand, financing sensitivity or fuel costs.",
"long_read": "The market snapshot and the news cut describe different parts of the day. The snapshot showed pressure in the S&P 500 and Russell 2000 while the Nasdaq 100 was nearly steady; a separate intraday participation proxy leaned weak within its own covered basket. End-of-day breadth was unavailable, so that reading is limited to its captured window and universe. The snapshot was already about 25 minutes old at the review cut, beyond its six-minute freshness mark. Its US 10-year row reported a 5.272% yield level and a +3.20 basis-point daily change. Those values describe the level and the move separately.\n\nThe economic and policy items did not point in one direction. The Bureau of Labor Statistics said August job openings and hires changed little. Fannie Mae broadened VantageScore 4.0 availability to approved lenders, which adds a scoring option but does not establish how lending or household spending will change. The Atlanta Fed reported a 1.5% decline in its July homeownership-affordability measure. These are useful conditions to track, not direct measures of travel bookings.\n\nEnergy was both a near-term uncertainty and a longer-term investment story. AP described market pressure alongside volatile oil and higher Treasury yields. The IEA reported that grid delays are leading some data-centre developers to consider on-site gas, while electricity-related spending approaches 60% of global energy investment. That points to infrastructure constraints and capital allocation; it does not quantify a named company’s sales, costs or returns. For the Carnival earnings story, the issuer’s own results and outlook remain separate evidence from this broad backdrop. The context supplies no company-specific estimate of fuel costs or financing sensitivity.",
"transcript": [
{
"speaker_id": "nate",
"text": "The broad snapshot leaned lower in the S&P 500 and smaller-company shares, while the Nasdaq was close to flat. A separate participation reading also leaned weak within its covered basket. By participation, I mean how many shares are advancing versus declining; it describes how widely a move is shared, not what caused it."
},
{
"speaker_id": "kenji",
"text": "The timestamps matter here: the benchmark snapshot was about 25 minutes old at the review cut, past its six-minute freshness mark. The Treasury row gave a 5.272% yield level and a +3.20 basis-point daily move. One is where the yield stood; the other is how much it changed."
},
{
"speaker_id": "elena",
"text": "A basis point is one-hundredth of a percentage point, so 3.20 basis points is a 0.032-point move. The BLS said August job openings and hires changed little. That is a monthly labor reading; it does not tell us directly whether households are booking cruises.",
"source_urls": [
"https://www.bls.gov/news.release/jolts.nr0.htm"
]
},
{
"speaker_id": "marcus",
"text": "The IEA adds a structural energy story. Grid delays are pushing some data-centre developers toward on-site gas, while electricity-related spending is nearing 60% of global energy investment. That tells us about infrastructure needs and capital flows, not immediate revenue for any one company.",
"source_urls": [
"https://www.iea.org/reports/key-questions-on-energy-and-ai",
"https://www.iea.org/topics/investment"
]
},
{
"speaker_id": "priya",
"text": "Oil and policy headlines add uncertainty to that picture. AP reported market pressure amid oil volatility; the shared cut also carried a report about a possible US diesel export restriction. Possible policy is not enacted policy, and none of this gives us a measured fuel-cost change for Carnival.",
"source_urls": [
"https://www.bbc.com/news/articles/cky9z3r00l9eo"
]
},
{
"speaker_id": "kenji",
"text": "The household side has two separate signals. Fannie Mae broadened VantageScore 4.0 availability to approved lenders, which means another scoring option is available; it does not guarantee more loans. The Atlanta Fed’s July affordability measure fell 1.5%, but neither item is a booking or spending measure.",
"source_urls": [
"https://capitalmarkets.fanniemae.com/mortgage-backed-securities/fannie-mae-broadens-availability-vantagescore",
"https://x.com/AtlantaFed/status/2104641075679776797"
]
},
{
"speaker_id": "elena",
"text": "So the evidence answers different questions: labor activity was little changed, credit scoring access widened, and energy infrastructure investment remains large. These conditions help frame what to watch around the Carnival earnings story, but they do not confirm demand or quantify the company’s cost exposure.",
"source_urls": [
"https://www.bls.gov/news.release/jolts.nr0.htm",
"https://www.iea.org/topics/investment"
]
}
],
"source_urls": [
"https://www.bls.gov/news.release/jolts.nr0.htm",
"https://www.iea.org/reports/key-questions-on-energy-and-ai",
"https://www.iea.org/topics/investment",
"https://www.bbc.com/news/articles/cky9z3r00l9eo",
"https://capitalmarkets.fanniemae.com/mortgage-backed-securities/fannie-mae-broadens-availability-vantagescore",
"https://x.com/AtlantaFed/status/2104641075679776797"
]
},
"context_roundtable_sources": [
{
"event_id": null,
"headline": "Job Openings and Labor Turnover Summary",
"url": "https://www.bls.gov/news.release/jolts.nr0.htm",
"publisher": "U.S. Bureau of Labor Statistics",
"source_quality": "primary",
"public_safe": true,
"published_at": null,
"available_at": null
},
{
"event_id": "mi_evt_747502d2181c77b5ec693237",
"headline": "Data-centre developers turn to onsite gas amid grid delays",
"url": "https://www.iea.org/reports/key-questions-on-energy-and-ai",
"publisher": "International Energy Agency",
"source_quality": "primary",
"public_safe": true,
"published_at": "2026-09-28T16:05:06Z",
"available_at": "2026-09-28T16:05:06+00:00"
},
{
"event_id": "mi_evt_7b1200df06df9d71de2f4676",
"headline": "Potential US diesel export ban could shift fuel costs globally",
"url": "https://www.bbc.com/news/articles/cky9z3r00l9eo",
"publisher": "BBC News",
"source_quality": "trusted_reporting",
"public_safe": true,
"published_at": "2026-09-28T18:19:57Z",
"available_at": "2026-09-28T18:19:57+00:00"
},
{
"event_id": "mi_evt_90085d777cbe5afad71c3e09",
"headline": "US homeownership affordability falls 1.5% in July",
"url": "https://x.com/AtlantaFed/status/2104641075679776797",
"publisher": "Atlanta Fed",
"source_quality": "primary",
"public_safe": true,
"published_at": "2026-09-28T18:35:09Z",
"available_at": "2026-09-28T18:35:09+00:00"
},
{
"event_id": "mi_evt_d0cfe25ecfe23031022ba6d8",
"headline": "Fannie Mae broadens VantageScore 4.0 availability to all approved lenders",
"url": "https://capitalmarkets.fanniemae.com/mortgage-backed-securities/fannie-mae-broadens-availability-vantagescore",
"publisher": "The Future Investors",
"source_quality": "primary",
"public_safe": true,
"published_at": "2026-09-29T09:05:39.387000Z",
"available_at": "2026-09-29T09:05:39.387000+00:00"
},
{
"event_id": "mi_evt_ce8ab58bc4731d9b43a671d9",
"headline": "Electricity-related spending approaches 60% of global energy investment",
"url": "https://www.iea.org/topics/investment",
"publisher": "International Energy Agency",
"source_quality": "primary",
"public_safe": true,
"published_at": "2026-09-29T11:35:03.034000Z",
"available_at": "2026-09-29T11:35:03.034000+00:00"
}
]
},
"updates": [
{
"day": 15,
"timestamp": "2026-10-20T22:24:59.041871Z",
"date": "Session 15 · Oct 20, 2026 · 18:24 NYSE",
"text": "CCL completed session 15 at $27.06, or +9.18% from the exact $24.785 episode reference. The tracking checkpoints were -0.99% at session 1, +7.24% at session 5, +7.85% at session 10 and +9.18% at session 15. Along the way, the return reached +12.16% at its best and -1.07% at its worst. The positive result supports persistence of the earnings-driven repricing through the tracking window, but it does not show whether the higher outlook translated into operating results. A separate after-market capture at $27.13 (+0.26%) does not change the completed result. The final dossier has no session-15 comparison against SPY or XLY. Market tracking ends here.",
"price": 27.06,
"pct": 9.18,
"return_vs_entry_pct": 9.16,
"return_vs_base_pct": 9.16,
"return_vs_prior_pct": null,
"previous_regular_close": null,
"change_vs_prior_session_pct": 2.46,
"session_day": 15,
"reference_price": 24.79,
"reference_text": "$27.06 · +9.16% from $24.79 base",
"timing": "",
"market_marker": null,
"extended_hours": null,
"relevant": true,
"active_relevant": false,
"terminal_closure": true,
"transcript_anchor": "transcript-entry-f827b48f18c958be2e26b85cb303efc7b372c5344baf9c646a3c6bb60e724c94",
"price_as_of": "2026-09-29T21:19:53Z",
"vwap_as_of": null
},
{
"day": 14,
"timestamp": "2026-10-19T22:18:05.050881Z",
"date": "Session 14 · Oct 19, 2026 · 18:18 NYSE",
"text": "CCL's tracked gain edged up 0.06 percentage points to 6.72%, while the quote rose 2.12% and held 0.69% above VWAP on 0.85 times average volume. Its 20-session lead over XLY remains 16.57 points and price is above .14, preserving the earnings-repricing case; lighter participation leaves today's advance short of stronger follow-through.",
"price": 26.45,
"pct": 6.72,
"return_vs_entry_pct": 6.7,
"return_vs_base_pct": 6.7,
"return_vs_prior_pct": null,
"previous_regular_close": null,
"change_vs_prior_session_pct": 0.1,
"session_day": 14,
"reference_price": 24.79,
"reference_text": "$26.45 · +6.70% from $24.79 base",
"timing": "",
"market_marker": null,
"extended_hours": null,
"relevant": false,
"active_relevant": false,
"terminal_closure": false,
"transcript_anchor": "",
"price_as_of": "2026-10-19T21:28:10Z",
"vwap_as_of": null
},
{
"day": 14,
"timestamp": "2026-10-19T19:27:05.670525Z",
"date": "Session 14 · Oct 19, 2026 · 15:27 NYSE",
"text": "CCL's tracked gain climbed 2.16 points to 6.66% from the last note, and the quote moved 0.69% above the average price weighted by trading volume, but volume was only 0.53 times its three-month average. Its 20-session lead over XLY narrowed from 17.30 to 16.43 points, while price remains above $22.14; the earnings-repricing thesis still holds, but today's rebound came with lighter participation and a slightly smaller relative lead.",
"price": 26.425,
"pct": 6.66,
"return_vs_entry_pct": 6.6,
"return_vs_base_pct": 6.6,
"return_vs_prior_pct": null,
"previous_regular_close": null,
"change_vs_prior_session_pct": 2.12,
"session_day": 14,
"reference_price": 24.79,
"reference_text": "$26.43 · +6.60% from $24.79 base",
"timing": "",
"market_marker": null,
"extended_hours": null,
"relevant": false,
"active_relevant": false,
"terminal_closure": false,
"transcript_anchor": "",
"price_as_of": "2026-10-19T19:21:30.182691Z",
"vwap_as_of": null
},
{
"day": 13,
"timestamp": "2026-10-16T22:05:44.315306Z",
"date": "Session 13 · Oct 16, 2026 · 18:05 NYSE",
"text": "CCL's tracked gain edged up 0.02 points to 4.50%, but the latest session fell 2.12%, closed near the range low and finished 1.83% below VWAP on 1.05 times normal volume. The 20-session lead over Consumer Cyclical remains 17.30 points, keeping the earnings-repricing case intact while the weak close leaves near-term follow-through less secure.",
"price": 25.9,
"pct": 4.5,
"return_vs_entry_pct": 4.48,
"return_vs_base_pct": 4.48,
"return_vs_prior_pct": null,
"previous_regular_close": null,
"change_vs_prior_session_pct": 0.02,
"session_day": 13,
"reference_price": 24.79,
"reference_text": "$25.90 · +4.48% from $24.79 base",
"timing": "",
"market_marker": null,
"extended_hours": null,
"relevant": false,
"active_relevant": false,
"terminal_closure": false,
"transcript_anchor": "",
"price_as_of": "2026-10-16T21:24:34Z",
"vwap_as_of": null
},
{
"day": 13,
"timestamp": "2026-10-16T19:42:32.563969Z",
"date": "Session 13 · Oct 16, 2026 · 15:42 NYSE",
"text": "CCL tracked gain fell 3.31 points to 4.48% from the latest note; the current quote is 1.8% below the session average price weighted by volume near the lower end of the range. Its 20-session lead over Consumer Cyclical still stands at 17.5 points, so this reversal weakens the follow-through case without erasing the earnings-based repricing thesis.",
"price": 25.895,
"pct": 4.48,
"return_vs_entry_pct": 4.46,
"return_vs_base_pct": 4.46,
"return_vs_prior_pct": null,
"previous_regular_close": null,
"change_vs_prior_session_pct": -3.39,
"session_day": 13,
"reference_price": 24.79,
"reference_text": "$25.89 · +4.46% from $24.79 base",
"timing": "",
"market_marker": null,
"extended_hours": null,
"relevant": true,
"active_relevant": true,
"terminal_closure": false,
"transcript_anchor": "transcript-entry-10a7be66e4a3c367e9ba1ee9bef4b2f4960c1155494daa1700b08ab806589a70",
"price_as_of": "2026-10-16T19:21:22.647785Z",
"vwap_as_of": null
},
{
"day": 13,
"timestamp": "2026-10-16T14:22:44.863836Z",
"date": "Session 13 · Oct 16, 2026 · 10:22 NYSE",
"text": "CCL's tracked gain added 1.03 points to 7.79%, but the latest quote was 0.22% below VWAP on only 0.11 of normal volume. Its 20-session lead over Consumer Cyclical remains 19.42 points, while no later operating result yet verifies that the higher full-year outlook is translating into sustained follow-through.",
"price": 26.735,
"pct": 7.79,
"return_vs_entry_pct": 7.85,
"return_vs_base_pct": 7.85,
"return_vs_prior_pct": null,
"previous_regular_close": null,
"change_vs_prior_session_pct": 1.11,
"session_day": 13,
"reference_price": 24.79,
"reference_text": "$26.73 · +7.85% from $24.79 base",
"timing": "",
"market_marker": null,
"extended_hours": null,
"relevant": false,
"active_relevant": false,
"terminal_closure": false,
"transcript_anchor": "",
"price_as_of": "2026-10-16T14:06:07.820265Z",
"vwap_as_of": null
},
{
"day": 12,
"timestamp": "2026-10-15T22:10:42.251287Z",
"date": "Session 12 · Oct 15, 2026 · 18:10 NYSE",
"text": "CCL's tracked gain eased 0.70 percentage points to 6.76%, even as shares rose 1.89% in the latest capture on 0.87 times average volume. The earnings response remains positive on a 20-session sector-relative basis, but no subsequent operating result yet verifies that the higher full-year outlook is translating into follow-through.",
"price": 26.46,
"pct": 6.76,
"return_vs_entry_pct": 6.74,
"return_vs_base_pct": 6.74,
"return_vs_prior_pct": null,
"previous_regular_close": null,
"change_vs_prior_session_pct": -0.74,
"session_day": 12,
"reference_price": 24.79,
"reference_text": "$26.46 · +6.74% from $24.79 base",
"timing": "",
"market_marker": null,
"extended_hours": null,
"relevant": false,
"active_relevant": false,
"terminal_closure": false,
"transcript_anchor": "",
"price_as_of": "2026-10-15T21:14:00Z",
"vwap_as_of": null
},
{
"day": 12,
"timestamp": "2026-10-15T20:16:28.475660Z",
"date": "Session 12 · Oct 15, 2026 · 16:16 NYSE",
"text": "CCL's tracked gain rose 2.48 points to 7.46%, with shares up 2.60%, 1.34% above VWAP near the day's high; its 20-session lead over XLY is 18.28 points. The stronger tape supports persistence of the earnings repricing, but no later operating result yet confirms the raised outlook's follow-through.",
"price": 26.645,
"pct": 7.46,
"return_vs_entry_pct": 7.48,
"return_vs_base_pct": 7.48,
"return_vs_prior_pct": null,
"previous_regular_close": null,
"change_vs_prior_session_pct": 2.26,
"session_day": 12,
"reference_price": 24.79,
"reference_text": "$26.64 · +7.48% from $24.79 base",
"timing": "",
"market_marker": null,
"extended_hours": null,
"relevant": false,
"active_relevant": false,
"terminal_closure": false,
"transcript_anchor": "",
"price_as_of": "2026-10-15T19:21:33.629030Z",
"vwap_as_of": null
},
{
"day": 12,
"timestamp": "2026-10-15T15:33:07.236883Z",
"date": "Session 12 · Oct 15, 2026 · 11:33 NYSE",
"text": "CCL's tracked gain added 0.20 points to 4.98%; shares rose 0.44% and held 0.40% above VWAP near the upper third of the range. Its 20-session lead over XLY stands at 16.60 points, but trading volume was only one-tenth of average and no later operating result confirms the earnings follow-through that anchors the thesis.",
"price": 26.085,
"pct": 4.98,
"return_vs_entry_pct": 5.22,
"return_vs_base_pct": 5.22,
"return_vs_prior_pct": null,
"previous_regular_close": null,
"change_vs_prior_session_pct": 0.46,
"session_day": 12,
"reference_price": 24.79,
"reference_text": "$26.09 · +5.22% from $24.79 base",
"timing": "",
"market_marker": null,
"extended_hours": null,
"relevant": false,
"active_relevant": false,
"terminal_closure": false,
"transcript_anchor": "",
"price_as_of": "2026-10-15T14:06:44.673876Z",
"vwap_as_of": null
},
{
"day": 11,
"timestamp": "2026-10-14T21:42:09.267522Z",
"date": "Session 11 · Oct 14, 2026 · 17:42 NYSE",
"text": "CCL's tracked gain recovered 0.42 points to 4.78%, yet shares fell 2.84% at the latest regular-session cut, 0.44% below VWAP near the lower fifth of the range; after-hours trading was 0.22% lower. The 20-session lead over XLY remains 15 points and price stays above the original 22.14 reference, so the published failure condition is not met. No later operating report confirms the raised outlook's follow-through.",
"price": 25.97,
"pct": 4.78,
"return_vs_entry_pct": 4.76,
"return_vs_base_pct": 4.76,
"return_vs_prior_pct": null,
"previous_regular_close": null,
"change_vs_prior_session_pct": 0.3,
"session_day": 11,
"reference_price": 24.79,
"reference_text": "$25.97 · +4.76% from $24.79 base",
"timing": "",
"market_marker": null,
"extended_hours": null,
"relevant": false,
"active_relevant": false,
"terminal_closure": false,
"transcript_anchor": "",
"price_as_of": "2026-10-14T21:11:00Z",
"vwap_as_of": null
},
{
"day": 11,
"timestamp": "2026-10-14T20:37:16.972823Z",
"date": "Session 11 · Oct 14, 2026 · 16:37 NYSE",
"text": "Carnival's tracked gain slipped 0.74 points to 4.36% as shares fell 3.12%, traded below VWAP near the lower part of the range, and trimmed their 20-session lead over Consumer Cyclical to 14.92 points. The reversal weakens recent price confirmation, while the higher outlook still has no reported operating results to confirm it.",
"price": 25.895,
"pct": 4.36,
"return_vs_entry_pct": 4.46,
"return_vs_base_pct": 4.46,
"return_vs_prior_pct": null,
"previous_regular_close": null,
"change_vs_prior_session_pct": -0.24,
"session_day": 11,
"reference_price": 24.79,
"reference_text": "$25.89 · +4.46% from $24.79 base",
"timing": "",
"market_marker": null,
"extended_hours": null,
"relevant": false,
"active_relevant": false,
"terminal_closure": false,
"transcript_anchor": "",
"price_as_of": "2026-10-14T19:41:13.876792Z",
"vwap_as_of": null
},
{
"day": 11,
"timestamp": "2026-10-14T15:09:43.480303Z",
"date": "Session 11 · Oct 14, 2026 · 11:09 NYSE",
"text": "For CCL, the tracked gain fell 2.75 points to 5.10% as shares dropped 2.90% below VWAP near the session low; its 20-session lead over Consumer Cyclical narrowed to 15.16 points. The reversal weakens prior price confirmation, while the higher outlook still has not been matched by reported operating results.",
"price": 25.955,
"pct": 5.1,
"return_vs_entry_pct": 4.7,
"return_vs_base_pct": 4.7,
"return_vs_prior_pct": null,
"previous_regular_close": null,
"change_vs_prior_session_pct": -3.13,
"session_day": 11,
"reference_price": 24.79,
"reference_text": "$25.95 · +4.70% from $24.79 base",
"timing": "",
"market_marker": null,
"extended_hours": null,
"relevant": false,
"active_relevant": false,
"terminal_closure": false,
"transcript_anchor": "",
"price_as_of": "2026-10-14T14:06:37.850462Z",
"vwap_as_of": null
},
{
"day": 10,
"timestamp": "2026-10-13T21:46:36.994524Z",
"date": "Session 10 · Oct 13, 2026 · 17:46 NYSE",
"text": "CCL's tracked gain slipped 0.06 percentage points to 7.85% even as shares rose 0.94%, held 0.34% above VWAP near the upper range, and kept a 19.57-point 20-session lead over Consumer Cyclical. Dollar turnover remained 0.62 times its 20-day average, so the relative price strength still does not show that the higher outlook is converting into operating results.",
"price": 26.73,
"pct": 7.85,
"return_vs_entry_pct": 7.83,
"return_vs_base_pct": 7.83,
"return_vs_prior_pct": null,
"previous_regular_close": null,
"change_vs_prior_session_pct": -0.22,
"session_day": 10,
"reference_price": 24.79,
"reference_text": "$26.73 · +7.83% from $24.79 base",
"timing": "",
"market_marker": null,
"extended_hours": null,
"relevant": false,
"active_relevant": false,
"terminal_closure": false,
"transcript_anchor": "",
"price_as_of": "2026-10-13T21:23:24Z",
"vwap_as_of": null
},
{
"day": 10,
"timestamp": "2026-10-13T20:08:04.588100Z",
"date": "Session 10 · Oct 13, 2026 · 16:08 NYSE",
"text": "CCL’s tracked gain rose 0.94 points to 7.91% as shares advanced 1.15%, above VWAP near the upper range on 0.48 times average volume. Its 19.72-point 20-session lead over Consumer Cyclical still supports the earnings repricing, but today’s light turnover does not verify cash generation or delivery of the higher outlook.",
"price": 26.785,
"pct": 7.91,
"return_vs_entry_pct": 8.05,
"return_vs_base_pct": 8.05,
"return_vs_prior_pct": null,
"previous_regular_close": null,
"change_vs_prior_session_pct": 1.09,
"session_day": 10,
"reference_price": 24.79,
"reference_text": "$26.79 · +8.05% from $24.79 base",
"timing": "",
"market_marker": null,
"extended_hours": null,
"relevant": false,
"active_relevant": false,
"terminal_closure": false,
"transcript_anchor": "",
"price_as_of": "2026-10-13T19:24:51.998952Z",
"vwap_as_of": null
},
{
"day": 10,
"timestamp": "2026-10-13T15:28:19.284754Z",
"date": "Session 10 · Oct 13, 2026 · 11:28 NYSE",
"text": "CCL's tracked gain added 0.13 percentage points to 6.97% as shares rose 0.13%, yet the capture sat 0.51% below the day's volume-weighted average price near the session low on light volume. Its 20-session lead over Consumer Cyclical remains 18.63 points. The relative record supports the earnings repricing, but today's tape adds little confirmation that the higher outlook is producing follow-through.",
"price": 26.515,
"pct": 6.97,
"return_vs_entry_pct": 6.96,
"return_vs_base_pct": 6.96,
"return_vs_prior_pct": null,
"previous_regular_close": null,
"change_vs_prior_session_pct": 0.14,
"session_day": 10,
"reference_price": 24.79,
"reference_text": "$26.52 · +6.96% from $24.79 base",
"timing": "",
"market_marker": null,
"extended_hours": null,
"relevant": false,
"active_relevant": false,
"terminal_closure": false,
"transcript_anchor": "",
"price_as_of": "2026-10-13T14:06:26.349567Z",
"vwap_as_of": null
},
{
"day": 9,
"timestamp": "2026-10-12T22:06:52.883578Z",
"date": "Session 9 · Oct 12, 2026 · 18:06 NYSE",
"text": "CCL's tracked gain rose 0.28 points to 6.84%, while shares added 0.49% but finished near the volume-weighted average price on 0.60 times their three-month average volume. Its 17.89-point 20-session lead over Consumer Cyclical persists, yet this small advance adds little confirmation; the earnings beat and higher full-year outlook still lack fresh operating follow-through.",
"price": 26.48,
"pct": 6.84,
"return_vs_entry_pct": 6.82,
"return_vs_base_pct": 6.82,
"return_vs_prior_pct": null,
"previous_regular_close": null,
"change_vs_prior_session_pct": -0.04,
"session_day": 9,
"reference_price": 24.79,
"reference_text": "$26.48 · +6.82% from $24.79 base",
"timing": "",
"market_marker": null,
"extended_hours": null,
"relevant": false,
"active_relevant": false,
"terminal_closure": false,
"transcript_anchor": "",
"price_as_of": "2026-10-12T21:39:09Z",
"vwap_as_of": null
},
{
"day": 9,
"timestamp": "2026-10-12T20:16:38.939597Z",
"date": "Session 9 · Oct 12, 2026 · 16:16 NYSE",
"text": "CCL's tracked gain added 0.34 points to 6.78%. Shares rose 0.53% but sat 0.03% below VWAP on 0.41 times average volume, so the small advance brought little price confirmation. The earnings beat and higher full-year outlook remain the thesis, but no new operating evidence supports follow-through.",
"price": 26.49,
"pct": 6.56,
"return_vs_entry_pct": 6.86,
"return_vs_base_pct": 6.86,
"return_vs_prior_pct": null,
"previous_regular_close": null,
"change_vs_prior_session_pct": 0.22,
"session_day": 9,
"reference_price": 24.79,
"reference_text": "$26.49 · +6.86% from $24.79 base",
"timing": "",
"market_marker": null,
"extended_hours": null,
"relevant": false,
"active_relevant": false,
"terminal_closure": false,
"transcript_anchor": "",
"price_as_of": "2026-10-12T18:48:37.209746Z",
"vwap_as_of": null
},
{
"day": 9,
"timestamp": "2026-10-12T19:44:30.043866Z",
"date": "Session 9 · Oct 12, 2026 · 15:44 NYSE",
"text": "CCL's tracked gain rose 0.12 percentage points to 6.56% as shares added 0.32%; price is still 0.21% below its volume-weighted average price, with volume at 0.44 times average. Its 17.74-point 20-session advantage over Consumer Cyclical remains strong, but the sector is down 0.52% and the earnings beat and higher outlook still lack later operating confirmation; the market response persists without resolving durability.",
"price": 26.435,
"pct": 6.56,
"return_vs_entry_pct": 6.64,
"return_vs_base_pct": 6.64,
"return_vs_prior_pct": null,
"previous_regular_close": null,
"change_vs_prior_session_pct": 0.34,
"session_day": 9,
"reference_price": 24.79,
"reference_text": "$26.43 · +6.64% from $24.79 base",
"timing": "",
"market_marker": null,
"extended_hours": null,
"relevant": false,
"active_relevant": false,
"terminal_closure": false,
"transcript_anchor": "",
"price_as_of": "2026-10-12T19:23:05.083706Z",
"vwap_as_of": null
},
{
"day": 8,
"timestamp": "2026-10-09T14:49:16.924724Z",
"date": "Session 8 · Oct 9, 2026 · 10:49 NYSE",
"text": "CCL tracked gain rose 1.01 points to 6.44%; the current quote is 0.85% higher and 0.31% above VWAP, though volume is 0.09 times average. Its twenty-session return remains 16.18 points ahead of the Consumer Cyclical sector. The earnings beat and higher full-year outlook still lack new evidence of operating follow-through.",
"price": 26.3524,
"pct": 6.44,
"return_vs_entry_pct": 6.3,
"return_vs_base_pct": 6.3,
"return_vs_prior_pct": null,
"previous_regular_close": null,
"change_vs_prior_session_pct": 0.89,
"session_day": 8,
"reference_price": 24.79,
"reference_text": "$26.35 · +6.30% from $24.79 base",
"timing": "",
"market_marker": null,
"extended_hours": null,
"relevant": false,
"active_relevant": false,
"terminal_closure": false,
"transcript_anchor": "",
"price_as_of": "2026-10-09T14:06:45.252947Z",
"vwap_as_of": null
},
{
"day": 7,
"timestamp": "2026-10-08T21:54:04.705689Z",
"date": "Session 7 · Oct 8, 2026 · 17:54 NYSE",
"text": "CCL's tracked gain rose 0.41 points to 5.43%; shares slipped 0.08% to $26.13 but held 0.58% above VWAP on 1.12 times average volume. Its 20-session lead over Consumer Cyclical is 16.51 points, yet price strength alone does not establish operating follow-through from the earnings beat and higher full-year outlook.",
"price": 26.13,
"pct": 5.43,
"return_vs_entry_pct": 5.41,
"return_vs_base_pct": 5.41,
"return_vs_prior_pct": null,
"previous_regular_close": null,
"change_vs_prior_session_pct": 0.27,
"session_day": 7,
"reference_price": 24.79,
"reference_text": "$26.13 · +5.41% from $24.79 base",
"timing": "",
"market_marker": {
"phase": "post",
"text": "Aftermarket update: $26.13 (0.00% vs regular close) · Oct 8, 2026 · 17:27 NYSE"
},
"extended_hours": {
"phase": "post",
"price": 26.13,
"ext_pct": 0.0,
"as_of": "2026-10-08T21:27:45Z",
"persisted": false
},
"relevant": false,
"active_relevant": false,
"terminal_closure": false,
"transcript_anchor": "",
"price_as_of": "2026-10-08T21:27:45Z",
"vwap_as_of": null
},
{
"day": 7,
"timestamp": "2026-10-08T20:15:55.556416Z",
"date": "Session 7 · Oct 8, 2026 · 16:15 NYSE",
"text": "CCL's tracked gain edged up 0.08 points from +5.51% while shares slipped 0.33% to $26.07, but stayed 0.33% above VWAP on 0.55 times average volume. Its 20-session lead over Consumer Cyclical remains 16.34 points. The earnings beat and higher full-year outlook still lack operating follow-through; relative strength remains supportive but not decisive.",
"price": 26.065,
"pct": 5.02,
"return_vs_entry_pct": 5.14,
"return_vs_base_pct": 5.14,
"return_vs_prior_pct": null,
"previous_regular_close": null,
"change_vs_prior_session_pct": 0.78,
"session_day": 7,
"reference_price": 24.79,
"reference_text": "$26.07 · +5.14% from $24.79 base",
"timing": "",
"market_marker": null,
"extended_hours": null,
"relevant": false,
"active_relevant": false,
"terminal_closure": false,
"transcript_anchor": "",
"price_as_of": "2026-10-08T19:22:13.087729Z",
"vwap_as_of": null
},
{
"day": 7,
"timestamp": "2026-10-08T15:02:12.702559Z",
"date": "Session 7 · Oct 8, 2026 · 11:02 NYSE",
"text": "CCL tracked gain narrowed 0.57 points to +4.94% as shares fell 1.07% on 0.14 times average volume. Price held 0.27% above VWAP and the twenty-session lead over Consumer Cyclical remains 15.98 points; the pullback softens the tape but does not confirm durable benefit from the earnings outlook.",
"price": 25.87,
"pct": 4.94,
"return_vs_entry_pct": 4.36,
"return_vs_base_pct": 4.36,
"return_vs_prior_pct": null,
"previous_regular_close": null,
"change_vs_prior_session_pct": -1.13,
"session_day": 7,
"reference_price": 24.79,
"reference_text": "$25.87 · +4.36% from $24.79 base",
"timing": "",
"market_marker": null,
"extended_hours": null,
"relevant": false,
"active_relevant": false,
"terminal_closure": false,
"transcript_anchor": "",
"price_as_of": "2026-10-08T14:06:42.195821Z",
"vwap_as_of": null
},
{
"day": 6,
"timestamp": "2026-10-07T22:09:23.677647Z",
"date": "Session 6 · Oct 7, 2026 · 18:09 NYSE",
"text": "On session 6, CCL tracked gain narrowed 0.77 points to +5.51% as shares fell 1.62% to $26.15 on 0.70 times average volume. Price was 0.27% below VWAP, although the twenty-session lead over Consumer Cyclical remained 16.18 points. The earnings beat and slightly higher full-year outlook still lack later operating confirmation; this lighter-volume pullback softens the tape without resolving that test.",
"price": 26.15,
"pct": 5.51,
"return_vs_entry_pct": 5.49,
"return_vs_base_pct": 5.49,
"return_vs_prior_pct": null,
"previous_regular_close": null,
"change_vs_prior_session_pct": -0.66,
"session_day": 6,
"reference_price": 24.79,
"reference_text": "$26.15 · +5.49% from $24.79 base",
"timing": "",
"market_marker": null,
"extended_hours": null,
"relevant": false,
"active_relevant": false,
"terminal_closure": false,
"transcript_anchor": "",
"price_as_of": "2026-10-07T21:19:15Z",
"vwap_as_of": null
},
{
"day": 6,
"timestamp": "2026-10-07T20:36:59.566600Z",
"date": "Session 6 · Oct 7, 2026 · 16:36 NYSE",
"text": "CCL's tracked gain recovered 1.01 points to +6.28% even as the $26.32 capture fell 1.00%. It held above VWAP in the upper part of the range, but volume was only 0.46 times average. The twenty-session lead over Consumer Cyclical remains 16.43 points; no later operating report has yet confirmed that the earnings beat and higher outlook are translating into results.",
"price": 26.315,
"pct": 6.28,
"return_vs_entry_pct": 6.15,
"return_vs_base_pct": 6.15,
"return_vs_prior_pct": null,
"previous_regular_close": null,
"change_vs_prior_session_pct": 0.85,
"session_day": 6,
"reference_price": 24.79,
"reference_text": "$26.32 · +6.15% from $24.79 base",
"timing": "",
"market_marker": null,
"extended_hours": null,
"relevant": false,
"active_relevant": false,
"terminal_closure": false,
"transcript_anchor": "",
"price_as_of": "2026-10-07T19:21:41.146640Z",
"vwap_as_of": null
},
{
"day": 6,
"timestamp": "2026-10-07T15:09:16.626987Z",
"date": "Session 6 · Oct 7, 2026 · 11:09 NYSE",
"text": "CCL's tracked gain eased 1.71 points to +5.27%; the $26.11 capture fell 1.79%, sat 0.40% below the session average near the lower quarter of its range and lagged the S&P 500 by 1.19 points in the same cut. It still leads Consumer Cyclical by 16.43 points over 20 sessions, but the weaker tape pressures follow-through. No later operating report confirms the earnings beat and raised outlook.",
"price": 26.105,
"pct": 5.27,
"return_vs_entry_pct": 5.3,
"return_vs_base_pct": 5.3,
"return_vs_prior_pct": null,
"previous_regular_close": null,
"change_vs_prior_session_pct": -1.94,
"session_day": 6,
"reference_price": 24.79,
"reference_text": "$26.11 · +5.30% from $24.79 base",
"timing": "",
"market_marker": null,
"extended_hours": null,
"relevant": false,
"active_relevant": false,
"terminal_closure": false,
"transcript_anchor": "",
"price_as_of": "2026-10-07T14:06:33.450164Z",
"vwap_as_of": null
},
{
"day": 5,
"timestamp": "2026-10-06T20:03:35.160248Z",
"date": "Session 5 · Oct 6, 2026 · 16:03 NYSE",
"text": "CCL's tracked return gained 0.59 points to +6.98%. The $26.59 capture rose 4.01%, held 0.55% above VWAP and stayed in the upper part of its range; its 20-session lead over Consumer Cyclical also widened. Daily participation remains below average, and the stock is extended above its trend reference. The earnings beat and slightly raised full-year outlook still need operating follow-through.",
"price": 26.585,
"pct": 6.98,
"return_vs_entry_pct": 7.24,
"return_vs_base_pct": 7.24,
"return_vs_prior_pct": null,
"previous_regular_close": null,
"change_vs_prior_session_pct": 0.3,
"session_day": 5,
"reference_price": 24.79,
"reference_text": "$26.59 · +7.24% from $24.79 base",
"timing": "",
"market_marker": null,
"extended_hours": null,
"relevant": false,
"active_relevant": false,
"terminal_closure": false,
"transcript_anchor": "",
"price_as_of": "2026-10-06T19:21:35.651397Z",
"vwap_as_of": null
},
{
"day": 5,
"timestamp": "2026-10-06T14:50:33.088972Z",
"date": "Session 5 · Oct 6, 2026 · 10:50 NYSE",
"text": "CCL's tracked return added 3.26 points to 6.39% since yesterday and recovered 1.99 points from the October 2 panel baseline. The $26.51 capture held 0.8% above VWAP near the upper range, and its 20-session lead over Consumer Cyclical widened to 16.57 points. But price remains 2.49 ATR above its EMA, and no later operating report confirms earnings follow-through.",
"price": 26.51,
"pct": 6.39,
"return_vs_entry_pct": 6.94,
"return_vs_base_pct": 6.94,
"return_vs_prior_pct": null,
"previous_regular_close": null,
"change_vs_prior_session_pct": 3.83,
"session_day": 5,
"reference_price": 24.79,
"reference_text": "$26.51 · +6.94% from $24.79 base",
"timing": "",
"market_marker": null,
"extended_hours": null,
"relevant": true,
"active_relevant": false,
"terminal_closure": false,
"transcript_anchor": "transcript-entry-fe285baf7c91662d767e057e92727039a0693c9c3a61689ea1d0f87d4bb6e693",
"price_as_of": "2026-10-06T14:06:59.842254Z",
"vwap_as_of": null
},
{
"day": 4,
"timestamp": "2026-10-05T22:34:22.000099Z",
"date": "Session 4 · Oct 5, 2026 · 18:34 NYSE",
"text": "CCL's tracked gain slipped from 3.19% to 3.13%; the $25.56 capture fell 0.78% yet stayed above VWAP on only 0.66 times expected volume. A 12.63-point 20-session lead over Consumer Cyclical remains, but distribution evidence tempers the session. The earnings beat and raised outlook are still the catalyst; this price action does not show whether they are translating into operating results.",
"price": 25.56,
"pct": 3.13,
"return_vs_entry_pct": 3.11,
"return_vs_base_pct": 3.11,
"return_vs_prior_pct": null,
"previous_regular_close": null,
"change_vs_prior_session_pct": -0.44,
"session_day": 4,
"reference_price": 24.79,
"reference_text": "$25.56 · +3.11% from $24.79 base",
"timing": "",
"market_marker": null,
"extended_hours": null,
"relevant": false,
"active_relevant": false,
"terminal_closure": false,
"transcript_anchor": "",
"price_as_of": "2026-10-05T21:04:18Z",
"vwap_as_of": null
},
{
"day": 4,
"timestamp": "2026-10-05T20:28:34.904015Z",
"date": "Session 4 · Oct 5, 2026 · 16:28 NYSE",
"text": "CCL's tracked gain slipped 0.50 points to 3.19% as the $25.67 capture fell 0.35%. It remained 0.25% above VWAP on 0.66 times expected volume, with a 12.72-point sector lead. The earnings beat and raised outlook remain the catalyst, but this softer, low-participation session still does not show whether the repricing is translating into operating results.",
"price": 25.67,
"pct": 3.19,
"return_vs_entry_pct": 3.55,
"return_vs_base_pct": 3.55,
"return_vs_prior_pct": null,
"previous_regular_close": null,
"change_vs_prior_session_pct": -0.04,
"session_day": 4,
"reference_price": 24.79,
"reference_text": "$25.67 · +3.55% from $24.79 base",
"timing": "",
"market_marker": null,
"extended_hours": null,
"relevant": false,
"active_relevant": false,
"terminal_closure": false,
"transcript_anchor": "",
"price_as_of": "2026-10-05T19:21:38.104627Z",
"vwap_as_of": null
},
{
"day": 4,
"timestamp": "2026-10-05T15:27:58.820843Z",
"date": "Session 4 · Oct 5, 2026 · 11:27 NYSE",
"text": "CCL's tracked gain slipped 0.71 points to 3.69%; the $25.68 capture fell 0.31% and sat 0.12% below VWAP on 0.41 time-adjusted volume. A 13.34-point twenty-session sector lead persists, but the softer tape still has not linked the earnings repricing to operating results.",
"price": 25.68,
"pct": 3.69,
"return_vs_entry_pct": 3.59,
"return_vs_base_pct": 3.59,
"return_vs_prior_pct": null,
"previous_regular_close": null,
"change_vs_prior_session_pct": -0.32,
"session_day": 4,
"reference_price": 24.79,
"reference_text": "$25.68 · +3.59% from $24.79 base",
"timing": "",
"market_marker": null,
"extended_hours": null,
"relevant": false,
"active_relevant": false,
"terminal_closure": false,
"transcript_anchor": "",
"price_as_of": "2026-10-05T14:06:51.007319Z",
"vwap_as_of": null
},
{
"day": 3,
"timestamp": "2026-10-03T11:27:22.252766Z",
"date": "Session 3 · Oct 3, 2026 · 07:27 NYSE",
"text": "CCL held a 4.40% tracked gain; the late $25.76 capture remained 0.49% above VWAP on 1.30 times average volume, and its 20-session lead over Consumer Cyclical stood at 15.22 points. The market response remains constructive, but the current record still does not establish that the earnings move is translating into operating results.",
"price": 25.76,
"pct": 4.4,
"return_vs_entry_pct": 3.91,
"return_vs_base_pct": 3.91,
"return_vs_prior_pct": null,
"previous_regular_close": null,
"change_vs_prior_session_pct": 0.06,
"session_day": 3,
"reference_price": 24.79,
"reference_text": "$25.76 · +3.91% from $24.79 base",
"timing": "",
"market_marker": null,
"extended_hours": null,
"relevant": false,
"active_relevant": false,
"terminal_closure": false,
"transcript_anchor": "",
"price_as_of": "2026-10-02T22:40:08Z",
"vwap_as_of": null
},
{
"day": 3,
"timestamp": "2026-10-02T20:32:46.631953Z",
"date": "Session 3 · Oct 2, 2026 · 16:32 NYSE",
"text": "CCL's tracked return recovered 5.39 percentage points to +4.40% by session 3 after the prior -0.99% reading. The latest capture was $25.75, 0.49% above VWAP on 0.96 times average volume, and its 20-session lead over Consumer Cyclical widened to 15.15 points. Distribution remains present and price is 2.16 ATR above its EMA; the near-even model does not confirm earnings follow-through.",
"price": 25.745,
"pct": 4.4,
"return_vs_entry_pct": 3.85,
"return_vs_base_pct": 3.85,
"return_vs_prior_pct": null,
"previous_regular_close": null,
"change_vs_prior_session_pct": 4.86,
"session_day": 3,
"reference_price": 24.79,
"reference_text": "$25.75 · +3.85% from $24.79 base",
"timing": "",
"market_marker": null,
"extended_hours": null,
"relevant": true,
"active_relevant": false,
"terminal_closure": false,
"transcript_anchor": "transcript-entry-6c9584b9e5210d62b30a6fe6054827a896bf0e6b7c100bb6ac9519ba9fbd5c9b",
"price_as_of": "2026-10-02T19:21:55.629539Z",
"vwap_as_of": null
},
{
"day": 1,
"timestamp": "2026-09-30T22:02:53.073090Z",
"date": "Session 1 · Sep 30, 2026 · 18:02 NYSE",
"text": "CCL tracked return fell 2.81 points, from a 1.82% gain to a 0.99% loss, as shares dropped 2.27% to $24.54, 1.84% below VWAP near the session low on 1.72 times average volume. Its 20-session lead over Consumer Cyclical remains 10.66 points and price stays above $22.14, but distribution and the failed earnings-day hold weaken follow-through.",
"price": 24.61,
"pct": -0.99,
"return_vs_entry_pct": -0.73,
"return_vs_base_pct": -0.73,
"return_vs_prior_pct": null,
"previous_regular_close": null,
"change_vs_prior_session_pct": -3.19,
"session_day": 1,
"reference_price": 24.79,
"reference_text": "$24.61 · -0.73% from $24.79 base",
"timing": "",
"market_marker": null,
"extended_hours": null,
"relevant": false,
"active_relevant": false,
"terminal_closure": false,
"transcript_anchor": "",
"price_as_of": "2026-09-30T19:58:16.738162Z",
"vwap_as_of": null
},
{
"day": 1,
"timestamp": "2026-09-30T22:02:53.073090Z",
"date": "Session 1 · Sep 30, 2026 · 18:02 NYSE",
"text": "CCL tracked return fell 2.81 points, from a 1.82% gain to a 0.99% loss, as shares dropped 2.27% to $24.54, 1.84% below VWAP near the session low on 1.72 times average volume. Its 20-session lead over Consumer Cyclical remains 10.66 points and price stays above $22.14, but distribution and the failed earnings-day hold weaken follow-through.",
"price": 24.54,
"pct": -0.99,
"return_vs_entry_pct": -1.01,
"return_vs_base_pct": -1.01,
"return_vs_prior_pct": null,
"previous_regular_close": null,
"change_vs_prior_session_pct": -0.28,
"session_day": 1,
"reference_price": 24.79,
"reference_text": "$24.54 · -1.01% from $24.79 base",
"timing": "",
"market_marker": null,
"extended_hours": null,
"relevant": false,
"active_relevant": false,
"terminal_closure": false,
"transcript_anchor": "",
"price_as_of": "2026-09-30T20:55:04Z",
"vwap_as_of": null
},
{
"day": 1,
"timestamp": "2026-09-30T15:24:25.822491Z",
"date": "Session 1 · Sep 30, 2026 · 11:24 NYSE",
"text": "CCL's tracked gain rose 0.51 percentage points to 1.82%. At 10 a.m., shares were 25.40 USD, up 1.15% and 0.63% above VWAP near the top of the range; time-adjusted volume was 1.38 times normal, while cumulative volume was 34% of its three-month average. Its 20-session lead over Consumer Cyclical widened to 13.83 points, but the flow measure remains negative, price is 2.15 ATR above its EMA reference and no structure is confirmed. The earnings response is holding so far, with follow-through still unproven.",
"price": 25.4,
"pct": 1.82,
"return_vs_entry_pct": 2.46,
"return_vs_base_pct": 2.46,
"return_vs_prior_pct": null,
"previous_regular_close": null,
"change_vs_prior_session_pct": 1.17,
"session_day": 1,
"reference_price": 24.79,
"reference_text": "$25.40 · +2.46% from $24.79 base",
"timing": "",
"market_marker": null,
"extended_hours": null,
"relevant": false,
"active_relevant": false,
"terminal_closure": false,
"transcript_anchor": "",
"price_as_of": "2026-09-30T14:10:11.628897Z",
"vwap_as_of": null
},
{
"day": 0,
"timestamp": "2026-09-29T21:53:30.485384Z",
"date": "Session 0 · Sep 29, 2026 · 17:53 NYSE",
"text": "CCL's tracked gain eased 0.34 points to +1.31% as shares rose 13.41% to $25.11 and held 1.25% above VWAP on dollar volume 3.57 times its 20-day norm. Its 11.49-point 20-session lead over Consumer Cyclical supports the earnings reaction, but the price is 2.08 ATR above its EMA reference, flow shows distribution and follow-through has not been established.",
"price": 25.11,
"pct": 1.31,
"return_vs_entry_pct": 1.29,
"return_vs_base_pct": 1.29,
"return_vs_prior_pct": null,
"previous_regular_close": null,
"change_vs_prior_session_pct": -0.06,
"session_day": 0,
"reference_price": 24.79,
"reference_text": "$25.11 · +1.29% from $24.79 base",
"timing": "",
"market_marker": {
"phase": "post",
"text": "Aftermarket update: $25.02 (-0.36% vs regular close) · Sep 29, 2026 · 17:26 NYSE"
},
"extended_hours": {
"phase": "post",
"price": 25.02,
"ext_pct": -0.36,
"as_of": "2026-09-29T21:26:14Z",
"persisted": false
},
"relevant": false,
"active_relevant": false,
"terminal_closure": false,
"transcript_anchor": "",
"price_as_of": "2026-09-29T21:26:14Z",
"vwap_as_of": null
},
{
"day": 0,
"timestamp": "2026-09-29T19:57:55.172147Z",
"date": "Session 0 · Sep 29, 2026 · 15:57 NYSE",
"text": "CCL's first tracked session is +1.65% as shares rose 13.48% to $25.13 and held 1.32% above the session VWAP on dollar volume nearly three times its 20-day average. Its 20-session return leads Consumer Cyclical by 11.37 points, keeping the earnings reaction strong, though price is 2.09 average daily ranges above reference with no confirmed structure and the flow measure shows distribution. KMX's model comparison remains a countercase from only eight examples; the next sessions must test whether CCL's repricing holds.",
"price": 25.125,
"pct": 1.65,
"return_vs_entry_pct": 1.35,
"return_vs_base_pct": 1.35,
"return_vs_prior_pct": null,
"previous_regular_close": null,
"change_vs_prior_session_pct": 1.35,
"session_day": 0,
"reference_price": 24.79,
"reference_text": "$25.12 · +1.35% from $24.79 base",
"timing": "",
"market_marker": null,
"extended_hours": null,
"relevant": false,
"active_relevant": false,
"terminal_closure": false,
"transcript_anchor": "",
"price_as_of": "2026-09-29T19:21:52.249581Z",
"vwap_as_of": null
}
],
"observed_outcomes": [
{
"label": "+1 sessions",
"status": "complete",
"return": -0.99,
"reference_text": "-0.99% from $24.79 base",
"price": 24.54,
"updated": "Sep 30, 2026 · 17:36 NYSE",
"mfe": 2.8,
"mae": -0.99
},
{
"label": "+5 sessions",
"status": "complete",
"return": 7.24,
"reference_text": "+7.24% from $24.79 base",
"price": 26.58,
"updated": "Oct 6, 2026 · 17:49 NYSE",
"mfe": 7.77,
"mae": -1.07
},
{
"label": "+10 sessions",
"status": "complete",
"return": 7.85,
"reference_text": "+7.85% from $24.79 base",
"price": 26.73,
"updated": "Oct 13, 2026 · 17:05 NYSE",
"mfe": 8.37,
"mae": -1.07
},
{
"label": "+15 sessions",
"status": "complete",
"return": 9.18,
"reference_text": "+9.18% from $24.79 base",
"price": 27.06,
"updated": "Oct 20, 2026 · 17:17 NYSE",
"mfe": 12.16,
"mae": -1.07
}
],
"candidate_comparison_history": [
{
"day": 0,
"timestamp": "2026-09-29T19:57:55.172147Z",
"comparison": {
"schema_version": "public-candidate-comparison.v1",
"captured_at": "2026-09-29T19:57:55.172147Z",
"base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
"source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
"rows": [
{
"symbol": "CCL",
"role": "selected",
"price": 25.125,
"base_price": 24.785,
"return_since_base_pct": 1.3718,
"session_return_pct": 13.48,
"change_since_prior_pct": 0.3996,
"volume_ratio": 3.17,
"rsi": 68.81,
"vwap": 24.8,
"vwap_distance_pct": 1.3105,
"position_52w_pct": 73.8,
"extended_hours_pct": null,
"as_of": "2026-09-29T19:21:52.249581Z",
"source": "yfinance_quote",
"name": "Carnival Corporation Ltd.",
"episode_id": "n0:CCL:2026-09-29",
"ema_trend": "22.79 > 23.18 > 24.59",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:18:03.945792Z",
"facts": [
"The supplied earnings coverage reports adjusted EPS of $1.43 versus $1.36 expected, revenue of $8.435B versus $8.300B expected, and a slight increase to full-year adjusted EPS guidance.",
"The N0 capture records +11.95% on 2.05x average volume. The provider series remained near the move through its final supplied observation.",
"The 20-session record shows CCL +4.48% versus its sector proxy -6.75%, a +11.23 percentage-point difference.",
"The active H3/H8/H15 positive-return estimates are 0.470/0.469/0.502; corresponding adverse-MAE medians are -4.49%/-7.15%/-9.26%. The separate audit-only H15 historical-dispersion output is P10 -19.62%, median -1.26%, P90 +7.16%. These comparisons use eight cases."
],
"price_as_of": "2026-09-29T19:21:52.249581Z",
"vwap_as_of": null
},
{
"symbol": "SMMT",
"role": "alternative",
"price": 16.445,
"base_price": 16.505,
"return_since_base_pct": -0.3635,
"session_return_pct": 6.2339,
"change_since_prior_pct": -0.7843,
"volume_ratio": 3.35,
"rsi": 42.99,
"vwap": 17.03,
"vwap_distance_pct": -3.4351,
"position_52w_pct": 56.43,
"extended_hours_pct": null,
"as_of": "2026-09-29T19:50:27Z",
"source": "yfinance_quote",
"name": "Summit Therapeutics Inc.",
"episode_id": "n0:SMMT:2026-09-29",
"ema_trend": "16.44 > 16.26 > 15.62",
"vwap_state": "below",
"selection_as_of": "2026-09-29T15:16:50.388704Z",
"facts": [
"The supplied event evidence describes a $2B AstraZeneca investment using newly issued convertible preferred shares and a clinical collaboration.",
"The N0 event capture was +6.62% on 3.35x average volume, but the provider series faded to about +5.33% and the intraday reading was below VWAP."
],
"price_as_of": "2026-09-29T19:50:27Z",
"vwap_as_of": null
},
{
"symbol": "HAFN",
"role": "alternative",
"price": 9.655,
"base_price": 9.56,
"return_since_base_pct": 0.9937,
"session_return_pct": 5.7503,
"change_since_prior_pct": 0.0518,
"volume_ratio": 1.24,
"rsi": 57.04,
"vwap": 9.53,
"vwap_distance_pct": 1.3116,
"position_52w_pct": 94.57,
"extended_hours_pct": null,
"as_of": "2026-09-29T19:50:14Z",
"source": "yfinance_quote",
"name": "Hafnia Limited",
"episode_id": "n0:HAFN:2026-09-29",
"ema_trend": "9.27 > 9.0 > 8.33",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:18:47.711682Z",
"facts": [
"The N0 capture was +4.71% on 1.24x average volume; later provider observations retained a somewhat larger gain and price was above VWAP.",
"No company-specific catalyst was established in the supplied dossier."
],
"price_as_of": "2026-09-29T19:50:14Z",
"vwap_as_of": null
},
{
"symbol": "NTWK",
"role": "alternative",
"price": 5.525,
"base_price": 5.5496,
"return_since_base_pct": -0.4433,
"session_return_pct": 2.8864,
"change_since_prior_pct": -0.6295,
"volume_ratio": 14.19,
"rsi": 89.74,
"vwap": 5.5,
"vwap_distance_pct": 0.4545,
"position_52w_pct": 98.75,
"extended_hours_pct": null,
"as_of": "2026-09-29T19:49:13Z",
"source": "yfinance_quote",
"name": "NetSol Technologies, Inc.",
"episode_id": "n0:NTWK:2026-09-29",
"ema_trend": "4.87 > 4.54 > 4.38",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:15:36.965867Z",
"facts": [
"The supplied FY26 results report revenue of $74.4M, up 12.5%, and FY27 revenue guidance of $84.1M-$86.3M.",
"The event capture was +3.36% on 14.19x average volume, but the dossier estimates about $2M of dollar turnover and places price 3.06 ATR above its EMA reference."
],
"price_as_of": "2026-09-29T19:49:13Z",
"vwap_as_of": null
},
{
"symbol": "ACET",
"role": "alternative",
"price": 6.775,
"base_price": 6.78,
"return_since_base_pct": -0.0737,
"session_return_pct": 6.6929,
"change_since_prior_pct": -1.0226,
"volume_ratio": 3.05,
"rsi": 31.39,
"vwap": 6.69,
"vwap_distance_pct": 1.2706,
"position_52w_pct": 38.99,
"extended_hours_pct": null,
"as_of": "2026-09-29T19:42:19Z",
"source": "yfinance_quote",
"name": "Adicet Bio, Inc.",
"episode_id": "n0:ACET:2026-09-29",
"ema_trend": "8.07 > 8.58 > 8.73",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:17:12.774775Z",
"facts": [
"The supplied Phase 1 lupus readout reports 54% DORIS remission and 50% complete renal response among 22 efficacy-evaluable patients after 12 months.",
"The N0 capture was +6.71% on about 3.05x average volume, while the 20-session asset return was -21.15% versus -0.40% for its healthcare proxy."
],
"price_as_of": "2026-09-29T19:42:19Z",
"vwap_as_of": null
},
{
"symbol": "PWP",
"role": "alternative",
"price": 16.36,
"base_price": 16.85,
"return_since_base_pct": -2.908,
"session_return_pct": 11.7486,
"change_since_prior_pct": 0.1837,
"volume_ratio": 5.79,
"rsi": 55.35,
"vwap": 16.26,
"vwap_distance_pct": 0.615,
"position_52w_pct": 65.01,
"extended_hours_pct": null,
"as_of": "2026-09-29T19:50:22Z",
"source": "yfinance_quote",
"name": "Perella Weinberg Partners",
"episode_id": "n0:PWP:2026-09-29",
"ema_trend": "14.6 > 14.8 > 15.42",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:15:55.598703Z",
"facts": [
"The catalyst is a report of acquisition talks, not a confirmed agreement.",
"The event capture was +15.1% on 5.79x average volume; the provider series retreated from its high but retained much of the move."
],
"price_as_of": "2026-09-29T19:50:22Z",
"vwap_as_of": null
},
{
"symbol": "KMX",
"role": "alternative",
"price": 59.91,
"base_price": 60.72,
"return_since_base_pct": -1.334,
"session_return_pct": 5.9416,
"change_since_prior_pct": 0.8416,
"volume_ratio": 2.26,
"rsi": 52.08,
"vwap": 61.4,
"vwap_distance_pct": -2.4267,
"position_52w_pct": 93.32,
"extended_hours_pct": null,
"as_of": "2026-09-29T19:50:17Z",
"source": "yfinance_quote",
"name": "CarMax, Inc.",
"episode_id": "n0:KMX:2026-09-29",
"ema_trend": "58.29 > 58.97 > 58.5",
"vwap_state": "below",
"selection_as_of": "2026-09-29T15:17:34.477760Z",
"facts": [
"The supplied earnings report shows EPS of $1.16 versus $0.73 expected and sales of $7.878B versus $6.976B expected.",
"The provider trajectory faded from about +5.72% to +3.24%; the intraday reading was below VWAP with a downward trend.",
"The active H3/H8/H15 positive-return estimates are 0.547/0.567/0.528, higher than CCL's at each horizon. Its corresponding adverse-MAE medians are -3.25%/-4.20%/-6.09%. The separate audit-only H15 historical-dispersion output is P10 -5.31%, median +4.18%, P90 +16.31%. These comparisons use eight cases."
],
"price_as_of": "2026-09-29T19:50:17Z",
"vwap_as_of": null
},
{
"symbol": "WYY",
"role": "alternative",
"price": 7.205,
"base_price": 6.4203,
"return_since_base_pct": 12.2222,
"session_return_pct": 21.9904,
"change_since_prior_pct": -2.1724,
"volume_ratio": 1.39,
"rsi": 29.28,
"vwap": 6.2,
"vwap_distance_pct": 16.2097,
"position_52w_pct": 26.56,
"extended_hours_pct": null,
"as_of": "2026-09-29T19:50:27Z",
"source": "yfinance_quote",
"name": "WidePoint Corporation",
"episode_id": "n0:WYY:2026-09-29",
"ema_trend": "8.81 > 9.89 > 10.68",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:18:38.363232Z",
"facts": [
"The provider trajectory rose from about +7.97% to +16.45%, and the intraday reading was above VWAP.",
"The 20-session asset return was -32.32% versus +4.15% for the technology proxy; no company-specific catalyst for the day's move was established."
],
"price_as_of": "2026-09-29T19:50:27Z",
"vwap_as_of": null
},
{
"symbol": "VIAV",
"role": "alternative",
"price": 41.98,
"base_price": 41.455,
"return_since_base_pct": 1.2664,
"session_return_pct": 2.7159,
"change_since_prior_pct": 0.865,
"volume_ratio": 0.53,
"rsi": 57.12,
"vwap": 41.77,
"vwap_distance_pct": 0.5028,
"position_52w_pct": 68.56,
"extended_hours_pct": null,
"as_of": "2026-09-29T19:50:28Z",
"source": "yfinance_quote",
"name": "Viavi Solutions Inc.",
"episode_id": "narrative:VIAV:b612043b612913e0",
"ema_trend": "38.56 > 37.68 > 38.08",
"vwap_state": "below",
"selection_as_of": "2026-09-29T17:19:34Z",
"facts": [
"The primary product announcement introduces a 100G testing platform but supplies no customer wins or expected revenue contribution.",
"The quote change was +1.37% on 0.53x average volume; price was below VWAP with a downward intraday trend."
],
"price_as_of": "2026-09-29T19:50:28Z",
"vwap_as_of": null
},
{
"symbol": "WH",
"role": "alternative",
"price": 72.575,
"base_price": 71.79,
"return_since_base_pct": 1.0935,
"session_return_pct": 2.4636,
"change_since_prior_pct": 0.007,
"volume_ratio": 0.32,
"rsi": 60.7,
"vwap": 71.82,
"vwap_distance_pct": 1.0512,
"position_52w_pct": 79.55,
"extended_hours_pct": null,
"as_of": "2026-09-29T19:50:28Z",
"source": "yfinance_quote",
"name": "Wyndham Hotels & Resorts, Inc.",
"episode_id": "narrative:WH:e6143a4ee8e53619",
"ema_trend": "69.87 > 70.21 > 72.36",
"vwap_state": "above",
"selection_as_of": "2026-09-29T17:19:31Z",
"facts": [
"The primary release reports a $400M increase to the share repurchase authorization.",
"The quote change was +1.47% on 0.32x average volume; the authorization does not establish that repurchases occurred."
],
"price_as_of": "2026-09-29T19:50:28Z",
"vwap_as_of": null
}
],
"benchmarks": [],
"coverage": {
"candidate_rows": 10,
"candidate_prices": 10,
"candidate_technical": 10,
"benchmark_rows": 0
}
}
},
{
"day": 0,
"timestamp": "2026-09-29T21:53:30.485384Z",
"comparison": {
"schema_version": "public-candidate-comparison.v1",
"captured_at": "2026-09-29T21:53:30.485384Z",
"base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
"source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
"rows": [
{
"symbol": "CCL",
"role": "selected",
"price": 25.02,
"base_price": 24.785,
"return_since_base_pct": 0.9482,
"session_return_pct": 13.41,
"change_since_prior_pct": -0.4179,
"volume_ratio": 3.83,
"rsi": 68.74,
"vwap": 24.8,
"vwap_distance_pct": 0.8871,
"position_52w_pct": 73.8,
"extended_hours_pct": -0.36,
"as_of": "2026-09-29T21:26:14Z",
"source": "sealed_extended_quote",
"name": "Carnival Corporation Ltd.",
"episode_id": "n0:CCL:2026-09-29",
"ema_trend": "22.79 > 23.18 > 24.59",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:18:03.945792Z",
"facts": [
"The supplied earnings coverage reports adjusted EPS of $1.43 versus $1.36 expected, revenue of $8.435B versus $8.300B expected, and a slight increase to full-year adjusted EPS guidance.",
"The N0 capture records +11.95% on 2.05x average volume. The provider series remained near the move through its final supplied observation.",
"The 20-session record shows CCL +4.48% versus its sector proxy -6.75%, a +11.23 percentage-point difference.",
"The active H3/H8/H15 positive-return estimates are 0.470/0.469/0.502; corresponding adverse-MAE medians are -4.49%/-7.15%/-9.26%. The separate audit-only H15 historical-dispersion output is P10 -19.62%, median -1.26%, P90 +7.16%. These comparisons use eight cases."
],
"price_as_of": "2026-09-29T21:26:14Z",
"vwap_as_of": null
},
{
"symbol": "SMMT",
"role": "alternative",
"price": 16.3387,
"base_price": 16.505,
"return_since_base_pct": -1.0076,
"session_return_pct": -0.313,
"change_since_prior_pct": -0.6464,
"volume_ratio": 3.35,
"rsi": 42.99,
"vwap": 17.03,
"vwap_distance_pct": -4.0593,
"position_52w_pct": 56.43,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:20:32Z",
"source": "yfinance_quote",
"name": "Summit Therapeutics Inc.",
"episode_id": "n0:SMMT:2026-09-29",
"ema_trend": "16.44 > 16.26 > 15.62",
"vwap_state": "below",
"selection_as_of": "2026-09-29T15:16:50.388704Z",
"facts": [
"The supplied event evidence describes a $2B AstraZeneca investment using newly issued convertible preferred shares and a clinical collaboration.",
"The N0 event capture was +6.62% on 3.35x average volume, but the provider series faded to about +5.33% and the intraday reading was below VWAP."
],
"price_as_of": "2026-09-29T21:20:32Z",
"vwap_as_of": null
},
{
"symbol": "HAFN",
"role": "alternative",
"price": 9.77,
"base_price": 9.56,
"return_since_base_pct": 2.1967,
"session_return_pct": 1.0341,
"change_since_prior_pct": 1.1911,
"volume_ratio": 1.24,
"rsi": 57.04,
"vwap": 9.53,
"vwap_distance_pct": 2.5184,
"position_52w_pct": 94.57,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:05:26Z",
"source": "yfinance_quote",
"name": "Hafnia Limited",
"episode_id": "n0:HAFN:2026-09-29",
"ema_trend": "9.27 > 9.0 > 8.33",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:18:47.711682Z",
"facts": [
"The N0 capture was +4.71% on 1.24x average volume; later provider observations retained a somewhat larger gain and price was above VWAP.",
"No company-specific catalyst was established in the supplied dossier."
],
"price_as_of": "2026-09-29T21:05:26Z",
"vwap_as_of": null
},
{
"symbol": "NTWK",
"role": "alternative",
"price": 5.56,
"base_price": 5.5496,
"return_since_base_pct": 0.1874,
"session_return_pct": 3.36,
"change_since_prior_pct": 0.6335,
"volume_ratio": 14.19,
"rsi": 89.74,
"vwap": 5.5,
"vwap_distance_pct": 1.0909,
"position_52w_pct": 98.75,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:10:08Z",
"source": "yfinance_quote",
"name": "NetSol Technologies, Inc.",
"episode_id": "n0:NTWK:2026-09-29",
"ema_trend": "4.87 > 4.54 > 4.38",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:15:36.965867Z",
"facts": [
"The supplied FY26 results report revenue of $74.4M, up 12.5%, and FY27 revenue guidance of $84.1M-$86.3M.",
"The event capture was +3.36% on 14.19x average volume, but the dossier estimates about $2M of dollar turnover and places price 3.06 ATR above its EMA reference."
],
"price_as_of": "2026-09-29T20:10:08Z",
"vwap_as_of": null
},
{
"symbol": "ACET",
"role": "alternative",
"price": 6.77,
"base_price": 6.78,
"return_since_base_pct": -0.1475,
"session_return_pct": -0.8785,
"change_since_prior_pct": -0.0738,
"volume_ratio": 3.05,
"rsi": 31.39,
"vwap": 6.69,
"vwap_distance_pct": 1.1958,
"position_52w_pct": 38.99,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:55:28Z",
"source": "yfinance_quote",
"name": "Adicet Bio, Inc.",
"episode_id": "n0:ACET:2026-09-29",
"ema_trend": "8.07 > 8.58 > 8.73",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:17:12.774775Z",
"facts": [
"The supplied Phase 1 lupus readout reports 54% DORIS remission and 50% complete renal response among 22 efficacy-evaluable patients after 12 months.",
"The N0 capture was +6.71% on about 3.05x average volume, while the 20-session asset return was -21.15% versus -0.40% for its healthcare proxy."
],
"price_as_of": "2026-09-29T20:55:28Z",
"vwap_as_of": null
},
{
"symbol": "PWP",
"role": "alternative",
"price": 17.1,
"base_price": 16.85,
"return_since_base_pct": 1.4837,
"session_return_pct": 4.4594,
"change_since_prior_pct": 4.5232,
"volume_ratio": 5.79,
"rsi": 55.35,
"vwap": 16.26,
"vwap_distance_pct": 5.1661,
"position_52w_pct": 65.01,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:13:05Z",
"source": "yfinance_quote",
"name": "Perella Weinberg Partners",
"episode_id": "n0:PWP:2026-09-29",
"ema_trend": "14.6 > 14.8 > 15.42",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:15:55.598703Z",
"facts": [
"The catalyst is a report of acquisition talks, not a confirmed agreement.",
"The event capture was +15.1% on 5.79x average volume; the provider series retreated from its high but retained much of the move."
],
"price_as_of": "2026-09-29T21:13:05Z",
"vwap_as_of": null
},
{
"symbol": "KMX",
"role": "alternative",
"price": 59.35,
"base_price": 60.72,
"return_since_base_pct": -2.2563,
"session_return_pct": 0.2026,
"change_since_prior_pct": -0.9347,
"volume_ratio": 2.26,
"rsi": 52.08,
"vwap": 61.4,
"vwap_distance_pct": -3.3388,
"position_52w_pct": 93.32,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:59:02Z",
"source": "yfinance_quote",
"name": "CarMax, Inc.",
"episode_id": "n0:KMX:2026-09-29",
"ema_trend": "58.29 > 58.97 > 58.5",
"vwap_state": "below",
"selection_as_of": "2026-09-29T15:17:34.477760Z",
"facts": [
"The supplied earnings report shows EPS of $1.16 versus $0.73 expected and sales of $7.878B versus $6.976B expected.",
"The provider trajectory faded from about +5.72% to +3.24%; the intraday reading was below VWAP with a downward trend.",
"The active H3/H8/H15 positive-return estimates are 0.547/0.567/0.528, higher than CCL's at each horizon. Its corresponding adverse-MAE medians are -3.25%/-4.20%/-6.09%. The separate audit-only H15 historical-dispersion output is P10 -5.31%, median +4.18%, P90 +16.31%. These comparisons use eight cases."
],
"price_as_of": "2026-09-29T20:59:02Z",
"vwap_as_of": null
},
{
"symbol": "WYY",
"role": "alternative",
"price": 7.28,
"base_price": 6.4203,
"return_since_base_pct": 13.3903,
"session_return_pct": -0.9524,
"change_since_prior_pct": 1.0409,
"volume_ratio": 1.39,
"rsi": 29.28,
"vwap": 6.2,
"vwap_distance_pct": 17.4194,
"position_52w_pct": 26.56,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:10:33Z",
"source": "yfinance_quote",
"name": "WidePoint Corporation",
"episode_id": "n0:WYY:2026-09-29",
"ema_trend": "8.81 > 9.89 > 10.68",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:18:38.363232Z",
"facts": [
"The provider trajectory rose from about +7.97% to +16.45%, and the intraday reading was above VWAP.",
"The 20-session asset return was -32.32% versus +4.15% for the technology proxy; no company-specific catalyst for the day's move was established."
],
"price_as_of": "2026-09-29T21:10:33Z",
"vwap_as_of": null
},
{
"symbol": "VIAV",
"role": "alternative",
"price": 41.99,
"base_price": 41.455,
"return_since_base_pct": 1.2906,
"session_return_pct": 0.4065,
"change_since_prior_pct": 0.0238,
"volume_ratio": 0.53,
"rsi": 57.12,
"vwap": 41.77,
"vwap_distance_pct": 0.5267,
"position_52w_pct": 68.56,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:16:33Z",
"source": "yfinance_quote",
"name": "Viavi Solutions Inc.",
"episode_id": "narrative:VIAV:b612043b612913e0",
"ema_trend": "38.56 > 37.68 > 38.08",
"vwap_state": "below",
"selection_as_of": "2026-09-29T17:19:34Z",
"facts": [
"The primary product announcement introduces a 100G testing platform but supplies no customer wins or expected revenue contribution.",
"The quote change was +1.37% on 0.53x average volume; price was below VWAP with a downward intraday trend."
],
"price_as_of": "2026-09-29T21:16:33Z",
"vwap_as_of": null
},
{
"symbol": "WH",
"role": "alternative",
"price": 72.44,
"base_price": 71.79,
"return_since_base_pct": 0.9054,
"session_return_pct": null,
"change_since_prior_pct": -0.186,
"volume_ratio": 0.32,
"rsi": 60.7,
"vwap": 71.82,
"vwap_distance_pct": 0.8633,
"position_52w_pct": 79.55,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:00:33Z",
"source": "yfinance_quote",
"name": "Wyndham Hotels & Resorts, Inc.",
"episode_id": "narrative:WH:e6143a4ee8e53619",
"ema_trend": "69.87 > 70.21 > 72.36",
"vwap_state": "above",
"selection_as_of": "2026-09-29T17:19:31Z",
"facts": [
"The primary release reports a $400M increase to the share repurchase authorization.",
"The quote change was +1.47% on 0.32x average volume; the authorization does not establish that repurchases occurred."
],
"price_as_of": "2026-09-29T20:00:33Z",
"vwap_as_of": null
}
],
"benchmarks": [],
"coverage": {
"candidate_rows": 10,
"candidate_prices": 10,
"candidate_technical": 10,
"benchmark_rows": 0
}
}
},
{
"day": 1,
"timestamp": "2026-09-30T15:24:25.822491Z",
"comparison": {
"schema_version": "public-candidate-comparison.v1",
"captured_at": "2026-09-30T15:24:25.822491Z",
"base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
"source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
"rows": [
{
"symbol": "CCL",
"role": "selected",
"price": 25.4,
"base_price": 24.785,
"return_since_base_pct": 2.4813,
"session_return_pct": 1.15,
"change_since_prior_pct": 1.5188,
"volume_ratio": 0.34,
"rsi": 72.57,
"vwap": 25.24,
"vwap_distance_pct": 0.6339,
"position_52w_pct": 74.6,
"extended_hours_pct": null,
"as_of": "2026-09-30T14:10:11.628897Z",
"source": "yfinance_quote",
"name": "Carnival Corporation Ltd.",
"episode_id": "n0:CCL:2026-09-29",
"ema_trend": "23.31 > 23.38 > 24.62",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:18:03.945792Z",
"facts": [
"The supplied earnings coverage reports adjusted EPS of $1.43 versus $1.36 expected, revenue of $8.435B versus $8.300B expected, and a slight increase to full-year adjusted EPS guidance.",
"The N0 capture records +11.95% on 2.05x average volume. The provider series remained near the move through its final supplied observation.",
"The 20-session record shows CCL +4.48% versus its sector proxy -6.75%, a +11.23 percentage-point difference.",
"The active H3/H8/H15 positive-return estimates are 0.470/0.469/0.502; corresponding adverse-MAE medians are -4.49%/-7.15%/-9.26%. The separate audit-only H15 historical-dispersion output is P10 -19.62%, median -1.26%, P90 +7.16%. These comparisons use eight cases."
],
"benchmark_excess_pct": {
"sp500": 0.5475,
"nasdaq100": 0.3374,
"russell2000": 0.9266
},
"price_as_of": "2026-09-30T14:10:11.628897Z",
"vwap_as_of": null
},
{
"symbol": "SMMT",
"role": "alternative",
"price": 16.3387,
"base_price": 16.505,
"return_since_base_pct": -1.0076,
"session_return_pct": -0.313,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.35,
"rsi": 42.99,
"vwap": 17.03,
"vwap_distance_pct": -4.0593,
"position_52w_pct": 56.43,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:20:32Z",
"source": "yfinance_quote",
"name": "Summit Therapeutics Inc.",
"episode_id": "n0:SMMT:2026-09-29",
"ema_trend": "16.44 > 16.26 > 15.62",
"vwap_state": "below",
"selection_as_of": "2026-09-29T15:16:50.388704Z",
"facts": [
"The supplied event evidence describes a $2B AstraZeneca investment using newly issued convertible preferred shares and a clinical collaboration.",
"The N0 event capture was +6.62% on 3.35x average volume, but the provider series faded to about +5.33% and the intraday reading was below VWAP."
],
"benchmark_excess_pct": {
"sp500": -0.9155,
"nasdaq100": -1.1256,
"russell2000": -0.5364
},
"price_as_of": "2026-09-29T21:20:32Z",
"vwap_as_of": null
},
{
"symbol": "HAFN",
"role": "alternative",
"price": 9.77,
"base_price": 9.56,
"return_since_base_pct": 2.1967,
"session_return_pct": 1.0341,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.24,
"rsi": 57.04,
"vwap": 9.53,
"vwap_distance_pct": 2.5184,
"position_52w_pct": 94.57,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:05:26Z",
"source": "yfinance_quote",
"name": "Hafnia Limited",
"episode_id": "n0:HAFN:2026-09-29",
"ema_trend": "9.27 > 9.0 > 8.33",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:18:47.711682Z",
"facts": [
"The N0 capture was +4.71% on 1.24x average volume; later provider observations retained a somewhat larger gain and price was above VWAP.",
"No company-specific catalyst was established in the supplied dossier."
],
"benchmark_excess_pct": {
"sp500": 0.4316,
"nasdaq100": 0.2215,
"russell2000": 0.8107
},
"price_as_of": "2026-09-29T21:05:26Z",
"vwap_as_of": null
},
{
"symbol": "NTWK",
"role": "alternative",
"price": 5.56,
"base_price": 5.5496,
"return_since_base_pct": 0.1874,
"session_return_pct": 3.36,
"change_since_prior_pct": 0.0,
"volume_ratio": 14.19,
"rsi": 89.74,
"vwap": 5.5,
"vwap_distance_pct": 1.0909,
"position_52w_pct": 98.75,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:10:08Z",
"source": "yfinance_quote",
"name": "NetSol Technologies, Inc.",
"episode_id": "n0:NTWK:2026-09-29",
"ema_trend": "4.87 > 4.54 > 4.38",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:15:36.965867Z",
"facts": [
"The supplied FY26 results report revenue of $74.4M, up 12.5%, and FY27 revenue guidance of $84.1M-$86.3M.",
"The event capture was +3.36% on 14.19x average volume, but the dossier estimates about $2M of dollar turnover and places price 3.06 ATR above its EMA reference."
],
"benchmark_excess_pct": {
"sp500": 2.7575,
"nasdaq100": 2.5474,
"russell2000": 3.1366
},
"price_as_of": "2026-09-29T20:10:08Z",
"vwap_as_of": null
},
{
"symbol": "ACET",
"role": "alternative",
"price": 6.77,
"base_price": 6.78,
"return_since_base_pct": -0.1475,
"session_return_pct": -0.8785,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.05,
"rsi": 31.39,
"vwap": 6.69,
"vwap_distance_pct": 1.1958,
"position_52w_pct": 38.99,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:55:28Z",
"source": "yfinance_quote",
"name": "Adicet Bio, Inc.",
"episode_id": "n0:ACET:2026-09-29",
"ema_trend": "8.07 > 8.58 > 8.73",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:17:12.774775Z",
"facts": [
"The supplied Phase 1 lupus readout reports 54% DORIS remission and 50% complete renal response among 22 efficacy-evaluable patients after 12 months.",
"The N0 capture was +6.71% on about 3.05x average volume, while the 20-session asset return was -21.15% versus -0.40% for its healthcare proxy."
],
"benchmark_excess_pct": {
"sp500": -1.481,
"nasdaq100": -1.6911,
"russell2000": -1.1019
},
"price_as_of": "2026-09-29T20:55:28Z",
"vwap_as_of": null
},
{
"symbol": "PWP",
"role": "alternative",
"price": 17.1,
"base_price": 16.85,
"return_since_base_pct": 1.4837,
"session_return_pct": 4.4594,
"change_since_prior_pct": 0.0,
"volume_ratio": 5.79,
"rsi": 55.35,
"vwap": 16.26,
"vwap_distance_pct": 5.1661,
"position_52w_pct": 65.01,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:13:05Z",
"source": "yfinance_quote",
"name": "Perella Weinberg Partners",
"episode_id": "n0:PWP:2026-09-29",
"ema_trend": "14.6 > 14.8 > 15.42",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:15:55.598703Z",
"facts": [
"The catalyst is a report of acquisition talks, not a confirmed agreement.",
"The event capture was +15.1% on 5.79x average volume; the provider series retreated from its high but retained much of the move."
],
"benchmark_excess_pct": {
"sp500": 3.8569,
"nasdaq100": 3.6468,
"russell2000": 4.236
},
"price_as_of": "2026-09-29T21:13:05Z",
"vwap_as_of": null
},
{
"symbol": "KMX",
"role": "alternative",
"price": 59.35,
"base_price": 60.72,
"return_since_base_pct": -2.2563,
"session_return_pct": 0.2026,
"change_since_prior_pct": 0.0,
"volume_ratio": 2.26,
"rsi": 52.08,
"vwap": 61.4,
"vwap_distance_pct": -3.3388,
"position_52w_pct": 93.32,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:59:02Z",
"source": "yfinance_quote",
"name": "CarMax, Inc.",
"episode_id": "n0:KMX:2026-09-29",
"ema_trend": "58.29 > 58.97 > 58.5",
"vwap_state": "below",
"selection_as_of": "2026-09-29T15:17:34.477760Z",
"facts": [
"The supplied earnings report shows EPS of $1.16 versus $0.73 expected and sales of $7.878B versus $6.976B expected.",
"The provider trajectory faded from about +5.72% to +3.24%; the intraday reading was below VWAP with a downward trend.",
"The active H3/H8/H15 positive-return estimates are 0.547/0.567/0.528, higher than CCL's at each horizon. Its corresponding adverse-MAE medians are -3.25%/-4.20%/-6.09%. The separate audit-only H15 historical-dispersion output is P10 -5.31%, median +4.18%, P90 +16.31%. These comparisons use eight cases."
],
"benchmark_excess_pct": {
"sp500": -0.3999,
"nasdaq100": -0.61,
"russell2000": -0.0208
},
"price_as_of": "2026-09-29T20:59:02Z",
"vwap_as_of": null
},
{
"symbol": "WYY",
"role": "alternative",
"price": 7.28,
"base_price": 6.4203,
"return_since_base_pct": 13.3903,
"session_return_pct": -0.9524,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.39,
"rsi": 29.28,
"vwap": 6.2,
"vwap_distance_pct": 17.4194,
"position_52w_pct": 26.56,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:10:33Z",
"source": "yfinance_quote",
"name": "WidePoint Corporation",
"episode_id": "n0:WYY:2026-09-29",
"ema_trend": "8.81 > 9.89 > 10.68",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:18:38.363232Z",
"facts": [
"The provider trajectory rose from about +7.97% to +16.45%, and the intraday reading was above VWAP.",
"The 20-session asset return was -32.32% versus +4.15% for the technology proxy; no company-specific catalyst for the day's move was established."
],
"benchmark_excess_pct": {
"sp500": -1.5549,
"nasdaq100": -1.765,
"russell2000": -1.1758
},
"price_as_of": "2026-09-29T21:10:33Z",
"vwap_as_of": null
},
{
"symbol": "VIAV",
"role": "alternative",
"price": 41.99,
"base_price": 41.455,
"return_since_base_pct": 1.2906,
"session_return_pct": 0.4065,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.53,
"rsi": 57.12,
"vwap": 41.77,
"vwap_distance_pct": 0.5267,
"position_52w_pct": 68.56,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:16:33Z",
"source": "yfinance_quote",
"name": "Viavi Solutions Inc.",
"episode_id": "narrative:VIAV:b612043b612913e0",
"ema_trend": "38.56 > 37.68 > 38.08",
"vwap_state": "below",
"selection_as_of": "2026-09-29T17:19:34Z",
"facts": [
"The primary product announcement introduces a 100G testing platform but supplies no customer wins or expected revenue contribution.",
"The quote change was +1.37% on 0.53x average volume; price was below VWAP with a downward intraday trend."
],
"benchmark_excess_pct": {
"sp500": -0.196,
"nasdaq100": -0.4061,
"russell2000": 0.1831
},
"price_as_of": "2026-09-29T21:16:33Z",
"vwap_as_of": null
},
{
"symbol": "WH",
"role": "alternative",
"price": 72.44,
"base_price": 71.79,
"return_since_base_pct": 0.9054,
"session_return_pct": null,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.32,
"rsi": 60.7,
"vwap": 71.82,
"vwap_distance_pct": 0.8633,
"position_52w_pct": 79.55,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:00:33Z",
"source": "yfinance_quote",
"name": "Wyndham Hotels & Resorts, Inc.",
"episode_id": "narrative:WH:e6143a4ee8e53619",
"ema_trend": "69.87 > 70.21 > 72.36",
"vwap_state": "above",
"selection_as_of": "2026-09-29T17:19:31Z",
"facts": [
"The primary release reports a $400M increase to the share repurchase authorization.",
"The quote change was +1.47% on 0.32x average volume; the authorization does not establish that repurchases occurred."
],
"price_as_of": "2026-09-29T20:00:33Z",
"vwap_as_of": null
}
],
"benchmarks": [
{
"id": "sp500",
"symbol": "^GSPC",
"label": "S&P 500",
"role": "benchmark",
"price": 7717.06,
"base_price": 7670.84,
"return_since_base_pct": 0.6025,
"session_return_pct": 0.6025,
"as_of": "2026-09-30T14:59:02.277945Z",
"source": "yfinance.ticker_info",
"base_definition": "previous regular close"
},
{
"id": "nasdaq100",
"symbol": "^NDX",
"label": "Nasdaq 100",
"role": "benchmark",
"price": 30585.883,
"base_price": 30339.332,
"return_since_base_pct": 0.8126,
"session_return_pct": 0.8126,
"as_of": "2026-09-30T14:59:02.277945Z",
"source": "yfinance.ticker_info",
"base_definition": "previous regular close"
},
{
"id": "russell2000",
"symbol": "^RUT",
"label": "Russell 2000",
"role": "benchmark",
"price": 2814.1946,
"base_price": 2807.922,
"return_since_base_pct": 0.2234,
"session_return_pct": 0.2234,
"as_of": "2026-09-30T14:59:02.277945Z",
"source": "yfinance.ticker_info",
"base_definition": "previous regular close"
}
],
"coverage": {
"candidate_rows": 10,
"candidate_prices": 10,
"candidate_technical": 10,
"benchmark_rows": 3
}
}
},
{
"day": 1,
"timestamp": "2026-09-30T22:02:53.073090Z",
"comparison": {
"schema_version": "public-candidate-comparison.v1",
"captured_at": "2026-09-30T22:02:53.073090Z",
"base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
"source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
"rows": [
{
"symbol": "CCL",
"role": "selected",
"price": 24.62,
"base_price": 24.785,
"return_since_base_pct": -0.6657,
"session_return_pct": -2.27,
"change_since_prior_pct": -3.0709,
"volume_ratio": 1.72,
"rsi": 65.29,
"vwap": 25.0,
"vwap_distance_pct": -1.52,
"position_52w_pct": 72.1,
"extended_hours_pct": 0.33,
"as_of": "2026-09-30T20:55:04Z",
"source": "sealed_extended_quote",
"name": "Carnival Corporation Ltd.",
"episode_id": "n0:CCL:2026-09-29",
"ema_trend": "23.14 > 23.31 > 24.59",
"vwap_state": "below",
"selection_as_of": "2026-09-29T15:18:03.945792Z",
"facts": [
"The supplied earnings coverage reports adjusted EPS of $1.43 versus $1.36 expected, revenue of $8.435B versus $8.300B expected, and a slight increase to full-year adjusted EPS guidance.",
"The N0 capture records +11.95% on 2.05x average volume. The provider series remained near the move through its final supplied observation.",
"The 20-session record shows CCL +4.48% versus its sector proxy -6.75%, a +11.23 percentage-point difference.",
"The active H3/H8/H15 positive-return estimates are 0.470/0.469/0.502; corresponding adverse-MAE medians are -4.49%/-7.15%/-9.26%. The separate audit-only H15 historical-dispersion output is P10 -19.62%, median -1.26%, P90 +7.16%. These comparisons use eight cases."
],
"benchmark_excess_pct": {
"sp500": -2.8725,
"nasdaq100": -3.0826,
"russell2000": -2.4934
},
"price_as_of": "2026-09-30T20:55:04Z",
"vwap_as_of": null
},
{
"symbol": "SMMT",
"role": "alternative",
"price": 16.3387,
"base_price": 16.505,
"return_since_base_pct": -1.0076,
"session_return_pct": -0.313,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.35,
"rsi": 42.99,
"vwap": 17.03,
"vwap_distance_pct": -4.0593,
"position_52w_pct": 56.43,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:20:32Z",
"source": "yfinance_quote",
"name": "Summit Therapeutics Inc.",
"episode_id": "n0:SMMT:2026-09-29",
"ema_trend": "16.44 > 16.26 > 15.62",
"vwap_state": "below",
"selection_as_of": "2026-09-29T15:16:50.388704Z",
"facts": [
"The supplied event evidence describes a $2B AstraZeneca investment using newly issued convertible preferred shares and a clinical collaboration.",
"The N0 event capture was +6.62% on 3.35x average volume, but the provider series faded to about +5.33% and the intraday reading was below VWAP."
],
"benchmark_excess_pct": {
"sp500": -0.9155,
"nasdaq100": -1.1256,
"russell2000": -0.5364
},
"price_as_of": "2026-09-29T21:20:32Z",
"vwap_as_of": null
},
{
"symbol": "HAFN",
"role": "alternative",
"price": 9.77,
"base_price": 9.56,
"return_since_base_pct": 2.1967,
"session_return_pct": 1.0341,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.24,
"rsi": 57.04,
"vwap": 9.53,
"vwap_distance_pct": 2.5184,
"position_52w_pct": 94.57,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:05:26Z",
"source": "yfinance_quote",
"name": "Hafnia Limited",
"episode_id": "n0:HAFN:2026-09-29",
"ema_trend": "9.27 > 9.0 > 8.33",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:18:47.711682Z",
"facts": [
"The N0 capture was +4.71% on 1.24x average volume; later provider observations retained a somewhat larger gain and price was above VWAP.",
"No company-specific catalyst was established in the supplied dossier."
],
"benchmark_excess_pct": {
"sp500": 0.4316,
"nasdaq100": 0.2215,
"russell2000": 0.8107
},
"price_as_of": "2026-09-29T21:05:26Z",
"vwap_as_of": null
},
{
"symbol": "NTWK",
"role": "alternative",
"price": 5.56,
"base_price": 5.5496,
"return_since_base_pct": 0.1874,
"session_return_pct": 3.36,
"change_since_prior_pct": 0.0,
"volume_ratio": 14.19,
"rsi": 89.74,
"vwap": 5.5,
"vwap_distance_pct": 1.0909,
"position_52w_pct": 98.75,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:10:08Z",
"source": "yfinance_quote",
"name": "NetSol Technologies, Inc.",
"episode_id": "n0:NTWK:2026-09-29",
"ema_trend": "4.87 > 4.54 > 4.38",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:15:36.965867Z",
"facts": [
"The supplied FY26 results report revenue of $74.4M, up 12.5%, and FY27 revenue guidance of $84.1M-$86.3M.",
"The event capture was +3.36% on 14.19x average volume, but the dossier estimates about $2M of dollar turnover and places price 3.06 ATR above its EMA reference."
],
"benchmark_excess_pct": {
"sp500": 2.7575,
"nasdaq100": 2.5474,
"russell2000": 3.1366
},
"price_as_of": "2026-09-29T20:10:08Z",
"vwap_as_of": null
},
{
"symbol": "ACET",
"role": "alternative",
"price": 6.77,
"base_price": 6.78,
"return_since_base_pct": -0.1475,
"session_return_pct": -0.8785,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.05,
"rsi": 31.39,
"vwap": 6.69,
"vwap_distance_pct": 1.1958,
"position_52w_pct": 38.99,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:55:28Z",
"source": "yfinance_quote",
"name": "Adicet Bio, Inc.",
"episode_id": "n0:ACET:2026-09-29",
"ema_trend": "8.07 > 8.58 > 8.73",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:17:12.774775Z",
"facts": [
"The supplied Phase 1 lupus readout reports 54% DORIS remission and 50% complete renal response among 22 efficacy-evaluable patients after 12 months.",
"The N0 capture was +6.71% on about 3.05x average volume, while the 20-session asset return was -21.15% versus -0.40% for its healthcare proxy."
],
"benchmark_excess_pct": {
"sp500": -1.481,
"nasdaq100": -1.6911,
"russell2000": -1.1019
},
"price_as_of": "2026-09-29T20:55:28Z",
"vwap_as_of": null
},
{
"symbol": "PWP",
"role": "alternative",
"price": 17.1,
"base_price": 16.85,
"return_since_base_pct": 1.4837,
"session_return_pct": 4.4594,
"change_since_prior_pct": 0.0,
"volume_ratio": 5.79,
"rsi": 55.35,
"vwap": 16.26,
"vwap_distance_pct": 5.1661,
"position_52w_pct": 65.01,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:13:05Z",
"source": "yfinance_quote",
"name": "Perella Weinberg Partners",
"episode_id": "n0:PWP:2026-09-29",
"ema_trend": "14.6 > 14.8 > 15.42",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:15:55.598703Z",
"facts": [
"The catalyst is a report of acquisition talks, not a confirmed agreement.",
"The event capture was +15.1% on 5.79x average volume; the provider series retreated from its high but retained much of the move."
],
"benchmark_excess_pct": {
"sp500": 3.8569,
"nasdaq100": 3.6468,
"russell2000": 4.236
},
"price_as_of": "2026-09-29T21:13:05Z",
"vwap_as_of": null
},
{
"symbol": "KMX",
"role": "alternative",
"price": 59.35,
"base_price": 60.72,
"return_since_base_pct": -2.2563,
"session_return_pct": 0.2026,
"change_since_prior_pct": 0.0,
"volume_ratio": 2.26,
"rsi": 52.08,
"vwap": 61.4,
"vwap_distance_pct": -3.3388,
"position_52w_pct": 93.32,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:59:02Z",
"source": "yfinance_quote",
"name": "CarMax, Inc.",
"episode_id": "n0:KMX:2026-09-29",
"ema_trend": "58.29 > 58.97 > 58.5",
"vwap_state": "below",
"selection_as_of": "2026-09-29T15:17:34.477760Z",
"facts": [
"The supplied earnings report shows EPS of $1.16 versus $0.73 expected and sales of $7.878B versus $6.976B expected.",
"The provider trajectory faded from about +5.72% to +3.24%; the intraday reading was below VWAP with a downward trend.",
"The active H3/H8/H15 positive-return estimates are 0.547/0.567/0.528, higher than CCL's at each horizon. Its corresponding adverse-MAE medians are -3.25%/-4.20%/-6.09%. The separate audit-only H15 historical-dispersion output is P10 -5.31%, median +4.18%, P90 +16.31%. These comparisons use eight cases."
],
"benchmark_excess_pct": {
"sp500": -0.3999,
"nasdaq100": -0.61,
"russell2000": -0.0208
},
"price_as_of": "2026-09-29T20:59:02Z",
"vwap_as_of": null
},
{
"symbol": "WYY",
"role": "alternative",
"price": 7.28,
"base_price": 6.4203,
"return_since_base_pct": 13.3903,
"session_return_pct": -0.9524,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.39,
"rsi": 29.28,
"vwap": 6.2,
"vwap_distance_pct": 17.4194,
"position_52w_pct": 26.56,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:10:33Z",
"source": "yfinance_quote",
"name": "WidePoint Corporation",
"episode_id": "n0:WYY:2026-09-29",
"ema_trend": "8.81 > 9.89 > 10.68",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:18:38.363232Z",
"facts": [
"The provider trajectory rose from about +7.97% to +16.45%, and the intraday reading was above VWAP.",
"The 20-session asset return was -32.32% versus +4.15% for the technology proxy; no company-specific catalyst for the day's move was established."
],
"benchmark_excess_pct": {
"sp500": -1.5549,
"nasdaq100": -1.765,
"russell2000": -1.1758
},
"price_as_of": "2026-09-29T21:10:33Z",
"vwap_as_of": null
},
{
"symbol": "VIAV",
"role": "alternative",
"price": 41.99,
"base_price": 41.455,
"return_since_base_pct": 1.2906,
"session_return_pct": 0.4065,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.53,
"rsi": 57.12,
"vwap": 41.77,
"vwap_distance_pct": 0.5267,
"position_52w_pct": 68.56,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:16:33Z",
"source": "yfinance_quote",
"name": "Viavi Solutions Inc.",
"episode_id": "narrative:VIAV:b612043b612913e0",
"ema_trend": "38.56 > 37.68 > 38.08",
"vwap_state": "below",
"selection_as_of": "2026-09-29T17:19:34Z",
"facts": [
"The primary product announcement introduces a 100G testing platform but supplies no customer wins or expected revenue contribution.",
"The quote change was +1.37% on 0.53x average volume; price was below VWAP with a downward intraday trend."
],
"benchmark_excess_pct": {
"sp500": -0.196,
"nasdaq100": -0.4061,
"russell2000": 0.1831
},
"price_as_of": "2026-09-29T21:16:33Z",
"vwap_as_of": null
},
{
"symbol": "WH",
"role": "alternative",
"price": 72.44,
"base_price": 71.79,
"return_since_base_pct": 0.9054,
"session_return_pct": null,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.32,
"rsi": 60.7,
"vwap": 71.82,
"vwap_distance_pct": 0.8633,
"position_52w_pct": 79.55,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:00:33Z",
"source": "yfinance_quote",
"name": "Wyndham Hotels & Resorts, Inc.",
"episode_id": "narrative:WH:e6143a4ee8e53619",
"ema_trend": "69.87 > 70.21 > 72.36",
"vwap_state": "above",
"selection_as_of": "2026-09-29T17:19:31Z",
"facts": [
"The primary release reports a $400M increase to the share repurchase authorization.",
"The quote change was +1.47% on 0.32x average volume; the authorization does not establish that repurchases occurred."
],
"price_as_of": "2026-09-29T20:00:33Z",
"vwap_as_of": null
}
],
"benchmarks": [
{
"id": "sp500",
"symbol": "^GSPC",
"label": "S&P 500",
"role": "benchmark",
"price": 7717.06,
"base_price": 7670.84,
"return_since_base_pct": 0.6025,
"session_return_pct": 0.6025,
"as_of": "2026-09-30T14:59:02.277945Z",
"source": "yfinance.ticker_info",
"base_definition": "previous regular close"
},
{
"id": "nasdaq100",
"symbol": "^NDX",
"label": "Nasdaq 100",
"role": "benchmark",
"price": 30585.883,
"base_price": 30339.332,
"return_since_base_pct": 0.8126,
"session_return_pct": 0.8126,
"as_of": "2026-09-30T14:59:02.277945Z",
"source": "yfinance.ticker_info",
"base_definition": "previous regular close"
},
{
"id": "russell2000",
"symbol": "^RUT",
"label": "Russell 2000",
"role": "benchmark",
"price": 2814.1946,
"base_price": 2807.922,
"return_since_base_pct": 0.2234,
"session_return_pct": 0.2234,
"as_of": "2026-09-30T14:59:02.277945Z",
"source": "yfinance.ticker_info",
"base_definition": "previous regular close"
}
],
"coverage": {
"candidate_rows": 10,
"candidate_prices": 10,
"candidate_technical": 10,
"benchmark_rows": 3
}
}
},
{
"day": 1,
"timestamp": "2026-09-30T22:02:53.073090Z",
"comparison": {
"schema_version": "public-candidate-comparison.v1",
"captured_at": "2026-09-30T22:02:53.073090Z",
"base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
"source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
"rows": [
{
"symbol": "CCL",
"role": "selected",
"price": 24.61,
"base_price": 24.785,
"return_since_base_pct": -0.7061,
"session_return_pct": -1.99,
"change_since_prior_pct": -0.0406,
"volume_ratio": 1.33,
"rsi": 65.92,
"vwap": 25.0,
"vwap_distance_pct": -1.56,
"position_52w_pct": 72.3,
"extended_hours_pct": null,
"as_of": "2026-09-30T19:58:16.738162Z",
"source": "yfinance_quote",
"name": "Carnival Corporation Ltd.",
"episode_id": "n0:CCL:2026-09-29",
"ema_trend": "23.15 > 23.31 > 24.59",
"vwap_state": "below",
"selection_as_of": "2026-09-29T15:18:03.945792Z",
"facts": [
"The supplied earnings coverage reports adjusted EPS of $1.43 versus $1.36 expected, revenue of $8.435B versus $8.300B expected, and a slight increase to full-year adjusted EPS guidance.",
"The N0 capture records +11.95% on 2.05x average volume. The provider series remained near the move through its final supplied observation.",
"The 20-session record shows CCL +4.48% versus its sector proxy -6.75%, a +11.23 percentage-point difference.",
"The active H3/H8/H15 positive-return estimates are 0.470/0.469/0.502; corresponding adverse-MAE medians are -4.49%/-7.15%/-9.26%. The separate audit-only H15 historical-dispersion output is P10 -19.62%, median -1.26%, P90 +7.16%. These comparisons use eight cases."
],
"price_as_of": "2026-09-30T19:58:16.738162Z",
"vwap_as_of": null
},
{
"symbol": "SMMT",
"role": "alternative",
"price": 16.3387,
"base_price": 16.505,
"return_since_base_pct": -1.0076,
"session_return_pct": -0.313,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.35,
"rsi": 42.99,
"vwap": 17.03,
"vwap_distance_pct": -4.0593,
"position_52w_pct": 56.43,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:20:32Z",
"source": "yfinance_quote",
"name": "Summit Therapeutics Inc.",
"episode_id": "n0:SMMT:2026-09-29",
"ema_trend": "16.44 > 16.26 > 15.62",
"vwap_state": "below",
"selection_as_of": "2026-09-29T15:16:50.388704Z",
"facts": [
"The supplied event evidence describes a $2B AstraZeneca investment using newly issued convertible preferred shares and a clinical collaboration.",
"The N0 event capture was +6.62% on 3.35x average volume, but the provider series faded to about +5.33% and the intraday reading was below VWAP."
],
"price_as_of": "2026-09-29T21:20:32Z",
"vwap_as_of": null
},
{
"symbol": "HAFN",
"role": "alternative",
"price": 9.77,
"base_price": 9.56,
"return_since_base_pct": 2.1967,
"session_return_pct": 1.0341,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.24,
"rsi": 57.04,
"vwap": 9.53,
"vwap_distance_pct": 2.5184,
"position_52w_pct": 94.57,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:05:26Z",
"source": "yfinance_quote",
"name": "Hafnia Limited",
"episode_id": "n0:HAFN:2026-09-29",
"ema_trend": "9.27 > 9.0 > 8.33",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:18:47.711682Z",
"facts": [
"The N0 capture was +4.71% on 1.24x average volume; later provider observations retained a somewhat larger gain and price was above VWAP.",
"No company-specific catalyst was established in the supplied dossier."
],
"price_as_of": "2026-09-29T21:05:26Z",
"vwap_as_of": null
},
{
"symbol": "NTWK",
"role": "alternative",
"price": 5.56,
"base_price": 5.5496,
"return_since_base_pct": 0.1874,
"session_return_pct": 3.36,
"change_since_prior_pct": 0.0,
"volume_ratio": 14.19,
"rsi": 89.74,
"vwap": 5.5,
"vwap_distance_pct": 1.0909,
"position_52w_pct": 98.75,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:10:08Z",
"source": "yfinance_quote",
"name": "NetSol Technologies, Inc.",
"episode_id": "n0:NTWK:2026-09-29",
"ema_trend": "4.87 > 4.54 > 4.38",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:15:36.965867Z",
"facts": [
"The supplied FY26 results report revenue of $74.4M, up 12.5%, and FY27 revenue guidance of $84.1M-$86.3M.",
"The event capture was +3.36% on 14.19x average volume, but the dossier estimates about $2M of dollar turnover and places price 3.06 ATR above its EMA reference."
],
"price_as_of": "2026-09-29T20:10:08Z",
"vwap_as_of": null
},
{
"symbol": "ACET",
"role": "alternative",
"price": 6.77,
"base_price": 6.78,
"return_since_base_pct": -0.1475,
"session_return_pct": -0.8785,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.05,
"rsi": 31.39,
"vwap": 6.69,
"vwap_distance_pct": 1.1958,
"position_52w_pct": 38.99,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:55:28Z",
"source": "yfinance_quote",
"name": "Adicet Bio, Inc.",
"episode_id": "n0:ACET:2026-09-29",
"ema_trend": "8.07 > 8.58 > 8.73",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:17:12.774775Z",
"facts": [
"The supplied Phase 1 lupus readout reports 54% DORIS remission and 50% complete renal response among 22 efficacy-evaluable patients after 12 months.",
"The N0 capture was +6.71% on about 3.05x average volume, while the 20-session asset return was -21.15% versus -0.40% for its healthcare proxy."
],
"price_as_of": "2026-09-29T20:55:28Z",
"vwap_as_of": null
},
{
"symbol": "PWP",
"role": "alternative",
"price": 17.1,
"base_price": 16.85,
"return_since_base_pct": 1.4837,
"session_return_pct": 4.4594,
"change_since_prior_pct": 0.0,
"volume_ratio": 5.79,
"rsi": 55.35,
"vwap": 16.26,
"vwap_distance_pct": 5.1661,
"position_52w_pct": 65.01,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:13:05Z",
"source": "yfinance_quote",
"name": "Perella Weinberg Partners",
"episode_id": "n0:PWP:2026-09-29",
"ema_trend": "14.6 > 14.8 > 15.42",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:15:55.598703Z",
"facts": [
"The catalyst is a report of acquisition talks, not a confirmed agreement.",
"The event capture was +15.1% on 5.79x average volume; the provider series retreated from its high but retained much of the move."
],
"price_as_of": "2026-09-29T21:13:05Z",
"vwap_as_of": null
},
{
"symbol": "KMX",
"role": "alternative",
"price": 59.35,
"base_price": 60.72,
"return_since_base_pct": -2.2563,
"session_return_pct": 0.2026,
"change_since_prior_pct": 0.0,
"volume_ratio": 2.26,
"rsi": 52.08,
"vwap": 61.4,
"vwap_distance_pct": -3.3388,
"position_52w_pct": 93.32,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:59:02Z",
"source": "yfinance_quote",
"name": "CarMax, Inc.",
"episode_id": "n0:KMX:2026-09-29",
"ema_trend": "58.29 > 58.97 > 58.5",
"vwap_state": "below",
"selection_as_of": "2026-09-29T15:17:34.477760Z",
"facts": [
"The supplied earnings report shows EPS of $1.16 versus $0.73 expected and sales of $7.878B versus $6.976B expected.",
"The provider trajectory faded from about +5.72% to +3.24%; the intraday reading was below VWAP with a downward trend.",
"The active H3/H8/H15 positive-return estimates are 0.547/0.567/0.528, higher than CCL's at each horizon. Its corresponding adverse-MAE medians are -3.25%/-4.20%/-6.09%. The separate audit-only H15 historical-dispersion output is P10 -5.31%, median +4.18%, P90 +16.31%. These comparisons use eight cases."
],
"price_as_of": "2026-09-29T20:59:02Z",
"vwap_as_of": null
},
{
"symbol": "WYY",
"role": "alternative",
"price": 7.28,
"base_price": 6.4203,
"return_since_base_pct": 13.3903,
"session_return_pct": -0.9524,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.39,
"rsi": 29.28,
"vwap": 6.2,
"vwap_distance_pct": 17.4194,
"position_52w_pct": 26.56,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:10:33Z",
"source": "yfinance_quote",
"name": "WidePoint Corporation",
"episode_id": "n0:WYY:2026-09-29",
"ema_trend": "8.81 > 9.89 > 10.68",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:18:38.363232Z",
"facts": [
"The provider trajectory rose from about +7.97% to +16.45%, and the intraday reading was above VWAP.",
"The 20-session asset return was -32.32% versus +4.15% for the technology proxy; no company-specific catalyst for the day's move was established."
],
"price_as_of": "2026-09-29T21:10:33Z",
"vwap_as_of": null
},
{
"symbol": "VIAV",
"role": "alternative",
"price": 41.99,
"base_price": 41.455,
"return_since_base_pct": 1.2906,
"session_return_pct": 0.4065,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.53,
"rsi": 57.12,
"vwap": 41.77,
"vwap_distance_pct": 0.5267,
"position_52w_pct": 68.56,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:16:33Z",
"source": "yfinance_quote",
"name": "Viavi Solutions Inc.",
"episode_id": "narrative:VIAV:b612043b612913e0",
"ema_trend": "38.56 > 37.68 > 38.08",
"vwap_state": "below",
"selection_as_of": "2026-09-29T17:19:34Z",
"facts": [
"The primary product announcement introduces a 100G testing platform but supplies no customer wins or expected revenue contribution.",
"The quote change was +1.37% on 0.53x average volume; price was below VWAP with a downward intraday trend."
],
"price_as_of": "2026-09-29T21:16:33Z",
"vwap_as_of": null
},
{
"symbol": "WH",
"role": "alternative",
"price": 72.44,
"base_price": 71.79,
"return_since_base_pct": 0.9054,
"session_return_pct": null,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.32,
"rsi": 60.7,
"vwap": 71.82,
"vwap_distance_pct": 0.8633,
"position_52w_pct": 79.55,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:00:33Z",
"source": "yfinance_quote",
"name": "Wyndham Hotels & Resorts, Inc.",
"episode_id": "narrative:WH:e6143a4ee8e53619",
"ema_trend": "69.87 > 70.21 > 72.36",
"vwap_state": "above",
"selection_as_of": "2026-09-29T17:19:31Z",
"facts": [
"The primary release reports a $400M increase to the share repurchase authorization.",
"The quote change was +1.47% on 0.32x average volume; the authorization does not establish that repurchases occurred."
],
"price_as_of": "2026-09-29T20:00:33Z",
"vwap_as_of": null
}
],
"benchmarks": [],
"coverage": {
"candidate_rows": 10,
"candidate_prices": 10,
"candidate_technical": 10,
"benchmark_rows": 0
}
}
},
{
"day": 3,
"timestamp": "2026-10-02T20:32:46.631953Z",
"comparison": {
"schema_version": "public-candidate-comparison.v1",
"captured_at": "2026-10-02T20:32:46.631953Z",
"base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
"source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
"rows": [
{
"symbol": "CCL",
"role": "selected",
"price": 25.745,
"base_price": 24.785,
"return_since_base_pct": 3.8733,
"session_return_pct": 2.69,
"change_since_prior_pct": 4.6119,
"volume_ratio": 0.96,
"rsi": 71.2,
"vwap": 25.62,
"vwap_distance_pct": 0.4879,
"position_52w_pct": 75.7,
"extended_hours_pct": null,
"as_of": "2026-10-02T19:21:55.629539Z",
"source": "yfinance_quote",
"name": "Carnival Corporation Ltd.",
"episode_id": "n0:CCL:2026-09-29",
"ema_trend": "23.97 > 23.67 > 24.65",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:18:03.945792Z",
"facts": [
"The supplied earnings coverage reports adjusted EPS of $1.43 versus $1.36 expected, revenue of $8.435B versus $8.300B expected, and a slight increase to full-year adjusted EPS guidance.",
"The N0 capture records +11.95% on 2.05x average volume. The provider series remained near the move through its final supplied observation.",
"The 20-session record shows CCL +4.48% versus its sector proxy -6.75%, a +11.23 percentage-point difference.",
"The active H3/H8/H15 positive-return estimates are 0.470/0.469/0.502; corresponding adverse-MAE medians are -4.49%/-7.15%/-9.26%. The separate audit-only H15 historical-dispersion output is P10 -19.62%, median -1.26%, P90 +7.16%. These comparisons use eight cases."
],
"benchmark_excess_pct": {
"sp500": 1.9567,
"nasdaq100": 1.7451,
"russell2000": 1.7073
},
"price_as_of": "2026-10-02T19:21:55.629539Z",
"vwap_as_of": null
},
{
"symbol": "SMMT",
"role": "alternative",
"price": 16.3387,
"base_price": 16.505,
"return_since_base_pct": -1.0076,
"session_return_pct": -0.313,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.35,
"rsi": 42.99,
"vwap": 17.03,
"vwap_distance_pct": -4.0593,
"position_52w_pct": 56.43,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:20:32Z",
"source": "yfinance_quote",
"name": "Summit Therapeutics Inc.",
"episode_id": "n0:SMMT:2026-09-29",
"ema_trend": "16.44 > 16.26 > 15.62",
"vwap_state": "below",
"selection_as_of": "2026-09-29T15:16:50.388704Z",
"facts": [
"The supplied event evidence describes a $2B AstraZeneca investment using newly issued convertible preferred shares and a clinical collaboration.",
"The N0 event capture was +6.62% on 3.35x average volume, but the provider series faded to about +5.33% and the intraday reading was below VWAP."
],
"benchmark_excess_pct": {
"sp500": -1.0463,
"nasdaq100": -1.2579,
"russell2000": -1.2957
},
"price_as_of": "2026-09-29T21:20:32Z",
"vwap_as_of": null
},
{
"symbol": "HAFN",
"role": "alternative",
"price": 9.77,
"base_price": 9.56,
"return_since_base_pct": 2.1967,
"session_return_pct": 1.0341,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.24,
"rsi": 57.04,
"vwap": 9.53,
"vwap_distance_pct": 2.5184,
"position_52w_pct": 94.57,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:05:26Z",
"source": "yfinance_quote",
"name": "Hafnia Limited",
"episode_id": "n0:HAFN:2026-09-29",
"ema_trend": "9.27 > 9.0 > 8.33",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:18:47.711682Z",
"facts": [
"The N0 capture was +4.71% on 1.24x average volume; later provider observations retained a somewhat larger gain and price was above VWAP.",
"No company-specific catalyst was established in the supplied dossier."
],
"benchmark_excess_pct": {
"sp500": 0.3008,
"nasdaq100": 0.0892,
"russell2000": 0.0514
},
"price_as_of": "2026-09-29T21:05:26Z",
"vwap_as_of": null
},
{
"symbol": "NTWK",
"role": "alternative",
"price": 5.56,
"base_price": 5.5496,
"return_since_base_pct": 0.1874,
"session_return_pct": 3.36,
"change_since_prior_pct": 0.0,
"volume_ratio": 14.19,
"rsi": 89.74,
"vwap": 5.5,
"vwap_distance_pct": 1.0909,
"position_52w_pct": 98.75,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:10:08Z",
"source": "yfinance_quote",
"name": "NetSol Technologies, Inc.",
"episode_id": "n0:NTWK:2026-09-29",
"ema_trend": "4.87 > 4.54 > 4.38",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:15:36.965867Z",
"facts": [
"The supplied FY26 results report revenue of $74.4M, up 12.5%, and FY27 revenue guidance of $84.1M-$86.3M.",
"The event capture was +3.36% on 14.19x average volume, but the dossier estimates about $2M of dollar turnover and places price 3.06 ATR above its EMA reference."
],
"benchmark_excess_pct": {
"sp500": 2.6267,
"nasdaq100": 2.4151,
"russell2000": 2.3773
},
"price_as_of": "2026-09-29T20:10:08Z",
"vwap_as_of": null
},
{
"symbol": "ACET",
"role": "alternative",
"price": 6.77,
"base_price": 6.78,
"return_since_base_pct": -0.1475,
"session_return_pct": -0.8785,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.05,
"rsi": 31.39,
"vwap": 6.69,
"vwap_distance_pct": 1.1958,
"position_52w_pct": 38.99,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:55:28Z",
"source": "yfinance_quote",
"name": "Adicet Bio, Inc.",
"episode_id": "n0:ACET:2026-09-29",
"ema_trend": "8.07 > 8.58 > 8.73",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:17:12.774775Z",
"facts": [
"The supplied Phase 1 lupus readout reports 54% DORIS remission and 50% complete renal response among 22 efficacy-evaluable patients after 12 months.",
"The N0 capture was +6.71% on about 3.05x average volume, while the 20-session asset return was -21.15% versus -0.40% for its healthcare proxy."
],
"benchmark_excess_pct": {
"sp500": -1.6118,
"nasdaq100": -1.8234,
"russell2000": -1.8612
},
"price_as_of": "2026-09-29T20:55:28Z",
"vwap_as_of": null
},
{
"symbol": "PWP",
"role": "alternative",
"price": 17.1,
"base_price": 16.85,
"return_since_base_pct": 1.4837,
"session_return_pct": 4.4594,
"change_since_prior_pct": 0.0,
"volume_ratio": 5.79,
"rsi": 55.35,
"vwap": 16.26,
"vwap_distance_pct": 5.1661,
"position_52w_pct": 65.01,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:13:05Z",
"source": "yfinance_quote",
"name": "Perella Weinberg Partners",
"episode_id": "n0:PWP:2026-09-29",
"ema_trend": "14.6 > 14.8 > 15.42",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:15:55.598703Z",
"facts": [
"The catalyst is a report of acquisition talks, not a confirmed agreement.",
"The event capture was +15.1% on 5.79x average volume; the provider series retreated from its high but retained much of the move."
],
"benchmark_excess_pct": {
"sp500": 3.7261,
"nasdaq100": 3.5145,
"russell2000": 3.4767
},
"price_as_of": "2026-09-29T21:13:05Z",
"vwap_as_of": null
},
{
"symbol": "KMX",
"role": "alternative",
"price": 59.35,
"base_price": 60.72,
"return_since_base_pct": -2.2563,
"session_return_pct": 0.2026,
"change_since_prior_pct": 0.0,
"volume_ratio": 2.26,
"rsi": 52.08,
"vwap": 61.4,
"vwap_distance_pct": -3.3388,
"position_52w_pct": 93.32,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:59:02Z",
"source": "yfinance_quote",
"name": "CarMax, Inc.",
"episode_id": "n0:KMX:2026-09-29",
"ema_trend": "58.29 > 58.97 > 58.5",
"vwap_state": "below",
"selection_as_of": "2026-09-29T15:17:34.477760Z",
"facts": [
"The supplied earnings report shows EPS of $1.16 versus $0.73 expected and sales of $7.878B versus $6.976B expected.",
"The provider trajectory faded from about +5.72% to +3.24%; the intraday reading was below VWAP with a downward trend.",
"The active H3/H8/H15 positive-return estimates are 0.547/0.567/0.528, higher than CCL's at each horizon. Its corresponding adverse-MAE medians are -3.25%/-4.20%/-6.09%. The separate audit-only H15 historical-dispersion output is P10 -5.31%, median +4.18%, P90 +16.31%. These comparisons use eight cases."
],
"benchmark_excess_pct": {
"sp500": -0.5307,
"nasdaq100": -0.7423,
"russell2000": -0.7801
},
"price_as_of": "2026-09-29T20:59:02Z",
"vwap_as_of": null
},
{
"symbol": "WYY",
"role": "alternative",
"price": 7.28,
"base_price": 6.4203,
"return_since_base_pct": 13.3903,
"session_return_pct": -0.9524,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.39,
"rsi": 29.28,
"vwap": 6.2,
"vwap_distance_pct": 17.4194,
"position_52w_pct": 26.56,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:10:33Z",
"source": "yfinance_quote",
"name": "WidePoint Corporation",
"episode_id": "n0:WYY:2026-09-29",
"ema_trend": "8.81 > 9.89 > 10.68",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:18:38.363232Z",
"facts": [
"The provider trajectory rose from about +7.97% to +16.45%, and the intraday reading was above VWAP.",
"The 20-session asset return was -32.32% versus +4.15% for the technology proxy; no company-specific catalyst for the day's move was established."
],
"benchmark_excess_pct": {
"sp500": -1.6857,
"nasdaq100": -1.8973,
"russell2000": -1.9351
},
"price_as_of": "2026-09-29T21:10:33Z",
"vwap_as_of": null
},
{
"symbol": "VIAV",
"role": "alternative",
"price": 41.99,
"base_price": 41.455,
"return_since_base_pct": 1.2906,
"session_return_pct": 0.4065,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.53,
"rsi": 57.12,
"vwap": 41.77,
"vwap_distance_pct": 0.5267,
"position_52w_pct": 68.56,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:16:33Z",
"source": "yfinance_quote",
"name": "Viavi Solutions Inc.",
"episode_id": "narrative:VIAV:b612043b612913e0",
"ema_trend": "38.56 > 37.68 > 38.08",
"vwap_state": "below",
"selection_as_of": "2026-09-29T17:19:34Z",
"facts": [
"The primary product announcement introduces a 100G testing platform but supplies no customer wins or expected revenue contribution.",
"The quote change was +1.37% on 0.53x average volume; price was below VWAP with a downward intraday trend."
],
"benchmark_excess_pct": {
"sp500": -0.3268,
"nasdaq100": -0.5384,
"russell2000": -0.5762
},
"price_as_of": "2026-09-29T21:16:33Z",
"vwap_as_of": null
},
{
"symbol": "WH",
"role": "alternative",
"price": 72.44,
"base_price": 71.79,
"return_since_base_pct": 0.9054,
"session_return_pct": null,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.32,
"rsi": 60.7,
"vwap": 71.82,
"vwap_distance_pct": 0.8633,
"position_52w_pct": 79.55,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:00:33Z",
"source": "yfinance_quote",
"name": "Wyndham Hotels & Resorts, Inc.",
"episode_id": "narrative:WH:e6143a4ee8e53619",
"ema_trend": "69.87 > 70.21 > 72.36",
"vwap_state": "above",
"selection_as_of": "2026-09-29T17:19:31Z",
"facts": [
"The primary release reports a $400M increase to the share repurchase authorization.",
"The quote change was +1.47% on 0.32x average volume; the authorization does not establish that repurchases occurred."
],
"price_as_of": "2026-09-29T20:00:33Z",
"vwap_as_of": null
}
],
"benchmarks": [
{
"id": "sp500",
"symbol": "^GSPC",
"label": "S&P 500",
"role": "benchmark",
"price": 7722.67,
"base_price": 7666.45,
"return_since_base_pct": 0.7333,
"session_return_pct": 0.7333,
"as_of": "2026-10-02T19:56:33.562446Z",
"source": "yfinance.ticker_info",
"base_definition": "previous regular close"
},
{
"id": "nasdaq100",
"symbol": "^NDX",
"label": "Nasdaq 100",
"role": "benchmark",
"price": 30789.762,
"base_price": 30501.56,
"return_since_base_pct": 0.9449,
"session_return_pct": 0.9449,
"as_of": "2026-10-02T19:56:33.562446Z",
"source": "yfinance.ticker_info",
"base_definition": "previous regular close"
},
{
"id": "russell2000",
"symbol": "^RUT",
"label": "Russell 2000",
"role": "benchmark",
"price": 2834.2056,
"base_price": 2806.625,
"return_since_base_pct": 0.9827,
"session_return_pct": 0.9827,
"as_of": "2026-10-02T19:56:33.562446Z",
"source": "yfinance.ticker_info",
"base_definition": "previous regular close"
}
],
"coverage": {
"candidate_rows": 10,
"candidate_prices": 10,
"candidate_technical": 10,
"benchmark_rows": 3
}
}
},
{
"day": 3,
"timestamp": "2026-10-03T11:27:22.252766Z",
"comparison": {
"schema_version": "public-candidate-comparison.v1",
"captured_at": "2026-10-03T11:27:22.252766Z",
"base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
"source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
"rows": [
{
"symbol": "CCL",
"role": "selected",
"price": 25.79,
"base_price": 24.785,
"return_since_base_pct": 4.0549,
"session_return_pct": 2.75,
"change_since_prior_pct": 0.1748,
"volume_ratio": 1.3,
"rsi": 71.28,
"vwap": 25.62,
"vwap_distance_pct": 0.6635,
"position_52w_pct": 75.7,
"extended_hours_pct": 0.11,
"as_of": "2026-10-02T22:40:08Z",
"source": "sealed_extended_quote",
"name": "Carnival Corporation Ltd.",
"episode_id": "n0:CCL:2026-09-29",
"ema_trend": "23.97 > 23.67 > 24.65",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:18:03.945792Z",
"facts": [
"The supplied earnings coverage reports adjusted EPS of $1.43 versus $1.36 expected, revenue of $8.435B versus $8.300B expected, and a slight increase to full-year adjusted EPS guidance.",
"The N0 capture records +11.95% on 2.05x average volume. The provider series remained near the move through its final supplied observation.",
"The 20-session record shows CCL +4.48% versus its sector proxy -6.75%, a +11.23 percentage-point difference.",
"The active H3/H8/H15 positive-return estimates are 0.470/0.469/0.502; corresponding adverse-MAE medians are -4.49%/-7.15%/-9.26%. The separate audit-only H15 historical-dispersion output is P10 -19.62%, median -1.26%, P90 +7.16%. These comparisons use eight cases."
],
"price_as_of": "2026-10-02T22:40:08Z",
"vwap_as_of": null
},
{
"symbol": "SMMT",
"role": "alternative",
"price": 16.3387,
"base_price": 16.505,
"return_since_base_pct": -1.0076,
"session_return_pct": -0.313,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.35,
"rsi": 42.99,
"vwap": 17.03,
"vwap_distance_pct": -4.0593,
"position_52w_pct": 56.43,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:20:32Z",
"source": "yfinance_quote",
"name": "Summit Therapeutics Inc.",
"episode_id": "n0:SMMT:2026-09-29",
"ema_trend": "16.44 > 16.26 > 15.62",
"vwap_state": "below",
"selection_as_of": "2026-09-29T15:16:50.388704Z",
"facts": [
"The supplied event evidence describes a $2B AstraZeneca investment using newly issued convertible preferred shares and a clinical collaboration.",
"The N0 event capture was +6.62% on 3.35x average volume, but the provider series faded to about +5.33% and the intraday reading was below VWAP."
],
"price_as_of": "2026-09-29T21:20:32Z",
"vwap_as_of": null
},
{
"symbol": "HAFN",
"role": "alternative",
"price": 9.77,
"base_price": 9.56,
"return_since_base_pct": 2.1967,
"session_return_pct": 1.0341,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.24,
"rsi": 57.04,
"vwap": 9.53,
"vwap_distance_pct": 2.5184,
"position_52w_pct": 94.57,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:05:26Z",
"source": "yfinance_quote",
"name": "Hafnia Limited",
"episode_id": "n0:HAFN:2026-09-29",
"ema_trend": "9.27 > 9.0 > 8.33",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:18:47.711682Z",
"facts": [
"The N0 capture was +4.71% on 1.24x average volume; later provider observations retained a somewhat larger gain and price was above VWAP.",
"No company-specific catalyst was established in the supplied dossier."
],
"price_as_of": "2026-09-29T21:05:26Z",
"vwap_as_of": null
},
{
"symbol": "NTWK",
"role": "alternative",
"price": 5.56,
"base_price": 5.5496,
"return_since_base_pct": 0.1874,
"session_return_pct": 3.36,
"change_since_prior_pct": 0.0,
"volume_ratio": 14.19,
"rsi": 89.74,
"vwap": 5.5,
"vwap_distance_pct": 1.0909,
"position_52w_pct": 98.75,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:10:08Z",
"source": "yfinance_quote",
"name": "NetSol Technologies, Inc.",
"episode_id": "n0:NTWK:2026-09-29",
"ema_trend": "4.87 > 4.54 > 4.38",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:15:36.965867Z",
"facts": [
"The supplied FY26 results report revenue of $74.4M, up 12.5%, and FY27 revenue guidance of $84.1M-$86.3M.",
"The event capture was +3.36% on 14.19x average volume, but the dossier estimates about $2M of dollar turnover and places price 3.06 ATR above its EMA reference."
],
"price_as_of": "2026-09-29T20:10:08Z",
"vwap_as_of": null
},
{
"symbol": "ACET",
"role": "alternative",
"price": 6.77,
"base_price": 6.78,
"return_since_base_pct": -0.1475,
"session_return_pct": -0.8785,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.05,
"rsi": 31.39,
"vwap": 6.69,
"vwap_distance_pct": 1.1958,
"position_52w_pct": 38.99,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:55:28Z",
"source": "yfinance_quote",
"name": "Adicet Bio, Inc.",
"episode_id": "n0:ACET:2026-09-29",
"ema_trend": "8.07 > 8.58 > 8.73",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:17:12.774775Z",
"facts": [
"The supplied Phase 1 lupus readout reports 54% DORIS remission and 50% complete renal response among 22 efficacy-evaluable patients after 12 months.",
"The N0 capture was +6.71% on about 3.05x average volume, while the 20-session asset return was -21.15% versus -0.40% for its healthcare proxy."
],
"price_as_of": "2026-09-29T20:55:28Z",
"vwap_as_of": null
},
{
"symbol": "PWP",
"role": "alternative",
"price": 17.1,
"base_price": 16.85,
"return_since_base_pct": 1.4837,
"session_return_pct": 4.4594,
"change_since_prior_pct": 0.0,
"volume_ratio": 5.79,
"rsi": 55.35,
"vwap": 16.26,
"vwap_distance_pct": 5.1661,
"position_52w_pct": 65.01,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:13:05Z",
"source": "yfinance_quote",
"name": "Perella Weinberg Partners",
"episode_id": "n0:PWP:2026-09-29",
"ema_trend": "14.6 > 14.8 > 15.42",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:15:55.598703Z",
"facts": [
"The catalyst is a report of acquisition talks, not a confirmed agreement.",
"The event capture was +15.1% on 5.79x average volume; the provider series retreated from its high but retained much of the move."
],
"price_as_of": "2026-09-29T21:13:05Z",
"vwap_as_of": null
},
{
"symbol": "KMX",
"role": "alternative",
"price": 59.35,
"base_price": 60.72,
"return_since_base_pct": -2.2563,
"session_return_pct": 0.2026,
"change_since_prior_pct": 0.0,
"volume_ratio": 2.26,
"rsi": 52.08,
"vwap": 61.4,
"vwap_distance_pct": -3.3388,
"position_52w_pct": 93.32,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:59:02Z",
"source": "yfinance_quote",
"name": "CarMax, Inc.",
"episode_id": "n0:KMX:2026-09-29",
"ema_trend": "58.29 > 58.97 > 58.5",
"vwap_state": "below",
"selection_as_of": "2026-09-29T15:17:34.477760Z",
"facts": [
"The supplied earnings report shows EPS of $1.16 versus $0.73 expected and sales of $7.878B versus $6.976B expected.",
"The provider trajectory faded from about +5.72% to +3.24%; the intraday reading was below VWAP with a downward trend.",
"The active H3/H8/H15 positive-return estimates are 0.547/0.567/0.528, higher than CCL's at each horizon. Its corresponding adverse-MAE medians are -3.25%/-4.20%/-6.09%. The separate audit-only H15 historical-dispersion output is P10 -5.31%, median +4.18%, P90 +16.31%. These comparisons use eight cases."
],
"price_as_of": "2026-09-29T20:59:02Z",
"vwap_as_of": null
},
{
"symbol": "WYY",
"role": "alternative",
"price": 7.28,
"base_price": 6.4203,
"return_since_base_pct": 13.3903,
"session_return_pct": -0.9524,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.39,
"rsi": 29.28,
"vwap": 6.2,
"vwap_distance_pct": 17.4194,
"position_52w_pct": 26.56,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:10:33Z",
"source": "yfinance_quote",
"name": "WidePoint Corporation",
"episode_id": "n0:WYY:2026-09-29",
"ema_trend": "8.81 > 9.89 > 10.68",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:18:38.363232Z",
"facts": [
"The provider trajectory rose from about +7.97% to +16.45%, and the intraday reading was above VWAP.",
"The 20-session asset return was -32.32% versus +4.15% for the technology proxy; no company-specific catalyst for the day's move was established."
],
"price_as_of": "2026-09-29T21:10:33Z",
"vwap_as_of": null
},
{
"symbol": "VIAV",
"role": "alternative",
"price": 41.99,
"base_price": 41.455,
"return_since_base_pct": 1.2906,
"session_return_pct": 0.4065,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.53,
"rsi": 57.12,
"vwap": 41.77,
"vwap_distance_pct": 0.5267,
"position_52w_pct": 68.56,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:16:33Z",
"source": "yfinance_quote",
"name": "Viavi Solutions Inc.",
"episode_id": "narrative:VIAV:b612043b612913e0",
"ema_trend": "38.56 > 37.68 > 38.08",
"vwap_state": "below",
"selection_as_of": "2026-09-29T17:19:34Z",
"facts": [
"The primary product announcement introduces a 100G testing platform but supplies no customer wins or expected revenue contribution.",
"The quote change was +1.37% on 0.53x average volume; price was below VWAP with a downward intraday trend."
],
"price_as_of": "2026-09-29T21:16:33Z",
"vwap_as_of": null
},
{
"symbol": "WH",
"role": "alternative",
"price": 72.44,
"base_price": 71.79,
"return_since_base_pct": 0.9054,
"session_return_pct": null,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.32,
"rsi": 60.7,
"vwap": 71.82,
"vwap_distance_pct": 0.8633,
"position_52w_pct": 79.55,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:00:33Z",
"source": "yfinance_quote",
"name": "Wyndham Hotels & Resorts, Inc.",
"episode_id": "narrative:WH:e6143a4ee8e53619",
"ema_trend": "69.87 > 70.21 > 72.36",
"vwap_state": "above",
"selection_as_of": "2026-09-29T17:19:31Z",
"facts": [
"The primary release reports a $400M increase to the share repurchase authorization.",
"The quote change was +1.47% on 0.32x average volume; the authorization does not establish that repurchases occurred."
],
"price_as_of": "2026-09-29T20:00:33Z",
"vwap_as_of": null
}
],
"benchmarks": [],
"coverage": {
"candidate_rows": 10,
"candidate_prices": 10,
"candidate_technical": 10,
"benchmark_rows": 0
}
}
},
{
"day": 4,
"timestamp": "2026-10-05T15:27:58.820843Z",
"comparison": {
"schema_version": "public-candidate-comparison.v1",
"captured_at": "2026-10-05T15:27:58.820843Z",
"base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
"source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
"rows": [
{
"symbol": "CCL",
"role": "selected",
"price": 25.68,
"base_price": 24.785,
"return_since_base_pct": 3.6111,
"session_return_pct": -0.31,
"change_since_prior_pct": -0.4265,
"volume_ratio": 0.15,
"rsi": 74.86,
"vwap": 25.71,
"vwap_distance_pct": -0.1167,
"position_52w_pct": 75.5,
"extended_hours_pct": null,
"as_of": "2026-10-05T14:06:51.007319Z",
"source": "yfinance_quote",
"name": "Carnival Corporation Ltd.",
"episode_id": "n0:CCL:2026-09-29",
"ema_trend": "24.31 > 23.86 > 24.69",
"vwap_state": "below",
"selection_as_of": "2026-09-29T15:18:03.945792Z",
"facts": [
"The supplied earnings coverage reports adjusted EPS of $1.43 versus $1.36 expected, revenue of $8.435B versus $8.300B expected, and a slight increase to full-year adjusted EPS guidance.",
"The N0 capture records +11.95% on 2.05x average volume. The provider series remained near the move through its final supplied observation.",
"The 20-session record shows CCL +4.48% versus its sector proxy -6.75%, a +11.23 percentage-point difference.",
"The active H3/H8/H15 positive-return estimates are 0.470/0.469/0.502; corresponding adverse-MAE medians are -4.49%/-7.15%/-9.26%. The separate audit-only H15 historical-dispersion output is P10 -19.62%, median -1.26%, P90 +7.16%. These comparisons use eight cases."
],
"benchmark_excess_pct": {
"sp500": -0.7025,
"nasdaq100": -0.8158,
"russell2000": -0.5102
},
"price_as_of": "2026-10-05T14:06:51.007319Z",
"vwap_as_of": null
},
{
"symbol": "SMMT",
"role": "alternative",
"price": 16.3387,
"base_price": 16.505,
"return_since_base_pct": -1.0076,
"session_return_pct": -0.313,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.35,
"rsi": 42.99,
"vwap": 17.03,
"vwap_distance_pct": -4.0593,
"position_52w_pct": 56.43,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:20:32Z",
"source": "yfinance_quote",
"name": "Summit Therapeutics Inc.",
"episode_id": "n0:SMMT:2026-09-29",
"ema_trend": "16.44 > 16.26 > 15.62",
"vwap_state": "below",
"selection_as_of": "2026-09-29T15:16:50.388704Z",
"facts": [
"The supplied event evidence describes a $2B AstraZeneca investment using newly issued convertible preferred shares and a clinical collaboration.",
"The N0 event capture was +6.62% on 3.35x average volume, but the provider series faded to about +5.33% and the intraday reading was below VWAP."
],
"benchmark_excess_pct": {
"sp500": -0.7055,
"nasdaq100": -0.8188,
"russell2000": -0.5132
},
"price_as_of": "2026-09-29T21:20:32Z",
"vwap_as_of": null
},
{
"symbol": "HAFN",
"role": "alternative",
"price": 9.77,
"base_price": 9.56,
"return_since_base_pct": 2.1967,
"session_return_pct": 1.0341,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.24,
"rsi": 57.04,
"vwap": 9.53,
"vwap_distance_pct": 2.5184,
"position_52w_pct": 94.57,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:05:26Z",
"source": "yfinance_quote",
"name": "Hafnia Limited",
"episode_id": "n0:HAFN:2026-09-29",
"ema_trend": "9.27 > 9.0 > 8.33",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:18:47.711682Z",
"facts": [
"The N0 capture was +4.71% on 1.24x average volume; later provider observations retained a somewhat larger gain and price was above VWAP.",
"No company-specific catalyst was established in the supplied dossier."
],
"benchmark_excess_pct": {
"sp500": 0.6416,
"nasdaq100": 0.5283,
"russell2000": 0.8339
},
"price_as_of": "2026-09-29T21:05:26Z",
"vwap_as_of": null
},
{
"symbol": "NTWK",
"role": "alternative",
"price": 5.56,
"base_price": 5.5496,
"return_since_base_pct": 0.1874,
"session_return_pct": 3.36,
"change_since_prior_pct": 0.0,
"volume_ratio": 14.19,
"rsi": 89.74,
"vwap": 5.5,
"vwap_distance_pct": 1.0909,
"position_52w_pct": 98.75,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:10:08Z",
"source": "yfinance_quote",
"name": "NetSol Technologies, Inc.",
"episode_id": "n0:NTWK:2026-09-29",
"ema_trend": "4.87 > 4.54 > 4.38",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:15:36.965867Z",
"facts": [
"The supplied FY26 results report revenue of $74.4M, up 12.5%, and FY27 revenue guidance of $84.1M-$86.3M.",
"The event capture was +3.36% on 14.19x average volume, but the dossier estimates about $2M of dollar turnover and places price 3.06 ATR above its EMA reference."
],
"benchmark_excess_pct": {
"sp500": 2.9675,
"nasdaq100": 2.8542,
"russell2000": 3.1598
},
"price_as_of": "2026-09-29T20:10:08Z",
"vwap_as_of": null
},
{
"symbol": "ACET",
"role": "alternative",
"price": 6.77,
"base_price": 6.78,
"return_since_base_pct": -0.1475,
"session_return_pct": -0.8785,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.05,
"rsi": 31.39,
"vwap": 6.69,
"vwap_distance_pct": 1.1958,
"position_52w_pct": 38.99,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:55:28Z",
"source": "yfinance_quote",
"name": "Adicet Bio, Inc.",
"episode_id": "n0:ACET:2026-09-29",
"ema_trend": "8.07 > 8.58 > 8.73",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:17:12.774775Z",
"facts": [
"The supplied Phase 1 lupus readout reports 54% DORIS remission and 50% complete renal response among 22 efficacy-evaluable patients after 12 months.",
"The N0 capture was +6.71% on about 3.05x average volume, while the 20-session asset return was -21.15% versus -0.40% for its healthcare proxy."
],
"benchmark_excess_pct": {
"sp500": -1.271,
"nasdaq100": -1.3843,
"russell2000": -1.0787
},
"price_as_of": "2026-09-29T20:55:28Z",
"vwap_as_of": null
},
{
"symbol": "PWP",
"role": "alternative",
"price": 17.1,
"base_price": 16.85,
"return_since_base_pct": 1.4837,
"session_return_pct": 4.4594,
"change_since_prior_pct": 0.0,
"volume_ratio": 5.79,
"rsi": 55.35,
"vwap": 16.26,
"vwap_distance_pct": 5.1661,
"position_52w_pct": 65.01,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:13:05Z",
"source": "yfinance_quote",
"name": "Perella Weinberg Partners",
"episode_id": "n0:PWP:2026-09-29",
"ema_trend": "14.6 > 14.8 > 15.42",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:15:55.598703Z",
"facts": [
"The catalyst is a report of acquisition talks, not a confirmed agreement.",
"The event capture was +15.1% on 5.79x average volume; the provider series retreated from its high but retained much of the move."
],
"benchmark_excess_pct": {
"sp500": 4.0669,
"nasdaq100": 3.9536,
"russell2000": 4.2592
},
"price_as_of": "2026-09-29T21:13:05Z",
"vwap_as_of": null
},
{
"symbol": "KMX",
"role": "alternative",
"price": 59.35,
"base_price": 60.72,
"return_since_base_pct": -2.2563,
"session_return_pct": 0.2026,
"change_since_prior_pct": 0.0,
"volume_ratio": 2.26,
"rsi": 52.08,
"vwap": 61.4,
"vwap_distance_pct": -3.3388,
"position_52w_pct": 93.32,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:59:02Z",
"source": "yfinance_quote",
"name": "CarMax, Inc.",
"episode_id": "n0:KMX:2026-09-29",
"ema_trend": "58.29 > 58.97 > 58.5",
"vwap_state": "below",
"selection_as_of": "2026-09-29T15:17:34.477760Z",
"facts": [
"The supplied earnings report shows EPS of $1.16 versus $0.73 expected and sales of $7.878B versus $6.976B expected.",
"The provider trajectory faded from about +5.72% to +3.24%; the intraday reading was below VWAP with a downward trend.",
"The active H3/H8/H15 positive-return estimates are 0.547/0.567/0.528, higher than CCL's at each horizon. Its corresponding adverse-MAE medians are -3.25%/-4.20%/-6.09%. The separate audit-only H15 historical-dispersion output is P10 -5.31%, median +4.18%, P90 +16.31%. These comparisons use eight cases."
],
"benchmark_excess_pct": {
"sp500": -0.1899,
"nasdaq100": -0.3032,
"russell2000": 0.0024
},
"price_as_of": "2026-09-29T20:59:02Z",
"vwap_as_of": null
},
{
"symbol": "WYY",
"role": "alternative",
"price": 7.28,
"base_price": 6.4203,
"return_since_base_pct": 13.3903,
"session_return_pct": -0.9524,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.39,
"rsi": 29.28,
"vwap": 6.2,
"vwap_distance_pct": 17.4194,
"position_52w_pct": 26.56,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:10:33Z",
"source": "yfinance_quote",
"name": "WidePoint Corporation",
"episode_id": "n0:WYY:2026-09-29",
"ema_trend": "8.81 > 9.89 > 10.68",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:18:38.363232Z",
"facts": [
"The provider trajectory rose from about +7.97% to +16.45%, and the intraday reading was above VWAP.",
"The 20-session asset return was -32.32% versus +4.15% for the technology proxy; no company-specific catalyst for the day's move was established."
],
"benchmark_excess_pct": {
"sp500": -1.3449,
"nasdaq100": -1.4582,
"russell2000": -1.1526
},
"price_as_of": "2026-09-29T21:10:33Z",
"vwap_as_of": null
},
{
"symbol": "VIAV",
"role": "alternative",
"price": 41.99,
"base_price": 41.455,
"return_since_base_pct": 1.2906,
"session_return_pct": 0.4065,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.53,
"rsi": 57.12,
"vwap": 41.77,
"vwap_distance_pct": 0.5267,
"position_52w_pct": 68.56,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:16:33Z",
"source": "yfinance_quote",
"name": "Viavi Solutions Inc.",
"episode_id": "narrative:VIAV:b612043b612913e0",
"ema_trend": "38.56 > 37.68 > 38.08",
"vwap_state": "below",
"selection_as_of": "2026-09-29T17:19:34Z",
"facts": [
"The primary product announcement introduces a 100G testing platform but supplies no customer wins or expected revenue contribution.",
"The quote change was +1.37% on 0.53x average volume; price was below VWAP with a downward intraday trend."
],
"benchmark_excess_pct": {
"sp500": 0.014,
"nasdaq100": -0.0993,
"russell2000": 0.2063
},
"price_as_of": "2026-09-29T21:16:33Z",
"vwap_as_of": null
},
{
"symbol": "WH",
"role": "alternative",
"price": 72.44,
"base_price": 71.79,
"return_since_base_pct": 0.9054,
"session_return_pct": null,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.32,
"rsi": 60.7,
"vwap": 71.82,
"vwap_distance_pct": 0.8633,
"position_52w_pct": 79.55,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:00:33Z",
"source": "yfinance_quote",
"name": "Wyndham Hotels & Resorts, Inc.",
"episode_id": "narrative:WH:e6143a4ee8e53619",
"ema_trend": "69.87 > 70.21 > 72.36",
"vwap_state": "above",
"selection_as_of": "2026-09-29T17:19:31Z",
"facts": [
"The primary release reports a $400M increase to the share repurchase authorization.",
"The quote change was +1.47% on 0.32x average volume; the authorization does not establish that repurchases occurred."
],
"price_as_of": "2026-09-29T20:00:33Z",
"vwap_as_of": null
}
],
"benchmarks": [
{
"id": "sp500",
"symbol": "^GSPC",
"label": "S&P 500",
"role": "benchmark",
"price": 7753.03,
"base_price": 7722.72,
"return_since_base_pct": 0.3925,
"session_return_pct": 0.3925,
"as_of": "2026-10-05T15:13:52.600430Z",
"source": "yfinance.ticker_info",
"base_definition": "previous regular close"
},
{
"id": "nasdaq100",
"symbol": "^NDX",
"label": "Nasdaq 100",
"role": "benchmark",
"price": 30963.771,
"base_price": 30807.932,
"return_since_base_pct": 0.5058,
"session_return_pct": 0.5058,
"as_of": "2026-10-05T15:13:52.600430Z",
"source": "yfinance.ticker_info",
"base_definition": "previous regular close"
},
{
"id": "russell2000",
"symbol": "^RUT",
"label": "Russell 2000",
"role": "benchmark",
"price": 2838.5664,
"base_price": 2832.8948,
"return_since_base_pct": 0.2002,
"session_return_pct": 0.2002,
"as_of": "2026-10-05T15:13:52.600430Z",
"source": "yfinance.ticker_info",
"base_definition": "previous regular close"
}
],
"coverage": {
"candidate_rows": 10,
"candidate_prices": 10,
"candidate_technical": 10,
"benchmark_rows": 3
}
}
},
{
"day": 4,
"timestamp": "2026-10-05T20:28:34.904015Z",
"comparison": {
"schema_version": "public-candidate-comparison.v1",
"captured_at": "2026-10-05T20:28:34.904015Z",
"base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
"source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
"rows": [
{
"symbol": "CCL",
"role": "selected",
"price": 25.67,
"base_price": 24.785,
"return_since_base_pct": 3.5707,
"session_return_pct": -0.35,
"change_since_prior_pct": -0.0389,
"volume_ratio": 0.68,
"rsi": 74.86,
"vwap": 25.61,
"vwap_distance_pct": 0.2343,
"position_52w_pct": 75.4,
"extended_hours_pct": null,
"as_of": "2026-10-05T19:21:38.104627Z",
"source": "yfinance_quote",
"name": "Carnival Corporation Ltd.",
"episode_id": "n0:CCL:2026-09-29",
"ema_trend": "24.31 > 23.86 > 24.69",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:18:03.945792Z",
"facts": [
"The supplied earnings coverage reports adjusted EPS of $1.43 versus $1.36 expected, revenue of $8.435B versus $8.300B expected, and a slight increase to full-year adjusted EPS guidance.",
"The N0 capture records +11.95% on 2.05x average volume. The provider series remained near the move through its final supplied observation.",
"The 20-session record shows CCL +4.48% versus its sector proxy -6.75%, a +11.23 percentage-point difference.",
"The active H3/H8/H15 positive-return estimates are 0.470/0.469/0.502; corresponding adverse-MAE medians are -4.49%/-7.15%/-9.26%. The separate audit-only H15 historical-dispersion output is P10 -19.62%, median -1.26%, P90 +7.16%. These comparisons use eight cases."
],
"benchmark_excess_pct": {
"sp500": -1.0134,
"nasdaq100": -1.2216,
"russell2000": -0.8527
},
"price_as_of": "2026-10-05T19:21:38.104627Z",
"vwap_as_of": null
},
{
"symbol": "SMMT",
"role": "alternative",
"price": 16.3387,
"base_price": 16.505,
"return_since_base_pct": -1.0076,
"session_return_pct": -0.313,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.35,
"rsi": 42.99,
"vwap": 17.03,
"vwap_distance_pct": -4.0593,
"position_52w_pct": 56.43,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:20:32Z",
"source": "yfinance_quote",
"name": "Summit Therapeutics Inc.",
"episode_id": "n0:SMMT:2026-09-29",
"ema_trend": "16.44 > 16.26 > 15.62",
"vwap_state": "below",
"selection_as_of": "2026-09-29T15:16:50.388704Z",
"facts": [
"The supplied event evidence describes a $2B AstraZeneca investment using newly issued convertible preferred shares and a clinical collaboration.",
"The N0 event capture was +6.62% on 3.35x average volume, but the provider series faded to about +5.33% and the intraday reading was below VWAP."
],
"benchmark_excess_pct": {
"sp500": -0.9764,
"nasdaq100": -1.1846,
"russell2000": -0.8157
},
"price_as_of": "2026-09-29T21:20:32Z",
"vwap_as_of": null
},
{
"symbol": "HAFN",
"role": "alternative",
"price": 9.77,
"base_price": 9.56,
"return_since_base_pct": 2.1967,
"session_return_pct": 1.0341,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.24,
"rsi": 57.04,
"vwap": 9.53,
"vwap_distance_pct": 2.5184,
"position_52w_pct": 94.57,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:05:26Z",
"source": "yfinance_quote",
"name": "Hafnia Limited",
"episode_id": "n0:HAFN:2026-09-29",
"ema_trend": "9.27 > 9.0 > 8.33",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:18:47.711682Z",
"facts": [
"The N0 capture was +4.71% on 1.24x average volume; later provider observations retained a somewhat larger gain and price was above VWAP.",
"No company-specific catalyst was established in the supplied dossier."
],
"benchmark_excess_pct": {
"sp500": 0.3707,
"nasdaq100": 0.1625,
"russell2000": 0.5314
},
"price_as_of": "2026-09-29T21:05:26Z",
"vwap_as_of": null
},
{
"symbol": "NTWK",
"role": "alternative",
"price": 5.56,
"base_price": 5.5496,
"return_since_base_pct": 0.1874,
"session_return_pct": 3.36,
"change_since_prior_pct": 0.0,
"volume_ratio": 14.19,
"rsi": 89.74,
"vwap": 5.5,
"vwap_distance_pct": 1.0909,
"position_52w_pct": 98.75,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:10:08Z",
"source": "yfinance_quote",
"name": "NetSol Technologies, Inc.",
"episode_id": "n0:NTWK:2026-09-29",
"ema_trend": "4.87 > 4.54 > 4.38",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:15:36.965867Z",
"facts": [
"The supplied FY26 results report revenue of $74.4M, up 12.5%, and FY27 revenue guidance of $84.1M-$86.3M.",
"The event capture was +3.36% on 14.19x average volume, but the dossier estimates about $2M of dollar turnover and places price 3.06 ATR above its EMA reference."
],
"benchmark_excess_pct": {
"sp500": 2.6966,
"nasdaq100": 2.4884,
"russell2000": 2.8573
},
"price_as_of": "2026-09-29T20:10:08Z",
"vwap_as_of": null
},
{
"symbol": "ACET",
"role": "alternative",
"price": 6.77,
"base_price": 6.78,
"return_since_base_pct": -0.1475,
"session_return_pct": -0.8785,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.05,
"rsi": 31.39,
"vwap": 6.69,
"vwap_distance_pct": 1.1958,
"position_52w_pct": 38.99,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:55:28Z",
"source": "yfinance_quote",
"name": "Adicet Bio, Inc.",
"episode_id": "n0:ACET:2026-09-29",
"ema_trend": "8.07 > 8.58 > 8.73",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:17:12.774775Z",
"facts": [
"The supplied Phase 1 lupus readout reports 54% DORIS remission and 50% complete renal response among 22 efficacy-evaluable patients after 12 months.",
"The N0 capture was +6.71% on about 3.05x average volume, while the 20-session asset return was -21.15% versus -0.40% for its healthcare proxy."
],
"benchmark_excess_pct": {
"sp500": -1.5419,
"nasdaq100": -1.7501,
"russell2000": -1.3812
},
"price_as_of": "2026-09-29T20:55:28Z",
"vwap_as_of": null
},
{
"symbol": "PWP",
"role": "alternative",
"price": 17.1,
"base_price": 16.85,
"return_since_base_pct": 1.4837,
"session_return_pct": 4.4594,
"change_since_prior_pct": 0.0,
"volume_ratio": 5.79,
"rsi": 55.35,
"vwap": 16.26,
"vwap_distance_pct": 5.1661,
"position_52w_pct": 65.01,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:13:05Z",
"source": "yfinance_quote",
"name": "Perella Weinberg Partners",
"episode_id": "n0:PWP:2026-09-29",
"ema_trend": "14.6 > 14.8 > 15.42",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:15:55.598703Z",
"facts": [
"The catalyst is a report of acquisition talks, not a confirmed agreement.",
"The event capture was +15.1% on 5.79x average volume; the provider series retreated from its high but retained much of the move."
],
"benchmark_excess_pct": {
"sp500": 3.796,
"nasdaq100": 3.5878,
"russell2000": 3.9567
},
"price_as_of": "2026-09-29T21:13:05Z",
"vwap_as_of": null
},
{
"symbol": "KMX",
"role": "alternative",
"price": 59.35,
"base_price": 60.72,
"return_since_base_pct": -2.2563,
"session_return_pct": 0.2026,
"change_since_prior_pct": 0.0,
"volume_ratio": 2.26,
"rsi": 52.08,
"vwap": 61.4,
"vwap_distance_pct": -3.3388,
"position_52w_pct": 93.32,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:59:02Z",
"source": "yfinance_quote",
"name": "CarMax, Inc.",
"episode_id": "n0:KMX:2026-09-29",
"ema_trend": "58.29 > 58.97 > 58.5",
"vwap_state": "below",
"selection_as_of": "2026-09-29T15:17:34.477760Z",
"facts": [
"The supplied earnings report shows EPS of $1.16 versus $0.73 expected and sales of $7.878B versus $6.976B expected.",
"The provider trajectory faded from about +5.72% to +3.24%; the intraday reading was below VWAP with a downward trend.",
"The active H3/H8/H15 positive-return estimates are 0.547/0.567/0.528, higher than CCL's at each horizon. Its corresponding adverse-MAE medians are -3.25%/-4.20%/-6.09%. The separate audit-only H15 historical-dispersion output is P10 -5.31%, median +4.18%, P90 +16.31%. These comparisons use eight cases."
],
"benchmark_excess_pct": {
"sp500": -0.4608,
"nasdaq100": -0.669,
"russell2000": -0.3001
},
"price_as_of": "2026-09-29T20:59:02Z",
"vwap_as_of": null
},
{
"symbol": "WYY",
"role": "alternative",
"price": 7.28,
"base_price": 6.4203,
"return_since_base_pct": 13.3903,
"session_return_pct": -0.9524,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.39,
"rsi": 29.28,
"vwap": 6.2,
"vwap_distance_pct": 17.4194,
"position_52w_pct": 26.56,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:10:33Z",
"source": "yfinance_quote",
"name": "WidePoint Corporation",
"episode_id": "n0:WYY:2026-09-29",
"ema_trend": "8.81 > 9.89 > 10.68",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:18:38.363232Z",
"facts": [
"The provider trajectory rose from about +7.97% to +16.45%, and the intraday reading was above VWAP.",
"The 20-session asset return was -32.32% versus +4.15% for the technology proxy; no company-specific catalyst for the day's move was established."
],
"benchmark_excess_pct": {
"sp500": -1.6158,
"nasdaq100": -1.824,
"russell2000": -1.4551
},
"price_as_of": "2026-09-29T21:10:33Z",
"vwap_as_of": null
},
{
"symbol": "VIAV",
"role": "alternative",
"price": 41.99,
"base_price": 41.455,
"return_since_base_pct": 1.2906,
"session_return_pct": 0.4065,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.53,
"rsi": 57.12,
"vwap": 41.77,
"vwap_distance_pct": 0.5267,
"position_52w_pct": 68.56,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:16:33Z",
"source": "yfinance_quote",
"name": "Viavi Solutions Inc.",
"episode_id": "narrative:VIAV:b612043b612913e0",
"ema_trend": "38.56 > 37.68 > 38.08",
"vwap_state": "below",
"selection_as_of": "2026-09-29T17:19:34Z",
"facts": [
"The primary product announcement introduces a 100G testing platform but supplies no customer wins or expected revenue contribution.",
"The quote change was +1.37% on 0.53x average volume; price was below VWAP with a downward intraday trend."
],
"benchmark_excess_pct": {
"sp500": -0.2569,
"nasdaq100": -0.4651,
"russell2000": -0.0962
},
"price_as_of": "2026-09-29T21:16:33Z",
"vwap_as_of": null
},
{
"symbol": "WH",
"role": "alternative",
"price": 72.44,
"base_price": 71.79,
"return_since_base_pct": 0.9054,
"session_return_pct": null,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.32,
"rsi": 60.7,
"vwap": 71.82,
"vwap_distance_pct": 0.8633,
"position_52w_pct": 79.55,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:00:33Z",
"source": "yfinance_quote",
"name": "Wyndham Hotels & Resorts, Inc.",
"episode_id": "narrative:WH:e6143a4ee8e53619",
"ema_trend": "69.87 > 70.21 > 72.36",
"vwap_state": "above",
"selection_as_of": "2026-09-29T17:19:31Z",
"facts": [
"The primary release reports a $400M increase to the share repurchase authorization.",
"The quote change was +1.47% on 0.32x average volume; the authorization does not establish that repurchases occurred."
],
"price_as_of": "2026-09-29T20:00:33Z",
"vwap_as_of": null
}
],
"benchmarks": [
{
"id": "sp500",
"symbol": "^GSPC",
"label": "S&P 500",
"role": "benchmark",
"price": 7773.95,
"base_price": 7722.72,
"return_since_base_pct": 0.6634,
"session_return_pct": 0.6634,
"as_of": "2026-10-05T20:28:24.894538Z",
"source": "yfinance.ticker_info",
"base_definition": "previous regular close"
},
{
"id": "nasdaq100",
"symbol": "^NDX",
"label": "Nasdaq 100",
"role": "benchmark",
"price": 31076.441,
"base_price": 30807.932,
"return_since_base_pct": 0.8716,
"session_return_pct": 0.8716,
"as_of": "2026-10-05T20:28:24.894538Z",
"source": "yfinance.ticker_info",
"base_definition": "previous regular close"
},
{
"id": "russell2000",
"symbol": "^RUT",
"label": "Russell 2000",
"role": "benchmark",
"price": 2847.1357,
"base_price": 2832.8948,
"return_since_base_pct": 0.5027,
"session_return_pct": 0.5027,
"as_of": "2026-10-05T20:28:24.894538Z",
"source": "yfinance.ticker_info",
"base_definition": "previous regular close"
}
],
"coverage": {
"candidate_rows": 10,
"candidate_prices": 10,
"candidate_technical": 10,
"benchmark_rows": 3
}
}
},
{
"day": 4,
"timestamp": "2026-10-05T22:34:22.000099Z",
"comparison": {
"schema_version": "public-candidate-comparison.v1",
"captured_at": "2026-10-05T22:34:22.000099Z",
"base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
"source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
"rows": [
{
"symbol": "CCL",
"role": "selected",
"price": 25.56,
"base_price": 24.785,
"return_since_base_pct": 3.1269,
"session_return_pct": -0.78,
"change_since_prior_pct": -0.4285,
"volume_ratio": 1.02,
"rsi": 73.73,
"vwap": 25.61,
"vwap_distance_pct": -0.1952,
"position_52w_pct": 75.1,
"extended_hours_pct": 0.0,
"as_of": "2026-10-05T21:04:18Z",
"source": "sealed_extended_quote",
"name": "Carnival Corporation Ltd.",
"episode_id": "n0:CCL:2026-09-29",
"ema_trend": "24.29 > 23.85 > 24.69",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:18:03.945792Z",
"facts": [
"The supplied earnings coverage reports adjusted EPS of $1.43 versus $1.36 expected, revenue of $8.435B versus $8.300B expected, and a slight increase to full-year adjusted EPS guidance.",
"The N0 capture records +11.95% on 2.05x average volume. The provider series remained near the move through its final supplied observation.",
"The 20-session record shows CCL +4.48% versus its sector proxy -6.75%, a +11.23 percentage-point difference.",
"The active H3/H8/H15 positive-return estimates are 0.470/0.469/0.502; corresponding adverse-MAE medians are -4.49%/-7.15%/-9.26%. The separate audit-only H15 historical-dispersion output is P10 -19.62%, median -1.26%, P90 +7.16%. These comparisons use eight cases."
],
"benchmark_excess_pct": {
"sp500": -1.4434,
"nasdaq100": -1.6516,
"russell2000": -1.2827
},
"price_as_of": "2026-10-05T21:04:18Z",
"vwap_as_of": null
},
{
"symbol": "SMMT",
"role": "alternative",
"price": 16.3387,
"base_price": 16.505,
"return_since_base_pct": -1.0076,
"session_return_pct": -0.313,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.35,
"rsi": 42.99,
"vwap": 17.03,
"vwap_distance_pct": -4.0593,
"position_52w_pct": 56.43,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:20:32Z",
"source": "yfinance_quote",
"name": "Summit Therapeutics Inc.",
"episode_id": "n0:SMMT:2026-09-29",
"ema_trend": "16.44 > 16.26 > 15.62",
"vwap_state": "below",
"selection_as_of": "2026-09-29T15:16:50.388704Z",
"facts": [
"The supplied event evidence describes a $2B AstraZeneca investment using newly issued convertible preferred shares and a clinical collaboration.",
"The N0 event capture was +6.62% on 3.35x average volume, but the provider series faded to about +5.33% and the intraday reading was below VWAP."
],
"benchmark_excess_pct": {
"sp500": -0.9764,
"nasdaq100": -1.1846,
"russell2000": -0.8157
},
"price_as_of": "2026-09-29T21:20:32Z",
"vwap_as_of": null
},
{
"symbol": "HAFN",
"role": "alternative",
"price": 9.77,
"base_price": 9.56,
"return_since_base_pct": 2.1967,
"session_return_pct": 1.0341,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.24,
"rsi": 57.04,
"vwap": 9.53,
"vwap_distance_pct": 2.5184,
"position_52w_pct": 94.57,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:05:26Z",
"source": "yfinance_quote",
"name": "Hafnia Limited",
"episode_id": "n0:HAFN:2026-09-29",
"ema_trend": "9.27 > 9.0 > 8.33",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:18:47.711682Z",
"facts": [
"The N0 capture was +4.71% on 1.24x average volume; later provider observations retained a somewhat larger gain and price was above VWAP.",
"No company-specific catalyst was established in the supplied dossier."
],
"benchmark_excess_pct": {
"sp500": 0.3707,
"nasdaq100": 0.1625,
"russell2000": 0.5314
},
"price_as_of": "2026-09-29T21:05:26Z",
"vwap_as_of": null
},
{
"symbol": "NTWK",
"role": "alternative",
"price": 5.56,
"base_price": 5.5496,
"return_since_base_pct": 0.1874,
"session_return_pct": 3.36,
"change_since_prior_pct": 0.0,
"volume_ratio": 14.19,
"rsi": 89.74,
"vwap": 5.5,
"vwap_distance_pct": 1.0909,
"position_52w_pct": 98.75,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:10:08Z",
"source": "yfinance_quote",
"name": "NetSol Technologies, Inc.",
"episode_id": "n0:NTWK:2026-09-29",
"ema_trend": "4.87 > 4.54 > 4.38",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:15:36.965867Z",
"facts": [
"The supplied FY26 results report revenue of $74.4M, up 12.5%, and FY27 revenue guidance of $84.1M-$86.3M.",
"The event capture was +3.36% on 14.19x average volume, but the dossier estimates about $2M of dollar turnover and places price 3.06 ATR above its EMA reference."
],
"benchmark_excess_pct": {
"sp500": 2.6966,
"nasdaq100": 2.4884,
"russell2000": 2.8573
},
"price_as_of": "2026-09-29T20:10:08Z",
"vwap_as_of": null
},
{
"symbol": "ACET",
"role": "alternative",
"price": 6.77,
"base_price": 6.78,
"return_since_base_pct": -0.1475,
"session_return_pct": -0.8785,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.05,
"rsi": 31.39,
"vwap": 6.69,
"vwap_distance_pct": 1.1958,
"position_52w_pct": 38.99,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:55:28Z",
"source": "yfinance_quote",
"name": "Adicet Bio, Inc.",
"episode_id": "n0:ACET:2026-09-29",
"ema_trend": "8.07 > 8.58 > 8.73",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:17:12.774775Z",
"facts": [
"The supplied Phase 1 lupus readout reports 54% DORIS remission and 50% complete renal response among 22 efficacy-evaluable patients after 12 months.",
"The N0 capture was +6.71% on about 3.05x average volume, while the 20-session asset return was -21.15% versus -0.40% for its healthcare proxy."
],
"benchmark_excess_pct": {
"sp500": -1.5419,
"nasdaq100": -1.7501,
"russell2000": -1.3812
},
"price_as_of": "2026-09-29T20:55:28Z",
"vwap_as_of": null
},
{
"symbol": "PWP",
"role": "alternative",
"price": 17.1,
"base_price": 16.85,
"return_since_base_pct": 1.4837,
"session_return_pct": 4.4594,
"change_since_prior_pct": 0.0,
"volume_ratio": 5.79,
"rsi": 55.35,
"vwap": 16.26,
"vwap_distance_pct": 5.1661,
"position_52w_pct": 65.01,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:13:05Z",
"source": "yfinance_quote",
"name": "Perella Weinberg Partners",
"episode_id": "n0:PWP:2026-09-29",
"ema_trend": "14.6 > 14.8 > 15.42",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:15:55.598703Z",
"facts": [
"The catalyst is a report of acquisition talks, not a confirmed agreement.",
"The event capture was +15.1% on 5.79x average volume; the provider series retreated from its high but retained much of the move."
],
"benchmark_excess_pct": {
"sp500": 3.796,
"nasdaq100": 3.5878,
"russell2000": 3.9567
},
"price_as_of": "2026-09-29T21:13:05Z",
"vwap_as_of": null
},
{
"symbol": "KMX",
"role": "alternative",
"price": 59.35,
"base_price": 60.72,
"return_since_base_pct": -2.2563,
"session_return_pct": 0.2026,
"change_since_prior_pct": 0.0,
"volume_ratio": 2.26,
"rsi": 52.08,
"vwap": 61.4,
"vwap_distance_pct": -3.3388,
"position_52w_pct": 93.32,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:59:02Z",
"source": "yfinance_quote",
"name": "CarMax, Inc.",
"episode_id": "n0:KMX:2026-09-29",
"ema_trend": "58.29 > 58.97 > 58.5",
"vwap_state": "below",
"selection_as_of": "2026-09-29T15:17:34.477760Z",
"facts": [
"The supplied earnings report shows EPS of $1.16 versus $0.73 expected and sales of $7.878B versus $6.976B expected.",
"The provider trajectory faded from about +5.72% to +3.24%; the intraday reading was below VWAP with a downward trend.",
"The active H3/H8/H15 positive-return estimates are 0.547/0.567/0.528, higher than CCL's at each horizon. Its corresponding adverse-MAE medians are -3.25%/-4.20%/-6.09%. The separate audit-only H15 historical-dispersion output is P10 -5.31%, median +4.18%, P90 +16.31%. These comparisons use eight cases."
],
"benchmark_excess_pct": {
"sp500": -0.4608,
"nasdaq100": -0.669,
"russell2000": -0.3001
},
"price_as_of": "2026-09-29T20:59:02Z",
"vwap_as_of": null
},
{
"symbol": "WYY",
"role": "alternative",
"price": 7.28,
"base_price": 6.4203,
"return_since_base_pct": 13.3903,
"session_return_pct": -0.9524,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.39,
"rsi": 29.28,
"vwap": 6.2,
"vwap_distance_pct": 17.4194,
"position_52w_pct": 26.56,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:10:33Z",
"source": "yfinance_quote",
"name": "WidePoint Corporation",
"episode_id": "n0:WYY:2026-09-29",
"ema_trend": "8.81 > 9.89 > 10.68",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:18:38.363232Z",
"facts": [
"The provider trajectory rose from about +7.97% to +16.45%, and the intraday reading was above VWAP.",
"The 20-session asset return was -32.32% versus +4.15% for the technology proxy; no company-specific catalyst for the day's move was established."
],
"benchmark_excess_pct": {
"sp500": -1.6158,
"nasdaq100": -1.824,
"russell2000": -1.4551
},
"price_as_of": "2026-09-29T21:10:33Z",
"vwap_as_of": null
},
{
"symbol": "VIAV",
"role": "alternative",
"price": 41.99,
"base_price": 41.455,
"return_since_base_pct": 1.2906,
"session_return_pct": 0.4065,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.53,
"rsi": 57.12,
"vwap": 41.77,
"vwap_distance_pct": 0.5267,
"position_52w_pct": 68.56,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:16:33Z",
"source": "yfinance_quote",
"name": "Viavi Solutions Inc.",
"episode_id": "narrative:VIAV:b612043b612913e0",
"ema_trend": "38.56 > 37.68 > 38.08",
"vwap_state": "below",
"selection_as_of": "2026-09-29T17:19:34Z",
"facts": [
"The primary product announcement introduces a 100G testing platform but supplies no customer wins or expected revenue contribution.",
"The quote change was +1.37% on 0.53x average volume; price was below VWAP with a downward intraday trend."
],
"benchmark_excess_pct": {
"sp500": -0.2569,
"nasdaq100": -0.4651,
"russell2000": -0.0962
},
"price_as_of": "2026-09-29T21:16:33Z",
"vwap_as_of": null
},
{
"symbol": "WH",
"role": "alternative",
"price": 72.44,
"base_price": 71.79,
"return_since_base_pct": 0.9054,
"session_return_pct": null,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.32,
"rsi": 60.7,
"vwap": 71.82,
"vwap_distance_pct": 0.8633,
"position_52w_pct": 79.55,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:00:33Z",
"source": "yfinance_quote",
"name": "Wyndham Hotels & Resorts, Inc.",
"episode_id": "narrative:WH:e6143a4ee8e53619",
"ema_trend": "69.87 > 70.21 > 72.36",
"vwap_state": "above",
"selection_as_of": "2026-09-29T17:19:31Z",
"facts": [
"The primary release reports a $400M increase to the share repurchase authorization.",
"The quote change was +1.47% on 0.32x average volume; the authorization does not establish that repurchases occurred."
],
"price_as_of": "2026-09-29T20:00:33Z",
"vwap_as_of": null
}
],
"benchmarks": [
{
"id": "sp500",
"symbol": "^GSPC",
"label": "S&P 500",
"role": "benchmark",
"price": 7773.95,
"base_price": 7722.72,
"return_since_base_pct": 0.6634,
"session_return_pct": 0.6634,
"as_of": "2026-10-05T22:30:02.530881Z",
"source": "yfinance.ticker_info",
"base_definition": "previous regular close"
},
{
"id": "nasdaq100",
"symbol": "^NDX",
"label": "Nasdaq 100",
"role": "benchmark",
"price": 31076.441,
"base_price": 30807.932,
"return_since_base_pct": 0.8716,
"session_return_pct": 0.8716,
"as_of": "2026-10-05T22:30:02.530881Z",
"source": "yfinance.ticker_info",
"base_definition": "previous regular close"
},
{
"id": "russell2000",
"symbol": "^RUT",
"label": "Russell 2000",
"role": "benchmark",
"price": 2847.1357,
"base_price": 2832.8948,
"return_since_base_pct": 0.5027,
"session_return_pct": 0.5027,
"as_of": "2026-10-05T22:30:02.530881Z",
"source": "yfinance.ticker_info",
"base_definition": "previous regular close"
}
],
"coverage": {
"candidate_rows": 10,
"candidate_prices": 10,
"candidate_technical": 10,
"benchmark_rows": 3
}
}
},
{
"day": 5,
"timestamp": "2026-10-06T14:50:33.088972Z",
"comparison": {
"schema_version": "public-candidate-comparison.v1",
"captured_at": "2026-10-06T14:50:33.088972Z",
"base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
"source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
"rows": [
{
"symbol": "CCL",
"role": "selected",
"price": 26.51,
"base_price": 24.785,
"return_since_base_pct": 6.9599,
"session_return_pct": 3.72,
"change_since_prior_pct": 3.7167,
"volume_ratio": 0.29,
"rsi": 76.05,
"vwap": 26.3,
"vwap_distance_pct": 0.7985,
"position_52w_pct": 77.9,
"extended_hours_pct": null,
"as_of": "2026-10-06T14:06:59.842254Z",
"source": "yfinance_quote",
"name": "Carnival Corporation Ltd.",
"episode_id": "n0:CCL:2026-09-29",
"ema_trend": "24.73 > 24.09 > 24.76",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:18:03.945792Z",
"facts": [
"The supplied earnings coverage reports adjusted EPS of $1.43 versus $1.36 expected, revenue of $8.435B versus $8.300B expected, and a slight increase to full-year adjusted EPS guidance.",
"The N0 capture records +11.95% on 2.05x average volume. The provider series remained near the move through its final supplied observation.",
"The 20-session record shows CCL +4.48% versus its sector proxy -6.75%, a +11.23 percentage-point difference.",
"The active H3/H8/H15 positive-return estimates are 0.470/0.469/0.502; corresponding adverse-MAE medians are -4.49%/-7.15%/-9.26%. The separate audit-only H15 historical-dispersion output is P10 -19.62%, median -1.26%, P90 +7.16%. These comparisons use eight cases."
],
"price_as_of": "2026-10-06T14:06:59.842254Z",
"vwap_as_of": null
},
{
"symbol": "SMMT",
"role": "alternative",
"price": 16.3387,
"base_price": 16.505,
"return_since_base_pct": -1.0076,
"session_return_pct": -0.313,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.35,
"rsi": 42.99,
"vwap": 17.03,
"vwap_distance_pct": -4.0593,
"position_52w_pct": 56.43,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:20:32Z",
"source": "yfinance_quote",
"name": "Summit Therapeutics Inc.",
"episode_id": "n0:SMMT:2026-09-29",
"ema_trend": "16.44 > 16.26 > 15.62",
"vwap_state": "below",
"selection_as_of": "2026-09-29T15:16:50.388704Z",
"facts": [
"The supplied event evidence describes a $2B AstraZeneca investment using newly issued convertible preferred shares and a clinical collaboration.",
"The N0 event capture was +6.62% on 3.35x average volume, but the provider series faded to about +5.33% and the intraday reading was below VWAP."
],
"price_as_of": "2026-09-29T21:20:32Z",
"vwap_as_of": null
},
{
"symbol": "HAFN",
"role": "alternative",
"price": 9.77,
"base_price": 9.56,
"return_since_base_pct": 2.1967,
"session_return_pct": 1.0341,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.24,
"rsi": 57.04,
"vwap": 9.53,
"vwap_distance_pct": 2.5184,
"position_52w_pct": 94.57,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:05:26Z",
"source": "yfinance_quote",
"name": "Hafnia Limited",
"episode_id": "n0:HAFN:2026-09-29",
"ema_trend": "9.27 > 9.0 > 8.33",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:18:47.711682Z",
"facts": [
"The N0 capture was +4.71% on 1.24x average volume; later provider observations retained a somewhat larger gain and price was above VWAP.",
"No company-specific catalyst was established in the supplied dossier."
],
"price_as_of": "2026-09-29T21:05:26Z",
"vwap_as_of": null
},
{
"symbol": "NTWK",
"role": "alternative",
"price": 5.56,
"base_price": 5.5496,
"return_since_base_pct": 0.1874,
"session_return_pct": 3.36,
"change_since_prior_pct": 0.0,
"volume_ratio": 14.19,
"rsi": 89.74,
"vwap": 5.5,
"vwap_distance_pct": 1.0909,
"position_52w_pct": 98.75,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:10:08Z",
"source": "yfinance_quote",
"name": "NetSol Technologies, Inc.",
"episode_id": "n0:NTWK:2026-09-29",
"ema_trend": "4.87 > 4.54 > 4.38",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:15:36.965867Z",
"facts": [
"The supplied FY26 results report revenue of $74.4M, up 12.5%, and FY27 revenue guidance of $84.1M-$86.3M.",
"The event capture was +3.36% on 14.19x average volume, but the dossier estimates about $2M of dollar turnover and places price 3.06 ATR above its EMA reference."
],
"price_as_of": "2026-09-29T20:10:08Z",
"vwap_as_of": null
},
{
"symbol": "ACET",
"role": "alternative",
"price": 6.77,
"base_price": 6.78,
"return_since_base_pct": -0.1475,
"session_return_pct": -0.8785,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.05,
"rsi": 31.39,
"vwap": 6.69,
"vwap_distance_pct": 1.1958,
"position_52w_pct": 38.99,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:55:28Z",
"source": "yfinance_quote",
"name": "Adicet Bio, Inc.",
"episode_id": "n0:ACET:2026-09-29",
"ema_trend": "8.07 > 8.58 > 8.73",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:17:12.774775Z",
"facts": [
"The supplied Phase 1 lupus readout reports 54% DORIS remission and 50% complete renal response among 22 efficacy-evaluable patients after 12 months.",
"The N0 capture was +6.71% on about 3.05x average volume, while the 20-session asset return was -21.15% versus -0.40% for its healthcare proxy."
],
"price_as_of": "2026-09-29T20:55:28Z",
"vwap_as_of": null
},
{
"symbol": "PWP",
"role": "alternative",
"price": 17.1,
"base_price": 16.85,
"return_since_base_pct": 1.4837,
"session_return_pct": 4.4594,
"change_since_prior_pct": 0.0,
"volume_ratio": 5.79,
"rsi": 55.35,
"vwap": 16.26,
"vwap_distance_pct": 5.1661,
"position_52w_pct": 65.01,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:13:05Z",
"source": "yfinance_quote",
"name": "Perella Weinberg Partners",
"episode_id": "n0:PWP:2026-09-29",
"ema_trend": "14.6 > 14.8 > 15.42",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:15:55.598703Z",
"facts": [
"The catalyst is a report of acquisition talks, not a confirmed agreement.",
"The event capture was +15.1% on 5.79x average volume; the provider series retreated from its high but retained much of the move."
],
"price_as_of": "2026-09-29T21:13:05Z",
"vwap_as_of": null
},
{
"symbol": "KMX",
"role": "alternative",
"price": 59.35,
"base_price": 60.72,
"return_since_base_pct": -2.2563,
"session_return_pct": 0.2026,
"change_since_prior_pct": 0.0,
"volume_ratio": 2.26,
"rsi": 52.08,
"vwap": 61.4,
"vwap_distance_pct": -3.3388,
"position_52w_pct": 93.32,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:59:02Z",
"source": "yfinance_quote",
"name": "CarMax, Inc.",
"episode_id": "n0:KMX:2026-09-29",
"ema_trend": "58.29 > 58.97 > 58.5",
"vwap_state": "below",
"selection_as_of": "2026-09-29T15:17:34.477760Z",
"facts": [
"The supplied earnings report shows EPS of $1.16 versus $0.73 expected and sales of $7.878B versus $6.976B expected.",
"The provider trajectory faded from about +5.72% to +3.24%; the intraday reading was below VWAP with a downward trend.",
"The active H3/H8/H15 positive-return estimates are 0.547/0.567/0.528, higher than CCL's at each horizon. Its corresponding adverse-MAE medians are -3.25%/-4.20%/-6.09%. The separate audit-only H15 historical-dispersion output is P10 -5.31%, median +4.18%, P90 +16.31%. These comparisons use eight cases."
],
"price_as_of": "2026-09-29T20:59:02Z",
"vwap_as_of": null
},
{
"symbol": "WYY",
"role": "alternative",
"price": 7.28,
"base_price": 6.4203,
"return_since_base_pct": 13.3903,
"session_return_pct": -0.9524,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.39,
"rsi": 29.28,
"vwap": 6.2,
"vwap_distance_pct": 17.4194,
"position_52w_pct": 26.56,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:10:33Z",
"source": "yfinance_quote",
"name": "WidePoint Corporation",
"episode_id": "n0:WYY:2026-09-29",
"ema_trend": "8.81 > 9.89 > 10.68",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:18:38.363232Z",
"facts": [
"The provider trajectory rose from about +7.97% to +16.45%, and the intraday reading was above VWAP.",
"The 20-session asset return was -32.32% versus +4.15% for the technology proxy; no company-specific catalyst for the day's move was established."
],
"price_as_of": "2026-09-29T21:10:33Z",
"vwap_as_of": null
},
{
"symbol": "VIAV",
"role": "alternative",
"price": 41.99,
"base_price": 41.455,
"return_since_base_pct": 1.2906,
"session_return_pct": 0.4065,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.53,
"rsi": 57.12,
"vwap": 41.77,
"vwap_distance_pct": 0.5267,
"position_52w_pct": 68.56,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:16:33Z",
"source": "yfinance_quote",
"name": "Viavi Solutions Inc.",
"episode_id": "narrative:VIAV:b612043b612913e0",
"ema_trend": "38.56 > 37.68 > 38.08",
"vwap_state": "below",
"selection_as_of": "2026-09-29T17:19:34Z",
"facts": [
"The primary product announcement introduces a 100G testing platform but supplies no customer wins or expected revenue contribution.",
"The quote change was +1.37% on 0.53x average volume; price was below VWAP with a downward intraday trend."
],
"price_as_of": "2026-09-29T21:16:33Z",
"vwap_as_of": null
},
{
"symbol": "WH",
"role": "alternative",
"price": 72.44,
"base_price": 71.79,
"return_since_base_pct": 0.9054,
"session_return_pct": null,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.32,
"rsi": 60.7,
"vwap": 71.82,
"vwap_distance_pct": 0.8633,
"position_52w_pct": 79.55,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:00:33Z",
"source": "yfinance_quote",
"name": "Wyndham Hotels & Resorts, Inc.",
"episode_id": "narrative:WH:e6143a4ee8e53619",
"ema_trend": "69.87 > 70.21 > 72.36",
"vwap_state": "above",
"selection_as_of": "2026-09-29T17:19:31Z",
"facts": [
"The primary release reports a $400M increase to the share repurchase authorization.",
"The quote change was +1.47% on 0.32x average volume; the authorization does not establish that repurchases occurred."
],
"price_as_of": "2026-09-29T20:00:33Z",
"vwap_as_of": null
}
],
"benchmarks": [],
"coverage": {
"candidate_rows": 10,
"candidate_prices": 10,
"candidate_technical": 10,
"benchmark_rows": 0
}
}
},
{
"day": 5,
"timestamp": "2026-10-06T20:03:35.160248Z",
"comparison": {
"schema_version": "public-candidate-comparison.v1",
"captured_at": "2026-10-06T20:03:35.160248Z",
"base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
"source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
"rows": [
{
"symbol": "CCL",
"role": "selected",
"price": 26.585,
"base_price": 24.785,
"return_since_base_pct": 7.2625,
"session_return_pct": 4.01,
"change_since_prior_pct": 0.2829,
"volume_ratio": 0.83,
"rsi": 76.29,
"vwap": 26.44,
"vwap_distance_pct": 0.5484,
"position_52w_pct": 78.1,
"extended_hours_pct": null,
"as_of": "2026-10-06T19:21:35.651397Z",
"source": "yfinance_quote",
"name": "Carnival Corporation Ltd.",
"episode_id": "n0:CCL:2026-09-29",
"ema_trend": "24.75 > 24.1 > 24.76",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:18:03.945792Z",
"facts": [
"The supplied earnings coverage reports adjusted EPS of $1.43 versus $1.36 expected, revenue of $8.435B versus $8.300B expected, and a slight increase to full-year adjusted EPS guidance.",
"The N0 capture records +11.95% on 2.05x average volume. The provider series remained near the move through its final supplied observation.",
"The 20-session record shows CCL +4.48% versus its sector proxy -6.75%, a +11.23 percentage-point difference.",
"The active H3/H8/H15 positive-return estimates are 0.470/0.469/0.502; corresponding adverse-MAE medians are -4.49%/-7.15%/-9.26%. The separate audit-only H15 historical-dispersion output is P10 -19.62%, median -1.26%, P90 +7.16%. These comparisons use eight cases."
],
"benchmark_excess_pct": {
"sp500": 3.4156,
"nasdaq100": 3.5229,
"russell2000": 4.7243
},
"price_as_of": "2026-10-06T19:21:35.651397Z",
"vwap_as_of": null
},
{
"symbol": "SMMT",
"role": "alternative",
"price": 16.3387,
"base_price": 16.505,
"return_since_base_pct": -1.0076,
"session_return_pct": -0.313,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.35,
"rsi": 42.99,
"vwap": 17.03,
"vwap_distance_pct": -4.0593,
"position_52w_pct": 56.43,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:20:32Z",
"source": "yfinance_quote",
"name": "Summit Therapeutics Inc.",
"episode_id": "n0:SMMT:2026-09-29",
"ema_trend": "16.44 > 16.26 > 15.62",
"vwap_state": "below",
"selection_as_of": "2026-09-29T15:16:50.388704Z",
"facts": [
"The supplied event evidence describes a $2B AstraZeneca investment using newly issued convertible preferred shares and a clinical collaboration.",
"The N0 event capture was +6.62% on 3.35x average volume, but the provider series faded to about +5.33% and the intraday reading was below VWAP."
],
"benchmark_excess_pct": {
"sp500": -0.9074,
"nasdaq100": -0.8001,
"russell2000": 0.4013
},
"price_as_of": "2026-09-29T21:20:32Z",
"vwap_as_of": null
},
{
"symbol": "HAFN",
"role": "alternative",
"price": 9.77,
"base_price": 9.56,
"return_since_base_pct": 2.1967,
"session_return_pct": 1.0341,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.24,
"rsi": 57.04,
"vwap": 9.53,
"vwap_distance_pct": 2.5184,
"position_52w_pct": 94.57,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:05:26Z",
"source": "yfinance_quote",
"name": "Hafnia Limited",
"episode_id": "n0:HAFN:2026-09-29",
"ema_trend": "9.27 > 9.0 > 8.33",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:18:47.711682Z",
"facts": [
"The N0 capture was +4.71% on 1.24x average volume; later provider observations retained a somewhat larger gain and price was above VWAP.",
"No company-specific catalyst was established in the supplied dossier."
],
"benchmark_excess_pct": {
"sp500": 0.4397,
"nasdaq100": 0.547,
"russell2000": 1.7484
},
"price_as_of": "2026-09-29T21:05:26Z",
"vwap_as_of": null
},
{
"symbol": "NTWK",
"role": "alternative",
"price": 5.56,
"base_price": 5.5496,
"return_since_base_pct": 0.1874,
"session_return_pct": 3.36,
"change_since_prior_pct": 0.0,
"volume_ratio": 14.19,
"rsi": 89.74,
"vwap": 5.5,
"vwap_distance_pct": 1.0909,
"position_52w_pct": 98.75,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:10:08Z",
"source": "yfinance_quote",
"name": "NetSol Technologies, Inc.",
"episode_id": "n0:NTWK:2026-09-29",
"ema_trend": "4.87 > 4.54 > 4.38",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:15:36.965867Z",
"facts": [
"The supplied FY26 results report revenue of $74.4M, up 12.5%, and FY27 revenue guidance of $84.1M-$86.3M.",
"The event capture was +3.36% on 14.19x average volume, but the dossier estimates about $2M of dollar turnover and places price 3.06 ATR above its EMA reference."
],
"benchmark_excess_pct": {
"sp500": 2.7656,
"nasdaq100": 2.8729,
"russell2000": 4.0743
},
"price_as_of": "2026-09-29T20:10:08Z",
"vwap_as_of": null
},
{
"symbol": "ACET",
"role": "alternative",
"price": 6.77,
"base_price": 6.78,
"return_since_base_pct": -0.1475,
"session_return_pct": -0.8785,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.05,
"rsi": 31.39,
"vwap": 6.69,
"vwap_distance_pct": 1.1958,
"position_52w_pct": 38.99,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:55:28Z",
"source": "yfinance_quote",
"name": "Adicet Bio, Inc.",
"episode_id": "n0:ACET:2026-09-29",
"ema_trend": "8.07 > 8.58 > 8.73",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:17:12.774775Z",
"facts": [
"The supplied Phase 1 lupus readout reports 54% DORIS remission and 50% complete renal response among 22 efficacy-evaluable patients after 12 months.",
"The N0 capture was +6.71% on about 3.05x average volume, while the 20-session asset return was -21.15% versus -0.40% for its healthcare proxy."
],
"benchmark_excess_pct": {
"sp500": -1.4729,
"nasdaq100": -1.3656,
"russell2000": -0.1642
},
"price_as_of": "2026-09-29T20:55:28Z",
"vwap_as_of": null
},
{
"symbol": "PWP",
"role": "alternative",
"price": 17.1,
"base_price": 16.85,
"return_since_base_pct": 1.4837,
"session_return_pct": 4.4594,
"change_since_prior_pct": 0.0,
"volume_ratio": 5.79,
"rsi": 55.35,
"vwap": 16.26,
"vwap_distance_pct": 5.1661,
"position_52w_pct": 65.01,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:13:05Z",
"source": "yfinance_quote",
"name": "Perella Weinberg Partners",
"episode_id": "n0:PWP:2026-09-29",
"ema_trend": "14.6 > 14.8 > 15.42",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:15:55.598703Z",
"facts": [
"The catalyst is a report of acquisition talks, not a confirmed agreement.",
"The event capture was +15.1% on 5.79x average volume; the provider series retreated from its high but retained much of the move."
],
"benchmark_excess_pct": {
"sp500": 3.865,
"nasdaq100": 3.9723,
"russell2000": 5.1737
},
"price_as_of": "2026-09-29T21:13:05Z",
"vwap_as_of": null
},
{
"symbol": "KMX",
"role": "alternative",
"price": 59.35,
"base_price": 60.72,
"return_since_base_pct": -2.2563,
"session_return_pct": 0.2026,
"change_since_prior_pct": 0.0,
"volume_ratio": 2.26,
"rsi": 52.08,
"vwap": 61.4,
"vwap_distance_pct": -3.3388,
"position_52w_pct": 93.32,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:59:02Z",
"source": "yfinance_quote",
"name": "CarMax, Inc.",
"episode_id": "n0:KMX:2026-09-29",
"ema_trend": "58.29 > 58.97 > 58.5",
"vwap_state": "below",
"selection_as_of": "2026-09-29T15:17:34.477760Z",
"facts": [
"The supplied earnings report shows EPS of $1.16 versus $0.73 expected and sales of $7.878B versus $6.976B expected.",
"The provider trajectory faded from about +5.72% to +3.24%; the intraday reading was below VWAP with a downward trend.",
"The active H3/H8/H15 positive-return estimates are 0.547/0.567/0.528, higher than CCL's at each horizon. Its corresponding adverse-MAE medians are -3.25%/-4.20%/-6.09%. The separate audit-only H15 historical-dispersion output is P10 -5.31%, median +4.18%, P90 +16.31%. These comparisons use eight cases."
],
"benchmark_excess_pct": {
"sp500": -0.3918,
"nasdaq100": -0.2845,
"russell2000": 0.9169
},
"price_as_of": "2026-09-29T20:59:02Z",
"vwap_as_of": null
},
{
"symbol": "WYY",
"role": "alternative",
"price": 7.28,
"base_price": 6.4203,
"return_since_base_pct": 13.3903,
"session_return_pct": -0.9524,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.39,
"rsi": 29.28,
"vwap": 6.2,
"vwap_distance_pct": 17.4194,
"position_52w_pct": 26.56,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:10:33Z",
"source": "yfinance_quote",
"name": "WidePoint Corporation",
"episode_id": "n0:WYY:2026-09-29",
"ema_trend": "8.81 > 9.89 > 10.68",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:18:38.363232Z",
"facts": [
"The provider trajectory rose from about +7.97% to +16.45%, and the intraday reading was above VWAP.",
"The 20-session asset return was -32.32% versus +4.15% for the technology proxy; no company-specific catalyst for the day's move was established."
],
"benchmark_excess_pct": {
"sp500": -1.5468,
"nasdaq100": -1.4395,
"russell2000": -0.2381
},
"price_as_of": "2026-09-29T21:10:33Z",
"vwap_as_of": null
},
{
"symbol": "VIAV",
"role": "alternative",
"price": 41.99,
"base_price": 41.455,
"return_since_base_pct": 1.2906,
"session_return_pct": 0.4065,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.53,
"rsi": 57.12,
"vwap": 41.77,
"vwap_distance_pct": 0.5267,
"position_52w_pct": 68.56,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:16:33Z",
"source": "yfinance_quote",
"name": "Viavi Solutions Inc.",
"episode_id": "narrative:VIAV:b612043b612913e0",
"ema_trend": "38.56 > 37.68 > 38.08",
"vwap_state": "below",
"selection_as_of": "2026-09-29T17:19:34Z",
"facts": [
"The primary product announcement introduces a 100G testing platform but supplies no customer wins or expected revenue contribution.",
"The quote change was +1.37% on 0.53x average volume; price was below VWAP with a downward intraday trend."
],
"benchmark_excess_pct": {
"sp500": -0.1879,
"nasdaq100": -0.0806,
"russell2000": 1.1208
},
"price_as_of": "2026-09-29T21:16:33Z",
"vwap_as_of": null
},
{
"symbol": "WH",
"role": "alternative",
"price": 72.44,
"base_price": 71.79,
"return_since_base_pct": 0.9054,
"session_return_pct": null,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.32,
"rsi": 60.7,
"vwap": 71.82,
"vwap_distance_pct": 0.8633,
"position_52w_pct": 79.55,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:00:33Z",
"source": "yfinance_quote",
"name": "Wyndham Hotels & Resorts, Inc.",
"episode_id": "narrative:WH:e6143a4ee8e53619",
"ema_trend": "69.87 > 70.21 > 72.36",
"vwap_state": "above",
"selection_as_of": "2026-09-29T17:19:31Z",
"facts": [
"The primary release reports a $400M increase to the share repurchase authorization.",
"The quote change was +1.47% on 0.32x average volume; the authorization does not establish that repurchases occurred."
],
"price_as_of": "2026-09-29T20:00:33Z",
"vwap_as_of": null
}
],
"benchmarks": [
{
"id": "sp500",
"symbol": "^GSPC",
"label": "S&P 500",
"role": "benchmark",
"price": 7820.16,
"base_price": 7773.95,
"return_since_base_pct": 0.5944,
"session_return_pct": 0.5944,
"as_of": "2026-10-06T19:59:33.026072Z",
"source": "yfinance.ticker_info",
"base_definition": "previous regular close"
},
{
"id": "nasdaq100",
"symbol": "^NDX",
"label": "Nasdaq 100",
"role": "benchmark",
"price": 31227.828,
"base_price": 31076.441,
"return_since_base_pct": 0.4871,
"session_return_pct": 0.4871,
"as_of": "2026-10-06T19:59:33.026072Z",
"source": "yfinance.ticker_info",
"base_definition": "previous regular close"
},
{
"id": "russell2000",
"symbol": "^RUT",
"label": "Russell 2000",
"role": "benchmark",
"price": 2826.798,
"base_price": 2847.1357,
"return_since_base_pct": -0.7143,
"session_return_pct": -0.7143,
"as_of": "2026-10-06T19:59:33.026072Z",
"source": "yfinance.ticker_info",
"base_definition": "previous regular close"
}
],
"coverage": {
"candidate_rows": 10,
"candidate_prices": 10,
"candidate_technical": 10,
"benchmark_rows": 3
}
}
},
{
"day": 6,
"timestamp": "2026-10-07T15:09:16.626987Z",
"comparison": {
"schema_version": "public-candidate-comparison.v1",
"captured_at": "2026-10-07T15:09:16.626987Z",
"base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
"source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
"rows": [
{
"symbol": "CCL",
"role": "selected",
"price": 26.105,
"base_price": 24.785,
"return_since_base_pct": 5.3258,
"session_return_pct": -1.79,
"change_since_prior_pct": -1.8055,
"volume_ratio": 0.13,
"rsi": 73.58,
"vwap": 26.21,
"vwap_distance_pct": -0.4006,
"position_52w_pct": 76.7,
"extended_hours_pct": null,
"as_of": "2026-10-07T14:06:33.450164Z",
"source": "yfinance_quote",
"name": "Carnival Corporation Ltd.",
"episode_id": "n0:CCL:2026-09-29",
"ema_trend": "25.02 > 24.28 > 24.82",
"vwap_state": "below",
"selection_as_of": "2026-09-29T15:18:03.945792Z",
"facts": [
"The supplied earnings coverage reports adjusted EPS of $1.43 versus $1.36 expected, revenue of $8.435B versus $8.300B expected, and a slight increase to full-year adjusted EPS guidance.",
"The N0 capture records +11.95% on 2.05x average volume. The provider series remained near the move through its final supplied observation.",
"The 20-session record shows CCL +4.48% versus its sector proxy -6.75%, a +11.23 percentage-point difference.",
"The active H3/H8/H15 positive-return estimates are 0.470/0.469/0.502; corresponding adverse-MAE medians are -4.49%/-7.15%/-9.26%. The separate audit-only H15 historical-dispersion output is P10 -19.62%, median -1.26%, P90 +7.16%. These comparisons use eight cases."
],
"price_as_of": "2026-10-07T14:06:33.450164Z",
"vwap_as_of": null
},
{
"symbol": "SMMT",
"role": "alternative",
"price": 16.3387,
"base_price": 16.505,
"return_since_base_pct": -1.0076,
"session_return_pct": -0.313,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.35,
"rsi": 42.99,
"vwap": 17.03,
"vwap_distance_pct": -4.0593,
"position_52w_pct": 56.43,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:20:32Z",
"source": "yfinance_quote",
"name": "Summit Therapeutics Inc.",
"episode_id": "n0:SMMT:2026-09-29",
"ema_trend": "16.44 > 16.26 > 15.62",
"vwap_state": "below",
"selection_as_of": "2026-09-29T15:16:50.388704Z",
"facts": [
"The supplied event evidence describes a $2B AstraZeneca investment using newly issued convertible preferred shares and a clinical collaboration.",
"The N0 event capture was +6.62% on 3.35x average volume, but the provider series faded to about +5.33% and the intraday reading was below VWAP."
],
"price_as_of": "2026-09-29T21:20:32Z",
"vwap_as_of": null
},
{
"symbol": "HAFN",
"role": "alternative",
"price": 9.77,
"base_price": 9.56,
"return_since_base_pct": 2.1967,
"session_return_pct": 1.0341,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.24,
"rsi": 57.04,
"vwap": 9.53,
"vwap_distance_pct": 2.5184,
"position_52w_pct": 94.57,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:05:26Z",
"source": "yfinance_quote",
"name": "Hafnia Limited",
"episode_id": "n0:HAFN:2026-09-29",
"ema_trend": "9.27 > 9.0 > 8.33",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:18:47.711682Z",
"facts": [
"The N0 capture was +4.71% on 1.24x average volume; later provider observations retained a somewhat larger gain and price was above VWAP.",
"No company-specific catalyst was established in the supplied dossier."
],
"price_as_of": "2026-09-29T21:05:26Z",
"vwap_as_of": null
},
{
"symbol": "NTWK",
"role": "alternative",
"price": 5.56,
"base_price": 5.5496,
"return_since_base_pct": 0.1874,
"session_return_pct": 3.36,
"change_since_prior_pct": 0.0,
"volume_ratio": 14.19,
"rsi": 89.74,
"vwap": 5.5,
"vwap_distance_pct": 1.0909,
"position_52w_pct": 98.75,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:10:08Z",
"source": "yfinance_quote",
"name": "NetSol Technologies, Inc.",
"episode_id": "n0:NTWK:2026-09-29",
"ema_trend": "4.87 > 4.54 > 4.38",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:15:36.965867Z",
"facts": [
"The supplied FY26 results report revenue of $74.4M, up 12.5%, and FY27 revenue guidance of $84.1M-$86.3M.",
"The event capture was +3.36% on 14.19x average volume, but the dossier estimates about $2M of dollar turnover and places price 3.06 ATR above its EMA reference."
],
"price_as_of": "2026-09-29T20:10:08Z",
"vwap_as_of": null
},
{
"symbol": "ACET",
"role": "alternative",
"price": 6.77,
"base_price": 6.78,
"return_since_base_pct": -0.1475,
"session_return_pct": -0.8785,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.05,
"rsi": 31.39,
"vwap": 6.69,
"vwap_distance_pct": 1.1958,
"position_52w_pct": 38.99,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:55:28Z",
"source": "yfinance_quote",
"name": "Adicet Bio, Inc.",
"episode_id": "n0:ACET:2026-09-29",
"ema_trend": "8.07 > 8.58 > 8.73",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:17:12.774775Z",
"facts": [
"The supplied Phase 1 lupus readout reports 54% DORIS remission and 50% complete renal response among 22 efficacy-evaluable patients after 12 months.",
"The N0 capture was +6.71% on about 3.05x average volume, while the 20-session asset return was -21.15% versus -0.40% for its healthcare proxy."
],
"price_as_of": "2026-09-29T20:55:28Z",
"vwap_as_of": null
},
{
"symbol": "PWP",
"role": "alternative",
"price": 17.1,
"base_price": 16.85,
"return_since_base_pct": 1.4837,
"session_return_pct": 4.4594,
"change_since_prior_pct": 0.0,
"volume_ratio": 5.79,
"rsi": 55.35,
"vwap": 16.26,
"vwap_distance_pct": 5.1661,
"position_52w_pct": 65.01,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:13:05Z",
"source": "yfinance_quote",
"name": "Perella Weinberg Partners",
"episode_id": "n0:PWP:2026-09-29",
"ema_trend": "14.6 > 14.8 > 15.42",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:15:55.598703Z",
"facts": [
"The catalyst is a report of acquisition talks, not a confirmed agreement.",
"The event capture was +15.1% on 5.79x average volume; the provider series retreated from its high but retained much of the move."
],
"price_as_of": "2026-09-29T21:13:05Z",
"vwap_as_of": null
},
{
"symbol": "KMX",
"role": "alternative",
"price": 59.35,
"base_price": 60.72,
"return_since_base_pct": -2.2563,
"session_return_pct": 0.2026,
"change_since_prior_pct": 0.0,
"volume_ratio": 2.26,
"rsi": 52.08,
"vwap": 61.4,
"vwap_distance_pct": -3.3388,
"position_52w_pct": 93.32,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:59:02Z",
"source": "yfinance_quote",
"name": "CarMax, Inc.",
"episode_id": "n0:KMX:2026-09-29",
"ema_trend": "58.29 > 58.97 > 58.5",
"vwap_state": "below",
"selection_as_of": "2026-09-29T15:17:34.477760Z",
"facts": [
"The supplied earnings report shows EPS of $1.16 versus $0.73 expected and sales of $7.878B versus $6.976B expected.",
"The provider trajectory faded from about +5.72% to +3.24%; the intraday reading was below VWAP with a downward trend.",
"The active H3/H8/H15 positive-return estimates are 0.547/0.567/0.528, higher than CCL's at each horizon. Its corresponding adverse-MAE medians are -3.25%/-4.20%/-6.09%. The separate audit-only H15 historical-dispersion output is P10 -5.31%, median +4.18%, P90 +16.31%. These comparisons use eight cases."
],
"price_as_of": "2026-09-29T20:59:02Z",
"vwap_as_of": null
},
{
"symbol": "WYY",
"role": "alternative",
"price": 7.28,
"base_price": 6.4203,
"return_since_base_pct": 13.3903,
"session_return_pct": -0.9524,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.39,
"rsi": 29.28,
"vwap": 6.2,
"vwap_distance_pct": 17.4194,
"position_52w_pct": 26.56,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:10:33Z",
"source": "yfinance_quote",
"name": "WidePoint Corporation",
"episode_id": "n0:WYY:2026-09-29",
"ema_trend": "8.81 > 9.89 > 10.68",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:18:38.363232Z",
"facts": [
"The provider trajectory rose from about +7.97% to +16.45%, and the intraday reading was above VWAP.",
"The 20-session asset return was -32.32% versus +4.15% for the technology proxy; no company-specific catalyst for the day's move was established."
],
"price_as_of": "2026-09-29T21:10:33Z",
"vwap_as_of": null
},
{
"symbol": "VIAV",
"role": "alternative",
"price": 41.99,
"base_price": 41.455,
"return_since_base_pct": 1.2906,
"session_return_pct": 0.4065,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.53,
"rsi": 57.12,
"vwap": 41.77,
"vwap_distance_pct": 0.5267,
"position_52w_pct": 68.56,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:16:33Z",
"source": "yfinance_quote",
"name": "Viavi Solutions Inc.",
"episode_id": "narrative:VIAV:b612043b612913e0",
"ema_trend": "38.56 > 37.68 > 38.08",
"vwap_state": "below",
"selection_as_of": "2026-09-29T17:19:34Z",
"facts": [
"The primary product announcement introduces a 100G testing platform but supplies no customer wins or expected revenue contribution.",
"The quote change was +1.37% on 0.53x average volume; price was below VWAP with a downward intraday trend."
],
"price_as_of": "2026-09-29T21:16:33Z",
"vwap_as_of": null
},
{
"symbol": "WH",
"role": "alternative",
"price": 72.44,
"base_price": 71.79,
"return_since_base_pct": 0.9054,
"session_return_pct": null,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.32,
"rsi": 60.7,
"vwap": 71.82,
"vwap_distance_pct": 0.8633,
"position_52w_pct": 79.55,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:00:33Z",
"source": "yfinance_quote",
"name": "Wyndham Hotels & Resorts, Inc.",
"episode_id": "narrative:WH:e6143a4ee8e53619",
"ema_trend": "69.87 > 70.21 > 72.36",
"vwap_state": "above",
"selection_as_of": "2026-09-29T17:19:31Z",
"facts": [
"The primary release reports a $400M increase to the share repurchase authorization.",
"The quote change was +1.47% on 0.32x average volume; the authorization does not establish that repurchases occurred."
],
"price_as_of": "2026-09-29T20:00:33Z",
"vwap_as_of": null
}
],
"benchmarks": [],
"coverage": {
"candidate_rows": 10,
"candidate_prices": 10,
"candidate_technical": 10,
"benchmark_rows": 0
}
}
},
{
"day": 6,
"timestamp": "2026-10-07T20:36:59.566600Z",
"comparison": {
"schema_version": "public-candidate-comparison.v1",
"captured_at": "2026-10-07T20:36:59.566600Z",
"base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
"source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
"rows": [
{
"symbol": "CCL",
"role": "selected",
"price": 26.315,
"base_price": 24.785,
"return_since_base_pct": 6.1731,
"session_return_pct": -1.0,
"change_since_prior_pct": 0.8044,
"volume_ratio": 0.46,
"rsi": 75.48,
"vwap": 26.22,
"vwap_distance_pct": 0.3623,
"position_52w_pct": 77.3,
"extended_hours_pct": null,
"as_of": "2026-10-07T19:21:41.146640Z",
"source": "yfinance_quote",
"name": "Carnival Corporation Ltd.",
"episode_id": "n0:CCL:2026-09-29",
"ema_trend": "25.06 > 24.3 > 24.82",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:18:03.945792Z",
"facts": [
"The supplied earnings coverage reports adjusted EPS of $1.43 versus $1.36 expected, revenue of $8.435B versus $8.300B expected, and a slight increase to full-year adjusted EPS guidance.",
"The N0 capture records +11.95% on 2.05x average volume. The provider series remained near the move through its final supplied observation.",
"The 20-session record shows CCL +4.48% versus its sector proxy -6.75%, a +11.23 percentage-point difference.",
"The active H3/H8/H15 positive-return estimates are 0.470/0.469/0.502; corresponding adverse-MAE medians are -4.49%/-7.15%/-9.26%. The separate audit-only H15 historical-dispersion output is P10 -19.62%, median -1.26%, P90 +7.16%. These comparisons use eight cases."
],
"benchmark_excess_pct": {
"sp500": -0.7805,
"nasdaq100": -0.7931,
"russell2000": 0.3106
},
"price_as_of": "2026-10-07T19:21:41.146640Z",
"vwap_as_of": null
},
{
"symbol": "SMMT",
"role": "alternative",
"price": 16.3387,
"base_price": 16.505,
"return_since_base_pct": -1.0076,
"session_return_pct": -0.313,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.35,
"rsi": 42.99,
"vwap": 17.03,
"vwap_distance_pct": -4.0593,
"position_52w_pct": 56.43,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:20:32Z",
"source": "yfinance_quote",
"name": "Summit Therapeutics Inc.",
"episode_id": "n0:SMMT:2026-09-29",
"ema_trend": "16.44 > 16.26 > 15.62",
"vwap_state": "below",
"selection_as_of": "2026-09-29T15:16:50.388704Z",
"facts": [
"The supplied event evidence describes a $2B AstraZeneca investment using newly issued convertible preferred shares and a clinical collaboration.",
"The N0 event capture was +6.62% on 3.35x average volume, but the provider series faded to about +5.33% and the intraday reading was below VWAP."
],
"benchmark_excess_pct": {
"sp500": -0.0935,
"nasdaq100": -0.1061,
"russell2000": 0.9976
},
"price_as_of": "2026-09-29T21:20:32Z",
"vwap_as_of": null
},
{
"symbol": "HAFN",
"role": "alternative",
"price": 9.77,
"base_price": 9.56,
"return_since_base_pct": 2.1967,
"session_return_pct": 1.0341,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.24,
"rsi": 57.04,
"vwap": 9.53,
"vwap_distance_pct": 2.5184,
"position_52w_pct": 94.57,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:05:26Z",
"source": "yfinance_quote",
"name": "Hafnia Limited",
"episode_id": "n0:HAFN:2026-09-29",
"ema_trend": "9.27 > 9.0 > 8.33",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:18:47.711682Z",
"facts": [
"The N0 capture was +4.71% on 1.24x average volume; later provider observations retained a somewhat larger gain and price was above VWAP.",
"No company-specific catalyst was established in the supplied dossier."
],
"benchmark_excess_pct": {
"sp500": 1.2536,
"nasdaq100": 1.241,
"russell2000": 2.3447
},
"price_as_of": "2026-09-29T21:05:26Z",
"vwap_as_of": null
},
{
"symbol": "NTWK",
"role": "alternative",
"price": 5.56,
"base_price": 5.5496,
"return_since_base_pct": 0.1874,
"session_return_pct": 3.36,
"change_since_prior_pct": 0.0,
"volume_ratio": 14.19,
"rsi": 89.74,
"vwap": 5.5,
"vwap_distance_pct": 1.0909,
"position_52w_pct": 98.75,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:10:08Z",
"source": "yfinance_quote",
"name": "NetSol Technologies, Inc.",
"episode_id": "n0:NTWK:2026-09-29",
"ema_trend": "4.87 > 4.54 > 4.38",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:15:36.965867Z",
"facts": [
"The supplied FY26 results report revenue of $74.4M, up 12.5%, and FY27 revenue guidance of $84.1M-$86.3M.",
"The event capture was +3.36% on 14.19x average volume, but the dossier estimates about $2M of dollar turnover and places price 3.06 ATR above its EMA reference."
],
"benchmark_excess_pct": {
"sp500": 3.5795,
"nasdaq100": 3.5669,
"russell2000": 4.6706
},
"price_as_of": "2026-09-29T20:10:08Z",
"vwap_as_of": null
},
{
"symbol": "ACET",
"role": "alternative",
"price": 6.77,
"base_price": 6.78,
"return_since_base_pct": -0.1475,
"session_return_pct": -0.8785,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.05,
"rsi": 31.39,
"vwap": 6.69,
"vwap_distance_pct": 1.1958,
"position_52w_pct": 38.99,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:55:28Z",
"source": "yfinance_quote",
"name": "Adicet Bio, Inc.",
"episode_id": "n0:ACET:2026-09-29",
"ema_trend": "8.07 > 8.58 > 8.73",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:17:12.774775Z",
"facts": [
"The supplied Phase 1 lupus readout reports 54% DORIS remission and 50% complete renal response among 22 efficacy-evaluable patients after 12 months.",
"The N0 capture was +6.71% on about 3.05x average volume, while the 20-session asset return was -21.15% versus -0.40% for its healthcare proxy."
],
"benchmark_excess_pct": {
"sp500": -0.659,
"nasdaq100": -0.6716,
"russell2000": 0.4321
},
"price_as_of": "2026-09-29T20:55:28Z",
"vwap_as_of": null
},
{
"symbol": "PWP",
"role": "alternative",
"price": 17.1,
"base_price": 16.85,
"return_since_base_pct": 1.4837,
"session_return_pct": 4.4594,
"change_since_prior_pct": 0.0,
"volume_ratio": 5.79,
"rsi": 55.35,
"vwap": 16.26,
"vwap_distance_pct": 5.1661,
"position_52w_pct": 65.01,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:13:05Z",
"source": "yfinance_quote",
"name": "Perella Weinberg Partners",
"episode_id": "n0:PWP:2026-09-29",
"ema_trend": "14.6 > 14.8 > 15.42",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:15:55.598703Z",
"facts": [
"The catalyst is a report of acquisition talks, not a confirmed agreement.",
"The event capture was +15.1% on 5.79x average volume; the provider series retreated from its high but retained much of the move."
],
"benchmark_excess_pct": {
"sp500": 4.6789,
"nasdaq100": 4.6663,
"russell2000": 5.77
},
"price_as_of": "2026-09-29T21:13:05Z",
"vwap_as_of": null
},
{
"symbol": "KMX",
"role": "alternative",
"price": 59.35,
"base_price": 60.72,
"return_since_base_pct": -2.2563,
"session_return_pct": 0.2026,
"change_since_prior_pct": 0.0,
"volume_ratio": 2.26,
"rsi": 52.08,
"vwap": 61.4,
"vwap_distance_pct": -3.3388,
"position_52w_pct": 93.32,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:59:02Z",
"source": "yfinance_quote",
"name": "CarMax, Inc.",
"episode_id": "n0:KMX:2026-09-29",
"ema_trend": "58.29 > 58.97 > 58.5",
"vwap_state": "below",
"selection_as_of": "2026-09-29T15:17:34.477760Z",
"facts": [
"The supplied earnings report shows EPS of $1.16 versus $0.73 expected and sales of $7.878B versus $6.976B expected.",
"The provider trajectory faded from about +5.72% to +3.24%; the intraday reading was below VWAP with a downward trend.",
"The active H3/H8/H15 positive-return estimates are 0.547/0.567/0.528, higher than CCL's at each horizon. Its corresponding adverse-MAE medians are -3.25%/-4.20%/-6.09%. The separate audit-only H15 historical-dispersion output is P10 -5.31%, median +4.18%, P90 +16.31%. These comparisons use eight cases."
],
"benchmark_excess_pct": {
"sp500": 0.4221,
"nasdaq100": 0.4095,
"russell2000": 1.5132
},
"price_as_of": "2026-09-29T20:59:02Z",
"vwap_as_of": null
},
{
"symbol": "WYY",
"role": "alternative",
"price": 7.28,
"base_price": 6.4203,
"return_since_base_pct": 13.3903,
"session_return_pct": -0.9524,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.39,
"rsi": 29.28,
"vwap": 6.2,
"vwap_distance_pct": 17.4194,
"position_52w_pct": 26.56,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:10:33Z",
"source": "yfinance_quote",
"name": "WidePoint Corporation",
"episode_id": "n0:WYY:2026-09-29",
"ema_trend": "8.81 > 9.89 > 10.68",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:18:38.363232Z",
"facts": [
"The provider trajectory rose from about +7.97% to +16.45%, and the intraday reading was above VWAP.",
"The 20-session asset return was -32.32% versus +4.15% for the technology proxy; no company-specific catalyst for the day's move was established."
],
"benchmark_excess_pct": {
"sp500": -0.7329,
"nasdaq100": -0.7455,
"russell2000": 0.3582
},
"price_as_of": "2026-09-29T21:10:33Z",
"vwap_as_of": null
},
{
"symbol": "VIAV",
"role": "alternative",
"price": 41.99,
"base_price": 41.455,
"return_since_base_pct": 1.2906,
"session_return_pct": 0.4065,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.53,
"rsi": 57.12,
"vwap": 41.77,
"vwap_distance_pct": 0.5267,
"position_52w_pct": 68.56,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:16:33Z",
"source": "yfinance_quote",
"name": "Viavi Solutions Inc.",
"episode_id": "narrative:VIAV:b612043b612913e0",
"ema_trend": "38.56 > 37.68 > 38.08",
"vwap_state": "below",
"selection_as_of": "2026-09-29T17:19:34Z",
"facts": [
"The primary product announcement introduces a 100G testing platform but supplies no customer wins or expected revenue contribution.",
"The quote change was +1.37% on 0.53x average volume; price was below VWAP with a downward intraday trend."
],
"benchmark_excess_pct": {
"sp500": 0.626,
"nasdaq100": 0.6134,
"russell2000": 1.7171
},
"price_as_of": "2026-09-29T21:16:33Z",
"vwap_as_of": null
},
{
"symbol": "WH",
"role": "alternative",
"price": 72.44,
"base_price": 71.79,
"return_since_base_pct": 0.9054,
"session_return_pct": null,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.32,
"rsi": 60.7,
"vwap": 71.82,
"vwap_distance_pct": 0.8633,
"position_52w_pct": 79.55,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:00:33Z",
"source": "yfinance_quote",
"name": "Wyndham Hotels & Resorts, Inc.",
"episode_id": "narrative:WH:e6143a4ee8e53619",
"ema_trend": "69.87 > 70.21 > 72.36",
"vwap_state": "above",
"selection_as_of": "2026-09-29T17:19:31Z",
"facts": [
"The primary release reports a $400M increase to the share repurchase authorization.",
"The quote change was +1.47% on 0.32x average volume; the authorization does not establish that repurchases occurred."
],
"price_as_of": "2026-09-29T20:00:33Z",
"vwap_as_of": null
}
],
"benchmarks": [
{
"id": "sp500",
"symbol": "^GSPC",
"label": "S&P 500",
"role": "benchmark",
"price": 7801.77,
"base_price": 7818.93,
"return_since_base_pct": -0.2195,
"session_return_pct": -0.2195,
"as_of": "2026-10-07T20:30:43.184621Z",
"source": "yfinance.ticker_info",
"base_definition": "previous regular close"
},
{
"id": "nasdaq100",
"symbol": "^NDX",
"label": "Nasdaq 100",
"role": "benchmark",
"price": 31160.076,
"base_price": 31224.686,
"return_since_base_pct": -0.2069,
"session_return_pct": -0.2069,
"as_of": "2026-10-07T20:30:43.184621Z",
"source": "yfinance.ticker_info",
"base_definition": "previous regular close"
},
{
"id": "russell2000",
"symbol": "^RUT",
"label": "Russell 2000",
"role": "benchmark",
"price": 2793.204,
"base_price": 2830.2974,
"return_since_base_pct": -1.3106,
"session_return_pct": -1.3106,
"as_of": "2026-10-07T20:30:43.184621Z",
"source": "yfinance.ticker_info",
"base_definition": "previous regular close"
}
],
"coverage": {
"candidate_rows": 10,
"candidate_prices": 10,
"candidate_technical": 10,
"benchmark_rows": 3
}
}
},
{
"day": 6,
"timestamp": "2026-10-07T22:09:23.677647Z",
"comparison": {
"schema_version": "public-candidate-comparison.v1",
"captured_at": "2026-10-07T22:09:23.677647Z",
"base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
"source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
"rows": [
{
"symbol": "CCL",
"role": "selected",
"price": 26.34,
"base_price": 24.785,
"return_since_base_pct": 6.274,
"session_return_pct": -1.62,
"change_since_prior_pct": 0.095,
"volume_ratio": 0.7,
"rsi": 73.98,
"vwap": 26.22,
"vwap_distance_pct": 0.4577,
"position_52w_pct": 76.8,
"extended_hours_pct": 0.74,
"as_of": "2026-10-07T21:19:15Z",
"source": "sealed_extended_quote",
"name": "Carnival Corporation Ltd.",
"episode_id": "n0:CCL:2026-09-29",
"ema_trend": "25.03 > 24.28 > 24.82",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:18:03.945792Z",
"facts": [
"The supplied earnings coverage reports adjusted EPS of $1.43 versus $1.36 expected, revenue of $8.435B versus $8.300B expected, and a slight increase to full-year adjusted EPS guidance.",
"The N0 capture records +11.95% on 2.05x average volume. The provider series remained near the move through its final supplied observation.",
"The 20-session record shows CCL +4.48% versus its sector proxy -6.75%, a +11.23 percentage-point difference.",
"The active H3/H8/H15 positive-return estimates are 0.470/0.469/0.502; corresponding adverse-MAE medians are -4.49%/-7.15%/-9.26%. The separate audit-only H15 historical-dispersion output is P10 -19.62%, median -1.26%, P90 +7.16%. These comparisons use eight cases."
],
"benchmark_excess_pct": {
"sp500": -1.4005,
"nasdaq100": -1.4131,
"russell2000": -0.3094
},
"price_as_of": "2026-10-07T21:19:15Z",
"vwap_as_of": null
},
{
"symbol": "SMMT",
"role": "alternative",
"price": 16.3387,
"base_price": 16.505,
"return_since_base_pct": -1.0076,
"session_return_pct": -0.313,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.35,
"rsi": 42.99,
"vwap": 17.03,
"vwap_distance_pct": -4.0593,
"position_52w_pct": 56.43,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:20:32Z",
"source": "yfinance_quote",
"name": "Summit Therapeutics Inc.",
"episode_id": "n0:SMMT:2026-09-29",
"ema_trend": "16.44 > 16.26 > 15.62",
"vwap_state": "below",
"selection_as_of": "2026-09-29T15:16:50.388704Z",
"facts": [
"The supplied event evidence describes a $2B AstraZeneca investment using newly issued convertible preferred shares and a clinical collaboration.",
"The N0 event capture was +6.62% on 3.35x average volume, but the provider series faded to about +5.33% and the intraday reading was below VWAP."
],
"benchmark_excess_pct": {
"sp500": -0.0935,
"nasdaq100": -0.1061,
"russell2000": 0.9976
},
"price_as_of": "2026-09-29T21:20:32Z",
"vwap_as_of": null
},
{
"symbol": "HAFN",
"role": "alternative",
"price": 9.77,
"base_price": 9.56,
"return_since_base_pct": 2.1967,
"session_return_pct": 1.0341,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.24,
"rsi": 57.04,
"vwap": 9.53,
"vwap_distance_pct": 2.5184,
"position_52w_pct": 94.57,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:05:26Z",
"source": "yfinance_quote",
"name": "Hafnia Limited",
"episode_id": "n0:HAFN:2026-09-29",
"ema_trend": "9.27 > 9.0 > 8.33",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:18:47.711682Z",
"facts": [
"The N0 capture was +4.71% on 1.24x average volume; later provider observations retained a somewhat larger gain and price was above VWAP.",
"No company-specific catalyst was established in the supplied dossier."
],
"benchmark_excess_pct": {
"sp500": 1.2536,
"nasdaq100": 1.241,
"russell2000": 2.3447
},
"price_as_of": "2026-09-29T21:05:26Z",
"vwap_as_of": null
},
{
"symbol": "NTWK",
"role": "alternative",
"price": 5.56,
"base_price": 5.5496,
"return_since_base_pct": 0.1874,
"session_return_pct": 3.36,
"change_since_prior_pct": 0.0,
"volume_ratio": 14.19,
"rsi": 89.74,
"vwap": 5.5,
"vwap_distance_pct": 1.0909,
"position_52w_pct": 98.75,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:10:08Z",
"source": "yfinance_quote",
"name": "NetSol Technologies, Inc.",
"episode_id": "n0:NTWK:2026-09-29",
"ema_trend": "4.87 > 4.54 > 4.38",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:15:36.965867Z",
"facts": [
"The supplied FY26 results report revenue of $74.4M, up 12.5%, and FY27 revenue guidance of $84.1M-$86.3M.",
"The event capture was +3.36% on 14.19x average volume, but the dossier estimates about $2M of dollar turnover and places price 3.06 ATR above its EMA reference."
],
"benchmark_excess_pct": {
"sp500": 3.5795,
"nasdaq100": 3.5669,
"russell2000": 4.6706
},
"price_as_of": "2026-09-29T20:10:08Z",
"vwap_as_of": null
},
{
"symbol": "ACET",
"role": "alternative",
"price": 6.77,
"base_price": 6.78,
"return_since_base_pct": -0.1475,
"session_return_pct": -0.8785,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.05,
"rsi": 31.39,
"vwap": 6.69,
"vwap_distance_pct": 1.1958,
"position_52w_pct": 38.99,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:55:28Z",
"source": "yfinance_quote",
"name": "Adicet Bio, Inc.",
"episode_id": "n0:ACET:2026-09-29",
"ema_trend": "8.07 > 8.58 > 8.73",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:17:12.774775Z",
"facts": [
"The supplied Phase 1 lupus readout reports 54% DORIS remission and 50% complete renal response among 22 efficacy-evaluable patients after 12 months.",
"The N0 capture was +6.71% on about 3.05x average volume, while the 20-session asset return was -21.15% versus -0.40% for its healthcare proxy."
],
"benchmark_excess_pct": {
"sp500": -0.659,
"nasdaq100": -0.6716,
"russell2000": 0.4321
},
"price_as_of": "2026-09-29T20:55:28Z",
"vwap_as_of": null
},
{
"symbol": "PWP",
"role": "alternative",
"price": 17.1,
"base_price": 16.85,
"return_since_base_pct": 1.4837,
"session_return_pct": 4.4594,
"change_since_prior_pct": 0.0,
"volume_ratio": 5.79,
"rsi": 55.35,
"vwap": 16.26,
"vwap_distance_pct": 5.1661,
"position_52w_pct": 65.01,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:13:05Z",
"source": "yfinance_quote",
"name": "Perella Weinberg Partners",
"episode_id": "n0:PWP:2026-09-29",
"ema_trend": "14.6 > 14.8 > 15.42",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:15:55.598703Z",
"facts": [
"The catalyst is a report of acquisition talks, not a confirmed agreement.",
"The event capture was +15.1% on 5.79x average volume; the provider series retreated from its high but retained much of the move."
],
"benchmark_excess_pct": {
"sp500": 4.6789,
"nasdaq100": 4.6663,
"russell2000": 5.77
},
"price_as_of": "2026-09-29T21:13:05Z",
"vwap_as_of": null
},
{
"symbol": "KMX",
"role": "alternative",
"price": 59.35,
"base_price": 60.72,
"return_since_base_pct": -2.2563,
"session_return_pct": 0.2026,
"change_since_prior_pct": 0.0,
"volume_ratio": 2.26,
"rsi": 52.08,
"vwap": 61.4,
"vwap_distance_pct": -3.3388,
"position_52w_pct": 93.32,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:59:02Z",
"source": "yfinance_quote",
"name": "CarMax, Inc.",
"episode_id": "n0:KMX:2026-09-29",
"ema_trend": "58.29 > 58.97 > 58.5",
"vwap_state": "below",
"selection_as_of": "2026-09-29T15:17:34.477760Z",
"facts": [
"The supplied earnings report shows EPS of $1.16 versus $0.73 expected and sales of $7.878B versus $6.976B expected.",
"The provider trajectory faded from about +5.72% to +3.24%; the intraday reading was below VWAP with a downward trend.",
"The active H3/H8/H15 positive-return estimates are 0.547/0.567/0.528, higher than CCL's at each horizon. Its corresponding adverse-MAE medians are -3.25%/-4.20%/-6.09%. The separate audit-only H15 historical-dispersion output is P10 -5.31%, median +4.18%, P90 +16.31%. These comparisons use eight cases."
],
"benchmark_excess_pct": {
"sp500": 0.4221,
"nasdaq100": 0.4095,
"russell2000": 1.5132
},
"price_as_of": "2026-09-29T20:59:02Z",
"vwap_as_of": null
},
{
"symbol": "WYY",
"role": "alternative",
"price": 7.28,
"base_price": 6.4203,
"return_since_base_pct": 13.3903,
"session_return_pct": -0.9524,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.39,
"rsi": 29.28,
"vwap": 6.2,
"vwap_distance_pct": 17.4194,
"position_52w_pct": 26.56,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:10:33Z",
"source": "yfinance_quote",
"name": "WidePoint Corporation",
"episode_id": "n0:WYY:2026-09-29",
"ema_trend": "8.81 > 9.89 > 10.68",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:18:38.363232Z",
"facts": [
"The provider trajectory rose from about +7.97% to +16.45%, and the intraday reading was above VWAP.",
"The 20-session asset return was -32.32% versus +4.15% for the technology proxy; no company-specific catalyst for the day's move was established."
],
"benchmark_excess_pct": {
"sp500": -0.7329,
"nasdaq100": -0.7455,
"russell2000": 0.3582
},
"price_as_of": "2026-09-29T21:10:33Z",
"vwap_as_of": null
},
{
"symbol": "VIAV",
"role": "alternative",
"price": 41.99,
"base_price": 41.455,
"return_since_base_pct": 1.2906,
"session_return_pct": 0.4065,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.53,
"rsi": 57.12,
"vwap": 41.77,
"vwap_distance_pct": 0.5267,
"position_52w_pct": 68.56,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:16:33Z",
"source": "yfinance_quote",
"name": "Viavi Solutions Inc.",
"episode_id": "narrative:VIAV:b612043b612913e0",
"ema_trend": "38.56 > 37.68 > 38.08",
"vwap_state": "below",
"selection_as_of": "2026-09-29T17:19:34Z",
"facts": [
"The primary product announcement introduces a 100G testing platform but supplies no customer wins or expected revenue contribution.",
"The quote change was +1.37% on 0.53x average volume; price was below VWAP with a downward intraday trend."
],
"benchmark_excess_pct": {
"sp500": 0.626,
"nasdaq100": 0.6134,
"russell2000": 1.7171
},
"price_as_of": "2026-09-29T21:16:33Z",
"vwap_as_of": null
},
{
"symbol": "WH",
"role": "alternative",
"price": 72.44,
"base_price": 71.79,
"return_since_base_pct": 0.9054,
"session_return_pct": null,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.32,
"rsi": 60.7,
"vwap": 71.82,
"vwap_distance_pct": 0.8633,
"position_52w_pct": 79.55,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:00:33Z",
"source": "yfinance_quote",
"name": "Wyndham Hotels & Resorts, Inc.",
"episode_id": "narrative:WH:e6143a4ee8e53619",
"ema_trend": "69.87 > 70.21 > 72.36",
"vwap_state": "above",
"selection_as_of": "2026-09-29T17:19:31Z",
"facts": [
"The primary release reports a $400M increase to the share repurchase authorization.",
"The quote change was +1.47% on 0.32x average volume; the authorization does not establish that repurchases occurred."
],
"price_as_of": "2026-09-29T20:00:33Z",
"vwap_as_of": null
}
],
"benchmarks": [
{
"id": "sp500",
"symbol": "^GSPC",
"label": "S&P 500",
"role": "benchmark",
"price": 7801.77,
"base_price": 7818.93,
"return_since_base_pct": -0.2195,
"session_return_pct": -0.2195,
"as_of": "2026-10-07T22:09:00.135906Z",
"source": "yfinance.ticker_info",
"base_definition": "previous regular close"
},
{
"id": "nasdaq100",
"symbol": "^NDX",
"label": "Nasdaq 100",
"role": "benchmark",
"price": 31160.076,
"base_price": 31224.686,
"return_since_base_pct": -0.2069,
"session_return_pct": -0.2069,
"as_of": "2026-10-07T22:09:00.135906Z",
"source": "yfinance.ticker_info",
"base_definition": "previous regular close"
},
{
"id": "russell2000",
"symbol": "^RUT",
"label": "Russell 2000",
"role": "benchmark",
"price": 2793.204,
"base_price": 2830.2974,
"return_since_base_pct": -1.3106,
"session_return_pct": -1.3106,
"as_of": "2026-10-07T22:09:00.135906Z",
"source": "yfinance.ticker_info",
"base_definition": "previous regular close"
}
],
"coverage": {
"candidate_rows": 10,
"candidate_prices": 10,
"candidate_technical": 10,
"benchmark_rows": 3
}
}
},
{
"day": 7,
"timestamp": "2026-10-08T15:02:12.702559Z",
"comparison": {
"schema_version": "public-candidate-comparison.v1",
"captured_at": "2026-10-08T15:02:12.702559Z",
"base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
"source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
"rows": [
{
"symbol": "CCL",
"role": "selected",
"price": 25.87,
"base_price": 24.785,
"return_since_base_pct": 4.3776,
"session_return_pct": -1.07,
"change_since_prior_pct": -1.7844,
"volume_ratio": 0.14,
"rsi": 74.49,
"vwap": 25.8,
"vwap_distance_pct": 0.2713,
"position_52w_pct": 76.0,
"extended_hours_pct": null,
"as_of": "2026-10-08T14:06:42.195821Z",
"source": "yfinance_quote",
"name": "Carnival Corporation Ltd.",
"episode_id": "n0:CCL:2026-09-29",
"ema_trend": "25.2 > 24.43 > 24.86",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:18:03.945792Z",
"facts": [
"The supplied earnings coverage reports adjusted EPS of $1.43 versus $1.36 expected, revenue of $8.435B versus $8.300B expected, and a slight increase to full-year adjusted EPS guidance.",
"The N0 capture records +11.95% on 2.05x average volume. The provider series remained near the move through its final supplied observation.",
"The 20-session record shows CCL +4.48% versus its sector proxy -6.75%, a +11.23 percentage-point difference.",
"The active H3/H8/H15 positive-return estimates are 0.470/0.469/0.502; corresponding adverse-MAE medians are -4.49%/-7.15%/-9.26%. The separate audit-only H15 historical-dispersion output is P10 -19.62%, median -1.26%, P90 +7.16%. These comparisons use eight cases."
],
"benchmark_excess_pct": {
"sp500": -0.7676,
"nasdaq100": -0.6037,
"russell2000": -0.4898
},
"price_as_of": "2026-10-08T14:06:42.195821Z",
"vwap_as_of": null
},
{
"symbol": "SMMT",
"role": "alternative",
"price": 16.3387,
"base_price": 16.505,
"return_since_base_pct": -1.0076,
"session_return_pct": -0.313,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.35,
"rsi": 42.99,
"vwap": 17.03,
"vwap_distance_pct": -4.0593,
"position_52w_pct": 56.43,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:20:32Z",
"source": "yfinance_quote",
"name": "Summit Therapeutics Inc.",
"episode_id": "n0:SMMT:2026-09-29",
"ema_trend": "16.44 > 16.26 > 15.62",
"vwap_state": "below",
"selection_as_of": "2026-09-29T15:16:50.388704Z",
"facts": [
"The supplied event evidence describes a $2B AstraZeneca investment using newly issued convertible preferred shares and a clinical collaboration.",
"The N0 event capture was +6.62% on 3.35x average volume, but the provider series faded to about +5.33% and the intraday reading was below VWAP."
],
"benchmark_excess_pct": {
"sp500": -0.0106,
"nasdaq100": 0.1533,
"russell2000": 0.2672
},
"price_as_of": "2026-09-29T21:20:32Z",
"vwap_as_of": null
},
{
"symbol": "HAFN",
"role": "alternative",
"price": 9.77,
"base_price": 9.56,
"return_since_base_pct": 2.1967,
"session_return_pct": 1.0341,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.24,
"rsi": 57.04,
"vwap": 9.53,
"vwap_distance_pct": 2.5184,
"position_52w_pct": 94.57,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:05:26Z",
"source": "yfinance_quote",
"name": "Hafnia Limited",
"episode_id": "n0:HAFN:2026-09-29",
"ema_trend": "9.27 > 9.0 > 8.33",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:18:47.711682Z",
"facts": [
"The N0 capture was +4.71% on 1.24x average volume; later provider observations retained a somewhat larger gain and price was above VWAP.",
"No company-specific catalyst was established in the supplied dossier."
],
"benchmark_excess_pct": {
"sp500": 1.3365,
"nasdaq100": 1.5004,
"russell2000": 1.6143
},
"price_as_of": "2026-09-29T21:05:26Z",
"vwap_as_of": null
},
{
"symbol": "NTWK",
"role": "alternative",
"price": 5.56,
"base_price": 5.5496,
"return_since_base_pct": 0.1874,
"session_return_pct": 3.36,
"change_since_prior_pct": 0.0,
"volume_ratio": 14.19,
"rsi": 89.74,
"vwap": 5.5,
"vwap_distance_pct": 1.0909,
"position_52w_pct": 98.75,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:10:08Z",
"source": "yfinance_quote",
"name": "NetSol Technologies, Inc.",
"episode_id": "n0:NTWK:2026-09-29",
"ema_trend": "4.87 > 4.54 > 4.38",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:15:36.965867Z",
"facts": [
"The supplied FY26 results report revenue of $74.4M, up 12.5%, and FY27 revenue guidance of $84.1M-$86.3M.",
"The event capture was +3.36% on 14.19x average volume, but the dossier estimates about $2M of dollar turnover and places price 3.06 ATR above its EMA reference."
],
"benchmark_excess_pct": {
"sp500": 3.6624,
"nasdaq100": 3.8263,
"russell2000": 3.9402
},
"price_as_of": "2026-09-29T20:10:08Z",
"vwap_as_of": null
},
{
"symbol": "ACET",
"role": "alternative",
"price": 6.77,
"base_price": 6.78,
"return_since_base_pct": -0.1475,
"session_return_pct": -0.8785,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.05,
"rsi": 31.39,
"vwap": 6.69,
"vwap_distance_pct": 1.1958,
"position_52w_pct": 38.99,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:55:28Z",
"source": "yfinance_quote",
"name": "Adicet Bio, Inc.",
"episode_id": "n0:ACET:2026-09-29",
"ema_trend": "8.07 > 8.58 > 8.73",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:17:12.774775Z",
"facts": [
"The supplied Phase 1 lupus readout reports 54% DORIS remission and 50% complete renal response among 22 efficacy-evaluable patients after 12 months.",
"The N0 capture was +6.71% on about 3.05x average volume, while the 20-session asset return was -21.15% versus -0.40% for its healthcare proxy."
],
"benchmark_excess_pct": {
"sp500": -0.5761,
"nasdaq100": -0.4122,
"russell2000": -0.2983
},
"price_as_of": "2026-09-29T20:55:28Z",
"vwap_as_of": null
},
{
"symbol": "PWP",
"role": "alternative",
"price": 17.1,
"base_price": 16.85,
"return_since_base_pct": 1.4837,
"session_return_pct": 4.4594,
"change_since_prior_pct": 0.0,
"volume_ratio": 5.79,
"rsi": 55.35,
"vwap": 16.26,
"vwap_distance_pct": 5.1661,
"position_52w_pct": 65.01,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:13:05Z",
"source": "yfinance_quote",
"name": "Perella Weinberg Partners",
"episode_id": "n0:PWP:2026-09-29",
"ema_trend": "14.6 > 14.8 > 15.42",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:15:55.598703Z",
"facts": [
"The catalyst is a report of acquisition talks, not a confirmed agreement.",
"The event capture was +15.1% on 5.79x average volume; the provider series retreated from its high but retained much of the move."
],
"benchmark_excess_pct": {
"sp500": 4.7618,
"nasdaq100": 4.9257,
"russell2000": 5.0396
},
"price_as_of": "2026-09-29T21:13:05Z",
"vwap_as_of": null
},
{
"symbol": "KMX",
"role": "alternative",
"price": 59.35,
"base_price": 60.72,
"return_since_base_pct": -2.2563,
"session_return_pct": 0.2026,
"change_since_prior_pct": 0.0,
"volume_ratio": 2.26,
"rsi": 52.08,
"vwap": 61.4,
"vwap_distance_pct": -3.3388,
"position_52w_pct": 93.32,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:59:02Z",
"source": "yfinance_quote",
"name": "CarMax, Inc.",
"episode_id": "n0:KMX:2026-09-29",
"ema_trend": "58.29 > 58.97 > 58.5",
"vwap_state": "below",
"selection_as_of": "2026-09-29T15:17:34.477760Z",
"facts": [
"The supplied earnings report shows EPS of $1.16 versus $0.73 expected and sales of $7.878B versus $6.976B expected.",
"The provider trajectory faded from about +5.72% to +3.24%; the intraday reading was below VWAP with a downward trend.",
"The active H3/H8/H15 positive-return estimates are 0.547/0.567/0.528, higher than CCL's at each horizon. Its corresponding adverse-MAE medians are -3.25%/-4.20%/-6.09%. The separate audit-only H15 historical-dispersion output is P10 -5.31%, median +4.18%, P90 +16.31%. These comparisons use eight cases."
],
"benchmark_excess_pct": {
"sp500": 0.505,
"nasdaq100": 0.6689,
"russell2000": 0.7828
},
"price_as_of": "2026-09-29T20:59:02Z",
"vwap_as_of": null
},
{
"symbol": "WYY",
"role": "alternative",
"price": 7.28,
"base_price": 6.4203,
"return_since_base_pct": 13.3903,
"session_return_pct": -0.9524,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.39,
"rsi": 29.28,
"vwap": 6.2,
"vwap_distance_pct": 17.4194,
"position_52w_pct": 26.56,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:10:33Z",
"source": "yfinance_quote",
"name": "WidePoint Corporation",
"episode_id": "n0:WYY:2026-09-29",
"ema_trend": "8.81 > 9.89 > 10.68",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:18:38.363232Z",
"facts": [
"The provider trajectory rose from about +7.97% to +16.45%, and the intraday reading was above VWAP.",
"The 20-session asset return was -32.32% versus +4.15% for the technology proxy; no company-specific catalyst for the day's move was established."
],
"benchmark_excess_pct": {
"sp500": -0.65,
"nasdaq100": -0.4861,
"russell2000": -0.3722
},
"price_as_of": "2026-09-29T21:10:33Z",
"vwap_as_of": null
},
{
"symbol": "VIAV",
"role": "alternative",
"price": 41.99,
"base_price": 41.455,
"return_since_base_pct": 1.2906,
"session_return_pct": 0.4065,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.53,
"rsi": 57.12,
"vwap": 41.77,
"vwap_distance_pct": 0.5267,
"position_52w_pct": 68.56,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:16:33Z",
"source": "yfinance_quote",
"name": "Viavi Solutions Inc.",
"episode_id": "narrative:VIAV:b612043b612913e0",
"ema_trend": "38.56 > 37.68 > 38.08",
"vwap_state": "below",
"selection_as_of": "2026-09-29T17:19:34Z",
"facts": [
"The primary product announcement introduces a 100G testing platform but supplies no customer wins or expected revenue contribution.",
"The quote change was +1.37% on 0.53x average volume; price was below VWAP with a downward intraday trend."
],
"benchmark_excess_pct": {
"sp500": 0.7089,
"nasdaq100": 0.8728,
"russell2000": 0.9867
},
"price_as_of": "2026-09-29T21:16:33Z",
"vwap_as_of": null
},
{
"symbol": "WH",
"role": "alternative",
"price": 72.44,
"base_price": 71.79,
"return_since_base_pct": 0.9054,
"session_return_pct": null,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.32,
"rsi": 60.7,
"vwap": 71.82,
"vwap_distance_pct": 0.8633,
"position_52w_pct": 79.55,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:00:33Z",
"source": "yfinance_quote",
"name": "Wyndham Hotels & Resorts, Inc.",
"episode_id": "narrative:WH:e6143a4ee8e53619",
"ema_trend": "69.87 > 70.21 > 72.36",
"vwap_state": "above",
"selection_as_of": "2026-09-29T17:19:31Z",
"facts": [
"The primary release reports a $400M increase to the share repurchase authorization.",
"The quote change was +1.47% on 0.32x average volume; the authorization does not establish that repurchases occurred."
],
"price_as_of": "2026-09-29T20:00:33Z",
"vwap_as_of": null
}
],
"benchmarks": [
{
"id": "sp500",
"symbol": "^GSPC",
"label": "S&P 500",
"role": "benchmark",
"price": 7778.18,
"base_price": 7801.77,
"return_since_base_pct": -0.3024,
"session_return_pct": -0.3024,
"as_of": "2026-10-08T14:55:12.664497Z",
"source": "yfinance.ticker_info",
"base_definition": "previous regular close"
},
{
"id": "nasdaq100",
"symbol": "^NDX",
"label": "Nasdaq 100",
"role": "benchmark",
"price": 31014.77,
"base_price": 31160.076,
"return_since_base_pct": -0.4663,
"session_return_pct": -0.4663,
"as_of": "2026-10-08T14:55:12.664497Z",
"source": "yfinance.ticker_info",
"base_definition": "previous regular close"
},
{
"id": "russell2000",
"symbol": "^RUT",
"label": "Russell 2000",
"role": "benchmark",
"price": 2776.999,
"base_price": 2793.204,
"return_since_base_pct": -0.5802,
"session_return_pct": -0.5802,
"as_of": "2026-10-08T14:55:12.664497Z",
"source": "yfinance.ticker_info",
"base_definition": "previous regular close"
}
],
"coverage": {
"candidate_rows": 10,
"candidate_prices": 10,
"candidate_technical": 10,
"benchmark_rows": 3
}
}
},
{
"day": 7,
"timestamp": "2026-10-08T20:15:55.556416Z",
"comparison": {
"schema_version": "public-candidate-comparison.v1",
"captured_at": "2026-10-08T20:15:55.556416Z",
"base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
"source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
"rows": [
{
"symbol": "CCL",
"role": "selected",
"price": 26.065,
"base_price": 24.785,
"return_since_base_pct": 5.1644,
"session_return_pct": -0.33,
"change_since_prior_pct": 0.7538,
"volume_ratio": 0.55,
"rsi": 76.23,
"vwap": 25.98,
"vwap_distance_pct": 0.3272,
"position_52w_pct": 76.6,
"extended_hours_pct": null,
"as_of": "2026-10-08T19:22:13.087729Z",
"source": "yfinance_quote",
"name": "Carnival Corporation Ltd.",
"episode_id": "n0:CCL:2026-09-29",
"ema_trend": "25.24 > 24.44 > 24.87",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:18:03.945792Z",
"facts": [
"The supplied earnings coverage reports adjusted EPS of $1.43 versus $1.36 expected, revenue of $8.435B versus $8.300B expected, and a slight increase to full-year adjusted EPS guidance.",
"The N0 capture records +11.95% on 2.05x average volume. The provider series remained near the move through its final supplied observation.",
"The 20-session record shows CCL +4.48% versus its sector proxy -6.75%, a +11.23 percentage-point difference.",
"The active H3/H8/H15 positive-return estimates are 0.470/0.469/0.502; corresponding adverse-MAE medians are -4.49%/-7.15%/-9.26%. The separate audit-only H15 historical-dispersion output is P10 -19.62%, median -1.26%, P90 +7.16%. These comparisons use eight cases."
],
"price_as_of": "2026-10-08T19:22:13.087729Z",
"vwap_as_of": null
},
{
"symbol": "SMMT",
"role": "alternative",
"price": 16.3387,
"base_price": 16.505,
"return_since_base_pct": -1.0076,
"session_return_pct": -0.313,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.35,
"rsi": 42.99,
"vwap": 17.03,
"vwap_distance_pct": -4.0593,
"position_52w_pct": 56.43,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:20:32Z",
"source": "yfinance_quote",
"name": "Summit Therapeutics Inc.",
"episode_id": "n0:SMMT:2026-09-29",
"ema_trend": "16.44 > 16.26 > 15.62",
"vwap_state": "below",
"selection_as_of": "2026-09-29T15:16:50.388704Z",
"facts": [
"The supplied event evidence describes a $2B AstraZeneca investment using newly issued convertible preferred shares and a clinical collaboration.",
"The N0 event capture was +6.62% on 3.35x average volume, but the provider series faded to about +5.33% and the intraday reading was below VWAP."
],
"price_as_of": "2026-09-29T21:20:32Z",
"vwap_as_of": null
},
{
"symbol": "HAFN",
"role": "alternative",
"price": 9.77,
"base_price": 9.56,
"return_since_base_pct": 2.1967,
"session_return_pct": 1.0341,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.24,
"rsi": 57.04,
"vwap": 9.53,
"vwap_distance_pct": 2.5184,
"position_52w_pct": 94.57,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:05:26Z",
"source": "yfinance_quote",
"name": "Hafnia Limited",
"episode_id": "n0:HAFN:2026-09-29",
"ema_trend": "9.27 > 9.0 > 8.33",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:18:47.711682Z",
"facts": [
"The N0 capture was +4.71% on 1.24x average volume; later provider observations retained a somewhat larger gain and price was above VWAP.",
"No company-specific catalyst was established in the supplied dossier."
],
"price_as_of": "2026-09-29T21:05:26Z",
"vwap_as_of": null
},
{
"symbol": "NTWK",
"role": "alternative",
"price": 5.56,
"base_price": 5.5496,
"return_since_base_pct": 0.1874,
"session_return_pct": 3.36,
"change_since_prior_pct": 0.0,
"volume_ratio": 14.19,
"rsi": 89.74,
"vwap": 5.5,
"vwap_distance_pct": 1.0909,
"position_52w_pct": 98.75,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:10:08Z",
"source": "yfinance_quote",
"name": "NetSol Technologies, Inc.",
"episode_id": "n0:NTWK:2026-09-29",
"ema_trend": "4.87 > 4.54 > 4.38",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:15:36.965867Z",
"facts": [
"The supplied FY26 results report revenue of $74.4M, up 12.5%, and FY27 revenue guidance of $84.1M-$86.3M.",
"The event capture was +3.36% on 14.19x average volume, but the dossier estimates about $2M of dollar turnover and places price 3.06 ATR above its EMA reference."
],
"price_as_of": "2026-09-29T20:10:08Z",
"vwap_as_of": null
},
{
"symbol": "ACET",
"role": "alternative",
"price": 6.77,
"base_price": 6.78,
"return_since_base_pct": -0.1475,
"session_return_pct": -0.8785,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.05,
"rsi": 31.39,
"vwap": 6.69,
"vwap_distance_pct": 1.1958,
"position_52w_pct": 38.99,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:55:28Z",
"source": "yfinance_quote",
"name": "Adicet Bio, Inc.",
"episode_id": "n0:ACET:2026-09-29",
"ema_trend": "8.07 > 8.58 > 8.73",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:17:12.774775Z",
"facts": [
"The supplied Phase 1 lupus readout reports 54% DORIS remission and 50% complete renal response among 22 efficacy-evaluable patients after 12 months.",
"The N0 capture was +6.71% on about 3.05x average volume, while the 20-session asset return was -21.15% versus -0.40% for its healthcare proxy."
],
"price_as_of": "2026-09-29T20:55:28Z",
"vwap_as_of": null
},
{
"symbol": "PWP",
"role": "alternative",
"price": 17.1,
"base_price": 16.85,
"return_since_base_pct": 1.4837,
"session_return_pct": 4.4594,
"change_since_prior_pct": 0.0,
"volume_ratio": 5.79,
"rsi": 55.35,
"vwap": 16.26,
"vwap_distance_pct": 5.1661,
"position_52w_pct": 65.01,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:13:05Z",
"source": "yfinance_quote",
"name": "Perella Weinberg Partners",
"episode_id": "n0:PWP:2026-09-29",
"ema_trend": "14.6 > 14.8 > 15.42",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:15:55.598703Z",
"facts": [
"The catalyst is a report of acquisition talks, not a confirmed agreement.",
"The event capture was +15.1% on 5.79x average volume; the provider series retreated from its high but retained much of the move."
],
"price_as_of": "2026-09-29T21:13:05Z",
"vwap_as_of": null
},
{
"symbol": "KMX",
"role": "alternative",
"price": 59.35,
"base_price": 60.72,
"return_since_base_pct": -2.2563,
"session_return_pct": 0.2026,
"change_since_prior_pct": 0.0,
"volume_ratio": 2.26,
"rsi": 52.08,
"vwap": 61.4,
"vwap_distance_pct": -3.3388,
"position_52w_pct": 93.32,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:59:02Z",
"source": "yfinance_quote",
"name": "CarMax, Inc.",
"episode_id": "n0:KMX:2026-09-29",
"ema_trend": "58.29 > 58.97 > 58.5",
"vwap_state": "below",
"selection_as_of": "2026-09-29T15:17:34.477760Z",
"facts": [
"The supplied earnings report shows EPS of $1.16 versus $0.73 expected and sales of $7.878B versus $6.976B expected.",
"The provider trajectory faded from about +5.72% to +3.24%; the intraday reading was below VWAP with a downward trend.",
"The active H3/H8/H15 positive-return estimates are 0.547/0.567/0.528, higher than CCL's at each horizon. Its corresponding adverse-MAE medians are -3.25%/-4.20%/-6.09%. The separate audit-only H15 historical-dispersion output is P10 -5.31%, median +4.18%, P90 +16.31%. These comparisons use eight cases."
],
"price_as_of": "2026-09-29T20:59:02Z",
"vwap_as_of": null
},
{
"symbol": "WYY",
"role": "alternative",
"price": 7.28,
"base_price": 6.4203,
"return_since_base_pct": 13.3903,
"session_return_pct": -0.9524,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.39,
"rsi": 29.28,
"vwap": 6.2,
"vwap_distance_pct": 17.4194,
"position_52w_pct": 26.56,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:10:33Z",
"source": "yfinance_quote",
"name": "WidePoint Corporation",
"episode_id": "n0:WYY:2026-09-29",
"ema_trend": "8.81 > 9.89 > 10.68",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:18:38.363232Z",
"facts": [
"The provider trajectory rose from about +7.97% to +16.45%, and the intraday reading was above VWAP.",
"The 20-session asset return was -32.32% versus +4.15% for the technology proxy; no company-specific catalyst for the day's move was established."
],
"price_as_of": "2026-09-29T21:10:33Z",
"vwap_as_of": null
},
{
"symbol": "VIAV",
"role": "alternative",
"price": 41.99,
"base_price": 41.455,
"return_since_base_pct": 1.2906,
"session_return_pct": 0.4065,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.53,
"rsi": 57.12,
"vwap": 41.77,
"vwap_distance_pct": 0.5267,
"position_52w_pct": 68.56,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:16:33Z",
"source": "yfinance_quote",
"name": "Viavi Solutions Inc.",
"episode_id": "narrative:VIAV:b612043b612913e0",
"ema_trend": "38.56 > 37.68 > 38.08",
"vwap_state": "below",
"selection_as_of": "2026-09-29T17:19:34Z",
"facts": [
"The primary product announcement introduces a 100G testing platform but supplies no customer wins or expected revenue contribution.",
"The quote change was +1.37% on 0.53x average volume; price was below VWAP with a downward intraday trend."
],
"price_as_of": "2026-09-29T21:16:33Z",
"vwap_as_of": null
},
{
"symbol": "WH",
"role": "alternative",
"price": 72.44,
"base_price": 71.79,
"return_since_base_pct": 0.9054,
"session_return_pct": null,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.32,
"rsi": 60.7,
"vwap": 71.82,
"vwap_distance_pct": 0.8633,
"position_52w_pct": 79.55,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:00:33Z",
"source": "yfinance_quote",
"name": "Wyndham Hotels & Resorts, Inc.",
"episode_id": "narrative:WH:e6143a4ee8e53619",
"ema_trend": "69.87 > 70.21 > 72.36",
"vwap_state": "above",
"selection_as_of": "2026-09-29T17:19:31Z",
"facts": [
"The primary release reports a $400M increase to the share repurchase authorization.",
"The quote change was +1.47% on 0.32x average volume; the authorization does not establish that repurchases occurred."
],
"price_as_of": "2026-09-29T20:00:33Z",
"vwap_as_of": null
}
],
"benchmarks": [],
"coverage": {
"candidate_rows": 10,
"candidate_prices": 10,
"candidate_technical": 10,
"benchmark_rows": 0
}
}
},
{
"day": 7,
"timestamp": "2026-10-08T21:54:04.705689Z",
"comparison": {
"schema_version": "public-candidate-comparison.v1",
"captured_at": "2026-10-08T21:54:04.705689Z",
"base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
"source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
"rows": [
{
"symbol": "CCL",
"role": "selected",
"price": 26.13,
"base_price": 24.785,
"return_since_base_pct": 5.4267,
"session_return_pct": -0.08,
"change_since_prior_pct": 0.2494,
"volume_ratio": 1.12,
"rsi": 76.85,
"vwap": 25.98,
"vwap_distance_pct": 0.5774,
"position_52w_pct": 76.8,
"extended_hours_pct": 0.0,
"as_of": "2026-10-08T21:27:45Z",
"source": "sealed_extended_quote",
"name": "Carnival Corporation Ltd.",
"episode_id": "n0:CCL:2026-09-29",
"ema_trend": "25.25 > 24.45 > 24.87",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:18:03.945792Z",
"facts": [
"The supplied earnings coverage reports adjusted EPS of $1.43 versus $1.36 expected, revenue of $8.435B versus $8.300B expected, and a slight increase to full-year adjusted EPS guidance.",
"The N0 capture records +11.95% on 2.05x average volume. The provider series remained near the move through its final supplied observation.",
"The 20-session record shows CCL +4.48% versus its sector proxy -6.75%, a +11.23 percentage-point difference.",
"The active H3/H8/H15 positive-return estimates are 0.470/0.469/0.502; corresponding adverse-MAE medians are -4.49%/-7.15%/-9.26%. The separate audit-only H15 historical-dispersion output is P10 -19.62%, median -1.26%, P90 +7.16%. These comparisons use eight cases."
],
"price_as_of": "2026-10-08T21:27:45Z",
"vwap_as_of": null
},
{
"symbol": "SMMT",
"role": "alternative",
"price": 16.3387,
"base_price": 16.505,
"return_since_base_pct": -1.0076,
"session_return_pct": -0.313,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.35,
"rsi": 42.99,
"vwap": 17.03,
"vwap_distance_pct": -4.0593,
"position_52w_pct": 56.43,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:20:32Z",
"source": "yfinance_quote",
"name": "Summit Therapeutics Inc.",
"episode_id": "n0:SMMT:2026-09-29",
"ema_trend": "16.44 > 16.26 > 15.62",
"vwap_state": "below",
"selection_as_of": "2026-09-29T15:16:50.388704Z",
"facts": [
"The supplied event evidence describes a $2B AstraZeneca investment using newly issued convertible preferred shares and a clinical collaboration.",
"The N0 event capture was +6.62% on 3.35x average volume, but the provider series faded to about +5.33% and the intraday reading was below VWAP."
],
"price_as_of": "2026-09-29T21:20:32Z",
"vwap_as_of": null
},
{
"symbol": "HAFN",
"role": "alternative",
"price": 9.77,
"base_price": 9.56,
"return_since_base_pct": 2.1967,
"session_return_pct": 1.0341,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.24,
"rsi": 57.04,
"vwap": 9.53,
"vwap_distance_pct": 2.5184,
"position_52w_pct": 94.57,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:05:26Z",
"source": "yfinance_quote",
"name": "Hafnia Limited",
"episode_id": "n0:HAFN:2026-09-29",
"ema_trend": "9.27 > 9.0 > 8.33",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:18:47.711682Z",
"facts": [
"The N0 capture was +4.71% on 1.24x average volume; later provider observations retained a somewhat larger gain and price was above VWAP.",
"No company-specific catalyst was established in the supplied dossier."
],
"price_as_of": "2026-09-29T21:05:26Z",
"vwap_as_of": null
},
{
"symbol": "NTWK",
"role": "alternative",
"price": 5.56,
"base_price": 5.5496,
"return_since_base_pct": 0.1874,
"session_return_pct": 3.36,
"change_since_prior_pct": 0.0,
"volume_ratio": 14.19,
"rsi": 89.74,
"vwap": 5.5,
"vwap_distance_pct": 1.0909,
"position_52w_pct": 98.75,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:10:08Z",
"source": "yfinance_quote",
"name": "NetSol Technologies, Inc.",
"episode_id": "n0:NTWK:2026-09-29",
"ema_trend": "4.87 > 4.54 > 4.38",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:15:36.965867Z",
"facts": [
"The supplied FY26 results report revenue of $74.4M, up 12.5%, and FY27 revenue guidance of $84.1M-$86.3M.",
"The event capture was +3.36% on 14.19x average volume, but the dossier estimates about $2M of dollar turnover and places price 3.06 ATR above its EMA reference."
],
"price_as_of": "2026-09-29T20:10:08Z",
"vwap_as_of": null
},
{
"symbol": "ACET",
"role": "alternative",
"price": 6.77,
"base_price": 6.78,
"return_since_base_pct": -0.1475,
"session_return_pct": -0.8785,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.05,
"rsi": 31.39,
"vwap": 6.69,
"vwap_distance_pct": 1.1958,
"position_52w_pct": 38.99,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:55:28Z",
"source": "yfinance_quote",
"name": "Adicet Bio, Inc.",
"episode_id": "n0:ACET:2026-09-29",
"ema_trend": "8.07 > 8.58 > 8.73",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:17:12.774775Z",
"facts": [
"The supplied Phase 1 lupus readout reports 54% DORIS remission and 50% complete renal response among 22 efficacy-evaluable patients after 12 months.",
"The N0 capture was +6.71% on about 3.05x average volume, while the 20-session asset return was -21.15% versus -0.40% for its healthcare proxy."
],
"price_as_of": "2026-09-29T20:55:28Z",
"vwap_as_of": null
},
{
"symbol": "PWP",
"role": "alternative",
"price": 17.1,
"base_price": 16.85,
"return_since_base_pct": 1.4837,
"session_return_pct": 4.4594,
"change_since_prior_pct": 0.0,
"volume_ratio": 5.79,
"rsi": 55.35,
"vwap": 16.26,
"vwap_distance_pct": 5.1661,
"position_52w_pct": 65.01,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:13:05Z",
"source": "yfinance_quote",
"name": "Perella Weinberg Partners",
"episode_id": "n0:PWP:2026-09-29",
"ema_trend": "14.6 > 14.8 > 15.42",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:15:55.598703Z",
"facts": [
"The catalyst is a report of acquisition talks, not a confirmed agreement.",
"The event capture was +15.1% on 5.79x average volume; the provider series retreated from its high but retained much of the move."
],
"price_as_of": "2026-09-29T21:13:05Z",
"vwap_as_of": null
},
{
"symbol": "KMX",
"role": "alternative",
"price": 59.35,
"base_price": 60.72,
"return_since_base_pct": -2.2563,
"session_return_pct": 0.2026,
"change_since_prior_pct": 0.0,
"volume_ratio": 2.26,
"rsi": 52.08,
"vwap": 61.4,
"vwap_distance_pct": -3.3388,
"position_52w_pct": 93.32,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:59:02Z",
"source": "yfinance_quote",
"name": "CarMax, Inc.",
"episode_id": "n0:KMX:2026-09-29",
"ema_trend": "58.29 > 58.97 > 58.5",
"vwap_state": "below",
"selection_as_of": "2026-09-29T15:17:34.477760Z",
"facts": [
"The supplied earnings report shows EPS of $1.16 versus $0.73 expected and sales of $7.878B versus $6.976B expected.",
"The provider trajectory faded from about +5.72% to +3.24%; the intraday reading was below VWAP with a downward trend.",
"The active H3/H8/H15 positive-return estimates are 0.547/0.567/0.528, higher than CCL's at each horizon. Its corresponding adverse-MAE medians are -3.25%/-4.20%/-6.09%. The separate audit-only H15 historical-dispersion output is P10 -5.31%, median +4.18%, P90 +16.31%. These comparisons use eight cases."
],
"price_as_of": "2026-09-29T20:59:02Z",
"vwap_as_of": null
},
{
"symbol": "WYY",
"role": "alternative",
"price": 7.28,
"base_price": 6.4203,
"return_since_base_pct": 13.3903,
"session_return_pct": -0.9524,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.39,
"rsi": 29.28,
"vwap": 6.2,
"vwap_distance_pct": 17.4194,
"position_52w_pct": 26.56,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:10:33Z",
"source": "yfinance_quote",
"name": "WidePoint Corporation",
"episode_id": "n0:WYY:2026-09-29",
"ema_trend": "8.81 > 9.89 > 10.68",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:18:38.363232Z",
"facts": [
"The provider trajectory rose from about +7.97% to +16.45%, and the intraday reading was above VWAP.",
"The 20-session asset return was -32.32% versus +4.15% for the technology proxy; no company-specific catalyst for the day's move was established."
],
"price_as_of": "2026-09-29T21:10:33Z",
"vwap_as_of": null
},
{
"symbol": "VIAV",
"role": "alternative",
"price": 41.99,
"base_price": 41.455,
"return_since_base_pct": 1.2906,
"session_return_pct": 0.4065,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.53,
"rsi": 57.12,
"vwap": 41.77,
"vwap_distance_pct": 0.5267,
"position_52w_pct": 68.56,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:16:33Z",
"source": "yfinance_quote",
"name": "Viavi Solutions Inc.",
"episode_id": "narrative:VIAV:b612043b612913e0",
"ema_trend": "38.56 > 37.68 > 38.08",
"vwap_state": "below",
"selection_as_of": "2026-09-29T17:19:34Z",
"facts": [
"The primary product announcement introduces a 100G testing platform but supplies no customer wins or expected revenue contribution.",
"The quote change was +1.37% on 0.53x average volume; price was below VWAP with a downward intraday trend."
],
"price_as_of": "2026-09-29T21:16:33Z",
"vwap_as_of": null
},
{
"symbol": "WH",
"role": "alternative",
"price": 72.44,
"base_price": 71.79,
"return_since_base_pct": 0.9054,
"session_return_pct": null,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.32,
"rsi": 60.7,
"vwap": 71.82,
"vwap_distance_pct": 0.8633,
"position_52w_pct": 79.55,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:00:33Z",
"source": "yfinance_quote",
"name": "Wyndham Hotels & Resorts, Inc.",
"episode_id": "narrative:WH:e6143a4ee8e53619",
"ema_trend": "69.87 > 70.21 > 72.36",
"vwap_state": "above",
"selection_as_of": "2026-09-29T17:19:31Z",
"facts": [
"The primary release reports a $400M increase to the share repurchase authorization.",
"The quote change was +1.47% on 0.32x average volume; the authorization does not establish that repurchases occurred."
],
"price_as_of": "2026-09-29T20:00:33Z",
"vwap_as_of": null
}
],
"benchmarks": [],
"coverage": {
"candidate_rows": 10,
"candidate_prices": 10,
"candidate_technical": 10,
"benchmark_rows": 0
}
}
},
{
"day": 8,
"timestamp": "2026-10-09T14:49:16.924724Z",
"comparison": {
"schema_version": "public-candidate-comparison.v1",
"captured_at": "2026-10-09T14:49:16.924724Z",
"base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
"source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
"rows": [
{
"symbol": "CCL",
"role": "selected",
"price": 26.3524,
"base_price": 24.785,
"return_since_base_pct": 6.324,
"session_return_pct": 0.85,
"change_since_prior_pct": 0.8511,
"volume_ratio": 0.09,
"rsi": 76.11,
"vwap": 26.27,
"vwap_distance_pct": 0.3137,
"position_52w_pct": 77.4,
"extended_hours_pct": null,
"as_of": "2026-10-09T14:06:45.252947Z",
"source": "yfinance_quote",
"name": "Carnival Corporation Ltd.",
"episode_id": "n0:CCL:2026-09-29",
"ema_trend": "25.47 > 24.62 > 24.93",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:18:03.945792Z",
"facts": [
"The supplied earnings coverage reports adjusted EPS of $1.43 versus $1.36 expected, revenue of $8.435B versus $8.300B expected, and a slight increase to full-year adjusted EPS guidance.",
"The N0 capture records +11.95% on 2.05x average volume. The provider series remained near the move through its final supplied observation.",
"The 20-session record shows CCL +4.48% versus its sector proxy -6.75%, a +11.23 percentage-point difference.",
"The active H3/H8/H15 positive-return estimates are 0.470/0.469/0.502; corresponding adverse-MAE medians are -4.49%/-7.15%/-9.26%. The separate audit-only H15 historical-dispersion output is P10 -19.62%, median -1.26%, P90 +7.16%. These comparisons use eight cases."
],
"price_as_of": "2026-10-09T14:06:45.252947Z",
"vwap_as_of": null
},
{
"symbol": "SMMT",
"role": "alternative",
"price": 16.3387,
"base_price": 16.505,
"return_since_base_pct": -1.0076,
"session_return_pct": -0.313,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.35,
"rsi": 42.99,
"vwap": 17.03,
"vwap_distance_pct": -4.0593,
"position_52w_pct": 56.43,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:20:32Z",
"source": "yfinance_quote",
"name": "Summit Therapeutics Inc.",
"episode_id": "n0:SMMT:2026-09-29",
"ema_trend": "16.44 > 16.26 > 15.62",
"vwap_state": "below",
"selection_as_of": "2026-09-29T15:16:50.388704Z",
"facts": [
"The supplied event evidence describes a $2B AstraZeneca investment using newly issued convertible preferred shares and a clinical collaboration.",
"The N0 event capture was +6.62% on 3.35x average volume, but the provider series faded to about +5.33% and the intraday reading was below VWAP."
],
"price_as_of": "2026-09-29T21:20:32Z",
"vwap_as_of": null
},
{
"symbol": "HAFN",
"role": "alternative",
"price": 9.77,
"base_price": 9.56,
"return_since_base_pct": 2.1967,
"session_return_pct": 1.0341,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.24,
"rsi": 57.04,
"vwap": 9.53,
"vwap_distance_pct": 2.5184,
"position_52w_pct": 94.57,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:05:26Z",
"source": "yfinance_quote",
"name": "Hafnia Limited",
"episode_id": "n0:HAFN:2026-09-29",
"ema_trend": "9.27 > 9.0 > 8.33",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:18:47.711682Z",
"facts": [
"The N0 capture was +4.71% on 1.24x average volume; later provider observations retained a somewhat larger gain and price was above VWAP.",
"No company-specific catalyst was established in the supplied dossier."
],
"price_as_of": "2026-09-29T21:05:26Z",
"vwap_as_of": null
},
{
"symbol": "NTWK",
"role": "alternative",
"price": 5.56,
"base_price": 5.5496,
"return_since_base_pct": 0.1874,
"session_return_pct": 3.36,
"change_since_prior_pct": 0.0,
"volume_ratio": 14.19,
"rsi": 89.74,
"vwap": 5.5,
"vwap_distance_pct": 1.0909,
"position_52w_pct": 98.75,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:10:08Z",
"source": "yfinance_quote",
"name": "NetSol Technologies, Inc.",
"episode_id": "n0:NTWK:2026-09-29",
"ema_trend": "4.87 > 4.54 > 4.38",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:15:36.965867Z",
"facts": [
"The supplied FY26 results report revenue of $74.4M, up 12.5%, and FY27 revenue guidance of $84.1M-$86.3M.",
"The event capture was +3.36% on 14.19x average volume, but the dossier estimates about $2M of dollar turnover and places price 3.06 ATR above its EMA reference."
],
"price_as_of": "2026-09-29T20:10:08Z",
"vwap_as_of": null
},
{
"symbol": "ACET",
"role": "alternative",
"price": 6.77,
"base_price": 6.78,
"return_since_base_pct": -0.1475,
"session_return_pct": -0.8785,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.05,
"rsi": 31.39,
"vwap": 6.69,
"vwap_distance_pct": 1.1958,
"position_52w_pct": 38.99,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:55:28Z",
"source": "yfinance_quote",
"name": "Adicet Bio, Inc.",
"episode_id": "n0:ACET:2026-09-29",
"ema_trend": "8.07 > 8.58 > 8.73",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:17:12.774775Z",
"facts": [
"The supplied Phase 1 lupus readout reports 54% DORIS remission and 50% complete renal response among 22 efficacy-evaluable patients after 12 months.",
"The N0 capture was +6.71% on about 3.05x average volume, while the 20-session asset return was -21.15% versus -0.40% for its healthcare proxy."
],
"price_as_of": "2026-09-29T20:55:28Z",
"vwap_as_of": null
},
{
"symbol": "PWP",
"role": "alternative",
"price": 17.1,
"base_price": 16.85,
"return_since_base_pct": 1.4837,
"session_return_pct": 4.4594,
"change_since_prior_pct": 0.0,
"volume_ratio": 5.79,
"rsi": 55.35,
"vwap": 16.26,
"vwap_distance_pct": 5.1661,
"position_52w_pct": 65.01,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:13:05Z",
"source": "yfinance_quote",
"name": "Perella Weinberg Partners",
"episode_id": "n0:PWP:2026-09-29",
"ema_trend": "14.6 > 14.8 > 15.42",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:15:55.598703Z",
"facts": [
"The catalyst is a report of acquisition talks, not a confirmed agreement.",
"The event capture was +15.1% on 5.79x average volume; the provider series retreated from its high but retained much of the move."
],
"price_as_of": "2026-09-29T21:13:05Z",
"vwap_as_of": null
},
{
"symbol": "KMX",
"role": "alternative",
"price": 59.35,
"base_price": 60.72,
"return_since_base_pct": -2.2563,
"session_return_pct": 0.2026,
"change_since_prior_pct": 0.0,
"volume_ratio": 2.26,
"rsi": 52.08,
"vwap": 61.4,
"vwap_distance_pct": -3.3388,
"position_52w_pct": 93.32,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:59:02Z",
"source": "yfinance_quote",
"name": "CarMax, Inc.",
"episode_id": "n0:KMX:2026-09-29",
"ema_trend": "58.29 > 58.97 > 58.5",
"vwap_state": "below",
"selection_as_of": "2026-09-29T15:17:34.477760Z",
"facts": [
"The supplied earnings report shows EPS of $1.16 versus $0.73 expected and sales of $7.878B versus $6.976B expected.",
"The provider trajectory faded from about +5.72% to +3.24%; the intraday reading was below VWAP with a downward trend.",
"The active H3/H8/H15 positive-return estimates are 0.547/0.567/0.528, higher than CCL's at each horizon. Its corresponding adverse-MAE medians are -3.25%/-4.20%/-6.09%. The separate audit-only H15 historical-dispersion output is P10 -5.31%, median +4.18%, P90 +16.31%. These comparisons use eight cases."
],
"price_as_of": "2026-09-29T20:59:02Z",
"vwap_as_of": null
},
{
"symbol": "WYY",
"role": "alternative",
"price": 7.28,
"base_price": 6.4203,
"return_since_base_pct": 13.3903,
"session_return_pct": -0.9524,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.39,
"rsi": 29.28,
"vwap": 6.2,
"vwap_distance_pct": 17.4194,
"position_52w_pct": 26.56,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:10:33Z",
"source": "yfinance_quote",
"name": "WidePoint Corporation",
"episode_id": "n0:WYY:2026-09-29",
"ema_trend": "8.81 > 9.89 > 10.68",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:18:38.363232Z",
"facts": [
"The provider trajectory rose from about +7.97% to +16.45%, and the intraday reading was above VWAP.",
"The 20-session asset return was -32.32% versus +4.15% for the technology proxy; no company-specific catalyst for the day's move was established."
],
"price_as_of": "2026-09-29T21:10:33Z",
"vwap_as_of": null
},
{
"symbol": "VIAV",
"role": "alternative",
"price": 41.99,
"base_price": 41.455,
"return_since_base_pct": 1.2906,
"session_return_pct": 0.4065,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.53,
"rsi": 57.12,
"vwap": 41.77,
"vwap_distance_pct": 0.5267,
"position_52w_pct": 68.56,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:16:33Z",
"source": "yfinance_quote",
"name": "Viavi Solutions Inc.",
"episode_id": "narrative:VIAV:b612043b612913e0",
"ema_trend": "38.56 > 37.68 > 38.08",
"vwap_state": "below",
"selection_as_of": "2026-09-29T17:19:34Z",
"facts": [
"The primary product announcement introduces a 100G testing platform but supplies no customer wins or expected revenue contribution.",
"The quote change was +1.37% on 0.53x average volume; price was below VWAP with a downward intraday trend."
],
"price_as_of": "2026-09-29T21:16:33Z",
"vwap_as_of": null
},
{
"symbol": "WH",
"role": "alternative",
"price": 72.44,
"base_price": 71.79,
"return_since_base_pct": 0.9054,
"session_return_pct": null,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.32,
"rsi": 60.7,
"vwap": 71.82,
"vwap_distance_pct": 0.8633,
"position_52w_pct": 79.55,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:00:33Z",
"source": "yfinance_quote",
"name": "Wyndham Hotels & Resorts, Inc.",
"episode_id": "narrative:WH:e6143a4ee8e53619",
"ema_trend": "69.87 > 70.21 > 72.36",
"vwap_state": "above",
"selection_as_of": "2026-09-29T17:19:31Z",
"facts": [
"The primary release reports a $400M increase to the share repurchase authorization.",
"The quote change was +1.47% on 0.32x average volume; the authorization does not establish that repurchases occurred."
],
"price_as_of": "2026-09-29T20:00:33Z",
"vwap_as_of": null
}
],
"benchmarks": [],
"coverage": {
"candidate_rows": 10,
"candidate_prices": 10,
"candidate_technical": 10,
"benchmark_rows": 0
}
}
},
{
"day": 9,
"timestamp": "2026-10-12T19:44:30.043866Z",
"comparison": {
"schema_version": "public-candidate-comparison.v1",
"captured_at": "2026-10-12T19:44:30.043866Z",
"base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
"source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
"rows": [
{
"symbol": "CCL",
"role": "selected",
"price": 26.435,
"base_price": 24.785,
"return_since_base_pct": 6.6573,
"session_return_pct": 0.32,
"change_since_prior_pct": 0.3134,
"volume_ratio": 0.44,
"rsi": 76.65,
"vwap": 26.49,
"vwap_distance_pct": -0.2076,
"position_52w_pct": 77.7,
"extended_hours_pct": null,
"as_of": "2026-10-12T19:23:05.083706Z",
"source": "yfinance_quote",
"name": "Carnival Corporation Ltd.",
"episode_id": "n0:CCL:2026-09-29",
"ema_trend": "25.66 > 24.79 > 24.99",
"vwap_state": "below",
"selection_as_of": "2026-09-29T15:18:03.945792Z",
"facts": [
"The supplied earnings coverage reports adjusted EPS of $1.43 versus $1.36 expected, revenue of $8.435B versus $8.300B expected, and a slight increase to full-year adjusted EPS guidance.",
"The N0 capture records +11.95% on 2.05x average volume. The provider series remained near the move through its final supplied observation.",
"The 20-session record shows CCL +4.48% versus its sector proxy -6.75%, a +11.23 percentage-point difference.",
"The active H3/H8/H15 positive-return estimates are 0.470/0.469/0.502; corresponding adverse-MAE medians are -4.49%/-7.15%/-9.26%. The separate audit-only H15 historical-dispersion output is P10 -19.62%, median -1.26%, P90 +7.16%. These comparisons use eight cases."
],
"price_as_of": "2026-10-12T19:23:05.083706Z",
"vwap_as_of": null
},
{
"symbol": "SMMT",
"role": "alternative",
"price": 16.3387,
"base_price": 16.505,
"return_since_base_pct": -1.0076,
"session_return_pct": -0.313,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.35,
"rsi": 42.99,
"vwap": 17.03,
"vwap_distance_pct": -4.0593,
"position_52w_pct": 56.43,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:20:32Z",
"source": "yfinance_quote",
"name": "Summit Therapeutics Inc.",
"episode_id": "n0:SMMT:2026-09-29",
"ema_trend": "16.44 > 16.26 > 15.62",
"vwap_state": "below",
"selection_as_of": "2026-09-29T15:16:50.388704Z",
"facts": [
"The supplied event evidence describes a $2B AstraZeneca investment using newly issued convertible preferred shares and a clinical collaboration.",
"The N0 event capture was +6.62% on 3.35x average volume, but the provider series faded to about +5.33% and the intraday reading was below VWAP."
],
"price_as_of": "2026-09-29T21:20:32Z",
"vwap_as_of": null
},
{
"symbol": "HAFN",
"role": "alternative",
"price": 9.77,
"base_price": 9.56,
"return_since_base_pct": 2.1967,
"session_return_pct": 1.0341,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.24,
"rsi": 57.04,
"vwap": 9.53,
"vwap_distance_pct": 2.5184,
"position_52w_pct": 94.57,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:05:26Z",
"source": "yfinance_quote",
"name": "Hafnia Limited",
"episode_id": "n0:HAFN:2026-09-29",
"ema_trend": "9.27 > 9.0 > 8.33",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:18:47.711682Z",
"facts": [
"The N0 capture was +4.71% on 1.24x average volume; later provider observations retained a somewhat larger gain and price was above VWAP.",
"No company-specific catalyst was established in the supplied dossier."
],
"price_as_of": "2026-09-29T21:05:26Z",
"vwap_as_of": null
},
{
"symbol": "NTWK",
"role": "alternative",
"price": 5.56,
"base_price": 5.5496,
"return_since_base_pct": 0.1874,
"session_return_pct": 3.36,
"change_since_prior_pct": 0.0,
"volume_ratio": 14.19,
"rsi": 89.74,
"vwap": 5.5,
"vwap_distance_pct": 1.0909,
"position_52w_pct": 98.75,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:10:08Z",
"source": "yfinance_quote",
"name": "NetSol Technologies, Inc.",
"episode_id": "n0:NTWK:2026-09-29",
"ema_trend": "4.87 > 4.54 > 4.38",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:15:36.965867Z",
"facts": [
"The supplied FY26 results report revenue of $74.4M, up 12.5%, and FY27 revenue guidance of $84.1M-$86.3M.",
"The event capture was +3.36% on 14.19x average volume, but the dossier estimates about $2M of dollar turnover and places price 3.06 ATR above its EMA reference."
],
"price_as_of": "2026-09-29T20:10:08Z",
"vwap_as_of": null
},
{
"symbol": "ACET",
"role": "alternative",
"price": 6.77,
"base_price": 6.78,
"return_since_base_pct": -0.1475,
"session_return_pct": -0.8785,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.05,
"rsi": 31.39,
"vwap": 6.69,
"vwap_distance_pct": 1.1958,
"position_52w_pct": 38.99,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:55:28Z",
"source": "yfinance_quote",
"name": "Adicet Bio, Inc.",
"episode_id": "n0:ACET:2026-09-29",
"ema_trend": "8.07 > 8.58 > 8.73",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:17:12.774775Z",
"facts": [
"The supplied Phase 1 lupus readout reports 54% DORIS remission and 50% complete renal response among 22 efficacy-evaluable patients after 12 months.",
"The N0 capture was +6.71% on about 3.05x average volume, while the 20-session asset return was -21.15% versus -0.40% for its healthcare proxy."
],
"price_as_of": "2026-09-29T20:55:28Z",
"vwap_as_of": null
},
{
"symbol": "PWP",
"role": "alternative",
"price": 17.1,
"base_price": 16.85,
"return_since_base_pct": 1.4837,
"session_return_pct": 4.4594,
"change_since_prior_pct": 0.0,
"volume_ratio": 5.79,
"rsi": 55.35,
"vwap": 16.26,
"vwap_distance_pct": 5.1661,
"position_52w_pct": 65.01,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:13:05Z",
"source": "yfinance_quote",
"name": "Perella Weinberg Partners",
"episode_id": "n0:PWP:2026-09-29",
"ema_trend": "14.6 > 14.8 > 15.42",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:15:55.598703Z",
"facts": [
"The catalyst is a report of acquisition talks, not a confirmed agreement.",
"The event capture was +15.1% on 5.79x average volume; the provider series retreated from its high but retained much of the move."
],
"price_as_of": "2026-09-29T21:13:05Z",
"vwap_as_of": null
},
{
"symbol": "KMX",
"role": "alternative",
"price": 59.35,
"base_price": 60.72,
"return_since_base_pct": -2.2563,
"session_return_pct": 0.2026,
"change_since_prior_pct": 0.0,
"volume_ratio": 2.26,
"rsi": 52.08,
"vwap": 61.4,
"vwap_distance_pct": -3.3388,
"position_52w_pct": 93.32,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:59:02Z",
"source": "yfinance_quote",
"name": "CarMax, Inc.",
"episode_id": "n0:KMX:2026-09-29",
"ema_trend": "58.29 > 58.97 > 58.5",
"vwap_state": "below",
"selection_as_of": "2026-09-29T15:17:34.477760Z",
"facts": [
"The supplied earnings report shows EPS of $1.16 versus $0.73 expected and sales of $7.878B versus $6.976B expected.",
"The provider trajectory faded from about +5.72% to +3.24%; the intraday reading was below VWAP with a downward trend.",
"The active H3/H8/H15 positive-return estimates are 0.547/0.567/0.528, higher than CCL's at each horizon. Its corresponding adverse-MAE medians are -3.25%/-4.20%/-6.09%. The separate audit-only H15 historical-dispersion output is P10 -5.31%, median +4.18%, P90 +16.31%. These comparisons use eight cases."
],
"price_as_of": "2026-09-29T20:59:02Z",
"vwap_as_of": null
},
{
"symbol": "WYY",
"role": "alternative",
"price": 7.28,
"base_price": 6.4203,
"return_since_base_pct": 13.3903,
"session_return_pct": -0.9524,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.39,
"rsi": 29.28,
"vwap": 6.2,
"vwap_distance_pct": 17.4194,
"position_52w_pct": 26.56,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:10:33Z",
"source": "yfinance_quote",
"name": "WidePoint Corporation",
"episode_id": "n0:WYY:2026-09-29",
"ema_trend": "8.81 > 9.89 > 10.68",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:18:38.363232Z",
"facts": [
"The provider trajectory rose from about +7.97% to +16.45%, and the intraday reading was above VWAP.",
"The 20-session asset return was -32.32% versus +4.15% for the technology proxy; no company-specific catalyst for the day's move was established."
],
"price_as_of": "2026-09-29T21:10:33Z",
"vwap_as_of": null
},
{
"symbol": "VIAV",
"role": "alternative",
"price": 41.99,
"base_price": 41.455,
"return_since_base_pct": 1.2906,
"session_return_pct": 0.4065,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.53,
"rsi": 57.12,
"vwap": 41.77,
"vwap_distance_pct": 0.5267,
"position_52w_pct": 68.56,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:16:33Z",
"source": "yfinance_quote",
"name": "Viavi Solutions Inc.",
"episode_id": "narrative:VIAV:b612043b612913e0",
"ema_trend": "38.56 > 37.68 > 38.08",
"vwap_state": "below",
"selection_as_of": "2026-09-29T17:19:34Z",
"facts": [
"The primary product announcement introduces a 100G testing platform but supplies no customer wins or expected revenue contribution.",
"The quote change was +1.37% on 0.53x average volume; price was below VWAP with a downward intraday trend."
],
"price_as_of": "2026-09-29T21:16:33Z",
"vwap_as_of": null
},
{
"symbol": "WH",
"role": "alternative",
"price": 72.44,
"base_price": 71.79,
"return_since_base_pct": 0.9054,
"session_return_pct": null,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.32,
"rsi": 60.7,
"vwap": 71.82,
"vwap_distance_pct": 0.8633,
"position_52w_pct": 79.55,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:00:33Z",
"source": "yfinance_quote",
"name": "Wyndham Hotels & Resorts, Inc.",
"episode_id": "narrative:WH:e6143a4ee8e53619",
"ema_trend": "69.87 > 70.21 > 72.36",
"vwap_state": "above",
"selection_as_of": "2026-09-29T17:19:31Z",
"facts": [
"The primary release reports a $400M increase to the share repurchase authorization.",
"The quote change was +1.47% on 0.32x average volume; the authorization does not establish that repurchases occurred."
],
"price_as_of": "2026-09-29T20:00:33Z",
"vwap_as_of": null
}
],
"benchmarks": [],
"coverage": {
"candidate_rows": 10,
"candidate_prices": 10,
"candidate_technical": 10,
"benchmark_rows": 0
}
}
},
{
"day": 9,
"timestamp": "2026-10-12T20:16:38.939597Z",
"comparison": {
"schema_version": "public-candidate-comparison.v1",
"captured_at": "2026-10-12T20:16:38.939597Z",
"base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
"source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
"rows": [
{
"symbol": "CCL",
"role": "selected",
"price": 26.49,
"base_price": 24.785,
"return_since_base_pct": 6.8792,
"session_return_pct": 0.53,
"change_since_prior_pct": 0.2081,
"volume_ratio": 0.41,
"rsi": 76.82,
"vwap": 26.5,
"vwap_distance_pct": -0.0377,
"position_52w_pct": 77.8,
"extended_hours_pct": null,
"as_of": "2026-10-12T18:48:37.209746Z",
"source": "yfinance_quote",
"name": "Carnival Corporation Ltd.",
"episode_id": "n0:CCL:2026-09-29",
"ema_trend": "25.67 > 24.79 > 24.99",
"vwap_state": "below",
"selection_as_of": "2026-09-29T15:18:03.945792Z",
"facts": [
"The supplied earnings coverage reports adjusted EPS of $1.43 versus $1.36 expected, revenue of $8.435B versus $8.300B expected, and a slight increase to full-year adjusted EPS guidance.",
"The N0 capture records +11.95% on 2.05x average volume. The provider series remained near the move through its final supplied observation.",
"The 20-session record shows CCL +4.48% versus its sector proxy -6.75%, a +11.23 percentage-point difference.",
"The active H3/H8/H15 positive-return estimates are 0.470/0.469/0.502; corresponding adverse-MAE medians are -4.49%/-7.15%/-9.26%. The separate audit-only H15 historical-dispersion output is P10 -19.62%, median -1.26%, P90 +7.16%. These comparisons use eight cases."
],
"benchmark_excess_pct": {
"sp500": 0.585,
"nasdaq100": 1.2373,
"russell2000": 0.9498
},
"price_as_of": "2026-10-12T18:48:37.209746Z",
"vwap_as_of": null
},
{
"symbol": "SMMT",
"role": "alternative",
"price": 16.3387,
"base_price": 16.505,
"return_since_base_pct": -1.0076,
"session_return_pct": -0.313,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.35,
"rsi": 42.99,
"vwap": 17.03,
"vwap_distance_pct": -4.0593,
"position_52w_pct": 56.43,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:20:32Z",
"source": "yfinance_quote",
"name": "Summit Therapeutics Inc.",
"episode_id": "n0:SMMT:2026-09-29",
"ema_trend": "16.44 > 16.26 > 15.62",
"vwap_state": "below",
"selection_as_of": "2026-09-29T15:16:50.388704Z",
"facts": [
"The supplied event evidence describes a $2B AstraZeneca investment using newly issued convertible preferred shares and a clinical collaboration.",
"The N0 event capture was +6.62% on 3.35x average volume, but the provider series faded to about +5.33% and the intraday reading was below VWAP."
],
"benchmark_excess_pct": {
"sp500": -0.258,
"nasdaq100": 0.3943,
"russell2000": 0.1068
},
"price_as_of": "2026-09-29T21:20:32Z",
"vwap_as_of": null
},
{
"symbol": "HAFN",
"role": "alternative",
"price": 9.77,
"base_price": 9.56,
"return_since_base_pct": 2.1967,
"session_return_pct": 1.0341,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.24,
"rsi": 57.04,
"vwap": 9.53,
"vwap_distance_pct": 2.5184,
"position_52w_pct": 94.57,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:05:26Z",
"source": "yfinance_quote",
"name": "Hafnia Limited",
"episode_id": "n0:HAFN:2026-09-29",
"ema_trend": "9.27 > 9.0 > 8.33",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:18:47.711682Z",
"facts": [
"The N0 capture was +4.71% on 1.24x average volume; later provider observations retained a somewhat larger gain and price was above VWAP.",
"No company-specific catalyst was established in the supplied dossier."
],
"benchmark_excess_pct": {
"sp500": 1.0891,
"nasdaq100": 1.7414,
"russell2000": 1.4539
},
"price_as_of": "2026-09-29T21:05:26Z",
"vwap_as_of": null
},
{
"symbol": "NTWK",
"role": "alternative",
"price": 5.56,
"base_price": 5.5496,
"return_since_base_pct": 0.1874,
"session_return_pct": 3.36,
"change_since_prior_pct": 0.0,
"volume_ratio": 14.19,
"rsi": 89.74,
"vwap": 5.5,
"vwap_distance_pct": 1.0909,
"position_52w_pct": 98.75,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:10:08Z",
"source": "yfinance_quote",
"name": "NetSol Technologies, Inc.",
"episode_id": "n0:NTWK:2026-09-29",
"ema_trend": "4.87 > 4.54 > 4.38",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:15:36.965867Z",
"facts": [
"The supplied FY26 results report revenue of $74.4M, up 12.5%, and FY27 revenue guidance of $84.1M-$86.3M.",
"The event capture was +3.36% on 14.19x average volume, but the dossier estimates about $2M of dollar turnover and places price 3.06 ATR above its EMA reference."
],
"benchmark_excess_pct": {
"sp500": 3.415,
"nasdaq100": 4.0673,
"russell2000": 3.7798
},
"price_as_of": "2026-09-29T20:10:08Z",
"vwap_as_of": null
},
{
"symbol": "ACET",
"role": "alternative",
"price": 6.77,
"base_price": 6.78,
"return_since_base_pct": -0.1475,
"session_return_pct": -0.8785,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.05,
"rsi": 31.39,
"vwap": 6.69,
"vwap_distance_pct": 1.1958,
"position_52w_pct": 38.99,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:55:28Z",
"source": "yfinance_quote",
"name": "Adicet Bio, Inc.",
"episode_id": "n0:ACET:2026-09-29",
"ema_trend": "8.07 > 8.58 > 8.73",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:17:12.774775Z",
"facts": [
"The supplied Phase 1 lupus readout reports 54% DORIS remission and 50% complete renal response among 22 efficacy-evaluable patients after 12 months.",
"The N0 capture was +6.71% on about 3.05x average volume, while the 20-session asset return was -21.15% versus -0.40% for its healthcare proxy."
],
"benchmark_excess_pct": {
"sp500": -0.8235,
"nasdaq100": -0.1712,
"russell2000": -0.4587
},
"price_as_of": "2026-09-29T20:55:28Z",
"vwap_as_of": null
},
{
"symbol": "PWP",
"role": "alternative",
"price": 17.1,
"base_price": 16.85,
"return_since_base_pct": 1.4837,
"session_return_pct": 4.4594,
"change_since_prior_pct": 0.0,
"volume_ratio": 5.79,
"rsi": 55.35,
"vwap": 16.26,
"vwap_distance_pct": 5.1661,
"position_52w_pct": 65.01,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:13:05Z",
"source": "yfinance_quote",
"name": "Perella Weinberg Partners",
"episode_id": "n0:PWP:2026-09-29",
"ema_trend": "14.6 > 14.8 > 15.42",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:15:55.598703Z",
"facts": [
"The catalyst is a report of acquisition talks, not a confirmed agreement.",
"The event capture was +15.1% on 5.79x average volume; the provider series retreated from its high but retained much of the move."
],
"benchmark_excess_pct": {
"sp500": 4.5144,
"nasdaq100": 5.1667,
"russell2000": 4.8792
},
"price_as_of": "2026-09-29T21:13:05Z",
"vwap_as_of": null
},
{
"symbol": "KMX",
"role": "alternative",
"price": 59.35,
"base_price": 60.72,
"return_since_base_pct": -2.2563,
"session_return_pct": 0.2026,
"change_since_prior_pct": 0.0,
"volume_ratio": 2.26,
"rsi": 52.08,
"vwap": 61.4,
"vwap_distance_pct": -3.3388,
"position_52w_pct": 93.32,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:59:02Z",
"source": "yfinance_quote",
"name": "CarMax, Inc.",
"episode_id": "n0:KMX:2026-09-29",
"ema_trend": "58.29 > 58.97 > 58.5",
"vwap_state": "below",
"selection_as_of": "2026-09-29T15:17:34.477760Z",
"facts": [
"The supplied earnings report shows EPS of $1.16 versus $0.73 expected and sales of $7.878B versus $6.976B expected.",
"The provider trajectory faded from about +5.72% to +3.24%; the intraday reading was below VWAP with a downward trend.",
"The active H3/H8/H15 positive-return estimates are 0.547/0.567/0.528, higher than CCL's at each horizon. Its corresponding adverse-MAE medians are -3.25%/-4.20%/-6.09%. The separate audit-only H15 historical-dispersion output is P10 -5.31%, median +4.18%, P90 +16.31%. These comparisons use eight cases."
],
"benchmark_excess_pct": {
"sp500": 0.2576,
"nasdaq100": 0.9099,
"russell2000": 0.6224
},
"price_as_of": "2026-09-29T20:59:02Z",
"vwap_as_of": null
},
{
"symbol": "WYY",
"role": "alternative",
"price": 7.28,
"base_price": 6.4203,
"return_since_base_pct": 13.3903,
"session_return_pct": -0.9524,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.39,
"rsi": 29.28,
"vwap": 6.2,
"vwap_distance_pct": 17.4194,
"position_52w_pct": 26.56,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:10:33Z",
"source": "yfinance_quote",
"name": "WidePoint Corporation",
"episode_id": "n0:WYY:2026-09-29",
"ema_trend": "8.81 > 9.89 > 10.68",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:18:38.363232Z",
"facts": [
"The provider trajectory rose from about +7.97% to +16.45%, and the intraday reading was above VWAP.",
"The 20-session asset return was -32.32% versus +4.15% for the technology proxy; no company-specific catalyst for the day's move was established."
],
"benchmark_excess_pct": {
"sp500": -0.8974,
"nasdaq100": -0.2451,
"russell2000": -0.5326
},
"price_as_of": "2026-09-29T21:10:33Z",
"vwap_as_of": null
},
{
"symbol": "VIAV",
"role": "alternative",
"price": 41.99,
"base_price": 41.455,
"return_since_base_pct": 1.2906,
"session_return_pct": 0.4065,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.53,
"rsi": 57.12,
"vwap": 41.77,
"vwap_distance_pct": 0.5267,
"position_52w_pct": 68.56,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:16:33Z",
"source": "yfinance_quote",
"name": "Viavi Solutions Inc.",
"episode_id": "narrative:VIAV:b612043b612913e0",
"ema_trend": "38.56 > 37.68 > 38.08",
"vwap_state": "below",
"selection_as_of": "2026-09-29T17:19:34Z",
"facts": [
"The primary product announcement introduces a 100G testing platform but supplies no customer wins or expected revenue contribution.",
"The quote change was +1.37% on 0.53x average volume; price was below VWAP with a downward intraday trend."
],
"benchmark_excess_pct": {
"sp500": 0.4615,
"nasdaq100": 1.1138,
"russell2000": 0.8263
},
"price_as_of": "2026-09-29T21:16:33Z",
"vwap_as_of": null
},
{
"symbol": "WH",
"role": "alternative",
"price": 72.44,
"base_price": 71.79,
"return_since_base_pct": 0.9054,
"session_return_pct": null,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.32,
"rsi": 60.7,
"vwap": 71.82,
"vwap_distance_pct": 0.8633,
"position_52w_pct": 79.55,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:00:33Z",
"source": "yfinance_quote",
"name": "Wyndham Hotels & Resorts, Inc.",
"episode_id": "narrative:WH:e6143a4ee8e53619",
"ema_trend": "69.87 > 70.21 > 72.36",
"vwap_state": "above",
"selection_as_of": "2026-09-29T17:19:31Z",
"facts": [
"The primary release reports a $400M increase to the share repurchase authorization.",
"The quote change was +1.47% on 0.32x average volume; the authorization does not establish that repurchases occurred."
],
"price_as_of": "2026-09-29T20:00:33Z",
"vwap_as_of": null
}
],
"benchmarks": [
{
"id": "sp500",
"symbol": "^GSPC",
"label": "S&P 500",
"role": "benchmark",
"price": 7807.24,
"base_price": 7811.54,
"return_since_base_pct": -0.055,
"session_return_pct": -0.055,
"as_of": "2026-10-12T20:14:36.141421Z",
"source": "yfinance.ticker_info",
"base_definition": "previous regular close"
},
{
"id": "nasdaq100",
"symbol": "^NDX",
"label": "Nasdaq 100",
"role": "benchmark",
"price": 30664.697,
"base_price": 30883.148,
"return_since_base_pct": -0.7073,
"session_return_pct": -0.7073,
"as_of": "2026-10-12T20:14:36.141421Z",
"source": "yfinance.ticker_info",
"base_definition": "previous regular close"
},
{
"id": "russell2000",
"symbol": "^RUT",
"label": "Russell 2000",
"role": "benchmark",
"price": 2795.199,
"base_price": 2806.9814,
"return_since_base_pct": -0.4198,
"session_return_pct": -0.4198,
"as_of": "2026-10-12T20:14:36.141421Z",
"source": "yfinance.ticker_info",
"base_definition": "previous regular close"
}
],
"coverage": {
"candidate_rows": 10,
"candidate_prices": 10,
"candidate_technical": 10,
"benchmark_rows": 3
}
}
},
{
"day": 9,
"timestamp": "2026-10-12T22:06:52.883578Z",
"comparison": {
"schema_version": "public-candidate-comparison.v1",
"captured_at": "2026-10-12T22:06:52.883578Z",
"base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
"source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
"rows": [
{
"symbol": "CCL",
"role": "selected",
"price": 26.44,
"base_price": 24.785,
"return_since_base_pct": 6.6774,
"session_return_pct": 0.49,
"change_since_prior_pct": -0.1888,
"volume_ratio": 0.6,
"rsi": 76.79,
"vwap": 26.49,
"vwap_distance_pct": -0.1888,
"position_52w_pct": 77.8,
"extended_hours_pct": -0.15,
"as_of": "2026-10-12T21:39:09Z",
"source": "sealed_extended_quote",
"name": "Carnival Corporation Ltd.",
"episode_id": "n0:CCL:2026-09-29",
"ema_trend": "25.67 > 24.79 > 24.99",
"vwap_state": "below",
"selection_as_of": "2026-09-29T15:18:03.945792Z",
"facts": [
"The supplied earnings coverage reports adjusted EPS of $1.43 versus $1.36 expected, revenue of $8.435B versus $8.300B expected, and a slight increase to full-year adjusted EPS guidance.",
"The N0 capture records +11.95% on 2.05x average volume. The provider series remained near the move through its final supplied observation.",
"The 20-session record shows CCL +4.48% versus its sector proxy -6.75%, a +11.23 percentage-point difference.",
"The active H3/H8/H15 positive-return estimates are 0.470/0.469/0.502; corresponding adverse-MAE medians are -4.49%/-7.15%/-9.26%. The separate audit-only H15 historical-dispersion output is P10 -19.62%, median -1.26%, P90 +7.16%. These comparisons use eight cases."
],
"price_as_of": "2026-10-12T21:39:09Z",
"vwap_as_of": null
},
{
"symbol": "SMMT",
"role": "alternative",
"price": 16.3387,
"base_price": 16.505,
"return_since_base_pct": -1.0076,
"session_return_pct": -0.313,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.35,
"rsi": 42.99,
"vwap": 17.03,
"vwap_distance_pct": -4.0593,
"position_52w_pct": 56.43,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:20:32Z",
"source": "yfinance_quote",
"name": "Summit Therapeutics Inc.",
"episode_id": "n0:SMMT:2026-09-29",
"ema_trend": "16.44 > 16.26 > 15.62",
"vwap_state": "below",
"selection_as_of": "2026-09-29T15:16:50.388704Z",
"facts": [
"The supplied event evidence describes a $2B AstraZeneca investment using newly issued convertible preferred shares and a clinical collaboration.",
"The N0 event capture was +6.62% on 3.35x average volume, but the provider series faded to about +5.33% and the intraday reading was below VWAP."
],
"price_as_of": "2026-09-29T21:20:32Z",
"vwap_as_of": null
},
{
"symbol": "HAFN",
"role": "alternative",
"price": 9.77,
"base_price": 9.56,
"return_since_base_pct": 2.1967,
"session_return_pct": 1.0341,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.24,
"rsi": 57.04,
"vwap": 9.53,
"vwap_distance_pct": 2.5184,
"position_52w_pct": 94.57,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:05:26Z",
"source": "yfinance_quote",
"name": "Hafnia Limited",
"episode_id": "n0:HAFN:2026-09-29",
"ema_trend": "9.27 > 9.0 > 8.33",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:18:47.711682Z",
"facts": [
"The N0 capture was +4.71% on 1.24x average volume; later provider observations retained a somewhat larger gain and price was above VWAP.",
"No company-specific catalyst was established in the supplied dossier."
],
"price_as_of": "2026-09-29T21:05:26Z",
"vwap_as_of": null
},
{
"symbol": "NTWK",
"role": "alternative",
"price": 5.56,
"base_price": 5.5496,
"return_since_base_pct": 0.1874,
"session_return_pct": 3.36,
"change_since_prior_pct": 0.0,
"volume_ratio": 14.19,
"rsi": 89.74,
"vwap": 5.5,
"vwap_distance_pct": 1.0909,
"position_52w_pct": 98.75,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:10:08Z",
"source": "yfinance_quote",
"name": "NetSol Technologies, Inc.",
"episode_id": "n0:NTWK:2026-09-29",
"ema_trend": "4.87 > 4.54 > 4.38",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:15:36.965867Z",
"facts": [
"The supplied FY26 results report revenue of $74.4M, up 12.5%, and FY27 revenue guidance of $84.1M-$86.3M.",
"The event capture was +3.36% on 14.19x average volume, but the dossier estimates about $2M of dollar turnover and places price 3.06 ATR above its EMA reference."
],
"price_as_of": "2026-09-29T20:10:08Z",
"vwap_as_of": null
},
{
"symbol": "ACET",
"role": "alternative",
"price": 6.77,
"base_price": 6.78,
"return_since_base_pct": -0.1475,
"session_return_pct": -0.8785,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.05,
"rsi": 31.39,
"vwap": 6.69,
"vwap_distance_pct": 1.1958,
"position_52w_pct": 38.99,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:55:28Z",
"source": "yfinance_quote",
"name": "Adicet Bio, Inc.",
"episode_id": "n0:ACET:2026-09-29",
"ema_trend": "8.07 > 8.58 > 8.73",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:17:12.774775Z",
"facts": [
"The supplied Phase 1 lupus readout reports 54% DORIS remission and 50% complete renal response among 22 efficacy-evaluable patients after 12 months.",
"The N0 capture was +6.71% on about 3.05x average volume, while the 20-session asset return was -21.15% versus -0.40% for its healthcare proxy."
],
"price_as_of": "2026-09-29T20:55:28Z",
"vwap_as_of": null
},
{
"symbol": "PWP",
"role": "alternative",
"price": 17.1,
"base_price": 16.85,
"return_since_base_pct": 1.4837,
"session_return_pct": 4.4594,
"change_since_prior_pct": 0.0,
"volume_ratio": 5.79,
"rsi": 55.35,
"vwap": 16.26,
"vwap_distance_pct": 5.1661,
"position_52w_pct": 65.01,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:13:05Z",
"source": "yfinance_quote",
"name": "Perella Weinberg Partners",
"episode_id": "n0:PWP:2026-09-29",
"ema_trend": "14.6 > 14.8 > 15.42",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:15:55.598703Z",
"facts": [
"The catalyst is a report of acquisition talks, not a confirmed agreement.",
"The event capture was +15.1% on 5.79x average volume; the provider series retreated from its high but retained much of the move."
],
"price_as_of": "2026-09-29T21:13:05Z",
"vwap_as_of": null
},
{
"symbol": "KMX",
"role": "alternative",
"price": 59.35,
"base_price": 60.72,
"return_since_base_pct": -2.2563,
"session_return_pct": 0.2026,
"change_since_prior_pct": 0.0,
"volume_ratio": 2.26,
"rsi": 52.08,
"vwap": 61.4,
"vwap_distance_pct": -3.3388,
"position_52w_pct": 93.32,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:59:02Z",
"source": "yfinance_quote",
"name": "CarMax, Inc.",
"episode_id": "n0:KMX:2026-09-29",
"ema_trend": "58.29 > 58.97 > 58.5",
"vwap_state": "below",
"selection_as_of": "2026-09-29T15:17:34.477760Z",
"facts": [
"The supplied earnings report shows EPS of $1.16 versus $0.73 expected and sales of $7.878B versus $6.976B expected.",
"The provider trajectory faded from about +5.72% to +3.24%; the intraday reading was below VWAP with a downward trend.",
"The active H3/H8/H15 positive-return estimates are 0.547/0.567/0.528, higher than CCL's at each horizon. Its corresponding adverse-MAE medians are -3.25%/-4.20%/-6.09%. The separate audit-only H15 historical-dispersion output is P10 -5.31%, median +4.18%, P90 +16.31%. These comparisons use eight cases."
],
"price_as_of": "2026-09-29T20:59:02Z",
"vwap_as_of": null
},
{
"symbol": "WYY",
"role": "alternative",
"price": 7.28,
"base_price": 6.4203,
"return_since_base_pct": 13.3903,
"session_return_pct": -0.9524,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.39,
"rsi": 29.28,
"vwap": 6.2,
"vwap_distance_pct": 17.4194,
"position_52w_pct": 26.56,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:10:33Z",
"source": "yfinance_quote",
"name": "WidePoint Corporation",
"episode_id": "n0:WYY:2026-09-29",
"ema_trend": "8.81 > 9.89 > 10.68",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:18:38.363232Z",
"facts": [
"The provider trajectory rose from about +7.97% to +16.45%, and the intraday reading was above VWAP.",
"The 20-session asset return was -32.32% versus +4.15% for the technology proxy; no company-specific catalyst for the day's move was established."
],
"price_as_of": "2026-09-29T21:10:33Z",
"vwap_as_of": null
},
{
"symbol": "VIAV",
"role": "alternative",
"price": 41.99,
"base_price": 41.455,
"return_since_base_pct": 1.2906,
"session_return_pct": 0.4065,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.53,
"rsi": 57.12,
"vwap": 41.77,
"vwap_distance_pct": 0.5267,
"position_52w_pct": 68.56,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:16:33Z",
"source": "yfinance_quote",
"name": "Viavi Solutions Inc.",
"episode_id": "narrative:VIAV:b612043b612913e0",
"ema_trend": "38.56 > 37.68 > 38.08",
"vwap_state": "below",
"selection_as_of": "2026-09-29T17:19:34Z",
"facts": [
"The primary product announcement introduces a 100G testing platform but supplies no customer wins or expected revenue contribution.",
"The quote change was +1.37% on 0.53x average volume; price was below VWAP with a downward intraday trend."
],
"price_as_of": "2026-09-29T21:16:33Z",
"vwap_as_of": null
},
{
"symbol": "WH",
"role": "alternative",
"price": 72.44,
"base_price": 71.79,
"return_since_base_pct": 0.9054,
"session_return_pct": null,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.32,
"rsi": 60.7,
"vwap": 71.82,
"vwap_distance_pct": 0.8633,
"position_52w_pct": 79.55,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:00:33Z",
"source": "yfinance_quote",
"name": "Wyndham Hotels & Resorts, Inc.",
"episode_id": "narrative:WH:e6143a4ee8e53619",
"ema_trend": "69.87 > 70.21 > 72.36",
"vwap_state": "above",
"selection_as_of": "2026-09-29T17:19:31Z",
"facts": [
"The primary release reports a $400M increase to the share repurchase authorization.",
"The quote change was +1.47% on 0.32x average volume; the authorization does not establish that repurchases occurred."
],
"price_as_of": "2026-09-29T20:00:33Z",
"vwap_as_of": null
}
],
"benchmarks": [],
"coverage": {
"candidate_rows": 10,
"candidate_prices": 10,
"candidate_technical": 10,
"benchmark_rows": 0
}
}
},
{
"day": 10,
"timestamp": "2026-10-13T15:28:19.284754Z",
"comparison": {
"schema_version": "public-candidate-comparison.v1",
"captured_at": "2026-10-13T15:28:19.284754Z",
"base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
"source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
"rows": [
{
"symbol": "CCL",
"role": "selected",
"price": 26.515,
"base_price": 24.785,
"return_since_base_pct": 6.98,
"session_return_pct": 0.13,
"change_since_prior_pct": 0.2837,
"volume_ratio": 0.11,
"rsi": 81.88,
"vwap": 26.65,
"vwap_distance_pct": -0.5066,
"position_52w_pct": 77.9,
"extended_hours_pct": null,
"as_of": "2026-10-13T14:06:26.349567Z",
"source": "yfinance_quote",
"name": "Carnival Corporation Ltd.",
"episode_id": "n0:CCL:2026-09-29",
"ema_trend": "25.84 > 24.95 > 25.05",
"vwap_state": "below",
"selection_as_of": "2026-09-29T15:18:03.945792Z",
"facts": [
"The supplied earnings coverage reports adjusted EPS of $1.43 versus $1.36 expected, revenue of $8.435B versus $8.300B expected, and a slight increase to full-year adjusted EPS guidance.",
"The N0 capture records +11.95% on 2.05x average volume. The provider series remained near the move through its final supplied observation.",
"The 20-session record shows CCL +4.48% versus its sector proxy -6.75%, a +11.23 percentage-point difference.",
"The active H3/H8/H15 positive-return estimates are 0.470/0.469/0.502; corresponding adverse-MAE medians are -4.49%/-7.15%/-9.26%. The separate audit-only H15 historical-dispersion output is P10 -19.62%, median -1.26%, P90 +7.16%. These comparisons use eight cases."
],
"price_as_of": "2026-10-13T14:06:26.349567Z",
"vwap_as_of": null
},
{
"symbol": "SMMT",
"role": "alternative",
"price": 16.3387,
"base_price": 16.505,
"return_since_base_pct": -1.0076,
"session_return_pct": -0.313,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.35,
"rsi": 42.99,
"vwap": 17.03,
"vwap_distance_pct": -4.0593,
"position_52w_pct": 56.43,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:20:32Z",
"source": "yfinance_quote",
"name": "Summit Therapeutics Inc.",
"episode_id": "n0:SMMT:2026-09-29",
"ema_trend": "16.44 > 16.26 > 15.62",
"vwap_state": "below",
"selection_as_of": "2026-09-29T15:16:50.388704Z",
"facts": [
"The supplied event evidence describes a $2B AstraZeneca investment using newly issued convertible preferred shares and a clinical collaboration.",
"The N0 event capture was +6.62% on 3.35x average volume, but the provider series faded to about +5.33% and the intraday reading was below VWAP."
],
"price_as_of": "2026-09-29T21:20:32Z",
"vwap_as_of": null
},
{
"symbol": "HAFN",
"role": "alternative",
"price": 9.77,
"base_price": 9.56,
"return_since_base_pct": 2.1967,
"session_return_pct": 1.0341,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.24,
"rsi": 57.04,
"vwap": 9.53,
"vwap_distance_pct": 2.5184,
"position_52w_pct": 94.57,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:05:26Z",
"source": "yfinance_quote",
"name": "Hafnia Limited",
"episode_id": "n0:HAFN:2026-09-29",
"ema_trend": "9.27 > 9.0 > 8.33",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:18:47.711682Z",
"facts": [
"The N0 capture was +4.71% on 1.24x average volume; later provider observations retained a somewhat larger gain and price was above VWAP.",
"No company-specific catalyst was established in the supplied dossier."
],
"price_as_of": "2026-09-29T21:05:26Z",
"vwap_as_of": null
},
{
"symbol": "NTWK",
"role": "alternative",
"price": 5.56,
"base_price": 5.5496,
"return_since_base_pct": 0.1874,
"session_return_pct": 3.36,
"change_since_prior_pct": 0.0,
"volume_ratio": 14.19,
"rsi": 89.74,
"vwap": 5.5,
"vwap_distance_pct": 1.0909,
"position_52w_pct": 98.75,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:10:08Z",
"source": "yfinance_quote",
"name": "NetSol Technologies, Inc.",
"episode_id": "n0:NTWK:2026-09-29",
"ema_trend": "4.87 > 4.54 > 4.38",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:15:36.965867Z",
"facts": [
"The supplied FY26 results report revenue of $74.4M, up 12.5%, and FY27 revenue guidance of $84.1M-$86.3M.",
"The event capture was +3.36% on 14.19x average volume, but the dossier estimates about $2M of dollar turnover and places price 3.06 ATR above its EMA reference."
],
"price_as_of": "2026-09-29T20:10:08Z",
"vwap_as_of": null
},
{
"symbol": "ACET",
"role": "alternative",
"price": 6.77,
"base_price": 6.78,
"return_since_base_pct": -0.1475,
"session_return_pct": -0.8785,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.05,
"rsi": 31.39,
"vwap": 6.69,
"vwap_distance_pct": 1.1958,
"position_52w_pct": 38.99,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:55:28Z",
"source": "yfinance_quote",
"name": "Adicet Bio, Inc.",
"episode_id": "n0:ACET:2026-09-29",
"ema_trend": "8.07 > 8.58 > 8.73",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:17:12.774775Z",
"facts": [
"The supplied Phase 1 lupus readout reports 54% DORIS remission and 50% complete renal response among 22 efficacy-evaluable patients after 12 months.",
"The N0 capture was +6.71% on about 3.05x average volume, while the 20-session asset return was -21.15% versus -0.40% for its healthcare proxy."
],
"price_as_of": "2026-09-29T20:55:28Z",
"vwap_as_of": null
},
{
"symbol": "PWP",
"role": "alternative",
"price": 17.1,
"base_price": 16.85,
"return_since_base_pct": 1.4837,
"session_return_pct": 4.4594,
"change_since_prior_pct": 0.0,
"volume_ratio": 5.79,
"rsi": 55.35,
"vwap": 16.26,
"vwap_distance_pct": 5.1661,
"position_52w_pct": 65.01,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:13:05Z",
"source": "yfinance_quote",
"name": "Perella Weinberg Partners",
"episode_id": "n0:PWP:2026-09-29",
"ema_trend": "14.6 > 14.8 > 15.42",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:15:55.598703Z",
"facts": [
"The catalyst is a report of acquisition talks, not a confirmed agreement.",
"The event capture was +15.1% on 5.79x average volume; the provider series retreated from its high but retained much of the move."
],
"price_as_of": "2026-09-29T21:13:05Z",
"vwap_as_of": null
},
{
"symbol": "KMX",
"role": "alternative",
"price": 59.35,
"base_price": 60.72,
"return_since_base_pct": -2.2563,
"session_return_pct": 0.2026,
"change_since_prior_pct": 0.0,
"volume_ratio": 2.26,
"rsi": 52.08,
"vwap": 61.4,
"vwap_distance_pct": -3.3388,
"position_52w_pct": 93.32,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:59:02Z",
"source": "yfinance_quote",
"name": "CarMax, Inc.",
"episode_id": "n0:KMX:2026-09-29",
"ema_trend": "58.29 > 58.97 > 58.5",
"vwap_state": "below",
"selection_as_of": "2026-09-29T15:17:34.477760Z",
"facts": [
"The supplied earnings report shows EPS of $1.16 versus $0.73 expected and sales of $7.878B versus $6.976B expected.",
"The provider trajectory faded from about +5.72% to +3.24%; the intraday reading was below VWAP with a downward trend.",
"The active H3/H8/H15 positive-return estimates are 0.547/0.567/0.528, higher than CCL's at each horizon. Its corresponding adverse-MAE medians are -3.25%/-4.20%/-6.09%. The separate audit-only H15 historical-dispersion output is P10 -5.31%, median +4.18%, P90 +16.31%. These comparisons use eight cases."
],
"price_as_of": "2026-09-29T20:59:02Z",
"vwap_as_of": null
},
{
"symbol": "WYY",
"role": "alternative",
"price": 7.28,
"base_price": 6.4203,
"return_since_base_pct": 13.3903,
"session_return_pct": -0.9524,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.39,
"rsi": 29.28,
"vwap": 6.2,
"vwap_distance_pct": 17.4194,
"position_52w_pct": 26.56,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:10:33Z",
"source": "yfinance_quote",
"name": "WidePoint Corporation",
"episode_id": "n0:WYY:2026-09-29",
"ema_trend": "8.81 > 9.89 > 10.68",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:18:38.363232Z",
"facts": [
"The provider trajectory rose from about +7.97% to +16.45%, and the intraday reading was above VWAP.",
"The 20-session asset return was -32.32% versus +4.15% for the technology proxy; no company-specific catalyst for the day's move was established."
],
"price_as_of": "2026-09-29T21:10:33Z",
"vwap_as_of": null
},
{
"symbol": "VIAV",
"role": "alternative",
"price": 41.99,
"base_price": 41.455,
"return_since_base_pct": 1.2906,
"session_return_pct": 0.4065,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.53,
"rsi": 57.12,
"vwap": 41.77,
"vwap_distance_pct": 0.5267,
"position_52w_pct": 68.56,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:16:33Z",
"source": "yfinance_quote",
"name": "Viavi Solutions Inc.",
"episode_id": "narrative:VIAV:b612043b612913e0",
"ema_trend": "38.56 > 37.68 > 38.08",
"vwap_state": "below",
"selection_as_of": "2026-09-29T17:19:34Z",
"facts": [
"The primary product announcement introduces a 100G testing platform but supplies no customer wins or expected revenue contribution.",
"The quote change was +1.37% on 0.53x average volume; price was below VWAP with a downward intraday trend."
],
"price_as_of": "2026-09-29T21:16:33Z",
"vwap_as_of": null
},
{
"symbol": "WH",
"role": "alternative",
"price": 72.44,
"base_price": 71.79,
"return_since_base_pct": 0.9054,
"session_return_pct": null,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.32,
"rsi": 60.7,
"vwap": 71.82,
"vwap_distance_pct": 0.8633,
"position_52w_pct": 79.55,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:00:33Z",
"source": "yfinance_quote",
"name": "Wyndham Hotels & Resorts, Inc.",
"episode_id": "narrative:WH:e6143a4ee8e53619",
"ema_trend": "69.87 > 70.21 > 72.36",
"vwap_state": "above",
"selection_as_of": "2026-09-29T17:19:31Z",
"facts": [
"The primary release reports a $400M increase to the share repurchase authorization.",
"The quote change was +1.47% on 0.32x average volume; the authorization does not establish that repurchases occurred."
],
"price_as_of": "2026-09-29T20:00:33Z",
"vwap_as_of": null
}
],
"benchmarks": [],
"coverage": {
"candidate_rows": 10,
"candidate_prices": 10,
"candidate_technical": 10,
"benchmark_rows": 0
}
}
},
{
"day": 10,
"timestamp": "2026-10-13T20:08:04.588100Z",
"comparison": {
"schema_version": "public-candidate-comparison.v1",
"captured_at": "2026-10-13T20:08:04.588100Z",
"base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
"source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
"rows": [
{
"symbol": "CCL",
"role": "selected",
"price": 26.785,
"base_price": 24.785,
"return_since_base_pct": 8.0694,
"session_return_pct": 1.15,
"change_since_prior_pct": 1.0183,
"volume_ratio": 0.48,
"rsi": 82.52,
"vwap": 26.64,
"vwap_distance_pct": 0.5443,
"position_52w_pct": 78.7,
"extended_hours_pct": null,
"as_of": "2026-10-13T19:24:51.998952Z",
"source": "yfinance_quote",
"name": "Carnival Corporation Ltd.",
"episode_id": "n0:CCL:2026-09-29",
"ema_trend": "25.89 > 24.97 > 25.06",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:18:03.945792Z",
"facts": [
"The supplied earnings coverage reports adjusted EPS of $1.43 versus $1.36 expected, revenue of $8.435B versus $8.300B expected, and a slight increase to full-year adjusted EPS guidance.",
"The N0 capture records +11.95% on 2.05x average volume. The provider series remained near the move through its final supplied observation.",
"The 20-session record shows CCL +4.48% versus its sector proxy -6.75%, a +11.23 percentage-point difference.",
"The active H3/H8/H15 positive-return estimates are 0.470/0.469/0.502; corresponding adverse-MAE medians are -4.49%/-7.15%/-9.26%. The separate audit-only H15 historical-dispersion output is P10 -19.62%, median -1.26%, P90 +7.16%. These comparisons use eight cases."
],
"price_as_of": "2026-10-13T19:24:51.998952Z",
"vwap_as_of": null
},
{
"symbol": "SMMT",
"role": "alternative",
"price": 16.3387,
"base_price": 16.505,
"return_since_base_pct": -1.0076,
"session_return_pct": -0.313,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.35,
"rsi": 42.99,
"vwap": 17.03,
"vwap_distance_pct": -4.0593,
"position_52w_pct": 56.43,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:20:32Z",
"source": "yfinance_quote",
"name": "Summit Therapeutics Inc.",
"episode_id": "n0:SMMT:2026-09-29",
"ema_trend": "16.44 > 16.26 > 15.62",
"vwap_state": "below",
"selection_as_of": "2026-09-29T15:16:50.388704Z",
"facts": [
"The supplied event evidence describes a $2B AstraZeneca investment using newly issued convertible preferred shares and a clinical collaboration.",
"The N0 event capture was +6.62% on 3.35x average volume, but the provider series faded to about +5.33% and the intraday reading was below VWAP."
],
"price_as_of": "2026-09-29T21:20:32Z",
"vwap_as_of": null
},
{
"symbol": "HAFN",
"role": "alternative",
"price": 9.77,
"base_price": 9.56,
"return_since_base_pct": 2.1967,
"session_return_pct": 1.0341,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.24,
"rsi": 57.04,
"vwap": 9.53,
"vwap_distance_pct": 2.5184,
"position_52w_pct": 94.57,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:05:26Z",
"source": "yfinance_quote",
"name": "Hafnia Limited",
"episode_id": "n0:HAFN:2026-09-29",
"ema_trend": "9.27 > 9.0 > 8.33",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:18:47.711682Z",
"facts": [
"The N0 capture was +4.71% on 1.24x average volume; later provider observations retained a somewhat larger gain and price was above VWAP.",
"No company-specific catalyst was established in the supplied dossier."
],
"price_as_of": "2026-09-29T21:05:26Z",
"vwap_as_of": null
},
{
"symbol": "NTWK",
"role": "alternative",
"price": 5.56,
"base_price": 5.5496,
"return_since_base_pct": 0.1874,
"session_return_pct": 3.36,
"change_since_prior_pct": 0.0,
"volume_ratio": 14.19,
"rsi": 89.74,
"vwap": 5.5,
"vwap_distance_pct": 1.0909,
"position_52w_pct": 98.75,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:10:08Z",
"source": "yfinance_quote",
"name": "NetSol Technologies, Inc.",
"episode_id": "n0:NTWK:2026-09-29",
"ema_trend": "4.87 > 4.54 > 4.38",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:15:36.965867Z",
"facts": [
"The supplied FY26 results report revenue of $74.4M, up 12.5%, and FY27 revenue guidance of $84.1M-$86.3M.",
"The event capture was +3.36% on 14.19x average volume, but the dossier estimates about $2M of dollar turnover and places price 3.06 ATR above its EMA reference."
],
"price_as_of": "2026-09-29T20:10:08Z",
"vwap_as_of": null
},
{
"symbol": "ACET",
"role": "alternative",
"price": 6.77,
"base_price": 6.78,
"return_since_base_pct": -0.1475,
"session_return_pct": -0.8785,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.05,
"rsi": 31.39,
"vwap": 6.69,
"vwap_distance_pct": 1.1958,
"position_52w_pct": 38.99,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:55:28Z",
"source": "yfinance_quote",
"name": "Adicet Bio, Inc.",
"episode_id": "n0:ACET:2026-09-29",
"ema_trend": "8.07 > 8.58 > 8.73",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:17:12.774775Z",
"facts": [
"The supplied Phase 1 lupus readout reports 54% DORIS remission and 50% complete renal response among 22 efficacy-evaluable patients after 12 months.",
"The N0 capture was +6.71% on about 3.05x average volume, while the 20-session asset return was -21.15% versus -0.40% for its healthcare proxy."
],
"price_as_of": "2026-09-29T20:55:28Z",
"vwap_as_of": null
},
{
"symbol": "PWP",
"role": "alternative",
"price": 17.1,
"base_price": 16.85,
"return_since_base_pct": 1.4837,
"session_return_pct": 4.4594,
"change_since_prior_pct": 0.0,
"volume_ratio": 5.79,
"rsi": 55.35,
"vwap": 16.26,
"vwap_distance_pct": 5.1661,
"position_52w_pct": 65.01,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:13:05Z",
"source": "yfinance_quote",
"name": "Perella Weinberg Partners",
"episode_id": "n0:PWP:2026-09-29",
"ema_trend": "14.6 > 14.8 > 15.42",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:15:55.598703Z",
"facts": [
"The catalyst is a report of acquisition talks, not a confirmed agreement.",
"The event capture was +15.1% on 5.79x average volume; the provider series retreated from its high but retained much of the move."
],
"price_as_of": "2026-09-29T21:13:05Z",
"vwap_as_of": null
},
{
"symbol": "KMX",
"role": "alternative",
"price": 59.35,
"base_price": 60.72,
"return_since_base_pct": -2.2563,
"session_return_pct": 0.2026,
"change_since_prior_pct": 0.0,
"volume_ratio": 2.26,
"rsi": 52.08,
"vwap": 61.4,
"vwap_distance_pct": -3.3388,
"position_52w_pct": 93.32,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:59:02Z",
"source": "yfinance_quote",
"name": "CarMax, Inc.",
"episode_id": "n0:KMX:2026-09-29",
"ema_trend": "58.29 > 58.97 > 58.5",
"vwap_state": "below",
"selection_as_of": "2026-09-29T15:17:34.477760Z",
"facts": [
"The supplied earnings report shows EPS of $1.16 versus $0.73 expected and sales of $7.878B versus $6.976B expected.",
"The provider trajectory faded from about +5.72% to +3.24%; the intraday reading was below VWAP with a downward trend.",
"The active H3/H8/H15 positive-return estimates are 0.547/0.567/0.528, higher than CCL's at each horizon. Its corresponding adverse-MAE medians are -3.25%/-4.20%/-6.09%. The separate audit-only H15 historical-dispersion output is P10 -5.31%, median +4.18%, P90 +16.31%. These comparisons use eight cases."
],
"price_as_of": "2026-09-29T20:59:02Z",
"vwap_as_of": null
},
{
"symbol": "WYY",
"role": "alternative",
"price": 7.28,
"base_price": 6.4203,
"return_since_base_pct": 13.3903,
"session_return_pct": -0.9524,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.39,
"rsi": 29.28,
"vwap": 6.2,
"vwap_distance_pct": 17.4194,
"position_52w_pct": 26.56,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:10:33Z",
"source": "yfinance_quote",
"name": "WidePoint Corporation",
"episode_id": "n0:WYY:2026-09-29",
"ema_trend": "8.81 > 9.89 > 10.68",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:18:38.363232Z",
"facts": [
"The provider trajectory rose from about +7.97% to +16.45%, and the intraday reading was above VWAP.",
"The 20-session asset return was -32.32% versus +4.15% for the technology proxy; no company-specific catalyst for the day's move was established."
],
"price_as_of": "2026-09-29T21:10:33Z",
"vwap_as_of": null
},
{
"symbol": "VIAV",
"role": "alternative",
"price": 41.99,
"base_price": 41.455,
"return_since_base_pct": 1.2906,
"session_return_pct": 0.4065,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.53,
"rsi": 57.12,
"vwap": 41.77,
"vwap_distance_pct": 0.5267,
"position_52w_pct": 68.56,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:16:33Z",
"source": "yfinance_quote",
"name": "Viavi Solutions Inc.",
"episode_id": "narrative:VIAV:b612043b612913e0",
"ema_trend": "38.56 > 37.68 > 38.08",
"vwap_state": "below",
"selection_as_of": "2026-09-29T17:19:34Z",
"facts": [
"The primary product announcement introduces a 100G testing platform but supplies no customer wins or expected revenue contribution.",
"The quote change was +1.37% on 0.53x average volume; price was below VWAP with a downward intraday trend."
],
"price_as_of": "2026-09-29T21:16:33Z",
"vwap_as_of": null
},
{
"symbol": "WH",
"role": "alternative",
"price": 72.44,
"base_price": 71.79,
"return_since_base_pct": 0.9054,
"session_return_pct": null,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.32,
"rsi": 60.7,
"vwap": 71.82,
"vwap_distance_pct": 0.8633,
"position_52w_pct": 79.55,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:00:33Z",
"source": "yfinance_quote",
"name": "Wyndham Hotels & Resorts, Inc.",
"episode_id": "narrative:WH:e6143a4ee8e53619",
"ema_trend": "69.87 > 70.21 > 72.36",
"vwap_state": "above",
"selection_as_of": "2026-09-29T17:19:31Z",
"facts": [
"The primary release reports a $400M increase to the share repurchase authorization.",
"The quote change was +1.47% on 0.32x average volume; the authorization does not establish that repurchases occurred."
],
"price_as_of": "2026-09-29T20:00:33Z",
"vwap_as_of": null
}
],
"benchmarks": [],
"coverage": {
"candidate_rows": 10,
"candidate_prices": 10,
"candidate_technical": 10,
"benchmark_rows": 0
}
}
},
{
"day": 10,
"timestamp": "2026-10-13T21:46:36.994524Z",
"comparison": {
"schema_version": "public-candidate-comparison.v1",
"captured_at": "2026-10-13T21:46:36.994524Z",
"base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
"source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
"rows": [
{
"symbol": "CCL",
"role": "selected",
"price": 26.73,
"base_price": 24.785,
"return_since_base_pct": 7.8475,
"session_return_pct": 0.94,
"change_since_prior_pct": -0.2053,
"volume_ratio": 0.7,
"rsi": 82.39,
"vwap": 26.64,
"vwap_distance_pct": 0.3378,
"position_52w_pct": 78.5,
"extended_hours_pct": 0.0,
"as_of": "2026-10-13T21:23:24Z",
"source": "sealed_extended_quote",
"name": "Carnival Corporation Ltd.",
"episode_id": "n0:CCL:2026-09-29",
"ema_trend": "25.88 > 24.97 > 25.06",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:18:03.945792Z",
"facts": [
"The supplied earnings coverage reports adjusted EPS of $1.43 versus $1.36 expected, revenue of $8.435B versus $8.300B expected, and a slight increase to full-year adjusted EPS guidance.",
"The N0 capture records +11.95% on 2.05x average volume. The provider series remained near the move through its final supplied observation.",
"The 20-session record shows CCL +4.48% versus its sector proxy -6.75%, a +11.23 percentage-point difference.",
"The active H3/H8/H15 positive-return estimates are 0.470/0.469/0.502; corresponding adverse-MAE medians are -4.49%/-7.15%/-9.26%. The separate audit-only H15 historical-dispersion output is P10 -19.62%, median -1.26%, P90 +7.16%. These comparisons use eight cases."
],
"price_as_of": "2026-10-13T21:23:24Z",
"vwap_as_of": null
},
{
"symbol": "SMMT",
"role": "alternative",
"price": 16.3387,
"base_price": 16.505,
"return_since_base_pct": -1.0076,
"session_return_pct": -0.313,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.35,
"rsi": 42.99,
"vwap": 17.03,
"vwap_distance_pct": -4.0593,
"position_52w_pct": 56.43,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:20:32Z",
"source": "yfinance_quote",
"name": "Summit Therapeutics Inc.",
"episode_id": "n0:SMMT:2026-09-29",
"ema_trend": "16.44 > 16.26 > 15.62",
"vwap_state": "below",
"selection_as_of": "2026-09-29T15:16:50.388704Z",
"facts": [
"The supplied event evidence describes a $2B AstraZeneca investment using newly issued convertible preferred shares and a clinical collaboration.",
"The N0 event capture was +6.62% on 3.35x average volume, but the provider series faded to about +5.33% and the intraday reading was below VWAP."
],
"price_as_of": "2026-09-29T21:20:32Z",
"vwap_as_of": null
},
{
"symbol": "HAFN",
"role": "alternative",
"price": 9.77,
"base_price": 9.56,
"return_since_base_pct": 2.1967,
"session_return_pct": 1.0341,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.24,
"rsi": 57.04,
"vwap": 9.53,
"vwap_distance_pct": 2.5184,
"position_52w_pct": 94.57,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:05:26Z",
"source": "yfinance_quote",
"name": "Hafnia Limited",
"episode_id": "n0:HAFN:2026-09-29",
"ema_trend": "9.27 > 9.0 > 8.33",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:18:47.711682Z",
"facts": [
"The N0 capture was +4.71% on 1.24x average volume; later provider observations retained a somewhat larger gain and price was above VWAP.",
"No company-specific catalyst was established in the supplied dossier."
],
"price_as_of": "2026-09-29T21:05:26Z",
"vwap_as_of": null
},
{
"symbol": "NTWK",
"role": "alternative",
"price": 5.56,
"base_price": 5.5496,
"return_since_base_pct": 0.1874,
"session_return_pct": 3.36,
"change_since_prior_pct": 0.0,
"volume_ratio": 14.19,
"rsi": 89.74,
"vwap": 5.5,
"vwap_distance_pct": 1.0909,
"position_52w_pct": 98.75,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:10:08Z",
"source": "yfinance_quote",
"name": "NetSol Technologies, Inc.",
"episode_id": "n0:NTWK:2026-09-29",
"ema_trend": "4.87 > 4.54 > 4.38",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:15:36.965867Z",
"facts": [
"The supplied FY26 results report revenue of $74.4M, up 12.5%, and FY27 revenue guidance of $84.1M-$86.3M.",
"The event capture was +3.36% on 14.19x average volume, but the dossier estimates about $2M of dollar turnover and places price 3.06 ATR above its EMA reference."
],
"price_as_of": "2026-09-29T20:10:08Z",
"vwap_as_of": null
},
{
"symbol": "ACET",
"role": "alternative",
"price": 6.77,
"base_price": 6.78,
"return_since_base_pct": -0.1475,
"session_return_pct": -0.8785,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.05,
"rsi": 31.39,
"vwap": 6.69,
"vwap_distance_pct": 1.1958,
"position_52w_pct": 38.99,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:55:28Z",
"source": "yfinance_quote",
"name": "Adicet Bio, Inc.",
"episode_id": "n0:ACET:2026-09-29",
"ema_trend": "8.07 > 8.58 > 8.73",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:17:12.774775Z",
"facts": [
"The supplied Phase 1 lupus readout reports 54% DORIS remission and 50% complete renal response among 22 efficacy-evaluable patients after 12 months.",
"The N0 capture was +6.71% on about 3.05x average volume, while the 20-session asset return was -21.15% versus -0.40% for its healthcare proxy."
],
"price_as_of": "2026-09-29T20:55:28Z",
"vwap_as_of": null
},
{
"symbol": "PWP",
"role": "alternative",
"price": 17.1,
"base_price": 16.85,
"return_since_base_pct": 1.4837,
"session_return_pct": 4.4594,
"change_since_prior_pct": 0.0,
"volume_ratio": 5.79,
"rsi": 55.35,
"vwap": 16.26,
"vwap_distance_pct": 5.1661,
"position_52w_pct": 65.01,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:13:05Z",
"source": "yfinance_quote",
"name": "Perella Weinberg Partners",
"episode_id": "n0:PWP:2026-09-29",
"ema_trend": "14.6 > 14.8 > 15.42",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:15:55.598703Z",
"facts": [
"The catalyst is a report of acquisition talks, not a confirmed agreement.",
"The event capture was +15.1% on 5.79x average volume; the provider series retreated from its high but retained much of the move."
],
"price_as_of": "2026-09-29T21:13:05Z",
"vwap_as_of": null
},
{
"symbol": "KMX",
"role": "alternative",
"price": 59.35,
"base_price": 60.72,
"return_since_base_pct": -2.2563,
"session_return_pct": 0.2026,
"change_since_prior_pct": 0.0,
"volume_ratio": 2.26,
"rsi": 52.08,
"vwap": 61.4,
"vwap_distance_pct": -3.3388,
"position_52w_pct": 93.32,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:59:02Z",
"source": "yfinance_quote",
"name": "CarMax, Inc.",
"episode_id": "n0:KMX:2026-09-29",
"ema_trend": "58.29 > 58.97 > 58.5",
"vwap_state": "below",
"selection_as_of": "2026-09-29T15:17:34.477760Z",
"facts": [
"The supplied earnings report shows EPS of $1.16 versus $0.73 expected and sales of $7.878B versus $6.976B expected.",
"The provider trajectory faded from about +5.72% to +3.24%; the intraday reading was below VWAP with a downward trend.",
"The active H3/H8/H15 positive-return estimates are 0.547/0.567/0.528, higher than CCL's at each horizon. Its corresponding adverse-MAE medians are -3.25%/-4.20%/-6.09%. The separate audit-only H15 historical-dispersion output is P10 -5.31%, median +4.18%, P90 +16.31%. These comparisons use eight cases."
],
"price_as_of": "2026-09-29T20:59:02Z",
"vwap_as_of": null
},
{
"symbol": "WYY",
"role": "alternative",
"price": 7.28,
"base_price": 6.4203,
"return_since_base_pct": 13.3903,
"session_return_pct": -0.9524,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.39,
"rsi": 29.28,
"vwap": 6.2,
"vwap_distance_pct": 17.4194,
"position_52w_pct": 26.56,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:10:33Z",
"source": "yfinance_quote",
"name": "WidePoint Corporation",
"episode_id": "n0:WYY:2026-09-29",
"ema_trend": "8.81 > 9.89 > 10.68",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:18:38.363232Z",
"facts": [
"The provider trajectory rose from about +7.97% to +16.45%, and the intraday reading was above VWAP.",
"The 20-session asset return was -32.32% versus +4.15% for the technology proxy; no company-specific catalyst for the day's move was established."
],
"price_as_of": "2026-09-29T21:10:33Z",
"vwap_as_of": null
},
{
"symbol": "VIAV",
"role": "alternative",
"price": 41.99,
"base_price": 41.455,
"return_since_base_pct": 1.2906,
"session_return_pct": 0.4065,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.53,
"rsi": 57.12,
"vwap": 41.77,
"vwap_distance_pct": 0.5267,
"position_52w_pct": 68.56,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:16:33Z",
"source": "yfinance_quote",
"name": "Viavi Solutions Inc.",
"episode_id": "narrative:VIAV:b612043b612913e0",
"ema_trend": "38.56 > 37.68 > 38.08",
"vwap_state": "below",
"selection_as_of": "2026-09-29T17:19:34Z",
"facts": [
"The primary product announcement introduces a 100G testing platform but supplies no customer wins or expected revenue contribution.",
"The quote change was +1.37% on 0.53x average volume; price was below VWAP with a downward intraday trend."
],
"price_as_of": "2026-09-29T21:16:33Z",
"vwap_as_of": null
},
{
"symbol": "WH",
"role": "alternative",
"price": 72.44,
"base_price": 71.79,
"return_since_base_pct": 0.9054,
"session_return_pct": null,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.32,
"rsi": 60.7,
"vwap": 71.82,
"vwap_distance_pct": 0.8633,
"position_52w_pct": 79.55,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:00:33Z",
"source": "yfinance_quote",
"name": "Wyndham Hotels & Resorts, Inc.",
"episode_id": "narrative:WH:e6143a4ee8e53619",
"ema_trend": "69.87 > 70.21 > 72.36",
"vwap_state": "above",
"selection_as_of": "2026-09-29T17:19:31Z",
"facts": [
"The primary release reports a $400M increase to the share repurchase authorization.",
"The quote change was +1.47% on 0.32x average volume; the authorization does not establish that repurchases occurred."
],
"price_as_of": "2026-09-29T20:00:33Z",
"vwap_as_of": null
}
],
"benchmarks": [],
"coverage": {
"candidate_rows": 10,
"candidate_prices": 10,
"candidate_technical": 10,
"benchmark_rows": 0
}
}
},
{
"day": 11,
"timestamp": "2026-10-14T15:09:43.480303Z",
"comparison": {
"schema_version": "public-candidate-comparison.v1",
"captured_at": "2026-10-14T15:09:43.480303Z",
"base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
"source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
"rows": [
{
"symbol": "CCL",
"role": "selected",
"price": 25.955,
"base_price": 24.785,
"return_since_base_pct": 4.7206,
"session_return_pct": -2.9,
"change_since_prior_pct": -2.8994,
"volume_ratio": 0.15,
"rsi": 74.82,
"vwap": 26.18,
"vwap_distance_pct": -0.8594,
"position_52w_pct": 76.3,
"extended_hours_pct": null,
"as_of": "2026-10-14T14:06:37.850462Z",
"source": "yfinance_quote",
"name": "Carnival Corporation Ltd.",
"episode_id": "n0:CCL:2026-09-29",
"ema_trend": "25.9 > 25.06 > 25.09",
"vwap_state": "below",
"selection_as_of": "2026-09-29T15:18:03.945792Z",
"facts": [
"The supplied earnings coverage reports adjusted EPS of $1.43 versus $1.36 expected, revenue of $8.435B versus $8.300B expected, and a slight increase to full-year adjusted EPS guidance.",
"The N0 capture records +11.95% on 2.05x average volume. The provider series remained near the move through its final supplied observation.",
"The 20-session record shows CCL +4.48% versus its sector proxy -6.75%, a +11.23 percentage-point difference.",
"The active H3/H8/H15 positive-return estimates are 0.470/0.469/0.502; corresponding adverse-MAE medians are -4.49%/-7.15%/-9.26%. The separate audit-only H15 historical-dispersion output is P10 -19.62%, median -1.26%, P90 +7.16%. These comparisons use eight cases."
],
"benchmark_excess_pct": {
"sp500": -2.1163,
"nasdaq100": -1.7065,
"russell2000": -1.6092
},
"price_as_of": "2026-10-14T14:06:37.850462Z",
"vwap_as_of": null
},
{
"symbol": "SMMT",
"role": "alternative",
"price": 16.3387,
"base_price": 16.505,
"return_since_base_pct": -1.0076,
"session_return_pct": -0.313,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.35,
"rsi": 42.99,
"vwap": 17.03,
"vwap_distance_pct": -4.0593,
"position_52w_pct": 56.43,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:20:32Z",
"source": "yfinance_quote",
"name": "Summit Therapeutics Inc.",
"episode_id": "n0:SMMT:2026-09-29",
"ema_trend": "16.44 > 16.26 > 15.62",
"vwap_state": "below",
"selection_as_of": "2026-09-29T15:16:50.388704Z",
"facts": [
"The supplied event evidence describes a $2B AstraZeneca investment using newly issued convertible preferred shares and a clinical collaboration.",
"The N0 event capture was +6.62% on 3.35x average volume, but the provider series faded to about +5.33% and the intraday reading was below VWAP."
],
"benchmark_excess_pct": {
"sp500": 0.4707,
"nasdaq100": 0.8805,
"russell2000": 0.9778
},
"price_as_of": "2026-09-29T21:20:32Z",
"vwap_as_of": null
},
{
"symbol": "HAFN",
"role": "alternative",
"price": 9.77,
"base_price": 9.56,
"return_since_base_pct": 2.1967,
"session_return_pct": 1.0341,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.24,
"rsi": 57.04,
"vwap": 9.53,
"vwap_distance_pct": 2.5184,
"position_52w_pct": 94.57,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:05:26Z",
"source": "yfinance_quote",
"name": "Hafnia Limited",
"episode_id": "n0:HAFN:2026-09-29",
"ema_trend": "9.27 > 9.0 > 8.33",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:18:47.711682Z",
"facts": [
"The N0 capture was +4.71% on 1.24x average volume; later provider observations retained a somewhat larger gain and price was above VWAP.",
"No company-specific catalyst was established in the supplied dossier."
],
"benchmark_excess_pct": {
"sp500": 1.8178,
"nasdaq100": 2.2276,
"russell2000": 2.3249
},
"price_as_of": "2026-09-29T21:05:26Z",
"vwap_as_of": null
},
{
"symbol": "NTWK",
"role": "alternative",
"price": 5.56,
"base_price": 5.5496,
"return_since_base_pct": 0.1874,
"session_return_pct": 3.36,
"change_since_prior_pct": 0.0,
"volume_ratio": 14.19,
"rsi": 89.74,
"vwap": 5.5,
"vwap_distance_pct": 1.0909,
"position_52w_pct": 98.75,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:10:08Z",
"source": "yfinance_quote",
"name": "NetSol Technologies, Inc.",
"episode_id": "n0:NTWK:2026-09-29",
"ema_trend": "4.87 > 4.54 > 4.38",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:15:36.965867Z",
"facts": [
"The supplied FY26 results report revenue of $74.4M, up 12.5%, and FY27 revenue guidance of $84.1M-$86.3M.",
"The event capture was +3.36% on 14.19x average volume, but the dossier estimates about $2M of dollar turnover and places price 3.06 ATR above its EMA reference."
],
"benchmark_excess_pct": {
"sp500": 4.1437,
"nasdaq100": 4.5535,
"russell2000": 4.6508
},
"price_as_of": "2026-09-29T20:10:08Z",
"vwap_as_of": null
},
{
"symbol": "ACET",
"role": "alternative",
"price": 6.77,
"base_price": 6.78,
"return_since_base_pct": -0.1475,
"session_return_pct": -0.8785,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.05,
"rsi": 31.39,
"vwap": 6.69,
"vwap_distance_pct": 1.1958,
"position_52w_pct": 38.99,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:55:28Z",
"source": "yfinance_quote",
"name": "Adicet Bio, Inc.",
"episode_id": "n0:ACET:2026-09-29",
"ema_trend": "8.07 > 8.58 > 8.73",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:17:12.774775Z",
"facts": [
"The supplied Phase 1 lupus readout reports 54% DORIS remission and 50% complete renal response among 22 efficacy-evaluable patients after 12 months.",
"The N0 capture was +6.71% on about 3.05x average volume, while the 20-session asset return was -21.15% versus -0.40% for its healthcare proxy."
],
"benchmark_excess_pct": {
"sp500": -0.0948,
"nasdaq100": 0.315,
"russell2000": 0.4123
},
"price_as_of": "2026-09-29T20:55:28Z",
"vwap_as_of": null
},
{
"symbol": "PWP",
"role": "alternative",
"price": 17.1,
"base_price": 16.85,
"return_since_base_pct": 1.4837,
"session_return_pct": 4.4594,
"change_since_prior_pct": 0.0,
"volume_ratio": 5.79,
"rsi": 55.35,
"vwap": 16.26,
"vwap_distance_pct": 5.1661,
"position_52w_pct": 65.01,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:13:05Z",
"source": "yfinance_quote",
"name": "Perella Weinberg Partners",
"episode_id": "n0:PWP:2026-09-29",
"ema_trend": "14.6 > 14.8 > 15.42",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:15:55.598703Z",
"facts": [
"The catalyst is a report of acquisition talks, not a confirmed agreement.",
"The event capture was +15.1% on 5.79x average volume; the provider series retreated from its high but retained much of the move."
],
"benchmark_excess_pct": {
"sp500": 5.2431,
"nasdaq100": 5.6529,
"russell2000": 5.7502
},
"price_as_of": "2026-09-29T21:13:05Z",
"vwap_as_of": null
},
{
"symbol": "KMX",
"role": "alternative",
"price": 59.35,
"base_price": 60.72,
"return_since_base_pct": -2.2563,
"session_return_pct": 0.2026,
"change_since_prior_pct": 0.0,
"volume_ratio": 2.26,
"rsi": 52.08,
"vwap": 61.4,
"vwap_distance_pct": -3.3388,
"position_52w_pct": 93.32,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:59:02Z",
"source": "yfinance_quote",
"name": "CarMax, Inc.",
"episode_id": "n0:KMX:2026-09-29",
"ema_trend": "58.29 > 58.97 > 58.5",
"vwap_state": "below",
"selection_as_of": "2026-09-29T15:17:34.477760Z",
"facts": [
"The supplied earnings report shows EPS of $1.16 versus $0.73 expected and sales of $7.878B versus $6.976B expected.",
"The provider trajectory faded from about +5.72% to +3.24%; the intraday reading was below VWAP with a downward trend.",
"The active H3/H8/H15 positive-return estimates are 0.547/0.567/0.528, higher than CCL's at each horizon. Its corresponding adverse-MAE medians are -3.25%/-4.20%/-6.09%. The separate audit-only H15 historical-dispersion output is P10 -5.31%, median +4.18%, P90 +16.31%. These comparisons use eight cases."
],
"benchmark_excess_pct": {
"sp500": 0.9863,
"nasdaq100": 1.3961,
"russell2000": 1.4934
},
"price_as_of": "2026-09-29T20:59:02Z",
"vwap_as_of": null
},
{
"symbol": "WYY",
"role": "alternative",
"price": 7.28,
"base_price": 6.4203,
"return_since_base_pct": 13.3903,
"session_return_pct": -0.9524,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.39,
"rsi": 29.28,
"vwap": 6.2,
"vwap_distance_pct": 17.4194,
"position_52w_pct": 26.56,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:10:33Z",
"source": "yfinance_quote",
"name": "WidePoint Corporation",
"episode_id": "n0:WYY:2026-09-29",
"ema_trend": "8.81 > 9.89 > 10.68",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:18:38.363232Z",
"facts": [
"The provider trajectory rose from about +7.97% to +16.45%, and the intraday reading was above VWAP.",
"The 20-session asset return was -32.32% versus +4.15% for the technology proxy; no company-specific catalyst for the day's move was established."
],
"benchmark_excess_pct": {
"sp500": -0.1687,
"nasdaq100": 0.2411,
"russell2000": 0.3384
},
"price_as_of": "2026-09-29T21:10:33Z",
"vwap_as_of": null
},
{
"symbol": "VIAV",
"role": "alternative",
"price": 41.99,
"base_price": 41.455,
"return_since_base_pct": 1.2906,
"session_return_pct": 0.4065,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.53,
"rsi": 57.12,
"vwap": 41.77,
"vwap_distance_pct": 0.5267,
"position_52w_pct": 68.56,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:16:33Z",
"source": "yfinance_quote",
"name": "Viavi Solutions Inc.",
"episode_id": "narrative:VIAV:b612043b612913e0",
"ema_trend": "38.56 > 37.68 > 38.08",
"vwap_state": "below",
"selection_as_of": "2026-09-29T17:19:34Z",
"facts": [
"The primary product announcement introduces a 100G testing platform but supplies no customer wins or expected revenue contribution.",
"The quote change was +1.37% on 0.53x average volume; price was below VWAP with a downward intraday trend."
],
"benchmark_excess_pct": {
"sp500": 1.1902,
"nasdaq100": 1.6,
"russell2000": 1.6973
},
"price_as_of": "2026-09-29T21:16:33Z",
"vwap_as_of": null
},
{
"symbol": "WH",
"role": "alternative",
"price": 72.44,
"base_price": 71.79,
"return_since_base_pct": 0.9054,
"session_return_pct": null,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.32,
"rsi": 60.7,
"vwap": 71.82,
"vwap_distance_pct": 0.8633,
"position_52w_pct": 79.55,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:00:33Z",
"source": "yfinance_quote",
"name": "Wyndham Hotels & Resorts, Inc.",
"episode_id": "narrative:WH:e6143a4ee8e53619",
"ema_trend": "69.87 > 70.21 > 72.36",
"vwap_state": "above",
"selection_as_of": "2026-09-29T17:19:31Z",
"facts": [
"The primary release reports a $400M increase to the share repurchase authorization.",
"The quote change was +1.47% on 0.32x average volume; the authorization does not establish that repurchases occurred."
],
"price_as_of": "2026-09-29T20:00:33Z",
"vwap_as_of": null
}
],
"benchmarks": [
{
"id": "sp500",
"symbol": "^GSPC",
"label": "S&P 500",
"role": "benchmark",
"price": 7744.28,
"base_price": 7805.45,
"return_since_base_pct": -0.7837,
"session_return_pct": -0.7837,
"as_of": "2026-10-14T15:07:18.695896Z",
"source": "yfinance.ticker_info",
"base_definition": "previous regular close"
},
{
"id": "nasdaq100",
"symbol": "^NDX",
"label": "Nasdaq 100",
"role": "benchmark",
"price": 30204.63,
"base_price": 30569.48,
"return_since_base_pct": -1.1935,
"session_return_pct": -1.1935,
"as_of": "2026-10-14T15:07:18.695896Z",
"source": "yfinance.ticker_info",
"base_definition": "previous regular close"
},
{
"id": "russell2000",
"symbol": "^RUT",
"label": "Russell 2000",
"role": "benchmark",
"price": 2747.4421,
"base_price": 2783.369,
"return_since_base_pct": -1.2908,
"session_return_pct": -1.2908,
"as_of": "2026-10-14T15:07:18.695896Z",
"source": "yfinance.ticker_info",
"base_definition": "previous regular close"
}
],
"coverage": {
"candidate_rows": 10,
"candidate_prices": 10,
"candidate_technical": 10,
"benchmark_rows": 3
}
}
},
{
"day": 11,
"timestamp": "2026-10-14T20:37:16.972823Z",
"comparison": {
"schema_version": "public-candidate-comparison.v1",
"captured_at": "2026-10-14T20:37:16.972823Z",
"base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
"source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
"rows": [
{
"symbol": "CCL",
"role": "selected",
"price": 25.895,
"base_price": 24.785,
"return_since_base_pct": 4.4785,
"session_return_pct": -3.12,
"change_since_prior_pct": -0.2312,
"volume_ratio": 0.63,
"rsi": 74.33,
"vwap": 26.01,
"vwap_distance_pct": -0.4421,
"position_52w_pct": 76.1,
"extended_hours_pct": null,
"as_of": "2026-10-14T19:41:13.876792Z",
"source": "yfinance_quote",
"name": "Carnival Corporation Ltd.",
"episode_id": "n0:CCL:2026-09-29",
"ema_trend": "25.89 > 25.05 > 25.09",
"vwap_state": "below",
"selection_as_of": "2026-09-29T15:18:03.945792Z",
"facts": [
"The supplied earnings coverage reports adjusted EPS of $1.43 versus $1.36 expected, revenue of $8.435B versus $8.300B expected, and a slight increase to full-year adjusted EPS guidance.",
"The N0 capture records +11.95% on 2.05x average volume. The provider series remained near the move through its final supplied observation.",
"The 20-session record shows CCL +4.48% versus its sector proxy -6.75%, a +11.23 percentage-point difference.",
"The active H3/H8/H15 positive-return estimates are 0.470/0.469/0.502; corresponding adverse-MAE medians are -4.49%/-7.15%/-9.26%. The separate audit-only H15 historical-dispersion output is P10 -19.62%, median -1.26%, P90 +7.16%. These comparisons use eight cases."
],
"price_as_of": "2026-10-14T19:41:13.876792Z",
"vwap_as_of": null
},
{
"symbol": "SMMT",
"role": "alternative",
"price": 16.3387,
"base_price": 16.505,
"return_since_base_pct": -1.0076,
"session_return_pct": -0.313,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.35,
"rsi": 42.99,
"vwap": 17.03,
"vwap_distance_pct": -4.0593,
"position_52w_pct": 56.43,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:20:32Z",
"source": "yfinance_quote",
"name": "Summit Therapeutics Inc.",
"episode_id": "n0:SMMT:2026-09-29",
"ema_trend": "16.44 > 16.26 > 15.62",
"vwap_state": "below",
"selection_as_of": "2026-09-29T15:16:50.388704Z",
"facts": [
"The supplied event evidence describes a $2B AstraZeneca investment using newly issued convertible preferred shares and a clinical collaboration.",
"The N0 event capture was +6.62% on 3.35x average volume, but the provider series faded to about +5.33% and the intraday reading was below VWAP."
],
"price_as_of": "2026-09-29T21:20:32Z",
"vwap_as_of": null
},
{
"symbol": "HAFN",
"role": "alternative",
"price": 9.77,
"base_price": 9.56,
"return_since_base_pct": 2.1967,
"session_return_pct": 1.0341,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.24,
"rsi": 57.04,
"vwap": 9.53,
"vwap_distance_pct": 2.5184,
"position_52w_pct": 94.57,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:05:26Z",
"source": "yfinance_quote",
"name": "Hafnia Limited",
"episode_id": "n0:HAFN:2026-09-29",
"ema_trend": "9.27 > 9.0 > 8.33",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:18:47.711682Z",
"facts": [
"The N0 capture was +4.71% on 1.24x average volume; later provider observations retained a somewhat larger gain and price was above VWAP.",
"No company-specific catalyst was established in the supplied dossier."
],
"price_as_of": "2026-09-29T21:05:26Z",
"vwap_as_of": null
},
{
"symbol": "NTWK",
"role": "alternative",
"price": 5.56,
"base_price": 5.5496,
"return_since_base_pct": 0.1874,
"session_return_pct": 3.36,
"change_since_prior_pct": 0.0,
"volume_ratio": 14.19,
"rsi": 89.74,
"vwap": 5.5,
"vwap_distance_pct": 1.0909,
"position_52w_pct": 98.75,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:10:08Z",
"source": "yfinance_quote",
"name": "NetSol Technologies, Inc.",
"episode_id": "n0:NTWK:2026-09-29",
"ema_trend": "4.87 > 4.54 > 4.38",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:15:36.965867Z",
"facts": [
"The supplied FY26 results report revenue of $74.4M, up 12.5%, and FY27 revenue guidance of $84.1M-$86.3M.",
"The event capture was +3.36% on 14.19x average volume, but the dossier estimates about $2M of dollar turnover and places price 3.06 ATR above its EMA reference."
],
"price_as_of": "2026-09-29T20:10:08Z",
"vwap_as_of": null
},
{
"symbol": "ACET",
"role": "alternative",
"price": 6.77,
"base_price": 6.78,
"return_since_base_pct": -0.1475,
"session_return_pct": -0.8785,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.05,
"rsi": 31.39,
"vwap": 6.69,
"vwap_distance_pct": 1.1958,
"position_52w_pct": 38.99,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:55:28Z",
"source": "yfinance_quote",
"name": "Adicet Bio, Inc.",
"episode_id": "n0:ACET:2026-09-29",
"ema_trend": "8.07 > 8.58 > 8.73",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:17:12.774775Z",
"facts": [
"The supplied Phase 1 lupus readout reports 54% DORIS remission and 50% complete renal response among 22 efficacy-evaluable patients after 12 months.",
"The N0 capture was +6.71% on about 3.05x average volume, while the 20-session asset return was -21.15% versus -0.40% for its healthcare proxy."
],
"price_as_of": "2026-09-29T20:55:28Z",
"vwap_as_of": null
},
{
"symbol": "PWP",
"role": "alternative",
"price": 17.1,
"base_price": 16.85,
"return_since_base_pct": 1.4837,
"session_return_pct": 4.4594,
"change_since_prior_pct": 0.0,
"volume_ratio": 5.79,
"rsi": 55.35,
"vwap": 16.26,
"vwap_distance_pct": 5.1661,
"position_52w_pct": 65.01,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:13:05Z",
"source": "yfinance_quote",
"name": "Perella Weinberg Partners",
"episode_id": "n0:PWP:2026-09-29",
"ema_trend": "14.6 > 14.8 > 15.42",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:15:55.598703Z",
"facts": [
"The catalyst is a report of acquisition talks, not a confirmed agreement.",
"The event capture was +15.1% on 5.79x average volume; the provider series retreated from its high but retained much of the move."
],
"price_as_of": "2026-09-29T21:13:05Z",
"vwap_as_of": null
},
{
"symbol": "KMX",
"role": "alternative",
"price": 59.35,
"base_price": 60.72,
"return_since_base_pct": -2.2563,
"session_return_pct": 0.2026,
"change_since_prior_pct": 0.0,
"volume_ratio": 2.26,
"rsi": 52.08,
"vwap": 61.4,
"vwap_distance_pct": -3.3388,
"position_52w_pct": 93.32,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:59:02Z",
"source": "yfinance_quote",
"name": "CarMax, Inc.",
"episode_id": "n0:KMX:2026-09-29",
"ema_trend": "58.29 > 58.97 > 58.5",
"vwap_state": "below",
"selection_as_of": "2026-09-29T15:17:34.477760Z",
"facts": [
"The supplied earnings report shows EPS of $1.16 versus $0.73 expected and sales of $7.878B versus $6.976B expected.",
"The provider trajectory faded from about +5.72% to +3.24%; the intraday reading was below VWAP with a downward trend.",
"The active H3/H8/H15 positive-return estimates are 0.547/0.567/0.528, higher than CCL's at each horizon. Its corresponding adverse-MAE medians are -3.25%/-4.20%/-6.09%. The separate audit-only H15 historical-dispersion output is P10 -5.31%, median +4.18%, P90 +16.31%. These comparisons use eight cases."
],
"price_as_of": "2026-09-29T20:59:02Z",
"vwap_as_of": null
},
{
"symbol": "WYY",
"role": "alternative",
"price": 7.28,
"base_price": 6.4203,
"return_since_base_pct": 13.3903,
"session_return_pct": -0.9524,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.39,
"rsi": 29.28,
"vwap": 6.2,
"vwap_distance_pct": 17.4194,
"position_52w_pct": 26.56,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:10:33Z",
"source": "yfinance_quote",
"name": "WidePoint Corporation",
"episode_id": "n0:WYY:2026-09-29",
"ema_trend": "8.81 > 9.89 > 10.68",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:18:38.363232Z",
"facts": [
"The provider trajectory rose from about +7.97% to +16.45%, and the intraday reading was above VWAP.",
"The 20-session asset return was -32.32% versus +4.15% for the technology proxy; no company-specific catalyst for the day's move was established."
],
"price_as_of": "2026-09-29T21:10:33Z",
"vwap_as_of": null
},
{
"symbol": "VIAV",
"role": "alternative",
"price": 41.99,
"base_price": 41.455,
"return_since_base_pct": 1.2906,
"session_return_pct": 0.4065,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.53,
"rsi": 57.12,
"vwap": 41.77,
"vwap_distance_pct": 0.5267,
"position_52w_pct": 68.56,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:16:33Z",
"source": "yfinance_quote",
"name": "Viavi Solutions Inc.",
"episode_id": "narrative:VIAV:b612043b612913e0",
"ema_trend": "38.56 > 37.68 > 38.08",
"vwap_state": "below",
"selection_as_of": "2026-09-29T17:19:34Z",
"facts": [
"The primary product announcement introduces a 100G testing platform but supplies no customer wins or expected revenue contribution.",
"The quote change was +1.37% on 0.53x average volume; price was below VWAP with a downward intraday trend."
],
"price_as_of": "2026-09-29T21:16:33Z",
"vwap_as_of": null
},
{
"symbol": "WH",
"role": "alternative",
"price": 72.44,
"base_price": 71.79,
"return_since_base_pct": 0.9054,
"session_return_pct": null,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.32,
"rsi": 60.7,
"vwap": 71.82,
"vwap_distance_pct": 0.8633,
"position_52w_pct": 79.55,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:00:33Z",
"source": "yfinance_quote",
"name": "Wyndham Hotels & Resorts, Inc.",
"episode_id": "narrative:WH:e6143a4ee8e53619",
"ema_trend": "69.87 > 70.21 > 72.36",
"vwap_state": "above",
"selection_as_of": "2026-09-29T17:19:31Z",
"facts": [
"The primary release reports a $400M increase to the share repurchase authorization.",
"The quote change was +1.47% on 0.32x average volume; the authorization does not establish that repurchases occurred."
],
"price_as_of": "2026-09-29T20:00:33Z",
"vwap_as_of": null
}
],
"benchmarks": [],
"coverage": {
"candidate_rows": 10,
"candidate_prices": 10,
"candidate_technical": 10,
"benchmark_rows": 0
}
}
},
{
"day": 11,
"timestamp": "2026-10-14T21:42:09.267522Z",
"comparison": {
"schema_version": "public-candidate-comparison.v1",
"captured_at": "2026-10-14T21:42:09.267522Z",
"base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
"source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
"rows": [
{
"symbol": "CCL",
"role": "selected",
"price": 25.91,
"base_price": 24.785,
"return_since_base_pct": 4.539,
"session_return_pct": -2.84,
"change_since_prior_pct": 0.0579,
"volume_ratio": 0.82,
"rsi": 75.0,
"vwap": 26.01,
"vwap_distance_pct": -0.3845,
"position_52w_pct": 76.3,
"extended_hours_pct": -0.22,
"as_of": "2026-10-14T21:11:00Z",
"source": "sealed_extended_quote",
"name": "Carnival Corporation Ltd.",
"episode_id": "n0:CCL:2026-09-29",
"ema_trend": "25.9 > 25.06 > 25.09",
"vwap_state": "below",
"selection_as_of": "2026-09-29T15:18:03.945792Z",
"facts": [
"The supplied earnings coverage reports adjusted EPS of $1.43 versus $1.36 expected, revenue of $8.435B versus $8.300B expected, and a slight increase to full-year adjusted EPS guidance.",
"The N0 capture records +11.95% on 2.05x average volume. The provider series remained near the move through its final supplied observation.",
"The 20-session record shows CCL +4.48% versus its sector proxy -6.75%, a +11.23 percentage-point difference.",
"The active H3/H8/H15 positive-return estimates are 0.470/0.469/0.502; corresponding adverse-MAE medians are -4.49%/-7.15%/-9.26%. The separate audit-only H15 historical-dispersion output is P10 -19.62%, median -1.26%, P90 +7.16%. These comparisons use eight cases."
],
"price_as_of": "2026-10-14T21:11:00Z",
"vwap_as_of": null
},
{
"symbol": "SMMT",
"role": "alternative",
"price": 16.3387,
"base_price": 16.505,
"return_since_base_pct": -1.0076,
"session_return_pct": -0.313,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.35,
"rsi": 42.99,
"vwap": 17.03,
"vwap_distance_pct": -4.0593,
"position_52w_pct": 56.43,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:20:32Z",
"source": "yfinance_quote",
"name": "Summit Therapeutics Inc.",
"episode_id": "n0:SMMT:2026-09-29",
"ema_trend": "16.44 > 16.26 > 15.62",
"vwap_state": "below",
"selection_as_of": "2026-09-29T15:16:50.388704Z",
"facts": [
"The supplied event evidence describes a $2B AstraZeneca investment using newly issued convertible preferred shares and a clinical collaboration.",
"The N0 event capture was +6.62% on 3.35x average volume, but the provider series faded to about +5.33% and the intraday reading was below VWAP."
],
"price_as_of": "2026-09-29T21:20:32Z",
"vwap_as_of": null
},
{
"symbol": "HAFN",
"role": "alternative",
"price": 9.77,
"base_price": 9.56,
"return_since_base_pct": 2.1967,
"session_return_pct": 1.0341,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.24,
"rsi": 57.04,
"vwap": 9.53,
"vwap_distance_pct": 2.5184,
"position_52w_pct": 94.57,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:05:26Z",
"source": "yfinance_quote",
"name": "Hafnia Limited",
"episode_id": "n0:HAFN:2026-09-29",
"ema_trend": "9.27 > 9.0 > 8.33",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:18:47.711682Z",
"facts": [
"The N0 capture was +4.71% on 1.24x average volume; later provider observations retained a somewhat larger gain and price was above VWAP.",
"No company-specific catalyst was established in the supplied dossier."
],
"price_as_of": "2026-09-29T21:05:26Z",
"vwap_as_of": null
},
{
"symbol": "NTWK",
"role": "alternative",
"price": 5.56,
"base_price": 5.5496,
"return_since_base_pct": 0.1874,
"session_return_pct": 3.36,
"change_since_prior_pct": 0.0,
"volume_ratio": 14.19,
"rsi": 89.74,
"vwap": 5.5,
"vwap_distance_pct": 1.0909,
"position_52w_pct": 98.75,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:10:08Z",
"source": "yfinance_quote",
"name": "NetSol Technologies, Inc.",
"episode_id": "n0:NTWK:2026-09-29",
"ema_trend": "4.87 > 4.54 > 4.38",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:15:36.965867Z",
"facts": [
"The supplied FY26 results report revenue of $74.4M, up 12.5%, and FY27 revenue guidance of $84.1M-$86.3M.",
"The event capture was +3.36% on 14.19x average volume, but the dossier estimates about $2M of dollar turnover and places price 3.06 ATR above its EMA reference."
],
"price_as_of": "2026-09-29T20:10:08Z",
"vwap_as_of": null
},
{
"symbol": "ACET",
"role": "alternative",
"price": 6.77,
"base_price": 6.78,
"return_since_base_pct": -0.1475,
"session_return_pct": -0.8785,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.05,
"rsi": 31.39,
"vwap": 6.69,
"vwap_distance_pct": 1.1958,
"position_52w_pct": 38.99,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:55:28Z",
"source": "yfinance_quote",
"name": "Adicet Bio, Inc.",
"episode_id": "n0:ACET:2026-09-29",
"ema_trend": "8.07 > 8.58 > 8.73",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:17:12.774775Z",
"facts": [
"The supplied Phase 1 lupus readout reports 54% DORIS remission and 50% complete renal response among 22 efficacy-evaluable patients after 12 months.",
"The N0 capture was +6.71% on about 3.05x average volume, while the 20-session asset return was -21.15% versus -0.40% for its healthcare proxy."
],
"price_as_of": "2026-09-29T20:55:28Z",
"vwap_as_of": null
},
{
"symbol": "PWP",
"role": "alternative",
"price": 17.1,
"base_price": 16.85,
"return_since_base_pct": 1.4837,
"session_return_pct": 4.4594,
"change_since_prior_pct": 0.0,
"volume_ratio": 5.79,
"rsi": 55.35,
"vwap": 16.26,
"vwap_distance_pct": 5.1661,
"position_52w_pct": 65.01,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:13:05Z",
"source": "yfinance_quote",
"name": "Perella Weinberg Partners",
"episode_id": "n0:PWP:2026-09-29",
"ema_trend": "14.6 > 14.8 > 15.42",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:15:55.598703Z",
"facts": [
"The catalyst is a report of acquisition talks, not a confirmed agreement.",
"The event capture was +15.1% on 5.79x average volume; the provider series retreated from its high but retained much of the move."
],
"price_as_of": "2026-09-29T21:13:05Z",
"vwap_as_of": null
},
{
"symbol": "KMX",
"role": "alternative",
"price": 59.35,
"base_price": 60.72,
"return_since_base_pct": -2.2563,
"session_return_pct": 0.2026,
"change_since_prior_pct": 0.0,
"volume_ratio": 2.26,
"rsi": 52.08,
"vwap": 61.4,
"vwap_distance_pct": -3.3388,
"position_52w_pct": 93.32,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:59:02Z",
"source": "yfinance_quote",
"name": "CarMax, Inc.",
"episode_id": "n0:KMX:2026-09-29",
"ema_trend": "58.29 > 58.97 > 58.5",
"vwap_state": "below",
"selection_as_of": "2026-09-29T15:17:34.477760Z",
"facts": [
"The supplied earnings report shows EPS of $1.16 versus $0.73 expected and sales of $7.878B versus $6.976B expected.",
"The provider trajectory faded from about +5.72% to +3.24%; the intraday reading was below VWAP with a downward trend.",
"The active H3/H8/H15 positive-return estimates are 0.547/0.567/0.528, higher than CCL's at each horizon. Its corresponding adverse-MAE medians are -3.25%/-4.20%/-6.09%. The separate audit-only H15 historical-dispersion output is P10 -5.31%, median +4.18%, P90 +16.31%. These comparisons use eight cases."
],
"price_as_of": "2026-09-29T20:59:02Z",
"vwap_as_of": null
},
{
"symbol": "WYY",
"role": "alternative",
"price": 7.28,
"base_price": 6.4203,
"return_since_base_pct": 13.3903,
"session_return_pct": -0.9524,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.39,
"rsi": 29.28,
"vwap": 6.2,
"vwap_distance_pct": 17.4194,
"position_52w_pct": 26.56,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:10:33Z",
"source": "yfinance_quote",
"name": "WidePoint Corporation",
"episode_id": "n0:WYY:2026-09-29",
"ema_trend": "8.81 > 9.89 > 10.68",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:18:38.363232Z",
"facts": [
"The provider trajectory rose from about +7.97% to +16.45%, and the intraday reading was above VWAP.",
"The 20-session asset return was -32.32% versus +4.15% for the technology proxy; no company-specific catalyst for the day's move was established."
],
"price_as_of": "2026-09-29T21:10:33Z",
"vwap_as_of": null
},
{
"symbol": "VIAV",
"role": "alternative",
"price": 41.99,
"base_price": 41.455,
"return_since_base_pct": 1.2906,
"session_return_pct": 0.4065,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.53,
"rsi": 57.12,
"vwap": 41.77,
"vwap_distance_pct": 0.5267,
"position_52w_pct": 68.56,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:16:33Z",
"source": "yfinance_quote",
"name": "Viavi Solutions Inc.",
"episode_id": "narrative:VIAV:b612043b612913e0",
"ema_trend": "38.56 > 37.68 > 38.08",
"vwap_state": "below",
"selection_as_of": "2026-09-29T17:19:34Z",
"facts": [
"The primary product announcement introduces a 100G testing platform but supplies no customer wins or expected revenue contribution.",
"The quote change was +1.37% on 0.53x average volume; price was below VWAP with a downward intraday trend."
],
"price_as_of": "2026-09-29T21:16:33Z",
"vwap_as_of": null
},
{
"symbol": "WH",
"role": "alternative",
"price": 72.44,
"base_price": 71.79,
"return_since_base_pct": 0.9054,
"session_return_pct": null,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.32,
"rsi": 60.7,
"vwap": 71.82,
"vwap_distance_pct": 0.8633,
"position_52w_pct": 79.55,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:00:33Z",
"source": "yfinance_quote",
"name": "Wyndham Hotels & Resorts, Inc.",
"episode_id": "narrative:WH:e6143a4ee8e53619",
"ema_trend": "69.87 > 70.21 > 72.36",
"vwap_state": "above",
"selection_as_of": "2026-09-29T17:19:31Z",
"facts": [
"The primary release reports a $400M increase to the share repurchase authorization.",
"The quote change was +1.47% on 0.32x average volume; the authorization does not establish that repurchases occurred."
],
"price_as_of": "2026-09-29T20:00:33Z",
"vwap_as_of": null
}
],
"benchmarks": [],
"coverage": {
"candidate_rows": 10,
"candidate_prices": 10,
"candidate_technical": 10,
"benchmark_rows": 0
}
}
},
{
"day": 12,
"timestamp": "2026-10-15T15:33:07.236883Z",
"comparison": {
"schema_version": "public-candidate-comparison.v1",
"captured_at": "2026-10-15T15:33:07.236883Z",
"base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
"source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
"rows": [
{
"symbol": "CCL",
"role": "selected",
"price": 26.085,
"base_price": 24.785,
"return_since_base_pct": 5.2451,
"session_return_pct": 0.44,
"change_since_prior_pct": 0.6754,
"volume_ratio": 0.12,
"rsi": 73.92,
"vwap": 25.98,
"vwap_distance_pct": 0.4042,
"position_52w_pct": 76.7,
"extended_hours_pct": null,
"as_of": "2026-10-15T14:06:44.673876Z",
"source": "yfinance_quote",
"name": "Carnival Corporation Ltd.",
"episode_id": "n0:CCL:2026-09-29",
"ema_trend": "25.94 > 25.15 > 25.13",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:18:03.945792Z",
"facts": [
"The supplied earnings coverage reports adjusted EPS of $1.43 versus $1.36 expected, revenue of $8.435B versus $8.300B expected, and a slight increase to full-year adjusted EPS guidance.",
"The N0 capture records +11.95% on 2.05x average volume. The provider series remained near the move through its final supplied observation.",
"The 20-session record shows CCL +4.48% versus its sector proxy -6.75%, a +11.23 percentage-point difference.",
"The active H3/H8/H15 positive-return estimates are 0.470/0.469/0.502; corresponding adverse-MAE medians are -4.49%/-7.15%/-9.26%. The separate audit-only H15 historical-dispersion output is P10 -19.62%, median -1.26%, P90 +7.16%. These comparisons use eight cases."
],
"price_as_of": "2026-10-15T14:06:44.673876Z",
"vwap_as_of": null
},
{
"symbol": "SMMT",
"role": "alternative",
"price": 16.3387,
"base_price": 16.505,
"return_since_base_pct": -1.0076,
"session_return_pct": -0.313,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.35,
"rsi": 42.99,
"vwap": 17.03,
"vwap_distance_pct": -4.0593,
"position_52w_pct": 56.43,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:20:32Z",
"source": "yfinance_quote",
"name": "Summit Therapeutics Inc.",
"episode_id": "n0:SMMT:2026-09-29",
"ema_trend": "16.44 > 16.26 > 15.62",
"vwap_state": "below",
"selection_as_of": "2026-09-29T15:16:50.388704Z",
"facts": [
"The supplied event evidence describes a $2B AstraZeneca investment using newly issued convertible preferred shares and a clinical collaboration.",
"The N0 event capture was +6.62% on 3.35x average volume, but the provider series faded to about +5.33% and the intraday reading was below VWAP."
],
"price_as_of": "2026-09-29T21:20:32Z",
"vwap_as_of": null
},
{
"symbol": "HAFN",
"role": "alternative",
"price": 9.77,
"base_price": 9.56,
"return_since_base_pct": 2.1967,
"session_return_pct": 1.0341,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.24,
"rsi": 57.04,
"vwap": 9.53,
"vwap_distance_pct": 2.5184,
"position_52w_pct": 94.57,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:05:26Z",
"source": "yfinance_quote",
"name": "Hafnia Limited",
"episode_id": "n0:HAFN:2026-09-29",
"ema_trend": "9.27 > 9.0 > 8.33",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:18:47.711682Z",
"facts": [
"The N0 capture was +4.71% on 1.24x average volume; later provider observations retained a somewhat larger gain and price was above VWAP.",
"No company-specific catalyst was established in the supplied dossier."
],
"price_as_of": "2026-09-29T21:05:26Z",
"vwap_as_of": null
},
{
"symbol": "NTWK",
"role": "alternative",
"price": 5.56,
"base_price": 5.5496,
"return_since_base_pct": 0.1874,
"session_return_pct": 3.36,
"change_since_prior_pct": 0.0,
"volume_ratio": 14.19,
"rsi": 89.74,
"vwap": 5.5,
"vwap_distance_pct": 1.0909,
"position_52w_pct": 98.75,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:10:08Z",
"source": "yfinance_quote",
"name": "NetSol Technologies, Inc.",
"episode_id": "n0:NTWK:2026-09-29",
"ema_trend": "4.87 > 4.54 > 4.38",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:15:36.965867Z",
"facts": [
"The supplied FY26 results report revenue of $74.4M, up 12.5%, and FY27 revenue guidance of $84.1M-$86.3M.",
"The event capture was +3.36% on 14.19x average volume, but the dossier estimates about $2M of dollar turnover and places price 3.06 ATR above its EMA reference."
],
"price_as_of": "2026-09-29T20:10:08Z",
"vwap_as_of": null
},
{
"symbol": "ACET",
"role": "alternative",
"price": 6.77,
"base_price": 6.78,
"return_since_base_pct": -0.1475,
"session_return_pct": -0.8785,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.05,
"rsi": 31.39,
"vwap": 6.69,
"vwap_distance_pct": 1.1958,
"position_52w_pct": 38.99,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:55:28Z",
"source": "yfinance_quote",
"name": "Adicet Bio, Inc.",
"episode_id": "n0:ACET:2026-09-29",
"ema_trend": "8.07 > 8.58 > 8.73",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:17:12.774775Z",
"facts": [
"The supplied Phase 1 lupus readout reports 54% DORIS remission and 50% complete renal response among 22 efficacy-evaluable patients after 12 months.",
"The N0 capture was +6.71% on about 3.05x average volume, while the 20-session asset return was -21.15% versus -0.40% for its healthcare proxy."
],
"price_as_of": "2026-09-29T20:55:28Z",
"vwap_as_of": null
},
{
"symbol": "PWP",
"role": "alternative",
"price": 17.1,
"base_price": 16.85,
"return_since_base_pct": 1.4837,
"session_return_pct": 4.4594,
"change_since_prior_pct": 0.0,
"volume_ratio": 5.79,
"rsi": 55.35,
"vwap": 16.26,
"vwap_distance_pct": 5.1661,
"position_52w_pct": 65.01,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:13:05Z",
"source": "yfinance_quote",
"name": "Perella Weinberg Partners",
"episode_id": "n0:PWP:2026-09-29",
"ema_trend": "14.6 > 14.8 > 15.42",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:15:55.598703Z",
"facts": [
"The catalyst is a report of acquisition talks, not a confirmed agreement.",
"The event capture was +15.1% on 5.79x average volume; the provider series retreated from its high but retained much of the move."
],
"price_as_of": "2026-09-29T21:13:05Z",
"vwap_as_of": null
},
{
"symbol": "KMX",
"role": "alternative",
"price": 59.35,
"base_price": 60.72,
"return_since_base_pct": -2.2563,
"session_return_pct": 0.2026,
"change_since_prior_pct": 0.0,
"volume_ratio": 2.26,
"rsi": 52.08,
"vwap": 61.4,
"vwap_distance_pct": -3.3388,
"position_52w_pct": 93.32,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:59:02Z",
"source": "yfinance_quote",
"name": "CarMax, Inc.",
"episode_id": "n0:KMX:2026-09-29",
"ema_trend": "58.29 > 58.97 > 58.5",
"vwap_state": "below",
"selection_as_of": "2026-09-29T15:17:34.477760Z",
"facts": [
"The supplied earnings report shows EPS of $1.16 versus $0.73 expected and sales of $7.878B versus $6.976B expected.",
"The provider trajectory faded from about +5.72% to +3.24%; the intraday reading was below VWAP with a downward trend.",
"The active H3/H8/H15 positive-return estimates are 0.547/0.567/0.528, higher than CCL's at each horizon. Its corresponding adverse-MAE medians are -3.25%/-4.20%/-6.09%. The separate audit-only H15 historical-dispersion output is P10 -5.31%, median +4.18%, P90 +16.31%. These comparisons use eight cases."
],
"price_as_of": "2026-09-29T20:59:02Z",
"vwap_as_of": null
},
{
"symbol": "WYY",
"role": "alternative",
"price": 7.28,
"base_price": 6.4203,
"return_since_base_pct": 13.3903,
"session_return_pct": -0.9524,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.39,
"rsi": 29.28,
"vwap": 6.2,
"vwap_distance_pct": 17.4194,
"position_52w_pct": 26.56,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:10:33Z",
"source": "yfinance_quote",
"name": "WidePoint Corporation",
"episode_id": "n0:WYY:2026-09-29",
"ema_trend": "8.81 > 9.89 > 10.68",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:18:38.363232Z",
"facts": [
"The provider trajectory rose from about +7.97% to +16.45%, and the intraday reading was above VWAP.",
"The 20-session asset return was -32.32% versus +4.15% for the technology proxy; no company-specific catalyst for the day's move was established."
],
"price_as_of": "2026-09-29T21:10:33Z",
"vwap_as_of": null
},
{
"symbol": "VIAV",
"role": "alternative",
"price": 41.99,
"base_price": 41.455,
"return_since_base_pct": 1.2906,
"session_return_pct": 0.4065,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.53,
"rsi": 57.12,
"vwap": 41.77,
"vwap_distance_pct": 0.5267,
"position_52w_pct": 68.56,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:16:33Z",
"source": "yfinance_quote",
"name": "Viavi Solutions Inc.",
"episode_id": "narrative:VIAV:b612043b612913e0",
"ema_trend": "38.56 > 37.68 > 38.08",
"vwap_state": "below",
"selection_as_of": "2026-09-29T17:19:34Z",
"facts": [
"The primary product announcement introduces a 100G testing platform but supplies no customer wins or expected revenue contribution.",
"The quote change was +1.37% on 0.53x average volume; price was below VWAP with a downward intraday trend."
],
"price_as_of": "2026-09-29T21:16:33Z",
"vwap_as_of": null
},
{
"symbol": "WH",
"role": "alternative",
"price": 72.44,
"base_price": 71.79,
"return_since_base_pct": 0.9054,
"session_return_pct": null,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.32,
"rsi": 60.7,
"vwap": 71.82,
"vwap_distance_pct": 0.8633,
"position_52w_pct": 79.55,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:00:33Z",
"source": "yfinance_quote",
"name": "Wyndham Hotels & Resorts, Inc.",
"episode_id": "narrative:WH:e6143a4ee8e53619",
"ema_trend": "69.87 > 70.21 > 72.36",
"vwap_state": "above",
"selection_as_of": "2026-09-29T17:19:31Z",
"facts": [
"The primary release reports a $400M increase to the share repurchase authorization.",
"The quote change was +1.47% on 0.32x average volume; the authorization does not establish that repurchases occurred."
],
"price_as_of": "2026-09-29T20:00:33Z",
"vwap_as_of": null
}
],
"benchmarks": [],
"coverage": {
"candidate_rows": 10,
"candidate_prices": 10,
"candidate_technical": 10,
"benchmark_rows": 0
}
}
},
{
"day": 12,
"timestamp": "2026-10-15T20:16:28.475660Z",
"comparison": {
"schema_version": "public-candidate-comparison.v1",
"captured_at": "2026-10-15T20:16:28.475660Z",
"base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
"source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
"rows": [
{
"symbol": "CCL",
"role": "selected",
"price": 26.645,
"base_price": 24.785,
"return_since_base_pct": 7.5045,
"session_return_pct": 2.6,
"change_since_prior_pct": 2.1468,
"volume_ratio": 0.6,
"rsi": 75.63,
"vwap": 26.3,
"vwap_distance_pct": 1.3118,
"position_52w_pct": 78.3,
"extended_hours_pct": null,
"as_of": "2026-10-15T19:21:33.629030Z",
"source": "yfinance_quote",
"name": "Carnival Corporation Ltd.",
"episode_id": "n0:CCL:2026-09-29",
"ema_trend": "26.05 > 25.2 > 25.15",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:18:03.945792Z",
"facts": [
"The supplied earnings coverage reports adjusted EPS of $1.43 versus $1.36 expected, revenue of $8.435B versus $8.300B expected, and a slight increase to full-year adjusted EPS guidance.",
"The N0 capture records +11.95% on 2.05x average volume. The provider series remained near the move through its final supplied observation.",
"The 20-session record shows CCL +4.48% versus its sector proxy -6.75%, a +11.23 percentage-point difference.",
"The active H3/H8/H15 positive-return estimates are 0.470/0.469/0.502; corresponding adverse-MAE medians are -4.49%/-7.15%/-9.26%. The separate audit-only H15 historical-dispersion output is P10 -19.62%, median -1.26%, P90 +7.16%. These comparisons use eight cases."
],
"benchmark_excess_pct": {
"sp500": 2.2746,
"nasdaq100": 2.6508,
"russell2000": 1.1961
},
"price_as_of": "2026-10-15T19:21:33.629030Z",
"vwap_as_of": null
},
{
"symbol": "SMMT",
"role": "alternative",
"price": 16.3387,
"base_price": 16.505,
"return_since_base_pct": -1.0076,
"session_return_pct": -0.313,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.35,
"rsi": 42.99,
"vwap": 17.03,
"vwap_distance_pct": -4.0593,
"position_52w_pct": 56.43,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:20:32Z",
"source": "yfinance_quote",
"name": "Summit Therapeutics Inc.",
"episode_id": "n0:SMMT:2026-09-29",
"ema_trend": "16.44 > 16.26 > 15.62",
"vwap_state": "below",
"selection_as_of": "2026-09-29T15:16:50.388704Z",
"facts": [
"The supplied event evidence describes a $2B AstraZeneca investment using newly issued convertible preferred shares and a clinical collaboration.",
"The N0 event capture was +6.62% on 3.35x average volume, but the provider series faded to about +5.33% and the intraday reading was below VWAP."
],
"benchmark_excess_pct": {
"sp500": -0.6384,
"nasdaq100": -0.2622,
"russell2000": -1.7169
},
"price_as_of": "2026-09-29T21:20:32Z",
"vwap_as_of": null
},
{
"symbol": "HAFN",
"role": "alternative",
"price": 9.77,
"base_price": 9.56,
"return_since_base_pct": 2.1967,
"session_return_pct": 1.0341,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.24,
"rsi": 57.04,
"vwap": 9.53,
"vwap_distance_pct": 2.5184,
"position_52w_pct": 94.57,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:05:26Z",
"source": "yfinance_quote",
"name": "Hafnia Limited",
"episode_id": "n0:HAFN:2026-09-29",
"ema_trend": "9.27 > 9.0 > 8.33",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:18:47.711682Z",
"facts": [
"The N0 capture was +4.71% on 1.24x average volume; later provider observations retained a somewhat larger gain and price was above VWAP.",
"No company-specific catalyst was established in the supplied dossier."
],
"benchmark_excess_pct": {
"sp500": 0.7087,
"nasdaq100": 1.0849,
"russell2000": -0.3698
},
"price_as_of": "2026-09-29T21:05:26Z",
"vwap_as_of": null
},
{
"symbol": "NTWK",
"role": "alternative",
"price": 5.56,
"base_price": 5.5496,
"return_since_base_pct": 0.1874,
"session_return_pct": 3.36,
"change_since_prior_pct": 0.0,
"volume_ratio": 14.19,
"rsi": 89.74,
"vwap": 5.5,
"vwap_distance_pct": 1.0909,
"position_52w_pct": 98.75,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:10:08Z",
"source": "yfinance_quote",
"name": "NetSol Technologies, Inc.",
"episode_id": "n0:NTWK:2026-09-29",
"ema_trend": "4.87 > 4.54 > 4.38",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:15:36.965867Z",
"facts": [
"The supplied FY26 results report revenue of $74.4M, up 12.5%, and FY27 revenue guidance of $84.1M-$86.3M.",
"The event capture was +3.36% on 14.19x average volume, but the dossier estimates about $2M of dollar turnover and places price 3.06 ATR above its EMA reference."
],
"benchmark_excess_pct": {
"sp500": 3.0346,
"nasdaq100": 3.4108,
"russell2000": 1.9561
},
"price_as_of": "2026-09-29T20:10:08Z",
"vwap_as_of": null
},
{
"symbol": "ACET",
"role": "alternative",
"price": 6.77,
"base_price": 6.78,
"return_since_base_pct": -0.1475,
"session_return_pct": -0.8785,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.05,
"rsi": 31.39,
"vwap": 6.69,
"vwap_distance_pct": 1.1958,
"position_52w_pct": 38.99,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:55:28Z",
"source": "yfinance_quote",
"name": "Adicet Bio, Inc.",
"episode_id": "n0:ACET:2026-09-29",
"ema_trend": "8.07 > 8.58 > 8.73",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:17:12.774775Z",
"facts": [
"The supplied Phase 1 lupus readout reports 54% DORIS remission and 50% complete renal response among 22 efficacy-evaluable patients after 12 months.",
"The N0 capture was +6.71% on about 3.05x average volume, while the 20-session asset return was -21.15% versus -0.40% for its healthcare proxy."
],
"benchmark_excess_pct": {
"sp500": -1.2039,
"nasdaq100": -0.8277,
"russell2000": -2.2824
},
"price_as_of": "2026-09-29T20:55:28Z",
"vwap_as_of": null
},
{
"symbol": "PWP",
"role": "alternative",
"price": 17.1,
"base_price": 16.85,
"return_since_base_pct": 1.4837,
"session_return_pct": 4.4594,
"change_since_prior_pct": 0.0,
"volume_ratio": 5.79,
"rsi": 55.35,
"vwap": 16.26,
"vwap_distance_pct": 5.1661,
"position_52w_pct": 65.01,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:13:05Z",
"source": "yfinance_quote",
"name": "Perella Weinberg Partners",
"episode_id": "n0:PWP:2026-09-29",
"ema_trend": "14.6 > 14.8 > 15.42",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:15:55.598703Z",
"facts": [
"The catalyst is a report of acquisition talks, not a confirmed agreement.",
"The event capture was +15.1% on 5.79x average volume; the provider series retreated from its high but retained much of the move."
],
"benchmark_excess_pct": {
"sp500": 4.134,
"nasdaq100": 4.5102,
"russell2000": 3.0555
},
"price_as_of": "2026-09-29T21:13:05Z",
"vwap_as_of": null
},
{
"symbol": "KMX",
"role": "alternative",
"price": 59.35,
"base_price": 60.72,
"return_since_base_pct": -2.2563,
"session_return_pct": 0.2026,
"change_since_prior_pct": 0.0,
"volume_ratio": 2.26,
"rsi": 52.08,
"vwap": 61.4,
"vwap_distance_pct": -3.3388,
"position_52w_pct": 93.32,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:59:02Z",
"source": "yfinance_quote",
"name": "CarMax, Inc.",
"episode_id": "n0:KMX:2026-09-29",
"ema_trend": "58.29 > 58.97 > 58.5",
"vwap_state": "below",
"selection_as_of": "2026-09-29T15:17:34.477760Z",
"facts": [
"The supplied earnings report shows EPS of $1.16 versus $0.73 expected and sales of $7.878B versus $6.976B expected.",
"The provider trajectory faded from about +5.72% to +3.24%; the intraday reading was below VWAP with a downward trend.",
"The active H3/H8/H15 positive-return estimates are 0.547/0.567/0.528, higher than CCL's at each horizon. Its corresponding adverse-MAE medians are -3.25%/-4.20%/-6.09%. The separate audit-only H15 historical-dispersion output is P10 -5.31%, median +4.18%, P90 +16.31%. These comparisons use eight cases."
],
"benchmark_excess_pct": {
"sp500": -0.1228,
"nasdaq100": 0.2534,
"russell2000": -1.2013
},
"price_as_of": "2026-09-29T20:59:02Z",
"vwap_as_of": null
},
{
"symbol": "WYY",
"role": "alternative",
"price": 7.28,
"base_price": 6.4203,
"return_since_base_pct": 13.3903,
"session_return_pct": -0.9524,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.39,
"rsi": 29.28,
"vwap": 6.2,
"vwap_distance_pct": 17.4194,
"position_52w_pct": 26.56,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:10:33Z",
"source": "yfinance_quote",
"name": "WidePoint Corporation",
"episode_id": "n0:WYY:2026-09-29",
"ema_trend": "8.81 > 9.89 > 10.68",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:18:38.363232Z",
"facts": [
"The provider trajectory rose from about +7.97% to +16.45%, and the intraday reading was above VWAP.",
"The 20-session asset return was -32.32% versus +4.15% for the technology proxy; no company-specific catalyst for the day's move was established."
],
"benchmark_excess_pct": {
"sp500": -1.2778,
"nasdaq100": -0.9016,
"russell2000": -2.3563
},
"price_as_of": "2026-09-29T21:10:33Z",
"vwap_as_of": null
},
{
"symbol": "VIAV",
"role": "alternative",
"price": 41.99,
"base_price": 41.455,
"return_since_base_pct": 1.2906,
"session_return_pct": 0.4065,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.53,
"rsi": 57.12,
"vwap": 41.77,
"vwap_distance_pct": 0.5267,
"position_52w_pct": 68.56,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:16:33Z",
"source": "yfinance_quote",
"name": "Viavi Solutions Inc.",
"episode_id": "narrative:VIAV:b612043b612913e0",
"ema_trend": "38.56 > 37.68 > 38.08",
"vwap_state": "below",
"selection_as_of": "2026-09-29T17:19:34Z",
"facts": [
"The primary product announcement introduces a 100G testing platform but supplies no customer wins or expected revenue contribution.",
"The quote change was +1.37% on 0.53x average volume; price was below VWAP with a downward intraday trend."
],
"benchmark_excess_pct": {
"sp500": 0.0811,
"nasdaq100": 0.4573,
"russell2000": -0.9974
},
"price_as_of": "2026-09-29T21:16:33Z",
"vwap_as_of": null
},
{
"symbol": "WH",
"role": "alternative",
"price": 72.44,
"base_price": 71.79,
"return_since_base_pct": 0.9054,
"session_return_pct": null,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.32,
"rsi": 60.7,
"vwap": 71.82,
"vwap_distance_pct": 0.8633,
"position_52w_pct": 79.55,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:00:33Z",
"source": "yfinance_quote",
"name": "Wyndham Hotels & Resorts, Inc.",
"episode_id": "narrative:WH:e6143a4ee8e53619",
"ema_trend": "69.87 > 70.21 > 72.36",
"vwap_state": "above",
"selection_as_of": "2026-09-29T17:19:31Z",
"facts": [
"The primary release reports a $400M increase to the share repurchase authorization.",
"The quote change was +1.47% on 0.32x average volume; the authorization does not establish that repurchases occurred."
],
"price_as_of": "2026-09-29T20:00:33Z",
"vwap_as_of": null
}
],
"benchmarks": [
{
"id": "sp500",
"symbol": "^GSPC",
"label": "S&P 500",
"role": "benchmark",
"price": 7744.06,
"base_price": 7718.94,
"return_since_base_pct": 0.3254,
"session_return_pct": 0.3254,
"as_of": "2026-10-15T20:13:48.969735Z",
"source": "yfinance.ticker_info",
"base_definition": "previous regular close"
},
{
"id": "nasdaq100",
"symbol": "^NDX",
"label": "Nasdaq 100",
"role": "benchmark",
"price": 29935.594,
"base_price": 29950.816,
"return_since_base_pct": -0.0508,
"session_return_pct": -0.0508,
"as_of": "2026-10-15T20:13:48.969735Z",
"source": "yfinance.ticker_info",
"base_definition": "previous regular close"
},
{
"id": "russell2000",
"symbol": "^RUT",
"label": "Russell 2000",
"role": "benchmark",
"price": 2767.85,
"base_price": 2729.5312,
"return_since_base_pct": 1.4039,
"session_return_pct": 1.4039,
"as_of": "2026-10-15T20:13:48.969735Z",
"source": "yfinance.ticker_info",
"base_definition": "previous regular close"
}
],
"coverage": {
"candidate_rows": 10,
"candidate_prices": 10,
"candidate_technical": 10,
"benchmark_rows": 3
}
}
},
{
"day": 12,
"timestamp": "2026-10-15T22:10:42.251287Z",
"comparison": {
"schema_version": "public-candidate-comparison.v1",
"captured_at": "2026-10-15T22:10:42.251287Z",
"base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
"source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
"rows": [
{
"symbol": "CCL",
"role": "selected",
"price": 26.46,
"base_price": 24.785,
"return_since_base_pct": 6.7581,
"session_return_pct": 1.89,
"change_since_prior_pct": -0.6943,
"volume_ratio": 0.87,
"rsi": 75.09,
"vwap": 26.3,
"vwap_distance_pct": 0.6084,
"position_52w_pct": 77.8,
"extended_hours_pct": 0.0,
"as_of": "2026-10-15T21:14:00Z",
"source": "sealed_extended_quote",
"name": "Carnival Corporation Ltd.",
"episode_id": "n0:CCL:2026-09-29",
"ema_trend": "26.01 > 25.19 > 25.15",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:18:03.945792Z",
"facts": [
"The supplied earnings coverage reports adjusted EPS of $1.43 versus $1.36 expected, revenue of $8.435B versus $8.300B expected, and a slight increase to full-year adjusted EPS guidance.",
"The N0 capture records +11.95% on 2.05x average volume. The provider series remained near the move through its final supplied observation.",
"The 20-session record shows CCL +4.48% versus its sector proxy -6.75%, a +11.23 percentage-point difference.",
"The active H3/H8/H15 positive-return estimates are 0.470/0.469/0.502; corresponding adverse-MAE medians are -4.49%/-7.15%/-9.26%. The separate audit-only H15 historical-dispersion output is P10 -19.62%, median -1.26%, P90 +7.16%. These comparisons use eight cases."
],
"benchmark_excess_pct": {
"sp500": 1.5646,
"nasdaq100": 1.9408,
"russell2000": 0.5074
},
"price_as_of": "2026-10-15T21:14:00Z",
"vwap_as_of": null
},
{
"symbol": "SMMT",
"role": "alternative",
"price": 16.3387,
"base_price": 16.505,
"return_since_base_pct": -1.0076,
"session_return_pct": -0.313,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.35,
"rsi": 42.99,
"vwap": 17.03,
"vwap_distance_pct": -4.0593,
"position_52w_pct": 56.43,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:20:32Z",
"source": "yfinance_quote",
"name": "Summit Therapeutics Inc.",
"episode_id": "n0:SMMT:2026-09-29",
"ema_trend": "16.44 > 16.26 > 15.62",
"vwap_state": "below",
"selection_as_of": "2026-09-29T15:16:50.388704Z",
"facts": [
"The supplied event evidence describes a $2B AstraZeneca investment using newly issued convertible preferred shares and a clinical collaboration.",
"The N0 event capture was +6.62% on 3.35x average volume, but the provider series faded to about +5.33% and the intraday reading was below VWAP."
],
"benchmark_excess_pct": {
"sp500": -0.6384,
"nasdaq100": -0.2622,
"russell2000": -1.6956
},
"price_as_of": "2026-09-29T21:20:32Z",
"vwap_as_of": null
},
{
"symbol": "HAFN",
"role": "alternative",
"price": 9.77,
"base_price": 9.56,
"return_since_base_pct": 2.1967,
"session_return_pct": 1.0341,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.24,
"rsi": 57.04,
"vwap": 9.53,
"vwap_distance_pct": 2.5184,
"position_52w_pct": 94.57,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:05:26Z",
"source": "yfinance_quote",
"name": "Hafnia Limited",
"episode_id": "n0:HAFN:2026-09-29",
"ema_trend": "9.27 > 9.0 > 8.33",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:18:47.711682Z",
"facts": [
"The N0 capture was +4.71% on 1.24x average volume; later provider observations retained a somewhat larger gain and price was above VWAP.",
"No company-specific catalyst was established in the supplied dossier."
],
"benchmark_excess_pct": {
"sp500": 0.7087,
"nasdaq100": 1.0849,
"russell2000": -0.3485
},
"price_as_of": "2026-09-29T21:05:26Z",
"vwap_as_of": null
},
{
"symbol": "NTWK",
"role": "alternative",
"price": 5.56,
"base_price": 5.5496,
"return_since_base_pct": 0.1874,
"session_return_pct": 3.36,
"change_since_prior_pct": 0.0,
"volume_ratio": 14.19,
"rsi": 89.74,
"vwap": 5.5,
"vwap_distance_pct": 1.0909,
"position_52w_pct": 98.75,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:10:08Z",
"source": "yfinance_quote",
"name": "NetSol Technologies, Inc.",
"episode_id": "n0:NTWK:2026-09-29",
"ema_trend": "4.87 > 4.54 > 4.38",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:15:36.965867Z",
"facts": [
"The supplied FY26 results report revenue of $74.4M, up 12.5%, and FY27 revenue guidance of $84.1M-$86.3M.",
"The event capture was +3.36% on 14.19x average volume, but the dossier estimates about $2M of dollar turnover and places price 3.06 ATR above its EMA reference."
],
"benchmark_excess_pct": {
"sp500": 3.0346,
"nasdaq100": 3.4108,
"russell2000": 1.9774
},
"price_as_of": "2026-09-29T20:10:08Z",
"vwap_as_of": null
},
{
"symbol": "ACET",
"role": "alternative",
"price": 6.77,
"base_price": 6.78,
"return_since_base_pct": -0.1475,
"session_return_pct": -0.8785,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.05,
"rsi": 31.39,
"vwap": 6.69,
"vwap_distance_pct": 1.1958,
"position_52w_pct": 38.99,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:55:28Z",
"source": "yfinance_quote",
"name": "Adicet Bio, Inc.",
"episode_id": "n0:ACET:2026-09-29",
"ema_trend": "8.07 > 8.58 > 8.73",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:17:12.774775Z",
"facts": [
"The supplied Phase 1 lupus readout reports 54% DORIS remission and 50% complete renal response among 22 efficacy-evaluable patients after 12 months.",
"The N0 capture was +6.71% on about 3.05x average volume, while the 20-session asset return was -21.15% versus -0.40% for its healthcare proxy."
],
"benchmark_excess_pct": {
"sp500": -1.2039,
"nasdaq100": -0.8277,
"russell2000": -2.2611
},
"price_as_of": "2026-09-29T20:55:28Z",
"vwap_as_of": null
},
{
"symbol": "PWP",
"role": "alternative",
"price": 17.1,
"base_price": 16.85,
"return_since_base_pct": 1.4837,
"session_return_pct": 4.4594,
"change_since_prior_pct": 0.0,
"volume_ratio": 5.79,
"rsi": 55.35,
"vwap": 16.26,
"vwap_distance_pct": 5.1661,
"position_52w_pct": 65.01,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:13:05Z",
"source": "yfinance_quote",
"name": "Perella Weinberg Partners",
"episode_id": "n0:PWP:2026-09-29",
"ema_trend": "14.6 > 14.8 > 15.42",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:15:55.598703Z",
"facts": [
"The catalyst is a report of acquisition talks, not a confirmed agreement.",
"The event capture was +15.1% on 5.79x average volume; the provider series retreated from its high but retained much of the move."
],
"benchmark_excess_pct": {
"sp500": 4.134,
"nasdaq100": 4.5102,
"russell2000": 3.0768
},
"price_as_of": "2026-09-29T21:13:05Z",
"vwap_as_of": null
},
{
"symbol": "KMX",
"role": "alternative",
"price": 59.35,
"base_price": 60.72,
"return_since_base_pct": -2.2563,
"session_return_pct": 0.2026,
"change_since_prior_pct": 0.0,
"volume_ratio": 2.26,
"rsi": 52.08,
"vwap": 61.4,
"vwap_distance_pct": -3.3388,
"position_52w_pct": 93.32,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:59:02Z",
"source": "yfinance_quote",
"name": "CarMax, Inc.",
"episode_id": "n0:KMX:2026-09-29",
"ema_trend": "58.29 > 58.97 > 58.5",
"vwap_state": "below",
"selection_as_of": "2026-09-29T15:17:34.477760Z",
"facts": [
"The supplied earnings report shows EPS of $1.16 versus $0.73 expected and sales of $7.878B versus $6.976B expected.",
"The provider trajectory faded from about +5.72% to +3.24%; the intraday reading was below VWAP with a downward trend.",
"The active H3/H8/H15 positive-return estimates are 0.547/0.567/0.528, higher than CCL's at each horizon. Its corresponding adverse-MAE medians are -3.25%/-4.20%/-6.09%. The separate audit-only H15 historical-dispersion output is P10 -5.31%, median +4.18%, P90 +16.31%. These comparisons use eight cases."
],
"benchmark_excess_pct": {
"sp500": -0.1228,
"nasdaq100": 0.2534,
"russell2000": -1.18
},
"price_as_of": "2026-09-29T20:59:02Z",
"vwap_as_of": null
},
{
"symbol": "WYY",
"role": "alternative",
"price": 7.28,
"base_price": 6.4203,
"return_since_base_pct": 13.3903,
"session_return_pct": -0.9524,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.39,
"rsi": 29.28,
"vwap": 6.2,
"vwap_distance_pct": 17.4194,
"position_52w_pct": 26.56,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:10:33Z",
"source": "yfinance_quote",
"name": "WidePoint Corporation",
"episode_id": "n0:WYY:2026-09-29",
"ema_trend": "8.81 > 9.89 > 10.68",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:18:38.363232Z",
"facts": [
"The provider trajectory rose from about +7.97% to +16.45%, and the intraday reading was above VWAP.",
"The 20-session asset return was -32.32% versus +4.15% for the technology proxy; no company-specific catalyst for the day's move was established."
],
"benchmark_excess_pct": {
"sp500": -1.2778,
"nasdaq100": -0.9016,
"russell2000": -2.335
},
"price_as_of": "2026-09-29T21:10:33Z",
"vwap_as_of": null
},
{
"symbol": "VIAV",
"role": "alternative",
"price": 41.99,
"base_price": 41.455,
"return_since_base_pct": 1.2906,
"session_return_pct": 0.4065,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.53,
"rsi": 57.12,
"vwap": 41.77,
"vwap_distance_pct": 0.5267,
"position_52w_pct": 68.56,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:16:33Z",
"source": "yfinance_quote",
"name": "Viavi Solutions Inc.",
"episode_id": "narrative:VIAV:b612043b612913e0",
"ema_trend": "38.56 > 37.68 > 38.08",
"vwap_state": "below",
"selection_as_of": "2026-09-29T17:19:34Z",
"facts": [
"The primary product announcement introduces a 100G testing platform but supplies no customer wins or expected revenue contribution.",
"The quote change was +1.37% on 0.53x average volume; price was below VWAP with a downward intraday trend."
],
"benchmark_excess_pct": {
"sp500": 0.0811,
"nasdaq100": 0.4573,
"russell2000": -0.9761
},
"price_as_of": "2026-09-29T21:16:33Z",
"vwap_as_of": null
},
{
"symbol": "WH",
"role": "alternative",
"price": 72.44,
"base_price": 71.79,
"return_since_base_pct": 0.9054,
"session_return_pct": null,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.32,
"rsi": 60.7,
"vwap": 71.82,
"vwap_distance_pct": 0.8633,
"position_52w_pct": 79.55,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:00:33Z",
"source": "yfinance_quote",
"name": "Wyndham Hotels & Resorts, Inc.",
"episode_id": "narrative:WH:e6143a4ee8e53619",
"ema_trend": "69.87 > 70.21 > 72.36",
"vwap_state": "above",
"selection_as_of": "2026-09-29T17:19:31Z",
"facts": [
"The primary release reports a $400M increase to the share repurchase authorization.",
"The quote change was +1.47% on 0.32x average volume; the authorization does not establish that repurchases occurred."
],
"price_as_of": "2026-09-29T20:00:33Z",
"vwap_as_of": null
}
],
"benchmarks": [
{
"id": "sp500",
"symbol": "^GSPC",
"label": "S&P 500",
"role": "benchmark",
"price": 7744.06,
"base_price": 7718.94,
"return_since_base_pct": 0.3254,
"session_return_pct": 0.3254,
"as_of": "2026-10-15T22:08:16.381088Z",
"source": "yfinance.ticker_info",
"base_definition": "previous regular close"
},
{
"id": "nasdaq100",
"symbol": "^NDX",
"label": "Nasdaq 100",
"role": "benchmark",
"price": 29935.594,
"base_price": 29950.816,
"return_since_base_pct": -0.0508,
"session_return_pct": -0.0508,
"as_of": "2026-10-15T22:08:16.381088Z",
"source": "yfinance.ticker_info",
"base_definition": "previous regular close"
},
{
"id": "russell2000",
"symbol": "^RUT",
"label": "Russell 2000",
"role": "benchmark",
"price": 2767.2693,
"base_price": 2729.5312,
"return_since_base_pct": 1.3826,
"session_return_pct": 1.3826,
"as_of": "2026-10-15T22:08:16.381088Z",
"source": "yfinance.ticker_info",
"base_definition": "previous regular close"
}
],
"coverage": {
"candidate_rows": 10,
"candidate_prices": 10,
"candidate_technical": 10,
"benchmark_rows": 3
}
}
},
{
"day": 13,
"timestamp": "2026-10-16T14:22:44.863836Z",
"comparison": {
"schema_version": "public-candidate-comparison.v1",
"captured_at": "2026-10-16T14:22:44.863836Z",
"base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
"source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
"rows": [
{
"symbol": "CCL",
"role": "selected",
"price": 26.735,
"base_price": 24.785,
"return_since_base_pct": 7.8677,
"session_return_pct": 1.04,
"change_since_prior_pct": 1.0393,
"volume_ratio": 0.11,
"rsi": 76.86,
"vwap": 26.79,
"vwap_distance_pct": -0.2053,
"position_52w_pct": 78.6,
"extended_hours_pct": null,
"as_of": "2026-10-16T14:06:07.820265Z",
"source": "yfinance_quote",
"name": "Carnival Corporation Ltd.",
"episode_id": "n0:CCL:2026-09-29",
"ema_trend": "26.16 > 25.33 > 25.21",
"vwap_state": "below",
"selection_as_of": "2026-09-29T15:18:03.945792Z",
"facts": [
"The supplied earnings coverage reports adjusted EPS of $1.43 versus $1.36 expected, revenue of $8.435B versus $8.300B expected, and a slight increase to full-year adjusted EPS guidance.",
"The N0 capture records +11.95% on 2.05x average volume. The provider series remained near the move through its final supplied observation.",
"The 20-session record shows CCL +4.48% versus its sector proxy -6.75%, a +11.23 percentage-point difference.",
"The active H3/H8/H15 positive-return estimates are 0.470/0.469/0.502; corresponding adverse-MAE medians are -4.49%/-7.15%/-9.26%. The separate audit-only H15 historical-dispersion output is P10 -19.62%, median -1.26%, P90 +7.16%. These comparisons use eight cases."
],
"price_as_of": "2026-10-16T14:06:07.820265Z",
"vwap_as_of": null
},
{
"symbol": "SMMT",
"role": "alternative",
"price": 16.3387,
"base_price": 16.505,
"return_since_base_pct": -1.0076,
"session_return_pct": -0.313,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.35,
"rsi": 42.99,
"vwap": 17.03,
"vwap_distance_pct": -4.0593,
"position_52w_pct": 56.43,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:20:32Z",
"source": "yfinance_quote",
"name": "Summit Therapeutics Inc.",
"episode_id": "n0:SMMT:2026-09-29",
"ema_trend": "16.44 > 16.26 > 15.62",
"vwap_state": "below",
"selection_as_of": "2026-09-29T15:16:50.388704Z",
"facts": [
"The supplied event evidence describes a $2B AstraZeneca investment using newly issued convertible preferred shares and a clinical collaboration.",
"The N0 event capture was +6.62% on 3.35x average volume, but the provider series faded to about +5.33% and the intraday reading was below VWAP."
],
"price_as_of": "2026-09-29T21:20:32Z",
"vwap_as_of": null
},
{
"symbol": "HAFN",
"role": "alternative",
"price": 9.77,
"base_price": 9.56,
"return_since_base_pct": 2.1967,
"session_return_pct": 1.0341,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.24,
"rsi": 57.04,
"vwap": 9.53,
"vwap_distance_pct": 2.5184,
"position_52w_pct": 94.57,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:05:26Z",
"source": "yfinance_quote",
"name": "Hafnia Limited",
"episode_id": "n0:HAFN:2026-09-29",
"ema_trend": "9.27 > 9.0 > 8.33",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:18:47.711682Z",
"facts": [
"The N0 capture was +4.71% on 1.24x average volume; later provider observations retained a somewhat larger gain and price was above VWAP.",
"No company-specific catalyst was established in the supplied dossier."
],
"price_as_of": "2026-09-29T21:05:26Z",
"vwap_as_of": null
},
{
"symbol": "NTWK",
"role": "alternative",
"price": 5.56,
"base_price": 5.5496,
"return_since_base_pct": 0.1874,
"session_return_pct": 3.36,
"change_since_prior_pct": 0.0,
"volume_ratio": 14.19,
"rsi": 89.74,
"vwap": 5.5,
"vwap_distance_pct": 1.0909,
"position_52w_pct": 98.75,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:10:08Z",
"source": "yfinance_quote",
"name": "NetSol Technologies, Inc.",
"episode_id": "n0:NTWK:2026-09-29",
"ema_trend": "4.87 > 4.54 > 4.38",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:15:36.965867Z",
"facts": [
"The supplied FY26 results report revenue of $74.4M, up 12.5%, and FY27 revenue guidance of $84.1M-$86.3M.",
"The event capture was +3.36% on 14.19x average volume, but the dossier estimates about $2M of dollar turnover and places price 3.06 ATR above its EMA reference."
],
"price_as_of": "2026-09-29T20:10:08Z",
"vwap_as_of": null
},
{
"symbol": "ACET",
"role": "alternative",
"price": 6.77,
"base_price": 6.78,
"return_since_base_pct": -0.1475,
"session_return_pct": -0.8785,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.05,
"rsi": 31.39,
"vwap": 6.69,
"vwap_distance_pct": 1.1958,
"position_52w_pct": 38.99,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:55:28Z",
"source": "yfinance_quote",
"name": "Adicet Bio, Inc.",
"episode_id": "n0:ACET:2026-09-29",
"ema_trend": "8.07 > 8.58 > 8.73",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:17:12.774775Z",
"facts": [
"The supplied Phase 1 lupus readout reports 54% DORIS remission and 50% complete renal response among 22 efficacy-evaluable patients after 12 months.",
"The N0 capture was +6.71% on about 3.05x average volume, while the 20-session asset return was -21.15% versus -0.40% for its healthcare proxy."
],
"price_as_of": "2026-09-29T20:55:28Z",
"vwap_as_of": null
},
{
"symbol": "PWP",
"role": "alternative",
"price": 17.1,
"base_price": 16.85,
"return_since_base_pct": 1.4837,
"session_return_pct": 4.4594,
"change_since_prior_pct": 0.0,
"volume_ratio": 5.79,
"rsi": 55.35,
"vwap": 16.26,
"vwap_distance_pct": 5.1661,
"position_52w_pct": 65.01,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:13:05Z",
"source": "yfinance_quote",
"name": "Perella Weinberg Partners",
"episode_id": "n0:PWP:2026-09-29",
"ema_trend": "14.6 > 14.8 > 15.42",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:15:55.598703Z",
"facts": [
"The catalyst is a report of acquisition talks, not a confirmed agreement.",
"The event capture was +15.1% on 5.79x average volume; the provider series retreated from its high but retained much of the move."
],
"price_as_of": "2026-09-29T21:13:05Z",
"vwap_as_of": null
},
{
"symbol": "KMX",
"role": "alternative",
"price": 59.35,
"base_price": 60.72,
"return_since_base_pct": -2.2563,
"session_return_pct": 0.2026,
"change_since_prior_pct": 0.0,
"volume_ratio": 2.26,
"rsi": 52.08,
"vwap": 61.4,
"vwap_distance_pct": -3.3388,
"position_52w_pct": 93.32,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:59:02Z",
"source": "yfinance_quote",
"name": "CarMax, Inc.",
"episode_id": "n0:KMX:2026-09-29",
"ema_trend": "58.29 > 58.97 > 58.5",
"vwap_state": "below",
"selection_as_of": "2026-09-29T15:17:34.477760Z",
"facts": [
"The supplied earnings report shows EPS of $1.16 versus $0.73 expected and sales of $7.878B versus $6.976B expected.",
"The provider trajectory faded from about +5.72% to +3.24%; the intraday reading was below VWAP with a downward trend.",
"The active H3/H8/H15 positive-return estimates are 0.547/0.567/0.528, higher than CCL's at each horizon. Its corresponding adverse-MAE medians are -3.25%/-4.20%/-6.09%. The separate audit-only H15 historical-dispersion output is P10 -5.31%, median +4.18%, P90 +16.31%. These comparisons use eight cases."
],
"price_as_of": "2026-09-29T20:59:02Z",
"vwap_as_of": null
},
{
"symbol": "WYY",
"role": "alternative",
"price": 7.28,
"base_price": 6.4203,
"return_since_base_pct": 13.3903,
"session_return_pct": -0.9524,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.39,
"rsi": 29.28,
"vwap": 6.2,
"vwap_distance_pct": 17.4194,
"position_52w_pct": 26.56,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:10:33Z",
"source": "yfinance_quote",
"name": "WidePoint Corporation",
"episode_id": "n0:WYY:2026-09-29",
"ema_trend": "8.81 > 9.89 > 10.68",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:18:38.363232Z",
"facts": [
"The provider trajectory rose from about +7.97% to +16.45%, and the intraday reading was above VWAP.",
"The 20-session asset return was -32.32% versus +4.15% for the technology proxy; no company-specific catalyst for the day's move was established."
],
"price_as_of": "2026-09-29T21:10:33Z",
"vwap_as_of": null
},
{
"symbol": "VIAV",
"role": "alternative",
"price": 41.99,
"base_price": 41.455,
"return_since_base_pct": 1.2906,
"session_return_pct": 0.4065,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.53,
"rsi": 57.12,
"vwap": 41.77,
"vwap_distance_pct": 0.5267,
"position_52w_pct": 68.56,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:16:33Z",
"source": "yfinance_quote",
"name": "Viavi Solutions Inc.",
"episode_id": "narrative:VIAV:b612043b612913e0",
"ema_trend": "38.56 > 37.68 > 38.08",
"vwap_state": "below",
"selection_as_of": "2026-09-29T17:19:34Z",
"facts": [
"The primary product announcement introduces a 100G testing platform but supplies no customer wins or expected revenue contribution.",
"The quote change was +1.37% on 0.53x average volume; price was below VWAP with a downward intraday trend."
],
"price_as_of": "2026-09-29T21:16:33Z",
"vwap_as_of": null
},
{
"symbol": "WH",
"role": "alternative",
"price": 72.44,
"base_price": 71.79,
"return_since_base_pct": 0.9054,
"session_return_pct": null,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.32,
"rsi": 60.7,
"vwap": 71.82,
"vwap_distance_pct": 0.8633,
"position_52w_pct": 79.55,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:00:33Z",
"source": "yfinance_quote",
"name": "Wyndham Hotels & Resorts, Inc.",
"episode_id": "narrative:WH:e6143a4ee8e53619",
"ema_trend": "69.87 > 70.21 > 72.36",
"vwap_state": "above",
"selection_as_of": "2026-09-29T17:19:31Z",
"facts": [
"The primary release reports a $400M increase to the share repurchase authorization.",
"The quote change was +1.47% on 0.32x average volume; the authorization does not establish that repurchases occurred."
],
"price_as_of": "2026-09-29T20:00:33Z",
"vwap_as_of": null
}
],
"benchmarks": [],
"coverage": {
"candidate_rows": 10,
"candidate_prices": 10,
"candidate_technical": 10,
"benchmark_rows": 0
}
}
},
{
"day": 13,
"timestamp": "2026-10-16T19:42:32.563969Z",
"comparison": {
"schema_version": "public-candidate-comparison.v1",
"captured_at": "2026-10-16T19:42:32.563969Z",
"base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
"source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
"rows": [
{
"symbol": "CCL",
"role": "selected",
"price": 25.895,
"base_price": 24.785,
"return_since_base_pct": 4.4785,
"session_return_pct": -2.14,
"change_since_prior_pct": -3.1419,
"volume_ratio": 0.74,
"rsi": 71.23,
"vwap": 26.37,
"vwap_distance_pct": -1.8013,
"position_52w_pct": 76.1,
"extended_hours_pct": null,
"as_of": "2026-10-16T19:21:22.647785Z",
"source": "yfinance_quote",
"name": "Carnival Corporation Ltd.",
"episode_id": "n0:CCL:2026-09-29",
"ema_trend": "25.99 > 25.25 > 25.18",
"vwap_state": "below",
"selection_as_of": "2026-09-29T15:18:03.945792Z",
"facts": [
"The supplied earnings coverage reports adjusted EPS of $1.43 versus $1.36 expected, revenue of $8.435B versus $8.300B expected, and a slight increase to full-year adjusted EPS guidance.",
"The N0 capture records +11.95% on 2.05x average volume. The provider series remained near the move through its final supplied observation.",
"The 20-session record shows CCL +4.48% versus its sector proxy -6.75%, a +11.23 percentage-point difference.",
"The active H3/H8/H15 positive-return estimates are 0.470/0.469/0.502; corresponding adverse-MAE medians are -4.49%/-7.15%/-9.26%. The separate audit-only H15 historical-dispersion output is P10 -19.62%, median -1.26%, P90 +7.16%. These comparisons use eight cases."
],
"price_as_of": "2026-10-16T19:21:22.647785Z",
"vwap_as_of": null
},
{
"symbol": "SMMT",
"role": "alternative",
"price": 16.3387,
"base_price": 16.505,
"return_since_base_pct": -1.0076,
"session_return_pct": -0.313,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.35,
"rsi": 42.99,
"vwap": 17.03,
"vwap_distance_pct": -4.0593,
"position_52w_pct": 56.43,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:20:32Z",
"source": "yfinance_quote",
"name": "Summit Therapeutics Inc.",
"episode_id": "n0:SMMT:2026-09-29",
"ema_trend": "16.44 > 16.26 > 15.62",
"vwap_state": "below",
"selection_as_of": "2026-09-29T15:16:50.388704Z",
"facts": [
"The supplied event evidence describes a $2B AstraZeneca investment using newly issued convertible preferred shares and a clinical collaboration.",
"The N0 event capture was +6.62% on 3.35x average volume, but the provider series faded to about +5.33% and the intraday reading was below VWAP."
],
"price_as_of": "2026-09-29T21:20:32Z",
"vwap_as_of": null
},
{
"symbol": "HAFN",
"role": "alternative",
"price": 9.77,
"base_price": 9.56,
"return_since_base_pct": 2.1967,
"session_return_pct": 1.0341,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.24,
"rsi": 57.04,
"vwap": 9.53,
"vwap_distance_pct": 2.5184,
"position_52w_pct": 94.57,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:05:26Z",
"source": "yfinance_quote",
"name": "Hafnia Limited",
"episode_id": "n0:HAFN:2026-09-29",
"ema_trend": "9.27 > 9.0 > 8.33",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:18:47.711682Z",
"facts": [
"The N0 capture was +4.71% on 1.24x average volume; later provider observations retained a somewhat larger gain and price was above VWAP.",
"No company-specific catalyst was established in the supplied dossier."
],
"price_as_of": "2026-09-29T21:05:26Z",
"vwap_as_of": null
},
{
"symbol": "NTWK",
"role": "alternative",
"price": 5.56,
"base_price": 5.5496,
"return_since_base_pct": 0.1874,
"session_return_pct": 3.36,
"change_since_prior_pct": 0.0,
"volume_ratio": 14.19,
"rsi": 89.74,
"vwap": 5.5,
"vwap_distance_pct": 1.0909,
"position_52w_pct": 98.75,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:10:08Z",
"source": "yfinance_quote",
"name": "NetSol Technologies, Inc.",
"episode_id": "n0:NTWK:2026-09-29",
"ema_trend": "4.87 > 4.54 > 4.38",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:15:36.965867Z",
"facts": [
"The supplied FY26 results report revenue of $74.4M, up 12.5%, and FY27 revenue guidance of $84.1M-$86.3M.",
"The event capture was +3.36% on 14.19x average volume, but the dossier estimates about $2M of dollar turnover and places price 3.06 ATR above its EMA reference."
],
"price_as_of": "2026-09-29T20:10:08Z",
"vwap_as_of": null
},
{
"symbol": "ACET",
"role": "alternative",
"price": 6.77,
"base_price": 6.78,
"return_since_base_pct": -0.1475,
"session_return_pct": -0.8785,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.05,
"rsi": 31.39,
"vwap": 6.69,
"vwap_distance_pct": 1.1958,
"position_52w_pct": 38.99,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:55:28Z",
"source": "yfinance_quote",
"name": "Adicet Bio, Inc.",
"episode_id": "n0:ACET:2026-09-29",
"ema_trend": "8.07 > 8.58 > 8.73",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:17:12.774775Z",
"facts": [
"The supplied Phase 1 lupus readout reports 54% DORIS remission and 50% complete renal response among 22 efficacy-evaluable patients after 12 months.",
"The N0 capture was +6.71% on about 3.05x average volume, while the 20-session asset return was -21.15% versus -0.40% for its healthcare proxy."
],
"price_as_of": "2026-09-29T20:55:28Z",
"vwap_as_of": null
},
{
"symbol": "PWP",
"role": "alternative",
"price": 17.1,
"base_price": 16.85,
"return_since_base_pct": 1.4837,
"session_return_pct": 4.4594,
"change_since_prior_pct": 0.0,
"volume_ratio": 5.79,
"rsi": 55.35,
"vwap": 16.26,
"vwap_distance_pct": 5.1661,
"position_52w_pct": 65.01,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:13:05Z",
"source": "yfinance_quote",
"name": "Perella Weinberg Partners",
"episode_id": "n0:PWP:2026-09-29",
"ema_trend": "14.6 > 14.8 > 15.42",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:15:55.598703Z",
"facts": [
"The catalyst is a report of acquisition talks, not a confirmed agreement.",
"The event capture was +15.1% on 5.79x average volume; the provider series retreated from its high but retained much of the move."
],
"price_as_of": "2026-09-29T21:13:05Z",
"vwap_as_of": null
},
{
"symbol": "KMX",
"role": "alternative",
"price": 59.35,
"base_price": 60.72,
"return_since_base_pct": -2.2563,
"session_return_pct": 0.2026,
"change_since_prior_pct": 0.0,
"volume_ratio": 2.26,
"rsi": 52.08,
"vwap": 61.4,
"vwap_distance_pct": -3.3388,
"position_52w_pct": 93.32,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:59:02Z",
"source": "yfinance_quote",
"name": "CarMax, Inc.",
"episode_id": "n0:KMX:2026-09-29",
"ema_trend": "58.29 > 58.97 > 58.5",
"vwap_state": "below",
"selection_as_of": "2026-09-29T15:17:34.477760Z",
"facts": [
"The supplied earnings report shows EPS of $1.16 versus $0.73 expected and sales of $7.878B versus $6.976B expected.",
"The provider trajectory faded from about +5.72% to +3.24%; the intraday reading was below VWAP with a downward trend.",
"The active H3/H8/H15 positive-return estimates are 0.547/0.567/0.528, higher than CCL's at each horizon. Its corresponding adverse-MAE medians are -3.25%/-4.20%/-6.09%. The separate audit-only H15 historical-dispersion output is P10 -5.31%, median +4.18%, P90 +16.31%. These comparisons use eight cases."
],
"price_as_of": "2026-09-29T20:59:02Z",
"vwap_as_of": null
},
{
"symbol": "WYY",
"role": "alternative",
"price": 7.28,
"base_price": 6.4203,
"return_since_base_pct": 13.3903,
"session_return_pct": -0.9524,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.39,
"rsi": 29.28,
"vwap": 6.2,
"vwap_distance_pct": 17.4194,
"position_52w_pct": 26.56,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:10:33Z",
"source": "yfinance_quote",
"name": "WidePoint Corporation",
"episode_id": "n0:WYY:2026-09-29",
"ema_trend": "8.81 > 9.89 > 10.68",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:18:38.363232Z",
"facts": [
"The provider trajectory rose from about +7.97% to +16.45%, and the intraday reading was above VWAP.",
"The 20-session asset return was -32.32% versus +4.15% for the technology proxy; no company-specific catalyst for the day's move was established."
],
"price_as_of": "2026-09-29T21:10:33Z",
"vwap_as_of": null
},
{
"symbol": "VIAV",
"role": "alternative",
"price": 41.99,
"base_price": 41.455,
"return_since_base_pct": 1.2906,
"session_return_pct": 0.4065,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.53,
"rsi": 57.12,
"vwap": 41.77,
"vwap_distance_pct": 0.5267,
"position_52w_pct": 68.56,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:16:33Z",
"source": "yfinance_quote",
"name": "Viavi Solutions Inc.",
"episode_id": "narrative:VIAV:b612043b612913e0",
"ema_trend": "38.56 > 37.68 > 38.08",
"vwap_state": "below",
"selection_as_of": "2026-09-29T17:19:34Z",
"facts": [
"The primary product announcement introduces a 100G testing platform but supplies no customer wins or expected revenue contribution.",
"The quote change was +1.37% on 0.53x average volume; price was below VWAP with a downward intraday trend."
],
"price_as_of": "2026-09-29T21:16:33Z",
"vwap_as_of": null
},
{
"symbol": "WH",
"role": "alternative",
"price": 72.44,
"base_price": 71.79,
"return_since_base_pct": 0.9054,
"session_return_pct": null,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.32,
"rsi": 60.7,
"vwap": 71.82,
"vwap_distance_pct": 0.8633,
"position_52w_pct": 79.55,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:00:33Z",
"source": "yfinance_quote",
"name": "Wyndham Hotels & Resorts, Inc.",
"episode_id": "narrative:WH:e6143a4ee8e53619",
"ema_trend": "69.87 > 70.21 > 72.36",
"vwap_state": "above",
"selection_as_of": "2026-09-29T17:19:31Z",
"facts": [
"The primary release reports a $400M increase to the share repurchase authorization.",
"The quote change was +1.47% on 0.32x average volume; the authorization does not establish that repurchases occurred."
],
"price_as_of": "2026-09-29T20:00:33Z",
"vwap_as_of": null
}
],
"benchmarks": [],
"coverage": {
"candidate_rows": 10,
"candidate_prices": 10,
"candidate_technical": 10,
"benchmark_rows": 0
}
}
},
{
"day": 13,
"timestamp": "2026-10-16T22:05:44.315306Z",
"comparison": {
"schema_version": "public-candidate-comparison.v1",
"captured_at": "2026-10-16T22:05:44.315306Z",
"base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
"source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
"rows": [
{
"symbol": "CCL",
"role": "selected",
"price": 25.77,
"base_price": 24.785,
"return_since_base_pct": 3.9742,
"session_return_pct": -2.12,
"change_since_prior_pct": -0.4827,
"volume_ratio": 1.05,
"rsi": 71.27,
"vwap": 26.37,
"vwap_distance_pct": -2.2753,
"position_52w_pct": 76.1,
"extended_hours_pct": -0.5,
"as_of": "2026-10-16T21:24:34Z",
"source": "sealed_extended_quote",
"name": "Carnival Corporation Ltd.",
"episode_id": "n0:CCL:2026-09-29",
"ema_trend": "25.99 > 25.25 > 25.18",
"vwap_state": "below",
"selection_as_of": "2026-09-29T15:18:03.945792Z",
"facts": [
"The supplied earnings coverage reports adjusted EPS of $1.43 versus $1.36 expected, revenue of $8.435B versus $8.300B expected, and a slight increase to full-year adjusted EPS guidance.",
"The N0 capture records +11.95% on 2.05x average volume. The provider series remained near the move through its final supplied observation.",
"The 20-session record shows CCL +4.48% versus its sector proxy -6.75%, a +11.23 percentage-point difference.",
"The active H3/H8/H15 positive-return estimates are 0.470/0.469/0.502; corresponding adverse-MAE medians are -4.49%/-7.15%/-9.26%. The separate audit-only H15 historical-dispersion output is P10 -19.62%, median -1.26%, P90 +7.16%. These comparisons use eight cases."
],
"price_as_of": "2026-10-16T21:24:34Z",
"vwap_as_of": null
},
{
"symbol": "SMMT",
"role": "alternative",
"price": 16.3387,
"base_price": 16.505,
"return_since_base_pct": -1.0076,
"session_return_pct": -0.313,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.35,
"rsi": 42.99,
"vwap": 17.03,
"vwap_distance_pct": -4.0593,
"position_52w_pct": 56.43,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:20:32Z",
"source": "yfinance_quote",
"name": "Summit Therapeutics Inc.",
"episode_id": "n0:SMMT:2026-09-29",
"ema_trend": "16.44 > 16.26 > 15.62",
"vwap_state": "below",
"selection_as_of": "2026-09-29T15:16:50.388704Z",
"facts": [
"The supplied event evidence describes a $2B AstraZeneca investment using newly issued convertible preferred shares and a clinical collaboration.",
"The N0 event capture was +6.62% on 3.35x average volume, but the provider series faded to about +5.33% and the intraday reading was below VWAP."
],
"price_as_of": "2026-09-29T21:20:32Z",
"vwap_as_of": null
},
{
"symbol": "HAFN",
"role": "alternative",
"price": 9.77,
"base_price": 9.56,
"return_since_base_pct": 2.1967,
"session_return_pct": 1.0341,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.24,
"rsi": 57.04,
"vwap": 9.53,
"vwap_distance_pct": 2.5184,
"position_52w_pct": 94.57,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:05:26Z",
"source": "yfinance_quote",
"name": "Hafnia Limited",
"episode_id": "n0:HAFN:2026-09-29",
"ema_trend": "9.27 > 9.0 > 8.33",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:18:47.711682Z",
"facts": [
"The N0 capture was +4.71% on 1.24x average volume; later provider observations retained a somewhat larger gain and price was above VWAP.",
"No company-specific catalyst was established in the supplied dossier."
],
"price_as_of": "2026-09-29T21:05:26Z",
"vwap_as_of": null
},
{
"symbol": "NTWK",
"role": "alternative",
"price": 5.56,
"base_price": 5.5496,
"return_since_base_pct": 0.1874,
"session_return_pct": 3.36,
"change_since_prior_pct": 0.0,
"volume_ratio": 14.19,
"rsi": 89.74,
"vwap": 5.5,
"vwap_distance_pct": 1.0909,
"position_52w_pct": 98.75,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:10:08Z",
"source": "yfinance_quote",
"name": "NetSol Technologies, Inc.",
"episode_id": "n0:NTWK:2026-09-29",
"ema_trend": "4.87 > 4.54 > 4.38",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:15:36.965867Z",
"facts": [
"The supplied FY26 results report revenue of $74.4M, up 12.5%, and FY27 revenue guidance of $84.1M-$86.3M.",
"The event capture was +3.36% on 14.19x average volume, but the dossier estimates about $2M of dollar turnover and places price 3.06 ATR above its EMA reference."
],
"price_as_of": "2026-09-29T20:10:08Z",
"vwap_as_of": null
},
{
"symbol": "ACET",
"role": "alternative",
"price": 6.77,
"base_price": 6.78,
"return_since_base_pct": -0.1475,
"session_return_pct": -0.8785,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.05,
"rsi": 31.39,
"vwap": 6.69,
"vwap_distance_pct": 1.1958,
"position_52w_pct": 38.99,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:55:28Z",
"source": "yfinance_quote",
"name": "Adicet Bio, Inc.",
"episode_id": "n0:ACET:2026-09-29",
"ema_trend": "8.07 > 8.58 > 8.73",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:17:12.774775Z",
"facts": [
"The supplied Phase 1 lupus readout reports 54% DORIS remission and 50% complete renal response among 22 efficacy-evaluable patients after 12 months.",
"The N0 capture was +6.71% on about 3.05x average volume, while the 20-session asset return was -21.15% versus -0.40% for its healthcare proxy."
],
"price_as_of": "2026-09-29T20:55:28Z",
"vwap_as_of": null
},
{
"symbol": "PWP",
"role": "alternative",
"price": 17.1,
"base_price": 16.85,
"return_since_base_pct": 1.4837,
"session_return_pct": 4.4594,
"change_since_prior_pct": 0.0,
"volume_ratio": 5.79,
"rsi": 55.35,
"vwap": 16.26,
"vwap_distance_pct": 5.1661,
"position_52w_pct": 65.01,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:13:05Z",
"source": "yfinance_quote",
"name": "Perella Weinberg Partners",
"episode_id": "n0:PWP:2026-09-29",
"ema_trend": "14.6 > 14.8 > 15.42",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:15:55.598703Z",
"facts": [
"The catalyst is a report of acquisition talks, not a confirmed agreement.",
"The event capture was +15.1% on 5.79x average volume; the provider series retreated from its high but retained much of the move."
],
"price_as_of": "2026-09-29T21:13:05Z",
"vwap_as_of": null
},
{
"symbol": "KMX",
"role": "alternative",
"price": 59.35,
"base_price": 60.72,
"return_since_base_pct": -2.2563,
"session_return_pct": 0.2026,
"change_since_prior_pct": 0.0,
"volume_ratio": 2.26,
"rsi": 52.08,
"vwap": 61.4,
"vwap_distance_pct": -3.3388,
"position_52w_pct": 93.32,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:59:02Z",
"source": "yfinance_quote",
"name": "CarMax, Inc.",
"episode_id": "n0:KMX:2026-09-29",
"ema_trend": "58.29 > 58.97 > 58.5",
"vwap_state": "below",
"selection_as_of": "2026-09-29T15:17:34.477760Z",
"facts": [
"The supplied earnings report shows EPS of $1.16 versus $0.73 expected and sales of $7.878B versus $6.976B expected.",
"The provider trajectory faded from about +5.72% to +3.24%; the intraday reading was below VWAP with a downward trend.",
"The active H3/H8/H15 positive-return estimates are 0.547/0.567/0.528, higher than CCL's at each horizon. Its corresponding adverse-MAE medians are -3.25%/-4.20%/-6.09%. The separate audit-only H15 historical-dispersion output is P10 -5.31%, median +4.18%, P90 +16.31%. These comparisons use eight cases."
],
"price_as_of": "2026-09-29T20:59:02Z",
"vwap_as_of": null
},
{
"symbol": "WYY",
"role": "alternative",
"price": 7.28,
"base_price": 6.4203,
"return_since_base_pct": 13.3903,
"session_return_pct": -0.9524,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.39,
"rsi": 29.28,
"vwap": 6.2,
"vwap_distance_pct": 17.4194,
"position_52w_pct": 26.56,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:10:33Z",
"source": "yfinance_quote",
"name": "WidePoint Corporation",
"episode_id": "n0:WYY:2026-09-29",
"ema_trend": "8.81 > 9.89 > 10.68",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:18:38.363232Z",
"facts": [
"The provider trajectory rose from about +7.97% to +16.45%, and the intraday reading was above VWAP.",
"The 20-session asset return was -32.32% versus +4.15% for the technology proxy; no company-specific catalyst for the day's move was established."
],
"price_as_of": "2026-09-29T21:10:33Z",
"vwap_as_of": null
},
{
"symbol": "VIAV",
"role": "alternative",
"price": 41.99,
"base_price": 41.455,
"return_since_base_pct": 1.2906,
"session_return_pct": 0.4065,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.53,
"rsi": 57.12,
"vwap": 41.77,
"vwap_distance_pct": 0.5267,
"position_52w_pct": 68.56,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:16:33Z",
"source": "yfinance_quote",
"name": "Viavi Solutions Inc.",
"episode_id": "narrative:VIAV:b612043b612913e0",
"ema_trend": "38.56 > 37.68 > 38.08",
"vwap_state": "below",
"selection_as_of": "2026-09-29T17:19:34Z",
"facts": [
"The primary product announcement introduces a 100G testing platform but supplies no customer wins or expected revenue contribution.",
"The quote change was +1.37% on 0.53x average volume; price was below VWAP with a downward intraday trend."
],
"price_as_of": "2026-09-29T21:16:33Z",
"vwap_as_of": null
},
{
"symbol": "WH",
"role": "alternative",
"price": 72.44,
"base_price": 71.79,
"return_since_base_pct": 0.9054,
"session_return_pct": null,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.32,
"rsi": 60.7,
"vwap": 71.82,
"vwap_distance_pct": 0.8633,
"position_52w_pct": 79.55,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:00:33Z",
"source": "yfinance_quote",
"name": "Wyndham Hotels & Resorts, Inc.",
"episode_id": "narrative:WH:e6143a4ee8e53619",
"ema_trend": "69.87 > 70.21 > 72.36",
"vwap_state": "above",
"selection_as_of": "2026-09-29T17:19:31Z",
"facts": [
"The primary release reports a $400M increase to the share repurchase authorization.",
"The quote change was +1.47% on 0.32x average volume; the authorization does not establish that repurchases occurred."
],
"price_as_of": "2026-09-29T20:00:33Z",
"vwap_as_of": null
}
],
"benchmarks": [],
"coverage": {
"candidate_rows": 10,
"candidate_prices": 10,
"candidate_technical": 10,
"benchmark_rows": 0
}
}
},
{
"day": 14,
"timestamp": "2026-10-19T19:27:05.670525Z",
"comparison": {
"schema_version": "public-candidate-comparison.v1",
"captured_at": "2026-10-19T19:27:05.670525Z",
"base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
"source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
"rows": [
{
"symbol": "CCL",
"role": "selected",
"price": 26.425,
"base_price": 24.785,
"return_since_base_pct": 6.6169,
"session_return_pct": 2.03,
"change_since_prior_pct": 2.5417,
"volume_ratio": 0.53,
"rsi": 60.28,
"vwap": 26.24,
"vwap_distance_pct": 0.705,
"position_52w_pct": 77.7,
"extended_hours_pct": null,
"as_of": "2026-10-19T19:21:30.182691Z",
"source": "yfinance_quote",
"name": "Carnival Corporation Ltd.",
"episode_id": "n0:CCL:2026-09-29",
"ema_trend": "26.08 > 25.36 > 25.22",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:18:03.945792Z",
"facts": [
"The supplied earnings coverage reports adjusted EPS of $1.43 versus $1.36 expected, revenue of $8.435B versus $8.300B expected, and a slight increase to full-year adjusted EPS guidance.",
"The N0 capture records +11.95% on 2.05x average volume. The provider series remained near the move through its final supplied observation.",
"The 20-session record shows CCL +4.48% versus its sector proxy -6.75%, a +11.23 percentage-point difference.",
"The active H3/H8/H15 positive-return estimates are 0.470/0.469/0.502; corresponding adverse-MAE medians are -4.49%/-7.15%/-9.26%. The separate audit-only H15 historical-dispersion output is P10 -19.62%, median -1.26%, P90 +7.16%. These comparisons use eight cases."
],
"price_as_of": "2026-10-19T19:21:30.182691Z",
"vwap_as_of": null
},
{
"symbol": "SMMT",
"role": "alternative",
"price": 16.3387,
"base_price": 16.505,
"return_since_base_pct": -1.0076,
"session_return_pct": -0.313,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.35,
"rsi": 42.99,
"vwap": 17.03,
"vwap_distance_pct": -4.0593,
"position_52w_pct": 56.43,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:20:32Z",
"source": "yfinance_quote",
"name": "Summit Therapeutics Inc.",
"episode_id": "n0:SMMT:2026-09-29",
"ema_trend": "16.44 > 16.26 > 15.62",
"vwap_state": "below",
"selection_as_of": "2026-09-29T15:16:50.388704Z",
"facts": [
"The supplied event evidence describes a $2B AstraZeneca investment using newly issued convertible preferred shares and a clinical collaboration.",
"The N0 event capture was +6.62% on 3.35x average volume, but the provider series faded to about +5.33% and the intraday reading was below VWAP."
],
"price_as_of": "2026-09-29T21:20:32Z",
"vwap_as_of": null
},
{
"symbol": "HAFN",
"role": "alternative",
"price": 9.77,
"base_price": 9.56,
"return_since_base_pct": 2.1967,
"session_return_pct": 1.0341,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.24,
"rsi": 57.04,
"vwap": 9.53,
"vwap_distance_pct": 2.5184,
"position_52w_pct": 94.57,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:05:26Z",
"source": "yfinance_quote",
"name": "Hafnia Limited",
"episode_id": "n0:HAFN:2026-09-29",
"ema_trend": "9.27 > 9.0 > 8.33",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:18:47.711682Z",
"facts": [
"The N0 capture was +4.71% on 1.24x average volume; later provider observations retained a somewhat larger gain and price was above VWAP.",
"No company-specific catalyst was established in the supplied dossier."
],
"price_as_of": "2026-09-29T21:05:26Z",
"vwap_as_of": null
},
{
"symbol": "NTWK",
"role": "alternative",
"price": 5.56,
"base_price": 5.5496,
"return_since_base_pct": 0.1874,
"session_return_pct": 3.36,
"change_since_prior_pct": 0.0,
"volume_ratio": 14.19,
"rsi": 89.74,
"vwap": 5.5,
"vwap_distance_pct": 1.0909,
"position_52w_pct": 98.75,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:10:08Z",
"source": "yfinance_quote",
"name": "NetSol Technologies, Inc.",
"episode_id": "n0:NTWK:2026-09-29",
"ema_trend": "4.87 > 4.54 > 4.38",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:15:36.965867Z",
"facts": [
"The supplied FY26 results report revenue of $74.4M, up 12.5%, and FY27 revenue guidance of $84.1M-$86.3M.",
"The event capture was +3.36% on 14.19x average volume, but the dossier estimates about $2M of dollar turnover and places price 3.06 ATR above its EMA reference."
],
"price_as_of": "2026-09-29T20:10:08Z",
"vwap_as_of": null
},
{
"symbol": "ACET",
"role": "alternative",
"price": 6.77,
"base_price": 6.78,
"return_since_base_pct": -0.1475,
"session_return_pct": -0.8785,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.05,
"rsi": 31.39,
"vwap": 6.69,
"vwap_distance_pct": 1.1958,
"position_52w_pct": 38.99,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:55:28Z",
"source": "yfinance_quote",
"name": "Adicet Bio, Inc.",
"episode_id": "n0:ACET:2026-09-29",
"ema_trend": "8.07 > 8.58 > 8.73",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:17:12.774775Z",
"facts": [
"The supplied Phase 1 lupus readout reports 54% DORIS remission and 50% complete renal response among 22 efficacy-evaluable patients after 12 months.",
"The N0 capture was +6.71% on about 3.05x average volume, while the 20-session asset return was -21.15% versus -0.40% for its healthcare proxy."
],
"price_as_of": "2026-09-29T20:55:28Z",
"vwap_as_of": null
},
{
"symbol": "PWP",
"role": "alternative",
"price": 17.1,
"base_price": 16.85,
"return_since_base_pct": 1.4837,
"session_return_pct": 4.4594,
"change_since_prior_pct": 0.0,
"volume_ratio": 5.79,
"rsi": 55.35,
"vwap": 16.26,
"vwap_distance_pct": 5.1661,
"position_52w_pct": 65.01,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:13:05Z",
"source": "yfinance_quote",
"name": "Perella Weinberg Partners",
"episode_id": "n0:PWP:2026-09-29",
"ema_trend": "14.6 > 14.8 > 15.42",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:15:55.598703Z",
"facts": [
"The catalyst is a report of acquisition talks, not a confirmed agreement.",
"The event capture was +15.1% on 5.79x average volume; the provider series retreated from its high but retained much of the move."
],
"price_as_of": "2026-09-29T21:13:05Z",
"vwap_as_of": null
},
{
"symbol": "KMX",
"role": "alternative",
"price": 59.35,
"base_price": 60.72,
"return_since_base_pct": -2.2563,
"session_return_pct": 0.2026,
"change_since_prior_pct": 0.0,
"volume_ratio": 2.26,
"rsi": 52.08,
"vwap": 61.4,
"vwap_distance_pct": -3.3388,
"position_52w_pct": 93.32,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:59:02Z",
"source": "yfinance_quote",
"name": "CarMax, Inc.",
"episode_id": "n0:KMX:2026-09-29",
"ema_trend": "58.29 > 58.97 > 58.5",
"vwap_state": "below",
"selection_as_of": "2026-09-29T15:17:34.477760Z",
"facts": [
"The supplied earnings report shows EPS of $1.16 versus $0.73 expected and sales of $7.878B versus $6.976B expected.",
"The provider trajectory faded from about +5.72% to +3.24%; the intraday reading was below VWAP with a downward trend.",
"The active H3/H8/H15 positive-return estimates are 0.547/0.567/0.528, higher than CCL's at each horizon. Its corresponding adverse-MAE medians are -3.25%/-4.20%/-6.09%. The separate audit-only H15 historical-dispersion output is P10 -5.31%, median +4.18%, P90 +16.31%. These comparisons use eight cases."
],
"price_as_of": "2026-09-29T20:59:02Z",
"vwap_as_of": null
},
{
"symbol": "WYY",
"role": "alternative",
"price": 7.28,
"base_price": 6.4203,
"return_since_base_pct": 13.3903,
"session_return_pct": -0.9524,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.39,
"rsi": 29.28,
"vwap": 6.2,
"vwap_distance_pct": 17.4194,
"position_52w_pct": 26.56,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:10:33Z",
"source": "yfinance_quote",
"name": "WidePoint Corporation",
"episode_id": "n0:WYY:2026-09-29",
"ema_trend": "8.81 > 9.89 > 10.68",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:18:38.363232Z",
"facts": [
"The provider trajectory rose from about +7.97% to +16.45%, and the intraday reading was above VWAP.",
"The 20-session asset return was -32.32% versus +4.15% for the technology proxy; no company-specific catalyst for the day's move was established."
],
"price_as_of": "2026-09-29T21:10:33Z",
"vwap_as_of": null
},
{
"symbol": "VIAV",
"role": "alternative",
"price": 41.99,
"base_price": 41.455,
"return_since_base_pct": 1.2906,
"session_return_pct": 0.4065,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.53,
"rsi": 57.12,
"vwap": 41.77,
"vwap_distance_pct": 0.5267,
"position_52w_pct": 68.56,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:16:33Z",
"source": "yfinance_quote",
"name": "Viavi Solutions Inc.",
"episode_id": "narrative:VIAV:b612043b612913e0",
"ema_trend": "38.56 > 37.68 > 38.08",
"vwap_state": "below",
"selection_as_of": "2026-09-29T17:19:34Z",
"facts": [
"The primary product announcement introduces a 100G testing platform but supplies no customer wins or expected revenue contribution.",
"The quote change was +1.37% on 0.53x average volume; price was below VWAP with a downward intraday trend."
],
"price_as_of": "2026-09-29T21:16:33Z",
"vwap_as_of": null
},
{
"symbol": "WH",
"role": "alternative",
"price": 72.44,
"base_price": 71.79,
"return_since_base_pct": 0.9054,
"session_return_pct": null,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.32,
"rsi": 60.7,
"vwap": 71.82,
"vwap_distance_pct": 0.8633,
"position_52w_pct": 79.55,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:00:33Z",
"source": "yfinance_quote",
"name": "Wyndham Hotels & Resorts, Inc.",
"episode_id": "narrative:WH:e6143a4ee8e53619",
"ema_trend": "69.87 > 70.21 > 72.36",
"vwap_state": "above",
"selection_as_of": "2026-09-29T17:19:31Z",
"facts": [
"The primary release reports a $400M increase to the share repurchase authorization.",
"The quote change was +1.47% on 0.32x average volume; the authorization does not establish that repurchases occurred."
],
"price_as_of": "2026-09-29T20:00:33Z",
"vwap_as_of": null
}
],
"benchmarks": [],
"coverage": {
"candidate_rows": 10,
"candidate_prices": 10,
"candidate_technical": 10,
"benchmark_rows": 0
}
}
},
{
"day": 14,
"timestamp": "2026-10-19T22:18:05.050881Z",
"comparison": {
"schema_version": "public-candidate-comparison.v1",
"captured_at": "2026-10-19T22:18:05.050881Z",
"base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
"source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
"rows": [
{
"symbol": "CCL",
"role": "selected",
"price": 26.45,
"base_price": 24.785,
"return_since_base_pct": 6.7178,
"session_return_pct": 2.12,
"change_since_prior_pct": 0.0946,
"volume_ratio": 0.85,
"rsi": 60.44,
"vwap": 26.24,
"vwap_distance_pct": 0.8003,
"position_52w_pct": 77.7,
"extended_hours_pct": 0.0,
"as_of": "2026-10-19T21:28:10Z",
"source": "sealed_extended_quote",
"name": "Carnival Corporation Ltd.",
"episode_id": "n0:CCL:2026-09-29",
"ema_trend": "26.08 > 25.36 > 25.23",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:18:03.945792Z",
"facts": [
"The supplied earnings coverage reports adjusted EPS of $1.43 versus $1.36 expected, revenue of $8.435B versus $8.300B expected, and a slight increase to full-year adjusted EPS guidance.",
"The N0 capture records +11.95% on 2.05x average volume. The provider series remained near the move through its final supplied observation.",
"The 20-session record shows CCL +4.48% versus its sector proxy -6.75%, a +11.23 percentage-point difference.",
"The active H3/H8/H15 positive-return estimates are 0.470/0.469/0.502; corresponding adverse-MAE medians are -4.49%/-7.15%/-9.26%. The separate audit-only H15 historical-dispersion output is P10 -19.62%, median -1.26%, P90 +7.16%. These comparisons use eight cases."
],
"price_as_of": "2026-10-19T21:28:10Z",
"vwap_as_of": null
},
{
"symbol": "SMMT",
"role": "alternative",
"price": 16.3387,
"base_price": 16.505,
"return_since_base_pct": -1.0076,
"session_return_pct": -0.313,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.35,
"rsi": 42.99,
"vwap": 17.03,
"vwap_distance_pct": -4.0593,
"position_52w_pct": 56.43,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:20:32Z",
"source": "yfinance_quote",
"name": "Summit Therapeutics Inc.",
"episode_id": "n0:SMMT:2026-09-29",
"ema_trend": "16.44 > 16.26 > 15.62",
"vwap_state": "below",
"selection_as_of": "2026-09-29T15:16:50.388704Z",
"facts": [
"The supplied event evidence describes a $2B AstraZeneca investment using newly issued convertible preferred shares and a clinical collaboration.",
"The N0 event capture was +6.62% on 3.35x average volume, but the provider series faded to about +5.33% and the intraday reading was below VWAP."
],
"price_as_of": "2026-09-29T21:20:32Z",
"vwap_as_of": null
},
{
"symbol": "HAFN",
"role": "alternative",
"price": 9.77,
"base_price": 9.56,
"return_since_base_pct": 2.1967,
"session_return_pct": 1.0341,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.24,
"rsi": 57.04,
"vwap": 9.53,
"vwap_distance_pct": 2.5184,
"position_52w_pct": 94.57,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:05:26Z",
"source": "yfinance_quote",
"name": "Hafnia Limited",
"episode_id": "n0:HAFN:2026-09-29",
"ema_trend": "9.27 > 9.0 > 8.33",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:18:47.711682Z",
"facts": [
"The N0 capture was +4.71% on 1.24x average volume; later provider observations retained a somewhat larger gain and price was above VWAP.",
"No company-specific catalyst was established in the supplied dossier."
],
"price_as_of": "2026-09-29T21:05:26Z",
"vwap_as_of": null
},
{
"symbol": "NTWK",
"role": "alternative",
"price": 5.56,
"base_price": 5.5496,
"return_since_base_pct": 0.1874,
"session_return_pct": 3.36,
"change_since_prior_pct": 0.0,
"volume_ratio": 14.19,
"rsi": 89.74,
"vwap": 5.5,
"vwap_distance_pct": 1.0909,
"position_52w_pct": 98.75,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:10:08Z",
"source": "yfinance_quote",
"name": "NetSol Technologies, Inc.",
"episode_id": "n0:NTWK:2026-09-29",
"ema_trend": "4.87 > 4.54 > 4.38",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:15:36.965867Z",
"facts": [
"The supplied FY26 results report revenue of $74.4M, up 12.5%, and FY27 revenue guidance of $84.1M-$86.3M.",
"The event capture was +3.36% on 14.19x average volume, but the dossier estimates about $2M of dollar turnover and places price 3.06 ATR above its EMA reference."
],
"price_as_of": "2026-09-29T20:10:08Z",
"vwap_as_of": null
},
{
"symbol": "ACET",
"role": "alternative",
"price": 6.77,
"base_price": 6.78,
"return_since_base_pct": -0.1475,
"session_return_pct": -0.8785,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.05,
"rsi": 31.39,
"vwap": 6.69,
"vwap_distance_pct": 1.1958,
"position_52w_pct": 38.99,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:55:28Z",
"source": "yfinance_quote",
"name": "Adicet Bio, Inc.",
"episode_id": "n0:ACET:2026-09-29",
"ema_trend": "8.07 > 8.58 > 8.73",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:17:12.774775Z",
"facts": [
"The supplied Phase 1 lupus readout reports 54% DORIS remission and 50% complete renal response among 22 efficacy-evaluable patients after 12 months.",
"The N0 capture was +6.71% on about 3.05x average volume, while the 20-session asset return was -21.15% versus -0.40% for its healthcare proxy."
],
"price_as_of": "2026-09-29T20:55:28Z",
"vwap_as_of": null
},
{
"symbol": "PWP",
"role": "alternative",
"price": 17.1,
"base_price": 16.85,
"return_since_base_pct": 1.4837,
"session_return_pct": 4.4594,
"change_since_prior_pct": 0.0,
"volume_ratio": 5.79,
"rsi": 55.35,
"vwap": 16.26,
"vwap_distance_pct": 5.1661,
"position_52w_pct": 65.01,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:13:05Z",
"source": "yfinance_quote",
"name": "Perella Weinberg Partners",
"episode_id": "n0:PWP:2026-09-29",
"ema_trend": "14.6 > 14.8 > 15.42",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:15:55.598703Z",
"facts": [
"The catalyst is a report of acquisition talks, not a confirmed agreement.",
"The event capture was +15.1% on 5.79x average volume; the provider series retreated from its high but retained much of the move."
],
"price_as_of": "2026-09-29T21:13:05Z",
"vwap_as_of": null
},
{
"symbol": "KMX",
"role": "alternative",
"price": 59.35,
"base_price": 60.72,
"return_since_base_pct": -2.2563,
"session_return_pct": 0.2026,
"change_since_prior_pct": 0.0,
"volume_ratio": 2.26,
"rsi": 52.08,
"vwap": 61.4,
"vwap_distance_pct": -3.3388,
"position_52w_pct": 93.32,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:59:02Z",
"source": "yfinance_quote",
"name": "CarMax, Inc.",
"episode_id": "n0:KMX:2026-09-29",
"ema_trend": "58.29 > 58.97 > 58.5",
"vwap_state": "below",
"selection_as_of": "2026-09-29T15:17:34.477760Z",
"facts": [
"The supplied earnings report shows EPS of $1.16 versus $0.73 expected and sales of $7.878B versus $6.976B expected.",
"The provider trajectory faded from about +5.72% to +3.24%; the intraday reading was below VWAP with a downward trend.",
"The active H3/H8/H15 positive-return estimates are 0.547/0.567/0.528, higher than CCL's at each horizon. Its corresponding adverse-MAE medians are -3.25%/-4.20%/-6.09%. The separate audit-only H15 historical-dispersion output is P10 -5.31%, median +4.18%, P90 +16.31%. These comparisons use eight cases."
],
"price_as_of": "2026-09-29T20:59:02Z",
"vwap_as_of": null
},
{
"symbol": "WYY",
"role": "alternative",
"price": 7.28,
"base_price": 6.4203,
"return_since_base_pct": 13.3903,
"session_return_pct": -0.9524,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.39,
"rsi": 29.28,
"vwap": 6.2,
"vwap_distance_pct": 17.4194,
"position_52w_pct": 26.56,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:10:33Z",
"source": "yfinance_quote",
"name": "WidePoint Corporation",
"episode_id": "n0:WYY:2026-09-29",
"ema_trend": "8.81 > 9.89 > 10.68",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:18:38.363232Z",
"facts": [
"The provider trajectory rose from about +7.97% to +16.45%, and the intraday reading was above VWAP.",
"The 20-session asset return was -32.32% versus +4.15% for the technology proxy; no company-specific catalyst for the day's move was established."
],
"price_as_of": "2026-09-29T21:10:33Z",
"vwap_as_of": null
},
{
"symbol": "VIAV",
"role": "alternative",
"price": 41.99,
"base_price": 41.455,
"return_since_base_pct": 1.2906,
"session_return_pct": 0.4065,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.53,
"rsi": 57.12,
"vwap": 41.77,
"vwap_distance_pct": 0.5267,
"position_52w_pct": 68.56,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:16:33Z",
"source": "yfinance_quote",
"name": "Viavi Solutions Inc.",
"episode_id": "narrative:VIAV:b612043b612913e0",
"ema_trend": "38.56 > 37.68 > 38.08",
"vwap_state": "below",
"selection_as_of": "2026-09-29T17:19:34Z",
"facts": [
"The primary product announcement introduces a 100G testing platform but supplies no customer wins or expected revenue contribution.",
"The quote change was +1.37% on 0.53x average volume; price was below VWAP with a downward intraday trend."
],
"price_as_of": "2026-09-29T21:16:33Z",
"vwap_as_of": null
},
{
"symbol": "WH",
"role": "alternative",
"price": 72.44,
"base_price": 71.79,
"return_since_base_pct": 0.9054,
"session_return_pct": null,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.32,
"rsi": 60.7,
"vwap": 71.82,
"vwap_distance_pct": 0.8633,
"position_52w_pct": 79.55,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:00:33Z",
"source": "yfinance_quote",
"name": "Wyndham Hotels & Resorts, Inc.",
"episode_id": "narrative:WH:e6143a4ee8e53619",
"ema_trend": "69.87 > 70.21 > 72.36",
"vwap_state": "above",
"selection_as_of": "2026-09-29T17:19:31Z",
"facts": [
"The primary release reports a $400M increase to the share repurchase authorization.",
"The quote change was +1.47% on 0.32x average volume; the authorization does not establish that repurchases occurred."
],
"price_as_of": "2026-09-29T20:00:33Z",
"vwap_as_of": null
}
],
"benchmarks": [],
"coverage": {
"candidate_rows": 10,
"candidate_prices": 10,
"candidate_technical": 10,
"benchmark_rows": 0
}
}
},
{
"day": 15,
"timestamp": "2026-10-20T22:24:59.041871Z",
"comparison": {
"schema_version": "public-candidate-comparison.v1",
"captured_at": "2026-10-20T22:24:59.041871Z",
"base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
"source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
"rows": [
{
"symbol": "CCL",
"role": "selected",
"price": 25.05,
"base_price": 24.785,
"return_since_base_pct": 1.0692,
"session_return_pct": -0.239,
"change_since_prior_pct": -5.293,
"volume_ratio": 2.05,
"rsi": 67.02,
"vwap": 24.72,
"vwap_distance_pct": 1.335,
"position_52w_pct": 72.74,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:19:53Z",
"source": "yfinance_quote",
"name": "Carnival Corporation Ltd.",
"episode_id": "n0:CCL:2026-09-29",
"ema_trend": "22.72 > 23.14 > 24.44",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:18:03.945792Z",
"facts": [
"The supplied earnings coverage reports adjusted EPS of $1.43 versus $1.36 expected, revenue of $8.435B versus $8.300B expected, and a slight increase to full-year adjusted EPS guidance.",
"The N0 capture records +11.95% on 2.05x average volume. The provider series remained near the move through its final supplied observation.",
"The 20-session record shows CCL +4.48% versus its sector proxy -6.75%, a +11.23 percentage-point difference.",
"The active H3/H8/H15 positive-return estimates are 0.470/0.469/0.502; corresponding adverse-MAE medians are -4.49%/-7.15%/-9.26%. The separate audit-only H15 historical-dispersion output is P10 -19.62%, median -1.26%, P90 +7.16%. These comparisons use eight cases."
],
"price_as_of": "2026-09-29T21:19:53Z",
"vwap_as_of": null
},
{
"symbol": "SMMT",
"role": "alternative",
"price": 16.3387,
"base_price": 16.505,
"return_since_base_pct": -1.0076,
"session_return_pct": -0.313,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.35,
"rsi": 42.99,
"vwap": 17.03,
"vwap_distance_pct": -4.0593,
"position_52w_pct": 56.43,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:20:32Z",
"source": "yfinance_quote",
"name": "Summit Therapeutics Inc.",
"episode_id": "n0:SMMT:2026-09-29",
"ema_trend": "16.44 > 16.26 > 15.62",
"vwap_state": "below",
"selection_as_of": "2026-09-29T15:16:50.388704Z",
"facts": [
"The supplied event evidence describes a $2B AstraZeneca investment using newly issued convertible preferred shares and a clinical collaboration.",
"The N0 event capture was +6.62% on 3.35x average volume, but the provider series faded to about +5.33% and the intraday reading was below VWAP."
],
"price_as_of": "2026-09-29T21:20:32Z",
"vwap_as_of": null
},
{
"symbol": "HAFN",
"role": "alternative",
"price": 9.77,
"base_price": 9.56,
"return_since_base_pct": 2.1967,
"session_return_pct": 1.0341,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.24,
"rsi": 57.04,
"vwap": 9.53,
"vwap_distance_pct": 2.5184,
"position_52w_pct": 94.57,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:05:26Z",
"source": "yfinance_quote",
"name": "Hafnia Limited",
"episode_id": "n0:HAFN:2026-09-29",
"ema_trend": "9.27 > 9.0 > 8.33",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:18:47.711682Z",
"facts": [
"The N0 capture was +4.71% on 1.24x average volume; later provider observations retained a somewhat larger gain and price was above VWAP.",
"No company-specific catalyst was established in the supplied dossier."
],
"price_as_of": "2026-09-29T21:05:26Z",
"vwap_as_of": null
},
{
"symbol": "NTWK",
"role": "alternative",
"price": 5.56,
"base_price": 5.5496,
"return_since_base_pct": 0.1874,
"session_return_pct": 3.36,
"change_since_prior_pct": 0.0,
"volume_ratio": 14.19,
"rsi": 89.74,
"vwap": 5.5,
"vwap_distance_pct": 1.0909,
"position_52w_pct": 98.75,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:10:08Z",
"source": "yfinance_quote",
"name": "NetSol Technologies, Inc.",
"episode_id": "n0:NTWK:2026-09-29",
"ema_trend": "4.87 > 4.54 > 4.38",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:15:36.965867Z",
"facts": [
"The supplied FY26 results report revenue of $74.4M, up 12.5%, and FY27 revenue guidance of $84.1M-$86.3M.",
"The event capture was +3.36% on 14.19x average volume, but the dossier estimates about $2M of dollar turnover and places price 3.06 ATR above its EMA reference."
],
"price_as_of": "2026-09-29T20:10:08Z",
"vwap_as_of": null
},
{
"symbol": "ACET",
"role": "alternative",
"price": 6.77,
"base_price": 6.78,
"return_since_base_pct": -0.1475,
"session_return_pct": -0.8785,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.05,
"rsi": 31.39,
"vwap": 6.69,
"vwap_distance_pct": 1.1958,
"position_52w_pct": 38.99,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:55:28Z",
"source": "yfinance_quote",
"name": "Adicet Bio, Inc.",
"episode_id": "n0:ACET:2026-09-29",
"ema_trend": "8.07 > 8.58 > 8.73",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:17:12.774775Z",
"facts": [
"The supplied Phase 1 lupus readout reports 54% DORIS remission and 50% complete renal response among 22 efficacy-evaluable patients after 12 months.",
"The N0 capture was +6.71% on about 3.05x average volume, while the 20-session asset return was -21.15% versus -0.40% for its healthcare proxy."
],
"price_as_of": "2026-09-29T20:55:28Z",
"vwap_as_of": null
},
{
"symbol": "PWP",
"role": "alternative",
"price": 17.1,
"base_price": 16.85,
"return_since_base_pct": 1.4837,
"session_return_pct": 4.4594,
"change_since_prior_pct": 0.0,
"volume_ratio": 5.79,
"rsi": 55.35,
"vwap": 16.26,
"vwap_distance_pct": 5.1661,
"position_52w_pct": 65.01,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:13:05Z",
"source": "yfinance_quote",
"name": "Perella Weinberg Partners",
"episode_id": "n0:PWP:2026-09-29",
"ema_trend": "14.6 > 14.8 > 15.42",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:15:55.598703Z",
"facts": [
"The catalyst is a report of acquisition talks, not a confirmed agreement.",
"The event capture was +15.1% on 5.79x average volume; the provider series retreated from its high but retained much of the move."
],
"price_as_of": "2026-09-29T21:13:05Z",
"vwap_as_of": null
},
{
"symbol": "KMX",
"role": "alternative",
"price": 59.35,
"base_price": 60.72,
"return_since_base_pct": -2.2563,
"session_return_pct": 0.2026,
"change_since_prior_pct": 0.0,
"volume_ratio": 2.26,
"rsi": 52.08,
"vwap": 61.4,
"vwap_distance_pct": -3.3388,
"position_52w_pct": 93.32,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:59:02Z",
"source": "yfinance_quote",
"name": "CarMax, Inc.",
"episode_id": "n0:KMX:2026-09-29",
"ema_trend": "58.29 > 58.97 > 58.5",
"vwap_state": "below",
"selection_as_of": "2026-09-29T15:17:34.477760Z",
"facts": [
"The supplied earnings report shows EPS of $1.16 versus $0.73 expected and sales of $7.878B versus $6.976B expected.",
"The provider trajectory faded from about +5.72% to +3.24%; the intraday reading was below VWAP with a downward trend.",
"The active H3/H8/H15 positive-return estimates are 0.547/0.567/0.528, higher than CCL's at each horizon. Its corresponding adverse-MAE medians are -3.25%/-4.20%/-6.09%. The separate audit-only H15 historical-dispersion output is P10 -5.31%, median +4.18%, P90 +16.31%. These comparisons use eight cases."
],
"price_as_of": "2026-09-29T20:59:02Z",
"vwap_as_of": null
},
{
"symbol": "WYY",
"role": "alternative",
"price": 7.28,
"base_price": 6.4203,
"return_since_base_pct": 13.3903,
"session_return_pct": -0.9524,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.39,
"rsi": 29.28,
"vwap": 6.2,
"vwap_distance_pct": 17.4194,
"position_52w_pct": 26.56,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:10:33Z",
"source": "yfinance_quote",
"name": "WidePoint Corporation",
"episode_id": "n0:WYY:2026-09-29",
"ema_trend": "8.81 > 9.89 > 10.68",
"vwap_state": "above",
"selection_as_of": "2026-09-29T15:18:38.363232Z",
"facts": [
"The provider trajectory rose from about +7.97% to +16.45%, and the intraday reading was above VWAP.",
"The 20-session asset return was -32.32% versus +4.15% for the technology proxy; no company-specific catalyst for the day's move was established."
],
"price_as_of": "2026-09-29T21:10:33Z",
"vwap_as_of": null
},
{
"symbol": "VIAV",
"role": "alternative",
"price": 41.99,
"base_price": 41.455,
"return_since_base_pct": 1.2906,
"session_return_pct": 0.4065,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.53,
"rsi": 57.12,
"vwap": 41.77,
"vwap_distance_pct": 0.5267,
"position_52w_pct": 68.56,
"extended_hours_pct": null,
"as_of": "2026-09-29T21:16:33Z",
"source": "yfinance_quote",
"name": "Viavi Solutions Inc.",
"episode_id": "narrative:VIAV:b612043b612913e0",
"ema_trend": "38.56 > 37.68 > 38.08",
"vwap_state": "below",
"selection_as_of": "2026-09-29T17:19:34Z",
"facts": [
"The primary product announcement introduces a 100G testing platform but supplies no customer wins or expected revenue contribution.",
"The quote change was +1.37% on 0.53x average volume; price was below VWAP with a downward intraday trend."
],
"price_as_of": "2026-09-29T21:16:33Z",
"vwap_as_of": null
},
{
"symbol": "WH",
"role": "alternative",
"price": 72.44,
"base_price": 71.79,
"return_since_base_pct": 0.9054,
"session_return_pct": null,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.32,
"rsi": 60.7,
"vwap": 71.82,
"vwap_distance_pct": 0.8633,
"position_52w_pct": 79.55,
"extended_hours_pct": null,
"as_of": "2026-09-29T20:00:33Z",
"source": "yfinance_quote",
"name": "Wyndham Hotels & Resorts, Inc.",
"episode_id": "narrative:WH:e6143a4ee8e53619",
"ema_trend": "69.87 > 70.21 > 72.36",
"vwap_state": "above",
"selection_as_of": "2026-09-29T17:19:31Z",
"facts": [
"The primary release reports a $400M increase to the share repurchase authorization.",
"The quote change was +1.47% on 0.32x average volume; the authorization does not establish that repurchases occurred."
],
"price_as_of": "2026-09-29T20:00:33Z",
"vwap_as_of": null
}
],
"benchmarks": [],
"coverage": {
"candidate_rows": 10,
"candidate_prices": 10,
"candidate_technical": 10,
"benchmark_rows": 0
}
}
}
],
"candidates": [
{
"symbol": "SMMT",
"name": "Summit Therapeutics Inc.",
"exchange": "NasdaqGM",
"tradingview_url": "https://es.tradingview.com/chart/?symbol=NASDAQ%3ASMMT&interval=60",
"score": 7,
"price": 16.505,
"change": 6.62,
"volume": 17082701,
"avg_volume_3m": 5094663,
"volume_ratio": 3.35,
"rsi": 42.99,
"ema_trend": "16.44 > 16.26 > 15.62",
"position_52w_pct": 56.43,
"vwap": 17.03,
"vwap_distance_pct": null,
"vwap_state": "below",
"facts": [
"The supplied event evidence describes a $2B AstraZeneca investment using newly issued convertible preferred shares and a clinical collaboration.",
"The N0 event capture was +6.62% on 3.35x average volume, but the provider series faded to about +5.33% and the intraday reading was below VWAP."
],
"role": "alternative",
"selected": false,
"reason": "not_selected"
},
{
"symbol": "HAFN",
"name": "Hafnia Limited",
"exchange": "NYSE",
"tradingview_url": "https://es.tradingview.com/chart/?symbol=NYSE%3AHAFN&interval=60",
"score": 4,
"price": 9.56,
"change": 4.71,
"volume": 2198159,
"avg_volume_3m": 1779788,
"volume_ratio": 1.24,
"rsi": 57.04,
"ema_trend": "9.27 > 9.0 > 8.33",
"position_52w_pct": 94.57,
"vwap": 9.53,
"vwap_distance_pct": null,
"vwap_state": "above",
"facts": [
"The N0 capture was +4.71% on 1.24x average volume; later provider observations retained a somewhat larger gain and price was above VWAP.",
"No company-specific catalyst was established in the supplied dossier."
],
"role": "alternative",
"selected": false,
"reason": "not_selected"
},
{
"symbol": "NTWK",
"name": "NetSol Technologies, Inc.",
"exchange": "NasdaqCM",
"tradingview_url": "https://es.tradingview.com/chart/?symbol=NASDAQ%3ANTWK&interval=60",
"score": 6,
"price": 5.5496,
"change": 3.36,
"volume": 363678,
"avg_volume_3m": 25636,
"volume_ratio": 14.19,
"rsi": 89.74,
"ema_trend": "4.87 > 4.54 > 4.38",
"position_52w_pct": 98.75,
"vwap": 5.5,
"vwap_distance_pct": null,
"vwap_state": "above",
"facts": [
"The supplied FY26 results report revenue of $74.4M, up 12.5%, and FY27 revenue guidance of $84.1M-$86.3M.",
"The event capture was +3.36% on 14.19x average volume, but the dossier estimates about $2M of dollar turnover and places price 3.06 ATR above its EMA reference."
],
"role": "alternative",
"selected": false,
"reason": "not_selected"
},
{
"symbol": "ACET",
"name": "Adicet Bio, Inc.",
"exchange": "NasdaqCM",
"tradingview_url": "https://es.tradingview.com/chart/?symbol=NASDAQ%3AACET&interval=60",
"score": 5,
"price": 6.78,
"change": 6.71,
"volume": 463655,
"avg_volume_3m": 151863,
"volume_ratio": 3.05,
"rsi": 31.39,
"ema_trend": "8.07 > 8.58 > 8.73",
"position_52w_pct": 38.99,
"vwap": 6.69,
"vwap_distance_pct": null,
"vwap_state": "above",
"facts": [
"The supplied Phase 1 lupus readout reports 54% DORIS remission and 50% complete renal response among 22 efficacy-evaluable patients after 12 months.",
"The N0 capture was +6.71% on about 3.05x average volume, while the 20-session asset return was -21.15% versus -0.40% for its healthcare proxy."
],
"role": "alternative",
"selected": false,
"reason": "not_selected"
},
{
"symbol": "PWP",
"name": "Perella Weinberg Partners",
"exchange": "NASDAQ",
"tradingview_url": "https://es.tradingview.com/chart/?symbol=NASDAQ%3APWP&interval=60",
"score": 7,
"price": 16.85,
"change": 15.1,
"volume": 7031887,
"avg_volume_3m": 1214271,
"volume_ratio": 5.79,
"rsi": 55.35,
"ema_trend": "14.6 > 14.8 > 15.42",
"position_52w_pct": 65.01,
"vwap": 16.26,
"vwap_distance_pct": null,
"vwap_state": "above",
"facts": [
"The catalyst is a report of acquisition talks, not a confirmed agreement.",
"The event capture was +15.1% on 5.79x average volume; the provider series retreated from its high but retained much of the move."
],
"role": "alternative",
"selected": false,
"reason": "not_selected"
},
{
"symbol": "KMX",
"name": "CarMax, Inc.",
"exchange": "NYSE",
"tradingview_url": "https://es.tradingview.com/chart/?symbol=NYSE%3AKMX&interval=60",
"score": 5,
"price": 60.72,
"change": 7.37,
"volume": 5309230,
"avg_volume_3m": 2352287,
"volume_ratio": 2.26,
"rsi": 52.08,
"ema_trend": "58.29 > 58.97 > 58.5",
"position_52w_pct": 93.32,
"vwap": 61.4,
"vwap_distance_pct": null,
"vwap_state": "below",
"facts": [
"The supplied earnings report shows EPS of $1.16 versus $0.73 expected and sales of $7.878B versus $6.976B expected.",
"The provider trajectory faded from about +5.72% to +3.24%; the intraday reading was below VWAP with a downward trend.",
"The active H3/H8/H15 positive-return estimates are 0.547/0.567/0.528, higher than CCL's at each horizon. Its corresponding adverse-MAE medians are -3.25%/-4.20%/-6.09%. The separate audit-only H15 historical-dispersion output is P10 -5.31%, median +4.18%, P90 +16.31%. These comparisons use eight cases."
],
"role": "alternative",
"selected": false,
"reason": "not_selected"
},
{
"symbol": "WYY",
"name": "WidePoint Corporation",
"exchange": "NYSE American",
"tradingview_url": "https://es.tradingview.com/chart/?symbol=NYSE%20AMERICAN%3AWYY&interval=60",
"score": 3,
"price": 6.4203,
"change": 8.82,
"volume": 313772,
"avg_volume_3m": 225363,
"volume_ratio": 1.39,
"rsi": 29.28,
"ema_trend": "8.81 > 9.89 > 10.68",
"position_52w_pct": 26.56,
"vwap": 6.2,
"vwap_distance_pct": null,
"vwap_state": "above",
"facts": [
"The provider trajectory rose from about +7.97% to +16.45%, and the intraday reading was above VWAP.",
"The 20-session asset return was -32.32% versus +4.15% for the technology proxy; no company-specific catalyst for the day's move was established."
],
"role": "alternative",
"selected": false,
"reason": "not_selected"
},
{
"symbol": "VIAV",
"name": "Viavi Solutions Inc.",
"exchange": "NASDAQ",
"tradingview_url": "https://es.tradingview.com/chart/?symbol=NASDAQ%3AVIAV&interval=60",
"score": null,
"price": 41.455,
"change": null,
"volume": 2623018.0,
"avg_volume_3m": 4980479.0,
"volume_ratio": 0.53,
"rsi": 57.12,
"ema_trend": "38.56 > 37.68 > 38.08",
"position_52w_pct": 68.56,
"vwap": 41.77,
"vwap_distance_pct": null,
"vwap_state": "below",
"facts": [
"The primary product announcement introduces a 100G testing platform but supplies no customer wins or expected revenue contribution.",
"The quote change was +1.37% on 0.53x average volume; price was below VWAP with a downward intraday trend."
],
"role": "alternative",
"selected": false,
"reason": "not_selected"
},
{
"symbol": "WH",
"name": "Wyndham Hotels & Resorts, Inc.",
"exchange": "NYSE",
"tradingview_url": "https://es.tradingview.com/chart/?symbol=NYSE%3AWH&interval=60",
"score": null,
"price": 71.79,
"change": null,
"volume": 398260.0,
"avg_volume_3m": 1288095.0,
"volume_ratio": 0.32,
"rsi": 60.7,
"ema_trend": "69.87 > 70.21 > 72.36",
"position_52w_pct": 79.55,
"vwap": 71.82,
"vwap_distance_pct": null,
"vwap_state": "above",
"facts": [
"The primary release reports a $400M increase to the share repurchase authorization.",
"The quote change was +1.47% on 0.32x average volume; the authorization does not establish that repurchases occurred."
],
"role": "alternative",
"selected": false,
"reason": "not_selected"
}
],
"news": [
{
"title": "SEC 8-K filing",
"url": "https://www.sec.gov/Archives/edgar/data/815097/000081509726000104/ccl-20260929.htm"
}
],
"transcript_url": null,
"initial_transcript_anchor": "transcript-entry-ace0983fbada532342b71249583310eec9e45dd467bb45ada78d695460ecd847",
"chart_url": null,
"secondary_chart_url": null,
"forecast_chart_url": null,
"methodology_url": "https://trydingday.com/methodology/",
"track_record_url": "https://trydingday.com/track-record/",
"market_timezone": "America/New_York"
}
}